
<html lang="en"     class="pb-page"  data-request-id="d1ea73b4-bfaa-481c-86aa-c3af2261db6d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2015.58.issue-14;article:article:10.1021/acs.jmedchem.5b00599"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases" /></meta><meta name="dc.Creator" content="Roberta  Farina" /></meta><meta name="dc.Creator" content="Leonardo  Pisani" /></meta><meta name="dc.Creator" content="Marco  Catto" /></meta><meta name="dc.Creator" content="Orazio  Nicolotti" /></meta><meta name="dc.Creator" content="Domenico  Gadaleta" /></meta><meta name="dc.Creator" content="Nunzio  Denora" /></meta><meta name="dc.Creator" content="Ramon  Soto-Otero" /></meta><meta name="dc.Creator" content="Estefania  Mendez-Alvarez" /></meta><meta name="dc.Creator" content="Carolina S.  Passos" /></meta><meta name="dc.Creator" content="Giovanni  Muncipinto" /></meta><meta name="dc.Creator" content="Cosimo D.  Altomare" /></meta><meta name="dc.Creator" content="Alessandra  Nurisso" /></meta><meta name="dc.Creator" content="Pierre-Alain  Carrupt" /></meta><meta name="dc.Creator" content="Angelo  Carotti" /></meta><meta name="dc.Description" content="The multifactorial nature of Alzheimer’s disease calls for the development of multitarget agents addressing key pathogenic processes. To this end, by following a docking-assisted hybridization stra..." /></meta><meta name="Description" content="The multifactorial nature of Alzheimer’s disease calls for the development of multitarget agents addressing key pathogenic processes. To this end, by following a docking-assisted hybridization stra..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 9, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00599" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00599" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00599" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00599" /></link>
        
    
    

<title>Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00599" /></meta><meta property="og:title" content="Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0019.jpeg" /></meta><meta property="og:description" content="The multifactorial nature of Alzheimer’s disease calls for the development of multitarget agents addressing key pathogenic processes. To this end, by following a docking-assisted hybridization strategy, a number of aminocoumarins were designed, prepared, and tested as monoamine oxidases (MAOs) and acetyl- and butyryl-cholinesterase (AChE and BChE) inhibitors. Highly flexible N-benzyl-N-alkyloxy coumarins 2–12 showed good inhibitory activities at MAO-B, AChE, and BChE but low selectivity. More rigid inhibitors, bearing meta- and para-xylyl linkers, displayed good inhibitory activities and high MAO-B selectivity. Compounds 21, 24, 37, and 39, the last two featuring an improved hydrophilic/lipophilic balance, exhibited excellent activity profiles with nanomolar inhibitory potency toward hMAO-B, high hMAO-B over hMAO-A selectivity and submicromolar potency at hAChE. Cell-based assays of BBB permeation, neurotoxicity, and neuroprotection supported the potential of compound 37 as a BBB-permeant neuroprotective agent against H2O2-induced oxidative stress with poor interaction as P-gp substrate and very low cytotoxicity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00599"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00599">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00599&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00599&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00599&amp;href=/doi/10.1021/acs.jmedchem.5b00599" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 5561-5578</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00573" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00606" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Based Design and Optimization of Multitarget-Directed 2<i>H</i>-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberta++Farina">Roberta Farina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leonardo++Pisani">Leonardo Pisani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Catto">Marco Catto</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Orazio++Nicolotti">Orazio Nicolotti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Domenico++Gadaleta">Domenico Gadaleta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nunzio++Denora">Nunzio Denora</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramon++Soto-Otero">Ramon Soto-Otero</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Estefania++Mendez-Alvarez">Estefania Mendez-Alvarez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carolina+S.++Passos">Carolina S. Passos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giovanni++Muncipinto">Giovanni Muncipinto</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cosimo+D.++Altomare">Cosimo D. Altomare</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessandra++Nurisso">Alessandra Nurisso</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pierre-Alain++Carrupt">Pierre-Alain Carrupt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angelo++Carotti">Angelo Carotti</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Dipartimento di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, Via E. Orabona 4, I-70125 Bari, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Grupo de Neuroquimica, Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad de Santiago de Compostela, San Francisco I, E-15782, Santiago de Compostela, Spain</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Quai Ernest Ansermet 30, CH-1211, Geneva 4, Switzerland</span></div><div class="corresp-info"><strong>*</strong>Marco Catto: phone, +39 080 5442803; fax, +39 080 5442230; E-mail, <a href="/cdn-cgi/l/email-protection#a4c9c5d6c7cb8ac7c5d0d0cbe4d1cacdc6c58acdd0"><span class="__cf_email__" data-cfemail="f69b97849599d89597828299b683989f9497d89f82">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>Angelo Carotti: phone, +39 080 5442782; fax, +39 080 5442230; E-mail, <a href="/cdn-cgi/l/email-protection#83e2ede4e6efecade0e2f1ecf7f7eac3f6edeae1e2adeaf7"><span class="__cf_email__" data-cfemail="23424d44464f4c0d4042514c57574a63564d4a41420d4a57">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00599&amp;href=/doi/10.1021%2Facs.jmedchem.5b00599" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 5561–5578</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 24, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 April 2015</li><li><span class="item_label"><b>Published</b> online</span>9 July 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 July 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00599" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00599</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5561%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRoberta%2BFarina%252C%2BLeonardo%2BPisani%252C%2BMarco%2BCatto%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D14%26contentID%3Dacs.jmedchem.5b00599%26title%3DStructure-Based%2BDesign%2Band%2BOptimization%2Bof%2BMultitarget-Directed%2B2H-Chromen-2-one%2BDerivatives%2Bas%2BPotent%2BInhibitors%2Bof%2BMonoamine%2BOxidase%2BB%2Band%2BCholinesterases%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5578%26publicationDate%3DJuly%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00599"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2227</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">67</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00599" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Roberta&quot;,&quot;last_name&quot;:&quot;Farina&quot;},{&quot;first_name&quot;:&quot;Leonardo&quot;,&quot;last_name&quot;:&quot;Pisani&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Catto&quot;},{&quot;first_name&quot;:&quot;Orazio&quot;,&quot;last_name&quot;:&quot;Nicolotti&quot;},{&quot;first_name&quot;:&quot;Domenico&quot;,&quot;last_name&quot;:&quot;Gadaleta&quot;},{&quot;first_name&quot;:&quot;Nunzio&quot;,&quot;last_name&quot;:&quot;Denora&quot;},{&quot;first_name&quot;:&quot;Ramon&quot;,&quot;last_name&quot;:&quot;Soto-Otero&quot;},{&quot;first_name&quot;:&quot;Estefania&quot;,&quot;last_name&quot;:&quot;Mendez-Alvarez&quot;},{&quot;first_name&quot;:&quot;Carolina&quot;,&quot;last_name&quot;:&quot;S. Passos&quot;},{&quot;first_name&quot;:&quot;Giovanni&quot;,&quot;last_name&quot;:&quot;Muncipinto&quot;},{&quot;first_name&quot;:&quot;Cosimo&quot;,&quot;last_name&quot;:&quot;D. Altomare&quot;},{&quot;first_name&quot;:&quot;Alessandra&quot;,&quot;last_name&quot;:&quot;Nurisso&quot;},{&quot;first_name&quot;:&quot;Pierre-Alain&quot;,&quot;last_name&quot;:&quot;Carrupt&quot;},{&quot;first_name&quot;:&quot;Angelo&quot;,&quot;last_name&quot;:&quot;Carotti&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;5561-5578&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00599&quot;},&quot;abstract&quot;:&quot;The multifactorial nature of Alzheimer’s disease calls for the development of multitarget agents addressing key pathogenic processes. To this end, by following a docking-assisted hybridization strategy, a number of aminocoumarins were designed, prepared, and tested as monoamine oxidases (MAOs) and acetyl- and butyryl-cholinesterase (AChE and BChE) inhibitors. Highly flexible N-benzyl-N-alkyloxy coumarins 2–12 showed good inhibitory activities at MAO-B, AChE, and BChE but low selectivity. More rigid inhibitors, bearing meta- and para-xylyl linkers, displayed good inhibitory activities and high MAO-B selectivity. Compounds 21, 24, 37, and 39, the last two featuring an improved hydrophilic/lipophilic balance, exhibited excellent activity profiles with nanomolar inhibitory potency toward hMAO-B, high hMAO-B over hMAO-A selectivity and submicromolar potency at hAChE. Cell-based assays of BBB permeation, neurotoxicity, and neuroprotection supported the potential of compound 37 as a BBB-permeant neuroprotective agen&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00599&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00599" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00599&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00599" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00599&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00599" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00599&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00599&amp;href=/doi/10.1021/acs.jmedchem.5b00599" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00599" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00599" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00599%26sid%3Dliteratum%253Aachs%26pmid%3D26107513%26genre%3Darticle%26aulast%3DFarina%26date%3D2015%26atitle%3DStructure-Based%2BDesign%2Band%2BOptimization%2Bof%2BMultitarget-Directed%2B2H-Chromen-2-one%2BDerivatives%2Bas%2BPotent%2BInhibitors%2Bof%2BMonoamine%2BOxidase%2BB%2Band%2BCholinesterases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D14%26spage%3D5561%26epage%3D5578%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/jmcmar.2015.58.issue-14/20150723/jmcmar.2015.58.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The multifactorial nature of Alzheimer’s disease calls for the development of multitarget agents addressing key pathogenic processes. To this end, by following a docking-assisted hybridization strategy, a number of aminocoumarins were designed, prepared, and tested as monoamine oxidases (MAOs) and acetyl- and butyryl-cholinesterase (AChE and BChE) inhibitors. Highly flexible <i>N</i>-benzyl-<i>N</i>-alkyloxy coumarins <b>2</b>–<b>12</b> showed good inhibitory activities at MAO-B, AChE, and BChE but low selectivity. More rigid inhibitors, bearing <i>meta</i>- and <i>para</i>-xylyl linkers, displayed good inhibitory activities and high MAO-B selectivity. Compounds <b>21</b>, <b>24</b>, <b>37</b>, and <b>39</b>, the last two featuring an improved hydrophilic/lipophilic balance, exhibited excellent activity profiles with nanomolar inhibitory potency toward hMAO-B, high hMAO-B over hMAO-A selectivity and submicromolar potency at hAChE. Cell-based assays of BBB permeation, neurotoxicity, and neuroprotection supported the potential of compound <b>37</b> as a BBB-permeant neuroprotective agent against H<sub>2</sub>O<sub>2</sub>-induced oxidative stress with poor interaction as P-gp substrate and very low cytotoxicity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00612" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00612" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Neurodegenerative diseases (NDs) are widely investigated pathologies because of the low efficacy of current therapies<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> and severe functional impairments for daily life activities, resulting in high familiar, social, and financial costs of patient care.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Despite the huge efforts in private and public research settings, most clinical trials of potential drug candidates for NDs, and for Alzheimer’s disease (AD) in particular,<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> failed. As a result, valuable disease-modifying therapies for NDs are still missing.</div><div class="NLM_p">AD and Parkinson’s disease (PD) are the most widespread and severe NDs. AD is the result of a progressive loss of neurons in basal forebrain regions associated with abnormal accumulation of beta amyloid protein (Aβ) in neuronal plaques and hyperphosphorylated tau protein in neurofibrillary tangles.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Neuronal degeneration in AD is triggered and maintained by low molecular weight Aβ oligomers and by reactive oxygen species (ROS), produced by oxidative degradation of neurotransmitters and xenobiotics.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The brain regions mostly affected by neuronal loss are essentially made of cholinergic neurons, so that restoring physiological acetylcholine levels has been considered a viable therapy in AD, as claimed by the so-called <i>cholinergic hypothesis</i>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> To date, drugs approved for AD therapy are the cholinesterase (ChE) inhibitors rivastigmine, galantamine, and donepezil<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>). The NMDA partial antagonist memantine has also been approved for the symptomatic treatment of AD for its contrasting effects over glutamate excitotoxicity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical Structures of Reference AChE and MAO Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Acetylcholinesterase (AChE, EC 3.1.1.7), the key enzyme targeted in the palliative therapy of AD, is present in both central and peripheral nervous system and in muscular motor plaques and is responsible for the enzymatic cleavage of neurotransmitter acetylcholine (ACh). The other ChE, butyrylcholinesterase (BChE, EC 3.1.1.8), present in brain and peripheral tissues, but prevalently in serum, is up-regulated in advanced AD and may play a role in the maintenance and progression of the disease.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">The catalytic cleavage of ACh involves a tight cooperation of three amino acids, the so-called catalytic triad (Ser-His-Glu) and aromatic amino acid residues responsible for cation−π interactions.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The catalytic bottom cleft represents one of the binding sites for substrates and inhibitors, along with the peripheral anionic binding site constituted by a larger region lined chiefly by aromatic amino acids. This structural arrangement accounts for the strong binding interactions observed for inhibitors such as decamethonium and donepezil, able to interact with both catalytic (CAS) and peripheral (PAS) anionic binding sites of AChE and, therefore, called dual binding site (DBS) inhibitors.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> As binding interactions at the PAS reduces the aggregation of Aβ peptide(s) leading to amyloid oligomers, DBS inhibitors are endowed with dual inhibitory activity on AChE and Aβ aggregation.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">The availability of X-ray crystallographic coordinates of many AChE–inhibitor complexes has allowed the identification of key interactions for high ligand binding affinity<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and has enabled the target-based design of potent and selective AChE inhibitors (AChEIs). In this context, potent AChE inhibition by coumarin derivatives,<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> homo- and heterobis-quaternary ammonium salts,<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> 2-quinolones,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and other heterocyclic compounds<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a> have been reported by our group.</div><div class="NLM_p">In the therapy of PD, a key target enzyme is represented by monoamine oxidase (MAO; amine-oxygen oxidoreductase, EC 1.4.3.4), a FAD-dependent enzyme, responsible for oxidative deamination of amine neurotransmitters, including dopamine that is depleted in PD, and exogenous amines.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Two isoforms of MAO, namely MAO-A and MAO-B, have been characterized in terms of amino acid sequence, tissue distribution, and selectivity toward substrates and inhibitors.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> Selective MAO-A inhibitors (MAO-AIs: e.g., clorgyline and moclobemide) are used in the treatment of depression, while selective MAO-BIs, i.e., rasagiline and selegiline, are employed as adjuvant or alternative drugs to L-DOPA in PD therapy.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a></div><div class="NLM_p">The resolution of the X-ray crystal structures of both human MAO-A<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> and MAO-B<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33-35)</a> bound to several inhibitors has newly spurred the research in the field of MAO inhibition, given to its therapeutic potential in neurological disorders, including AD, where selective MAO-BIs may play a role.<a onclick="showRef(event, 'ref29 ref36'); return false;" href="javascript:void(0);" class="ref ref29 ref36">(29, 36)</a></div><div class="NLM_p last">Growing evidence in the past few years has outlined the multifactorial etiopathogenesis of AD, PD, and other NDs. Actually, neurodegeneration is a complex pathological event resulting from the imbalance and deregulation of multiple biochemical pathways, ultimately depending on transcriptional and epigenetic modulations and on environmental factors.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> As a consequence, holistic, multifaceted pathologies are currently tackled by a polypharmacological approach based on multitargeted therapy.<a onclick="showRef(event, 'ref29 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref29 ref38 ref39">(29, 38, 39)</a> The paradigm “one drug–one target” has nowadays evolved into a more challenging “one drug–more targets” approach, provided that a good balance among potencies and efficacy toward selected targets, and optimal ADME-T properties, can be achieved.<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40-42)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Multitarget-Ligand Design: Rationale and Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36862" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36862" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The experience achieved by our group in the field of ligand- and target-based design of potent, selective, and reversible MAO<a onclick="showRef(event, 'ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50">(43-50)</a> and ChE inhibitors,<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24">(17-24)</a> prompted us to further explore the challenging field of multitargeted ligand design by addressing compounds with dual MAO and AChE inhibition. The earliest application of this approach by us was reported nearly 15 years ago, when we discovered coumarin derivatives endowed with good and moderate inhibition against MAO-B and AChE, respectively.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Additional data have been later presented in an international meeting.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div class="NLM_p">Since then, many authors have described the potential therapeutic application of multimodal MAO-Is displaying additional activities, such as AChE inhibition,<a onclick="showRef(event, 'ref53 ref54 ref55 ref56 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref53 ref54 ref55 ref56 ref57 ref58 ref59">(53-59)</a> metal ion chelation,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> antioxidant,<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61, 62)</a> and neuroprotective activities.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Further studies suggested the combination of MAO and ChE inhibition in the same molecule as a promising strategy in the treatment of AD.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><div class="NLM_p">Starting from our previous findings,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> we designed, synthesized, and tested a new series of suitably substituted coumarin derivatives with the aim of discovering multipotent compounds with different bioactivity profiles toward MAO-B and AChE. While MAO-B selectivity was an important goal of our study to avoid unwanted side effects arising from the intestinal MAO-A inhibition and the consequent hypertensive effect coming from tyramine-rich food (tyramine is indeed metabolized by intestinal MAO-A),<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> the lack of AChE over BChE selectivity was not deemed as important<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> due to a likely pathogenic role of BChE in advanced AD.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><div class="NLM_p">The molecular framework of our new multitarget ligands was built following a hybridization strategy. Starting from known ligands of the two enzymes, simple pharmacophore motifs were selected and joined in a unique molecular entity. As molecular flexibility plays a key role in accommodating ligands inside the AChE narrow gorge, a small series of hybrids was designed by connecting the coumarin core of 7-(3-chlorobenzyloxy)-3-methylcoumarin (MC 1095)<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> to the <i>N</i>-benzylaminomethyl group characterizing many AChE inhibitors (e.g., donepezil) through a flexible spacer (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). The 2<i>H</i>-chromen-2-one ring of such compound was chosen as the moiety able to efficiently fit the MAO-B enzymatic cleft by facing the isoalloxazine ring of FAD. In the additional series of more rigid hybrids, to improve AChE inhibitory potency of 7-benzyloxycoumarins,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> we approached a “designing in” strategy<a onclick="showRef(event, 'ref29 ref39 ref42'); return false;" href="javascript:void(0);" class="ref ref29 ref39 ref42">(29, 39, 42)</a> by adding in a suitable position of the coumarin ring a protonatable basic moiety that might bind CAS through π–cation interactions (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Taking into account that, as recently reported,<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68, 69)</a> the steric hindrance of substituents placed at position 4 of the coumarin ring exerts a negative impact on MAO affinity, the basic head was anchored to the 7-benzyloxy substituent. This rational hybrid design was supported by prospective docking studies based on X-ray crystal structures of the two target enzymes. As suggested by docking calculations, the protonatable head may establish π–cation interactions at the CAS of AChE, while the coumarin moiety may interact with PAS.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Such a pose resembled that of donepezil in the PDB complexes (entries: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EVE">1EVE</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7">4EY7</a>). As for the binding to MAO-B, docking studies revealed that the coumarin nucleus can be accommodated in the catalytic region in proximity of FAD, thus matching the pose experimentally observed in the X-ray crystal structure of MAO-B selective coumarin inhibitor NW-1772 (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The spacer tethering the two main pharmacophore features, namely the coumarin nucleus and the protonatable amine moiety, was examined also in terms of a reduced flexibility, by synthesizing the <i>meta</i>- and <i>para</i>-xylyl derivatives listed in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, to determine the optimal distance between the two key binding moieties in both target enzymes.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Hybridization strategy for flexible multitarget MAO-B/AChE inhibitors <b>2</b>–<b>12</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Hybridization strategy for rigid molecules as multitarget MAO-B/AChE inhibitors <b>13</b>–<b>40</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. MAOs and ChEs Inhibition Data of Coumarin Derivatives <b>2</b>–<b>12</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0015.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">IC<sub>50</sub>, μM (or inhibition % at 10 μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">MAO-A<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">MAO-B<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">AChE<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">BChE<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" rowspan="2" align="left" valign="middle">–(CH<sub>2</sub>)<sub>3</sub>–</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">(35%)</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">7.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">7.4</td><td class="colsep0 rowsep0" align="char" char=".">0.98</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="8" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>4</sub>–</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">6.6</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">0.49</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="8" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" rowspan="6" align="left" valign="middle">–(CH<sub>2</sub>)<sub>5</sub>–</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">2.2</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">0.94</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">4.2</td><td class="colsep0 rowsep0" align="char" char=".">0.98</td><td class="colsep0 rowsep0" align="char" char=".">0.55</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="center">5.3</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="center">(42%)</td><td class="colsep0 rowsep0" align="char" char=".">8.9</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="center">(48%)</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">9.5</td><td class="colsep0 rowsep0" align="char" char=".">7.8</td><td class="colsep0 rowsep0" align="char" char=".">0.75</td><td class="colsep0 rowsep0" align="char" char=".">0.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="8" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" rowspan="2" align="left" valign="middle">–(CH<sub>2</sub>)<sub>6</sub>–</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.51</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">0.095</td><td class="colsep0 rowsep0" align="char" char=".">0.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">2.1</td><td class="colsep0 rowsep0" align="char" char=".">0.72</td><td class="colsep0 rowsep0" align="char" char=".">0.32</td><td class="colsep0 rowsep0" align="char" char=".">0.49</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">From rat brain.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">From electric eel.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">From equine serum. Values are mean of two/three independent experiments; SEM < 10%.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Hydrochloride salt.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. MAOs and ChEs Inhibition Data of Coumarin Derivatives <b>13</b>–<b>40</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0016.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0017.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">From rat brain.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">From electric eel.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">From equine serum. Values are mean of two/three independent experiments; SEM < 10%.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Hydrochloride salt.</p></div></div><div></div></div><div class="NLM_p">Docking studies suggested that both polymethylene and xylyl linkers overlaid, at least in part, with the 7-benzyloxy group of NW-1772 that faces the MAO-B entrance cavity (acting as B/A structural determinants for selectivity) and keeps the basic moiety close to the aromatic region more proximal to the solvent.</div><div class="NLM_p">The newly synthesized coumarin derivatives <b>2</b>–<b>40</b>, <b>42</b>, and <b>43</b> were tested in vitro for their inhibition of rat MAO-A and MAO-B (rMAOs), electric eel AChE (eeAChE), and equine serum BChE (esBChE). The quinolone isoster <b>45</b> was also synthesized and tested, taking into account our previous findings on AChE inhibitors,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> with the aim of retaining activity toward the target enzymes while possibly improving the pharmacokinetics properties (i.e., lowering lipophilicity and increasing metabolic stability). The most potent inhibitors at rMAO-B and eeAChE were also assayed on the human isoforms of the two MAOs and ChEs. The inhibition data of nonhuman and human enzymes are reported in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1–3 and 4">Tables 1–3 and 4</a>, respectively. Finally, compound <b>37</b>, which showed outstanding activities on human enzymes together with well-balanced solubility/lipophilicity properties, was also investigated as potential CNS-permeant neuroprotective agent in vitro.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. MAOs and ChEs Inhibition Data of Derivatives <b>42</b>, <b>43</b>, and <b>45</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0018.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">IC<sub>50</sub>, μM (or inhibition % at 10 μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">MAO-A<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">MAO-B<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">AChE<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">BChE<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="center">(12%)</td><td class="colsep0 rowsep0" align="center">4.1</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">–(CH<sub>2</sub>)<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="center">1.7</td><td class="colsep0 rowsep0" align="center">(45%)</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">0.64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="center">(10%)</td><td class="colsep0 rowsep0" align="center">(29%)</td><td class="colsep0 rowsep0" align="char" char=".">0.49</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">From rat brain.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">From electric eel.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">From equine serum. Values are mean of two/three independent experiments; SEM < 10%.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Hydrochloride salt.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibition Data on hMAOs and hChEs</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">IC<sub>50</sub>, μM (or inhibition % at 10 μM) ± SEM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hMAO-A<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">hMAO-B<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">hAChE<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">hBChE<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">(17 ± 6%)</td><td class="colsep0 rowsep0" align="center">0.134 ± 0.018</td><td class="colsep0 rowsep0" align="center">1.0 ± 0.1</td><td class="colsep0 rowsep0" align="center">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="center">0.48 ± 0.04</td><td class="colsep0 rowsep0" align="center">0.096 ± 0.006</td><td class="colsep0 rowsep0" align="center">0.79 ± 0.01</td><td class="colsep0 rowsep0" align="center">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">0.39 ± 0.05</td><td class="colsep0 rowsep0" align="center">0.029 ± 0.006</td><td class="colsep0 rowsep0" align="center">0.30 ± 0.01</td><td class="colsep0 rowsep0" align="center">0.95 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="center">0.191 ± 0.053</td><td class="colsep0 rowsep0" align="center">0.321 ± 0.038</td><td class="colsep0 rowsep0" align="center">0.34 ± 0.03</td><td class="colsep0 rowsep0" align="center">0.95 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">0.115 ± 0.015</td><td class="colsep0 rowsep0" align="center">0.018 ± 0.003</td><td class="colsep0 rowsep0" align="center">0.44 ± 0.06</td><td class="colsep0 rowsep0" align="center">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="center">(0%)</td><td class="colsep0 rowsep0" align="center">0.041 ± 0.008</td><td class="colsep0 rowsep0" align="center">0.95 ± 0.08</td><td class="colsep0 rowsep0" align="center">0.89 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">nt</td><td class="colsep0 rowsep0" align="center">nt</td><td class="colsep0 rowsep0" align="center">0.50 ± 0.03</td><td class="colsep0 rowsep0" align="center">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">nt</td><td class="colsep0 rowsep0" align="center">nt</td><td class="colsep0 rowsep0" align="center">0.91 ± 0.07</td><td class="colsep0 rowsep0" align="center">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">4.3 ± 0.1</td><td class="colsep0 rowsep0" align="center">0.053 ± 0.001</td><td class="colsep0 rowsep0" align="center">0.45 ± 0.03</td><td class="colsep0 rowsep0" align="center">(46 ± 4%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">nt</td><td class="colsep0 rowsep0" align="center">nt</td><td class="colsep0 rowsep0" align="center">1.0 ± 0.2</td><td class="colsep0 rowsep0" align="center">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">(0%)</td><td class="colsep0 rowsep0" align="center">0.045 ± 0.013</td><td class="colsep0 rowsep0" align="center">6.0 ± 0.5</td><td class="colsep0 rowsep0" align="center">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">(11 ± 3%)</td><td class="colsep0 rowsep0" align="center">0.017 ± 0.004</td><td class="colsep0 rowsep0" align="center">nt</td><td class="colsep0 rowsep0" align="center">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">(39 ± 2%)</td><td class="colsep0 rowsep0" align="center">0.039 ± 0.001</td><td class="colsep0 rowsep0" align="center">8.5 ± 0.8</td><td class="colsep0 rowsep0" align="center">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">(31 ± 4%)</td><td class="colsep0 rowsep0" align="center">0.024 ± 0.003</td><td class="colsep0 rowsep0" align="center">3.9 ± 0.5</td><td class="colsep0 rowsep0" align="center">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">15.8 ± 2</td><td class="colsep0 rowsep0" align="center">0.010 ± 0.002</td><td class="colsep0 rowsep0" align="center">0.12 ± 0.01</td><td class="colsep0 rowsep0" align="center">9.3 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">13.0 ± 2</td><td class="colsep0 rowsep0" align="center">0.024 ± 0.004</td><td class="colsep0 rowsep0" align="center">0.33 ± 0.03</td><td class="colsep0 rowsep0" align="center">(14 ± 3%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">4.48 ± 0.4</td><td class="colsep0 rowsep0" align="center">0.0057 ± 0.0008</td><td class="colsep0 rowsep0" align="center">nt</td><td class="colsep0 rowsep0" align="center">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="center">(14 ± 3%)<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">4.5 ± 0.2</td><td class="colsep0 rowsep0" align="center">1.5 ± 0.1</td><td class="colsep0 rowsep0" align="center">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Donepezil</td><td class="colsep0 rowsep0" align="center">(0%)</td><td class="colsep0 rowsep0" align="center">(0%)</td><td class="colsep0 rowsep0" align="center">0.015 ± 0.003</td><td class="colsep0 rowsep0" align="center">4.8 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Clorgyline</td><td class="colsep0 rowsep0" align="center">0.0049</td><td class="colsep0 rowsep0" align="center">11.0</td><td class="colsep0 rowsep0" align="center">nt</td><td class="colsep0 rowsep0" align="center">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Pargyline</td><td class="colsep0 rowsep0" align="center">4.10</td><td class="colsep0 rowsep0" align="center">0.13</td><td class="colsep0 rowsep0" align="center">nt</td><td class="colsep0 rowsep0" align="center">nt</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Human recombinant MAOs on Supersomes.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Human recombinant AChE.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Human serum BChE.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Hydrochloride salt.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Determined at 4 μM concentration. nt, not tested.</p></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>2</b>–<b>40</b> were prepared from bromo-coumarin intermediates <b>1a</b>–<b>k</b> through microwave-assisted reaction with appropriate benzylamines, in the presence of anhydrous potassium carbonate and a catalytic amount of potassium iodide, in anhydrous acetonitrile. Bromides <b>1a</b>–<b>k</b> were, in turn, prepared from 7-hydroxycoumarin derivatives and commercial dibromides, as depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Synthesis of analogues <b>42</b> and <b>43</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) started from the reduction of 4-(bromomethyl)phenylacetic acid with BH<sub>3</sub>·SMe<sub>2</sub> complex to obtain alcohol <b>41a</b> that was then coupled with 7-hydroxycoumarin. CBr<sub>4</sub>/PPh<sub>3</sub>-mediated bromination of <b>41b</b> afforded <b>41c</b> that underwent a final microwave-assisted nucleophilic substitution with the appropriate benzylamine, yielding the desired coumarins <b>42</b>–<b>43</b>. As illustrated in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, 7-hydroxy-2-quinolone <b>44b</b> was prepared from the condensation of <i>trans</i>-cinnamic acid chloride with <i>m</i>-anisidine, followed by an intramolecular Friedel–Crafts acylation/dearylation<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> reaction in refluxing chlorobenzene in the presence of aluminum chloride as Lewis acid. Sequential regioselective alkylation of phenolic-OH with α,α′-dibromo-<i>p</i>-xylene and reaction of intermediate <b>44c</b> with benzylmethylamine in the usual conditions gave final compound <b>45</b>.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>2</b>–<b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) suitable dibromo-derivative (1,3-dibromopropane for <b>1a</b>, 1,4-dibromobutane for <b>1b</b>, 1,5-dibromopentane for <b>1c</b>, 1,6-dibromohexane for <b>1d</b>, α,α′-dibromo-<i>m</i>-xylene for <b>1e</b>, α,α′-dibromo-<i>p</i>-xylene for <b>1f</b>–<b>k</b>), K<sub>2</sub>CO<sub>3</sub>, dry acetonitrile, 30 min, 130 °C, MW; (b) substituted benzylamine, K<sub>2</sub>CO<sub>3</sub>, KI (cat.) (for compounds <b>2</b>–<b>12</b>), dry acetonitrile, 30 min, 130 °C, MW.</p></p></figure><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>42</b>–<b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BH<sub>3</sub>·SMe<sub>2</sub>, THF, 0 °C to room temperature, 4 h; (b) 7-hydroxycoumarin, K<sub>2</sub>CO<sub>3</sub>, dry acetonitrile, 130 °C, 30 min, MW; (c) CBr<sub>4</sub>, PPh<sub>3</sub>, dry dichloromethane, 0 °C to room temperature, 4 h; (d) benzylamine or <i>N</i>-benzylmethylamine, K<sub>2</sub>CO<sub>3</sub>, dry acetonitrile, KI (cat.), 130 °C, 30 min, MW.</p></p></figure><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0014.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of compound <b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) cinnamoyl chloride, dry dichloromethane, 4 h, reflux, (ii) AlCl<sub>3</sub>, chlorobenzene, 8 h, reflux; (b) α,α′-dibromo-<i>p</i>-xylene, K<sub>2</sub>CO<sub>3</sub>, dry acetonitrile, 130 °C, 30 min, MW; (c) <i>N</i>-methylbenzylamine, K<sub>2</sub>CO<sub>3</sub>, dry acetonitrile, 130 °C, 30 min, MW.</p></p></figure><div class="NLM_p last">Analytical and spectroscopic data of tested compounds <b>2</b>–<b>40</b>, <b>42</b>, <b>43</b>, and <b>45</b> are reported in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Biological Assays</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15511" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15511" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All compounds were tested for their inhibitory activities on rat MAOs (rMAOs), electric eel AChE (eeAChE), and equine serum BChE (esBChE) enzymes. For MAO inhibition test, the protocol using mitochondrial rMAO-A and -B obtained from rat brain homogenates was used as previously described.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> As for eeAChE and esBChE, the well-known Ellman’s spectrophotometric test<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> was used to determine both IC<sub>50</sub>s and inhibition kinetics. Results are reported in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> as IC<sub>50</sub> (μM) or, for poorly active compounds, as percentage of inhibition at 10 μM. Inhibition kinetics plots are depicted in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Lineweaver–Burk plots of inhibition kinetics of compounds <b>11</b> (A), <b>24</b> (B), and <b>37</b> (C). Reciprocals of enzyme activity (eeAChE) vs reciprocals of substrate (<i>S</i>-acetylthiocholine) concentration in the presence of different concentrations (0−1 μM) of inhibitor. Concentrations used for inhibitors are reported in inserts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds <b>2</b>, <b>4</b>, <b>5</b>, <b>11</b>, <b>12</b>, <b>21</b>-<b>24</b>, <b>29</b>, <b>31</b>-<b>34</b>, <b>37</b>, <b>39</b>, <b>40</b>, and <b>45</b> were also tested on human isoenzymes of MAOs (hMAOs) and/or ChEs (hChEs). While hChEs were tested through the Ellman’s method, the assays for hMAOs were carried out with a fluorescence-based method using kynuramine as a nonselective substrate of hMAO-A and hMAO-B.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Results of inhibition tests on hMAOs and hChEs are reported in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>.</div><div class="NLM_p">Apical to basolateral (AP-BL) and basolateral to apical (BL-AP) apparent permeability (<i>P</i><sub>app</sub>) of compound <b>37</b> was measured using Madin–Darby canine kidney (MDCK) cells, retrovirally transfected with the human MDR1 cDNA (MDCKII-MDR1). <i>P</i><sub>app</sub> and efflux ratio (ER) were calculated and reported in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Bidirectional Transport across MDCKII-MDR1 Cells of Compound <b>37</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="×" /></col><col align="char" char="×" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="×"><i>P</i><sub>app</sub>, AP-BL (cm/s)</th><th class="colsep0 rowsep0" align="center" char="×"><i>P</i><sub>app</sub>, BL-AP (cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">ER<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a><i>P</i><sub>app</sub>BL-AP/<i>P</i><sub>app</sub>AP-BL</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char="×">1.91 × 10<sup>–5</sup></td><td class="colsep0 rowsep0" align="char" char="×">3.38 × 10<sup>–5</sup></td><td class="colsep0 rowsep0" align="char" char=".">1.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Diazepam</td><td class="colsep0 rowsep0" align="char" char="×">1.56 × 10<sup>–5</sup></td><td class="colsep0 rowsep0" align="char" char="×">1.23 × 10<sup>–5</sup></td><td class="colsep0 rowsep0" align="char" char=".">0.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>FD-4</b></td><td class="colsep0 rowsep0" align="char" char="×">1.13 × 10<sup>–6</sup></td><td class="colsep0 rowsep0" align="char" char="×">2.68 × 10<sup>–7</sup></td><td class="colsep0 rowsep0" align="char" char=".">0.23</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Efflux ratio (ER) was calculated using the following equation: ER = <i>P</i><sub>app</sub>, BL-AP/<i>P</i><sub>app</sub>, AP-BL, where <i>P</i><sub>app</sub>, BL-AP is the apparent permeability of basal-to-apical transport, and <i>P</i><sub>app</sub>, AP-BL is the apparent permeability of apical-to-basal transport. An efflux ratio greater than 2 indicates that a test compound is likely to be a substrate for P-gp transport.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Analytical Data of Compounds <b>2</b>–<b>40</b>, <b>42</b>, <b>43</b>, and <b>45</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">anal. calcd %</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">anal. found %</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">melting point, °C (CC or cryst solvent)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">C</th><th class="colsep0 rowsep0" align="center" char=".">H</th><th class="colsep0 rowsep0" align="center" char=".">N</th><th class="colsep0 rowsep0" align="center" char=".">C</th><th class="colsep0 rowsep0" align="center" char=".">H</th><th class="colsep0 rowsep0" align="center" char=".">N</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">201–3 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">68.12</td><td class="colsep0 rowsep0" align="char" char=".">6.76</td><td class="colsep0 rowsep0" align="char" char=".">3.61</td><td class="colsep0 rowsep0" align="char" char=".">68.10</td><td class="colsep0 rowsep0" align="char" char=".">6.86</td><td class="colsep0 rowsep0" align="char" char=".">3.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">183–5 (CC) </td><td class="colsep0 rowsep0" align="char" char=".">68.73</td><td class="colsep0 rowsep0" align="char" char=".">7.02</td><td class="colsep0 rowsep0" align="char" char=".">3.48</td><td class="colsep0 rowsep0" align="char" char=".">68.43</td><td class="colsep0 rowsep0" align="char" char=".">6.75</td><td class="colsep0 rowsep0" align="char" char=".">3.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">38–9 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">75.59</td><td class="colsep0 rowsep0" align="char" char=".">7.45</td><td class="colsep0 rowsep0" align="char" char=".">3.83</td><td class="colsep0 rowsep0" align="char" char=".">75.78</td><td class="colsep0 rowsep0" align="char" char=".">7.55</td><td class="colsep0 rowsep0" align="char" char=".">3.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">238–40 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">68.73</td><td class="colsep0 rowsep0" align="char" char=".">7.02</td><td class="colsep0 rowsep0" align="char" char=".">3.48</td><td class="colsep0 rowsep0" align="char" char=".">68.40</td><td class="colsep0 rowsep0" align="char" char=".">6.87</td><td class="colsep0 rowsep0" align="char" char=".">3.58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">66–7 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">75.96</td><td class="colsep0 rowsep0" align="char" char=".">7.70</td><td class="colsep0 rowsep0" align="char" char=".">3.69</td><td class="colsep0 rowsep0" align="char" char=".">75.58</td><td class="colsep0 rowsep0" align="char" char=".">7.45</td><td class="colsep0 rowsep0" align="char" char=".">3.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">247–9 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">68.09</td><td class="colsep0 rowsep0" align="char" char=".">6.63</td><td class="colsep0 rowsep0" align="char" char=".">6.35</td><td class="colsep0 rowsep0" align="char" char=".">67.73</td><td class="colsep0 rowsep0" align="char" char=".">6.62</td><td class="colsep0 rowsep0" align="char" char=".">6.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">204–6 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">64.00</td><td class="colsep0 rowsep0" align="char" char=".">6.49</td><td class="colsep0 rowsep0" align="char" char=".">3.11</td><td class="colsep0 rowsep0" align="char" char=".">63.94</td><td class="colsep0 rowsep0" align="char" char=".">6.35</td><td class="colsep0 rowsep0" align="char" char=".">2.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">201–3 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">68.09</td><td class="colsep0 rowsep0" align="char" char=".">6.63</td><td class="colsep0 rowsep0" align="char" char=".">6.35</td><td class="colsep0 rowsep0" align="char" char=".">67.70</td><td class="colsep0 rowsep0" align="char" char=".">6.53</td><td class="colsep0 rowsep0" align="char" char=".">6.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">193–4 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">69.83</td><td class="colsep0 rowsep0" align="char" char=".">7.50</td><td class="colsep0 rowsep0" align="char" char=".">3.26</td><td class="colsep0 rowsep0" align="char" char=".">69.55</td><td class="colsep0 rowsep0" align="char" char=".">7.37</td><td class="colsep0 rowsep0" align="char" char=".">3.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">54–5 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">76.30</td><td class="colsep0 rowsep0" align="char" char=".">7.94</td><td class="colsep0 rowsep0" align="char" char=".">3.56</td><td class="colsep0 rowsep0" align="char" char=".">75.99</td><td class="colsep0 rowsep0" align="char" char=".">7.88</td><td class="colsep0 rowsep0" align="char" char=".">3.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">171–3 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">70.33</td><td class="colsep0 rowsep0" align="char" char=".">7.72</td><td class="colsep0 rowsep0" align="char" char=".">3.15</td><td class="colsep0 rowsep0" align="char" char=".">70.51</td><td class="colsep0 rowsep0" align="char" char=".">8.03</td><td class="colsep0 rowsep0" align="char" char=".">3.48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">181–2 (EtOH)</td><td class="colsep0 rowsep0" align="char" char=".">73.77</td><td class="colsep0 rowsep0" align="char" char=".">6.19</td><td class="colsep0 rowsep0" align="char" char=".">4.53</td><td class="colsep0 rowsep0" align="char" char=".">73.42</td><td class="colsep0 rowsep0" align="char" char=".">6.36</td><td class="colsep0 rowsep0" align="char" char=".">4.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">225–7 (EtOH)</td><td class="colsep0 rowsep0" align="char" char=".">67.46</td><td class="colsep0 rowsep0" align="char" char=".">6.47</td><td class="colsep0 rowsep0" align="char" char=".">3.75</td><td class="colsep0 rowsep0" align="char" char=".">67.27</td><td class="colsep0 rowsep0" align="char" char=".">6.50</td><td class="colsep0 rowsep0" align="char" char=".">3.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">156–7 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">71.67</td><td class="colsep0 rowsep0" align="char" char=".">6.01</td><td class="colsep0 rowsep0" align="char" char=".">3.63</td><td class="colsep0 rowsep0" align="char" char=".">71.29</td><td class="colsep0 rowsep0" align="char" char=".">5.78</td><td class="colsep0 rowsep0" align="char" char=".">3.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">132–4 (EtOH)</td><td class="colsep0 rowsep0" align="char" char=".">69.87</td><td class="colsep0 rowsep0" align="char" char=".">5.19</td><td class="colsep0 rowsep0" align="char" char=".">6.27</td><td class="colsep0 rowsep0" align="char" char=".">69.51</td><td class="colsep0 rowsep0" align="char" char=".">5.54</td><td class="colsep0 rowsep0" align="char" char=".">6.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">121–3 (EtOH)</td><td class="colsep0 rowsep0" align="char" char=".">69.10</td><td class="colsep0 rowsep0" align="char" char=".">5.80</td><td class="colsep0 rowsep0" align="char" char=".">3.10</td><td class="colsep0 rowsep0" align="char" char=".">68.81</td><td class="colsep0 rowsep0" align="char" char=".">5.64</td><td class="colsep0 rowsep0" align="char" char=".">3.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">131–3 (EtOH)</td><td class="colsep0 rowsep0" align="char" char=".">65.80</td><td class="colsep0 rowsep0" align="char" char=".">5.08</td><td class="colsep0 rowsep0" align="char" char=".">3.07</td><td class="colsep0 rowsep0" align="char" char=".">65.55</td><td class="colsep0 rowsep0" align="char" char=".">5.29</td><td class="colsep0 rowsep0" align="char" char=".">3.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">108–9 (EtOH/Et<sub>2</sub>O)</td><td class="colsep0 rowsep0" align="char" char=".">73.77</td><td class="colsep0 rowsep0" align="char" char=".">6.19</td><td class="colsep0 rowsep0" align="char" char=".">4.53</td><td class="colsep0 rowsep0" align="char" char=".">73.88</td><td class="colsep0 rowsep0" align="char" char=".">6.41</td><td class="colsep0 rowsep0" align="char" char=".">4.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">167–8 (EtOH/Et<sub>2</sub>O)</td><td class="colsep0 rowsep0" align="char" char=".">74.75</td><td class="colsep0 rowsep0" align="char" char=".">6.87</td><td class="colsep0 rowsep0" align="char" char=".">4.15</td><td class="colsep0 rowsep0" align="char" char=".">74.93</td><td class="colsep0 rowsep0" align="char" char=".">6.47</td><td class="colsep0 rowsep0" align="char" char=".">4.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">106–7 (EtOH)</td><td class="colsep0 rowsep0" align="char" char=".">71.67</td><td class="colsep0 rowsep0" align="char" char=".">6.01</td><td class="colsep0 rowsep0" align="char" char=".">3.63</td><td class="colsep0 rowsep0" align="char" char=".">71.44</td><td class="colsep0 rowsep0" align="char" char=".">5.89</td><td class="colsep0 rowsep0" align="char" char=".">3.55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>250 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">71.63</td><td class="colsep0 rowsep0" align="char" char=".">6.01</td><td class="colsep0 rowsep0" align="char" char=".">3.21</td><td class="colsep0 rowsep0" align="char" char=".">71.31</td><td class="colsep0 rowsep0" align="char" char=".">5.95</td><td class="colsep0 rowsep0" align="char" char=".">3.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>250 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">71.63</td><td class="colsep0 rowsep0" align="char" char=".">6.01</td><td class="colsep0 rowsep0" align="char" char=".">3.21</td><td class="colsep0 rowsep0" align="char" char=".">71.37</td><td class="colsep0 rowsep0" align="char" char=".">6.06</td><td class="colsep0 rowsep0" align="char" char=".">3.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">226–8 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">72.07</td><td class="colsep0 rowsep0" align="char" char=".">6.27</td><td class="colsep0 rowsep0" align="char" char=".">3.11</td><td class="colsep0 rowsep0" align="char" char=".">71.77</td><td class="colsep0 rowsep0" align="char" char=".">6.23</td><td class="colsep0 rowsep0" align="char" char=".">3.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">129–31 dec. (EtOH)</td><td class="colsep0 rowsep0" align="char" char=".">69.87</td><td class="colsep0 rowsep0" align="char" char=".">5.19</td><td class="colsep0 rowsep0" align="char" char=".">6.27</td><td class="colsep0 rowsep0" align="char" char=".">69.64</td><td class="colsep0 rowsep0" align="char" char=".">5.33</td><td class="colsep0 rowsep0" align="char" char=".">6.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">128–30 (EtOH)</td><td class="colsep0 rowsep0" align="char" char=".">69.10</td><td class="colsep0 rowsep0" align="char" char=".">5.80</td><td class="colsep0 rowsep0" align="char" char=".">3.10</td><td class="colsep0 rowsep0" align="char" char=".">69.34</td><td class="colsep0 rowsep0" align="char" char=".">5.51</td><td class="colsep0 rowsep0" align="char" char=".">3.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">124–6 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">65.80</td><td class="colsep0 rowsep0" align="char" char=".">5.08</td><td class="colsep0 rowsep0" align="char" char=".">3.07</td><td class="colsep0 rowsep0" align="char" char=".">65.97</td><td class="colsep0 rowsep0" align="char" char=".">5.35</td><td class="colsep0 rowsep0" align="char" char=".">3.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>250 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">66.39</td><td class="colsep0 rowsep0" align="char" char=".">5.36</td><td class="colsep0 rowsep0" align="char" char=".">2.98</td><td class="colsep0 rowsep0" align="char" char=".">66.04</td><td class="colsep0 rowsep0" align="char" char=".">5.29</td><td class="colsep0 rowsep0" align="char" char=".">2.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">247–50 dec (CC)</td><td class="colsep0 rowsep0" align="char" char=".">66.39</td><td class="colsep0 rowsep0" align="char" char=".">5.36</td><td class="colsep0 rowsep0" align="char" char=".">2.98</td><td class="colsep0 rowsep0" align="char" char=".">65.99</td><td class="colsep0 rowsep0" align="char" char=".">5.39</td><td class="colsep0 rowsep0" align="char" char=".">2.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">236–8 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">66.95</td><td class="colsep0 rowsep0" align="char" char=".">5.62</td><td class="colsep0 rowsep0" align="char" char=".">2.89</td><td class="colsep0 rowsep0" align="char" char=".">67.31</td><td class="colsep0 rowsep0" align="char" char=".">5.80</td><td class="colsep0 rowsep0" align="char" char=".">3.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">147–9 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">69.87</td><td class="colsep0 rowsep0" align="char" char=".">5.19</td><td class="colsep0 rowsep0" align="char" char=".">6.27</td><td class="colsep0 rowsep0" align="char" char=".">70.12</td><td class="colsep0 rowsep0" align="char" char=".">5.29</td><td class="colsep0 rowsep0" align="char" char=".">6.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">242–4 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">70.35</td><td class="colsep0 rowsep0" align="char" char=".">5.47</td><td class="colsep0 rowsep0" align="char" char=".">6.08</td><td class="colsep0 rowsep0" align="char" char=".">69.99</td><td class="colsep0 rowsep0" align="char" char=".">5.49</td><td class="colsep0 rowsep0" align="char" char=".">6.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">224–6 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">70.35</td><td class="colsep0 rowsep0" align="char" char=".">5.47</td><td class="colsep0 rowsep0" align="char" char=".">6.08</td><td class="colsep0 rowsep0" align="char" char=".">70.72</td><td class="colsep0 rowsep0" align="char" char=".">5.59</td><td class="colsep0 rowsep0" align="char" char=".">6.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">225–7 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">70.80</td><td class="colsep0 rowsep0" align="char" char=".">5.73</td><td class="colsep0 rowsep0" align="char" char=".">5.90</td><td class="colsep0 rowsep0" align="char" char=".">70.55</td><td class="colsep0 rowsep0" align="char" char=".">5.97</td><td class="colsep0 rowsep0" align="char" char=".">5.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">155–7 dec. (CC)</td><td class="colsep0 rowsep0" align="char" char=".">69.87</td><td class="colsep0 rowsep0" align="char" char=".">5.19</td><td class="colsep0 rowsep0" align="char" char=".">6.27</td><td class="colsep0 rowsep0" align="char" char=".">69.46</td><td class="colsep0 rowsep0" align="char" char=".">5.55</td><td class="colsep0 rowsep0" align="char" char=".">5.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">183–5 dec. (CC)</td><td class="colsep0 rowsep0" align="char" char=".">68.72</td><td class="colsep0 rowsep0" align="char" char=".">4.70</td><td class="colsep0 rowsep0" align="char" char=".">8.90</td><td class="colsep0 rowsep0" align="char" char=".">68.88</td><td class="colsep0 rowsep0" align="char" char=".">4.79</td><td class="colsep0 rowsep0" align="char" char=".">8.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">235–6 dec. (CC)</td><td class="colsep0 rowsep0" align="char" char=".">69.10</td><td class="colsep0 rowsep0" align="char" char=".">5.80</td><td class="colsep0 rowsep0" align="char" char=".">3.10</td><td class="colsep0 rowsep0" align="char" char=".">69.15</td><td class="colsep0 rowsep0" align="char" char=".">5.71</td><td class="colsep0 rowsep0" align="char" char=".">3.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">109 dec, 130–2 (EtOH)</td><td class="colsep0 rowsep0" align="char" char=".">74.80</td><td class="colsep0 rowsep0" align="char" char=".">5.77</td><td class="colsep0 rowsep0" align="char" char=".">3.49</td><td class="colsep0 rowsep0" align="char" char=".">74.44</td><td class="colsep0 rowsep0" align="char" char=".">5.69</td><td class="colsep0 rowsep0" align="char" char=".">3.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">231–36 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">64.20</td><td class="colsep0 rowsep0" align="char" char=".">5.18</td><td class="colsep0 rowsep0" align="char" char=".">2.88</td><td class="colsep0 rowsep0" align="char" char=".">63.80</td><td class="colsep0 rowsep0" align="char" char=".">5.13</td><td class="colsep0 rowsep0" align="char" char=".">2.89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">150–2 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">67.99</td><td class="colsep0 rowsep0" align="char" char=".">5.28</td><td class="colsep0 rowsep0" align="char" char=".">5.87</td><td class="colsep0 rowsep0" align="char" char=".">67.61</td><td class="colsep0 rowsep0" align="char" char=".">5.29</td><td class="colsep0 rowsep0" align="char" char=".">5.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">207–9 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">71.63</td><td class="colsep0 rowsep0" align="char" char=".">6.01</td><td class="colsep0 rowsep0" align="char" char=".">3.21</td><td class="colsep0 rowsep0" align="char" char=".">71.81</td><td class="colsep0 rowsep0" align="char" char=".">5.91</td><td class="colsep0 rowsep0" align="char" char=".">3.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>250 (CC)</td><td class="colsep0 rowsep0" align="char" char=".">71.17</td><td class="colsep0 rowsep0" align="char" char=".">5.73</td><td class="colsep0 rowsep0" align="char" char=".">3.32</td><td class="colsep0 rowsep0" align="char" char=".">71.27</td><td class="colsep0 rowsep0" align="char" char=".">5.47</td><td class="colsep0 rowsep0" align="char" char=".">3.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">154–5<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (CC)</td><td class="colsep0 rowsep0" align="char" char=".">71.33</td><td class="colsep0 rowsep0" align="char" char=".">5.99</td><td class="colsep0 rowsep0" align="char" char=".">6.65</td><td class="colsep0 rowsep0" align="char" char=".">71.61</td><td class="colsep0 rowsep0" align="char" char=".">6.04</td><td class="colsep0 rowsep0" align="char" char=".">6.32</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">CC: column chromatography (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for details).</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Hydrochloride salt.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Free base.</p></div></div></div><div class="NLM_p last">Cytotoxicity of compound <b>37</b> was evaluated in human neuroblastoma cell line SH-SY5Y through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) viability assay (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> The same cell-based method was used to for preliminarily investigate the cytoprotective effects of compound <b>37</b> against cell death induced by H<sub>2</sub>O<sub>2</sub> (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>).</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77350" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77350" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For the sake of clarity, structure–activity and structure–selectivity relationships (SAR and SSR, respectively) will be discussed first separately for the different classes of compounds reported in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1–3">Tables 1–3</a>, then a comparison will be made among the inhibition data from rMAOs and eeAChE with the corresponding data from hMAOs, hAChE and to a lesser extent hBChE (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>).</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> SARs and SSRs of <i>N</i>-Benzyl-<i>N</i>-alkyloxy Coumarin Derivatives (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>)</h3><div class="NLM_p">Compounds <b>2</b>–<b>12</b> were designed to investigate the effects on inhibition potency and selectivity at the target enzymes of the length of the polymethylene linker and of the <i>N</i>-substitution at the NH-benzyl moiety with methyl and ethyl groups. A few substituents were also introduced on the benzyl ring of compound <b>6</b>, bearing a pentamethylene linker, to extend the knowledge of SARs and SSRs.</div><div class="NLM_p">The inhibition data in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> showed that, with a few exceptions, the designed compounds display from low- to submicromolar potencies against rMAO-B and eeAChE, whereas potencies against rMAO-A and esBChE were slightly lower. As the result, promising dual MAO-B and AChE inhibitors were discovered with limited MAO-B over MAO-A and AChE over BChE selectivity.</div><div class="NLM_p">Interestingly, compounds <b>3</b>, <b>5</b>, <b>6</b>, and <b>12</b>, characterized by linkers of different length, displayed submicromolar affinities at both rMAO-B and eeAChE with a limited selectivity over rMAO-A and esBChE, respectively. The gradual elongation of the linker in the <i>N</i>-Me derivative <b>2</b>, affording compounds <b>4</b>, <b>6</b>, and <b>11</b>, provided a consistent increase of potency toward eeAChE (from 1.3 μM of <b>2</b> to 0.095 μM of <b>11</b>) and esBChE (from 7.8 μM of <b>2</b> to 0.67 μM of <b>11</b>), whereas an opposite effect was observed with rMAO-B (from 0.33 μM of <b>2</b> to 1.7 μM of <b>11</b>). Therefore, in this series of compounds, the goal of optimizing both MAO-B and AChE activities could not be achieved by varying the length of the linker. However, moving from the <i>N</i>-methyl derivative <b>11</b> to the <i>N</i>-ethyl homologue <b>12</b> good activities at the three target enzymes, rMAO-B, eeAChE, and esBChE, were obtained but along with a very low MAO-B over MAO-A selectivity (SI = 3; SI is the selectivity index calculated as the ratio IC<sub>50</sub> MAO-A/IC<sub>50</sub> MAO-B). Compound <b>11</b> was endowed with the highest eeAChE inhibitory potency within the whole examined series (IC<sub>50</sub> = 0.095 μM) and, surprisingly, the highest rMAO-A inhibitory potency (IC<sub>50</sub> = 0.51 μM) leading to a reversal of rMAO selectivity (SI = 0.3). Kinetics of eeAChE inhibition resulted in a mixed-type mechanism, as expected from putative dual binding site inhibitors (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A), with <i>K</i><sub>i</sub> equal to 0.080 ± 0.002 μM.</div><div class="NLM_p">Notably, compounds with the longest linker <b>11</b> and <b>12</b> displayed the highest inhibitory potency on rMAO-A (IC<sub>50</sub> = 0.51 and 2.1 μM, respectively) and ChEs (IC<sub>50</sub> = 0.095 and 0.32 μM, respectively, at AChE, and 0.67 and 0.49 μM, respectively, at BChE). No clear relationship emerged from the comparison of inhibition potency of <i>N</i>-methyl and <i>N</i>-ethyl derivatives.</div><div class="NLM_p last">The introduction in compound <b>6</b> of a cyano group in position <i>meta</i> and <i>para</i> (<b>7</b> and <b>9</b>, respectively) and of a chlorine at position <i>meta</i> (compound <b>8</b>) did diminish the inhibitory potency toward all the tested enzymes except for compound <b>8</b> at both ChEs.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> SARs and SSRs of <i>meta</i>- and <i>para</i>-<i>N</i>,<i>N</i>-Dialkylaminomethyl-7-benzyloxycoumarin Derivatives (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>)</h3><div class="NLM_p">Compounds <b>13</b>–<b>40</b> were designed to investigate the effects on inhibition potency and selectivity at the three target enzymes of the <i>N</i>,<i>N</i>-dialkylaminomethyl substituents at the <i>meta</i> and <i>para</i> positions of the 7-benzyloxy moiety and of substituents at position 3 and 4 of the coumarin ring, having in mind our previous findings,<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68, 69)</a> which highlighted the steric requirements for this region in binding MAO-B enzymatic cleft. A number of substituents were also introduced on the <i>N</i>-benzyl ring in R<sub>4</sub> to extend the study of SARs and SSRs.</div><div class="NLM_p">It is worth underlining that all the examined compounds shared a <i>meta</i>- or <i>para</i>-xylyl linker joining the oxygen at position 7 of coumarin with the basic <i>N</i>,<i>N</i>-dialkylamino substituents. Both xylyl linkers have a lower conformational flexibility compared to the polymethylene linkers of compounds <b>2</b>–<b>12</b>, and this might result in a higher (iso)enzyme selectivity. Indeed, this was the case for rMAOs, as most compounds achieved micromolar to submicromolar rMAO-B inhibitory potency whereas an inhibition lower than 20% at 10 μM was generally displayed at rMAO-A. The same effect on selectivity was not observed for the ChEs even though most compounds appeared slightly more AChE-selective. Inhibition potency on eeAChE reached the submicromolar level in 11 cases, the most potent inhibitor being compound <b>24</b> (IC<sub>50</sub> = 0.10 μM), while on esBChE only six compounds exhibited a submicromolar activity, with compound <b>19</b> showing the highest potency (IC<sub>50</sub> = 0.24 μM).</div><div class="NLM_p">As the <i>N</i>,<i>N</i>-dimethylaminomethyl derivative <b>13</b>, the lead compound of the <i>meta</i>-xylyl series, showed very low inhibitory effect on rMAO-A and eeAChE (IC<sub>50</sub> = 10 μM and 38% inhibition at 10 μM, respectively) and moderate activity on rMAO-B and esBChE (IC<sub>50</sub> = 3.2 and 5.3 μM, respectively), its <i>N</i>,<i>N</i>-diethylamino <b>14</b> and <i>N</i>-methyl-<i>N</i>-benzylamino <b>15</b> congeners were synthesized. Improved potencies were definitely gained with compound <b>15</b> that showed an interesting profile of inhibition with low micromolar potencies on rMAOB, eeAChE, and esBChE (IC<sub>50</sub> = 2.0, 2.3, and 1.0 μM, respectively) and very weak activity at rMAO-A (8% inhibition at 10 μM). The introduction of cyano, methoxy, and chloro substituents at the <i>meta</i> position of the phenyl ring of the <i>N</i>-benzylamino moiety, leading to compounds <b>16</b>, <b>17</b> and <b>18</b>, respectively, resulted in lower inhibitory potencies on rMAO-B and eeAChE, whereas a 3-fold increased inhibition was observed for the chloro derivative <b>18</b> on esBChE (IC<sub>50</sub> = 0.31 vs 1.0 μM).</div><div class="NLM_p">The <i>para</i>-<i>N</i>,<i>N</i>-dimethylamino- and <i>N</i>,<i>N</i>-diethylamino-methyl derivatives <b>19</b> and <b>20</b> displayed lower activity against rMAO-A, similar activity against rMAO-B, and higher activity against esBChE when compared to the corresponding <i>meta</i>-substituted isomers <b>13</b> and <b>14</b>. Better results were obtained with the <i>para</i>-<i>N</i>-methyl-<i>N</i>-benzylaminomethyl derivative <b>21</b> that achieved submicromolar potency toward rMAO-B and eeAChE (IC<sub>50</sub> = 0.85 and 0.75 μM, respectively) and a significantly lower activity against rMAO-A and esBChE (7% at 10 μM and IC<sub>50</sub> = 11 μM, respectively).</div><div class="NLM_p">Methyl substituents were introduced at the positions 3 and 4 of the coumarin ring to give the monomethyl derivatives <b>22</b> and <b>23</b> and the dimethyl derivative <b>24</b>. Compared to the lead compound <b>21</b>, the rMAO-B activity decreased while a significant increase of the inhibitory potency on eeAChE (IC<sub>50</sub> = 0.26, 0.18, and 0.10 μM) and esBChE (IC<sub>50</sub> = 1.1, 1.0, and 0.69 μM) was observed for compounds <b>22</b>, <b>23</b>, and <b>24</b>, respectively. It is worth noting that these very simple structural changes led to the most potent eeAChE inhibitors of the whole series of compounds and, even more interestingly, for compound <b>24</b> an impressive combination of high inhibitory activities toward rMAO-B, eeAChE, and esBChE and high rMAO-B selectivity was revealed (IC<sub>50</sub> = 1.2, 0.10, and 0.69 μM at rMAO-B, eeAChE, and esBChE, respectively, and 0% inhibition at 10 μM at rMAO-A). As for open chain derivative <b>11</b>, also compound <b>24</b> displayed mixed-mode kinetics for eeAChE inhibition, with <i>K</i><sub>i</sub> equal to 0.22 ± 0.03 μM (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B).</div><div class="NLM_p">As done for lead compound <b>15</b>, the isomeric compound <b>21</b> was modified by introducing cyano, methoxy, and chloro substituents at position <i>meta</i>, and the cyano group at position <i>para</i> as well, in the aromatic ring of the <i>N</i>-benzylamino moiety. <i>Meta</i>-substituted derivatives <b>25</b>–<b>27</b> proved to be less potent inhibitors than the lead compound <b>21</b> on rMAO-B. <i>Meta</i>-chloro derivative <b>27</b> maintained, however, an attractive inhibition profile (12% inhibition at 10 μM at rMAO-A; IC<sub>50</sub> = 2.7, 0.59, and 1.2 μM, at rMAO-B, eeAChE, and esBChE, respectively). Therefore, compound <b>27</b> was slightly modified by introducing methyl substituents at the positions 3 and 4 to afford the monomethyl derivatives <b>28</b> and <b>29</b> and the dimethyl derivative <b>30</b>. Compared to <b>27</b>, rMAO-B, rMAO-A, and esBChE activities considerably decreased, while the potency toward AChE was maintained, or even improved, in particular for the 4-methyl derivative <b>29</b> (IC<sub>50</sub> = 0.12 vs 0.59 μM). Compared to <b>21</b>, 4-cyanobenzylamino derivative <b>31</b> displayed lower activities toward rMAO-A, eeAChE, and esBChE and a 3-fold increase of rMAO-B activity. The introduction in compound <b>31</b> of methyl substituents at the positions 3 and 4, to give the monomethyl derivatives <b>32</b> and <b>33</b> and the dimethyl derivative <b>34</b>, generally diminished the activity on almost all enzymatic targets.</div><div class="NLM_p">The final structural modifications of lead compound <b>21</b> were aimed at reducing molecular lipophilicity while maintaining good inhibitory activities on the target enzymes. One approach aimed at the modulation of the p<i>K</i><sub>b</sub> of the basic head, through the elongation of an arm of the linker that allowed a higher distance between the two electron withdrawing phenyl rings from the basic nitrogen, resulting in lower p<i>K</i><sub>b</sub> and log <i>D</i>. This structural modification increased the distance between the two key binding moieties of <b>21</b>, that is, the coumarin ring and the <i>N</i>-benzyl group, giving rise to the more flexible <i>N</i>-benzyl, <i>N</i>-phenethyl analogue <b>42</b> (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). In addition, <i>N</i>-demethylated derivative <b>43</b> was synthesized to test the effect of having a more hydrophilic basic moiety endowed with HB-donor ability. Compared to compound <b>21</b>, the homologue <b>42</b> showed a similar activity toward eeAChE (IC<sub>50</sub> = 0.85 vs 0.75 μM) and rMAO-A (12% vs 7%), a much higher activity at esBChE (IC<sub>50</sub> = 0.52 vs 11 μM), and a decreased activity at rMAO-B (IC<sub>50</sub> = 4.1 vs 0.85 μM). To our surprise, the <i>N</i>-demethylated congener <b>43</b> reversed MAO selectivity, being the activity on rMAO-A higher than that on rMAO-B (IC<sub>50</sub> = 1.7 μM and 45% inhibition at 10 μM, respectively). The inhibition potency on eeAChE worsened (IC<sub>50</sub> = 4.7 vs 0.85 μM), while conversely the potency against esBChE remained nearly unchanged (IC<sub>50</sub> = 0.64 vs 0.52 μM). An additional less lipophilic analogue of <b>21</b>, namely <b>45</b> in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, was prepared through bioisosteric replacement of the 2<i>H</i>-chromen-2-one with the 2-quinolone as successfully done in the past for a dual binding site AChE inhibitor.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Actually, the activity toward both cholinesterases improved (IC<sub>50</sub> = 0.49 vs 0.75 μM and 1.7 vs 11 μM at eeAChE and esBChE, respectively) and the low activity on rMAO-A was maintained but, unexpectedly, the activity on rMAO-B dramatically decreased (29% inhibition at 10 μM vs IC<sub>50</sub> = 0.85 μM).</div><div class="NLM_p">As the homologation of the basic head and the isosteric replacement yielded unsatisfying results, compound <b>21</b> was modified by introducing polar groups on the coumarin core. The insertion of a polar cyano group on the coumarin ring at position 3 (comp. <b>35</b>) was highly detrimental for rMAO-B activity (41% at 10 μM vs IC<sub>50</sub> = 0.85 μM), while a 3- and 2-fold potency increase was observed against eeAChE (IC<sub>50</sub> = 0.20 vs 0.75 μM) and esBChE (IC<sub>50</sub> = 5.5 vs 11 μM), respectively. Better results on rMAO-B but much worse toward both ChEs came from the introduction of a second polar substituent, a <i>para</i>-cyano group on the <i>N</i>-benzyl ring (comp. <b>36</b>).</div><div class="NLM_p">Guided by docking simulations and a 3D-QSAR model recently developed from a large series of 4,7-disubstituted coumarins,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> a different, more polar substituent, that is the hydroxymethyl group, was introduced at position 4 of the coumarin core. Very satisfactorily, inhibitor <b>37</b> showed good inhibitory activities with the three target enzymes (IC<sub>50</sub> = 0.41, 0.42, and 1.1 μM at rMAO-B, eeAChE, and esBChE, respectively) and no activity on rMAO-A (0% inhibition at 10 μM). As for compounds <b>11</b> and <b>24</b>, also <b>37</b> showed a mixed-type inhibition mode (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C), with a <i>K</i><sub>i</sub> equal to 0.10 ± 0.01 μM. The <i>N</i>-demethylated derivative of <b>37</b>, that is compound <b>38</b>, was also prepared and tested. Its inhibitory potencies and selectivity profile (IC<sub>50</sub> = 0.53, 0.44, and 0.57 μM at rMAO-B, eeAChE, and esBChE, respectively, and 19% inhibition at rMAO-A at 10 μM) were very good and compared well with those of the <i>N</i>-methyl analogue.</div><div class="NLM_p">As previous SAR/3D-QSAR<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and current docking studies (data not shown) suggested favorable interactions of a halogen atom at the <i>meta</i> position of a benzyl ring at AChE and MAO-B binding sites, the <i>meta</i>-chloro derivative <b>39</b> was synthesized and tested. Its excellent inhibitory activities on the three target enzymes (IC<sub>50</sub> = 0.24, 0.25, and 0.63 μM for rMAO-B, eeAChE, and esBChE, respectively, and 0% inhibition toward rMAO-A at 10 μM) proved the goodness of our molecular design. Indeed, compound <b>39</b> attained the pursued combination of strong and well-balanced inhibitory potencies and an excellent rMAO-B over rMAO-A selectivity.</div><div class="NLM_p last">The introduction of a <i>para-</i>cyano substituent in the <i>N</i>-benzyl ring of <b>37</b> led to <b>40</b>, which showed an exquisite rMAO-B activity and selectivity (rMAO-B, IC<sub>50</sub> = 0.035 μM; rMAO-A, 0% inhibition at 10 μM) but also a dramatic drop of activity at eeAChE (IC<sub>50</sub> = 6.3 μM) and esBChE (23% inhibition at 10 μM), indeed resulting as the most potent MAO-B inhibitor of the whole set of compounds herein investigated.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Inhibitory Activities on Human Enzymes</h3><div class="NLM_p">The good biological profiles of many inhibitors toward MAO and ChE enzymes, prompted us to extend our inhibition assays to the corresponding human enzymes. On the basis of our previous studies,<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> significant changes of inhibitory activities were expected for hMAOs (generally an improvement, especially at hMAO-B), whereas more limited differences were awaited for hAChE inhibition. However, to gain further support to these general predictions and select compounds with high activity on hMAO-B and hAChE, a prospective docking study was performed on the series of inhibitors listed in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>. Inhibition activities on human enzymes were not assessed for compounds exhibiting low potency against the corresponding rMAO and eeAChE enzymes.</div><div class="NLM_p">Prospective docking simulations were carried out using GOLD Suite v5.2<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> on the X-ray crystal structures of AChE and MAO-B available from the PDB. For AChE studies, the X-ray crystal structures of <i>Torpedo californica</i> AChE (TcAChE) (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EVE">1EVE</a>) and human recombinant AChE (hAChE) (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7">4EY7</a>), both complexed with donepezil, were used. The careful inspection of the two crystal structures revealed that PAS and CAS binding sites of AChE are at about 18 Å distance (measured between the Cα carbon atoms of Trp86 and Trp286 of hAChE). Distances between the two putative binding moieties close to such a value might ensure efficient interactions at both PAS and CAS. On this basis, we conceived predictive docking studies aimed at forecasting the optimal length of the polymethylene spacer joining the pharmacophore features, ensuring strong AChE binding. In this respect, the in silico studies were focused on two compounds (<b>2</b> and <b>11</b> of <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), bridging the protonatable basic tail and the coumarin head with a short (trimethylene) or long (hexamethylene) linear linker, respectively. Interestingly, docking simulations returned similar poses for the two compounds, which were both able to engage steady π–π stacking interactions with the aromatic residues of Trp86 and Trp286. The compound bearing the longer linear linker showed a higher score (−106.2 kJ/mol for hAChE and −96.3 kJ/mol for TcAChE) compared to that bearing the shorter linker (score: −98.2 kJ/mol for hAChE and −88.6 kJ/mol for TcAChE). For clarity, a zoomed in view of top-scored solutions is shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>. Compounds <b>2</b> and <b>11</b> actually proved effective in inhibiting AChE, in good agreement with the docking scores.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Docking poses of inhibitor <b>2</b> (A) and <b>11</b> (B) into human AChE binding site (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7">4EY7</a>). Inhibitors are represented in sticks, while relevant amino acid residues are in ball-and-sticks, colored according to the atom code (C atoms in cyan and green for inhibitors and amino acid residues, respectively). Docking scores are equal to −98.2 and −106.2 kJ/mol for inhibitor <b>2</b> and <b>11</b>, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For MAO-B studies, the X-ray crystal structure of hMAO-B (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V60">2V60</a>) and a homology model for the rMAO-B were used. We performed a number of exploratory docking runs to assess whether the decoration of the well-known 7-benzyloxycoumarin with a protonatable amino tail (mimicking the basic head of donepezil) could be suitable in biasing also MAO-B. To this end, we docked three probe compounds (<b>23</b>, <b>32</b>, and <b>33</b> in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) into the binding site of MAO-B and observed that the ad hoc incorporated benzylamine fragment was located in a peripheral region surrounded by Tyr112, His115 (mutated to Tyr115 in rMAO-B), and Asn116. As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, the residue at position 115 is critical in establishing π–π stacking interactions with the terminal benzyl ring of <b>32</b>, although the scores at hMAO-B were consistently higher than those at rMAO-B. These interspecies differences were even more pronounced in enzyme inhibition potency of <b>32</b>, showing two log units higher activity at hMAO-B compared to rMAO-B (IC<sub>50</sub> = 0.017 vs 1.7 μM). We hypothesized that such scoring and biological differences in hMAO-B and rMAO-B can rely on a likely greater strength of the π–π stacking interactions engaged by the imidazole ring of His115 compared to that of the phenyl ring of Tyr115.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking poses of inhibitor <b>32</b> into human (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V60">2V60</a>) (A) and rat MAO-B (homology model) (B) binding sites. Inhibitors and FAD cofactor are represented in sticks, while relevant amino acid residues are in ball-and-sticks, colored according to the atom code (C atoms in cyan, yellow, and green for inhibitors, cofactor, and amino acid residues, respectively). Docking scores are equal to −88.21 and −80.22 kJ/mol for inhibitor <b>32</b> into human and rat isoforms, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The potential benefit of introducing a cyano group at the <i>para</i> position of the benzylamine was also challenged by docking compounds <b>23</b> and <b>33</b>. Actually, we did not observe any appreciable difference in the scores; however, the presence of the cyano group increased the rMAO-B inhibition approximately 10-fold (<b>23</b>, IC<sub>50</sub> = 4.1 μM vs <b>33</b>, IC<sub>50</sub> = 0.41 μM). We tentatively explained this experimental result by visually inspecting the docking poses of <b>23</b> and <b>33</b>. As shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>, the cyano group could form HBs (even water-mediated) with Asn116 or Tyr112.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Docking poses of inhibitor <b>23</b> (A) and <b>33</b> (B) into rat MAO-B binding site (homology model). Inhibitors and FAD cofactor are represented in sticks, while relevant amino acid residues in ball-and-sticks, colored according to the atom code (C atoms in cyan, yellow, and green for inhibitors, cofactor, and amino acid residues, respectively).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For the sake of completeness, additional modeling studies were conducted on <b>37</b>, one of the most potent multitarget inhibitors of the series. <b>37</b> was first docked into both hAChE and TcAChE to assess the binding interactions resulting from the substitution of an aliphatic linker with an aromatic one and of the 4-H atom with a more polar 4-hydroxymethyl group. Beyond hydrophobic interactions already described for inhibitors <b>2</b> and <b>11</b> bearing an aliphatic linker, inhibitor <b>37</b> was engaged in a π–π interaction involving the <i>para</i>-xylyl linker and the aromatic side chain of Tyr341 (hAChE numbering referred to PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7">4EY7</a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In addition, a HB occurred between the 4-hydroxymethyl group and Ser293 of hAChE as shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A. The higher score of <b>37</b> toward hAChE (−109.38 kJ/mol) compared to <b>2</b> and <b>11</b> may be therefore ascribed to both π–π and HB interactions (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A).</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Docking poses of inhibitor <b>37</b> into (A) hAChE (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7">4EY7</a>) and (B) hMAO-B (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V60">2V60</a>) binding sites. Inhibitors are represented in sticks, while relevant amino acid residues in ball-and-sticks, colored according to the atom code (C atoms in cyan and green for inhibitors and amino acid residues, respectively). Structural water molecules (that are HOH1159 and HOH1351 according to the numbering of <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V60">2V60</a>) are represented as red balls. Hydrogen bonds are represented as red dashed lines. Docking scores are equal to −109.38 and −95.95 kJ/mol for inhibitor <b>37</b> into hAChE and hMAO-B, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As reported in previous studies,<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68, 69)</a> the introduction of polar groups at position 4 of the coumarin scaffold improved physicochemically relevant properties (e.g., aqueous solubility and lipophilicity) while maintaining good MAO-B inhibitory potency and selectivity. Thus, inhibitor <b>37</b> was docked also on hMAO-B, resulting in a binding pose similar to that of <b>23</b>, <b>32</b>, and <b>33</b> but with a higher score (−95.95 kJ/mol). Most likely the high hMAO-B inhibitory potency arose from the formation of multiple HBs between the hydroxyl group and structural water molecules<a onclick="showRef(event, 'ref45 ref49 ref68'); return false;" href="javascript:void(0);" class="ref ref45 ref49 ref68">(45, 49, 68)</a> as illustrated in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B.</div><div class="NLM_p">Inhibition data in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> fulfilled our expectations and docking calculations. As far as the inhibitory activities on hMAO-B are concerned, a consistent increase of activity, from 2.5-fold for compound <b>2</b> up to 121-fold for <b>34</b>, was recorded, whereas the activities on hMAO-A remained low or were slightly incremented, from 2.7-fold for compound <b>11</b> to 18-fold for compound <b>12</b>. As the result, the hMAO-B over hMAO-A selectivity strongly raised. Actually, the SIs measured for compounds <b>37</b>, <b>39</b>, and <b>40</b> were 2210, 842, and 910, respectively. Because many other inhibitory activities on hMAO-A remained very low, the IC<sub>50</sub> values were not measured and the hMAO selectivity could not be exactly assessed. Nevertheless, taking into account the low percentage of inhibition of hMAO-A at 10 μM concentration, high hMAO-B over hMAO-A selectivity can be confidently foreseen also for inhibitors <b>21</b>, <b>31</b>, and <b>32</b>.</div><div class="NLM_p">It is worth noting that all the coumarin derivatives listed in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> attained submicromolar inhibitory activities on hMAO-B. Coumarin derivatives <b>37</b> and <b>40</b>, bearing the 4-CH<sub>2</sub>OH group, were the most potent inhibitors within the whole molecular series examined, with IC<sub>50</sub> values in the low nanomolar range (10 and 5.7 nM, respectively). Interestingly, some similarities and striking differences emerged by comparing inhibitory activities at rat and human MAO enzymes. For instance, 4-CH<sub>2</sub>OH-bearing coumarin derivatives <b>37</b>, <b>39</b>, and <b>40</b> resulted in the most active MAO-B inhibitors at both the human and rat enzymes, with compound <b>40</b> showing the highest activities (IC<sub>50</sub> = 0.0057 and 0.035 μM, respectively). It is noteworthy that the inverted selectivity observed on rMAOs for compound <b>11</b>, bearing the longest polymethylene linker, was maintained also on hMAOs.</div><div class="NLM_p">As anticipated in the Introduction, the selective inhibition of either AChE or BChE was not a primary aim of our work. Nonetheless, a number of representative compounds, that is <b>5</b>, <b>11</b>, <b>21</b>, <b>24</b>, <b>37</b>, and <b>39</b>, were tested also on hBChE (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Despite an 89.4% of amino acid sequence identity, the human and equine enzymes displayed significant differences in the catalytic site and even more in the peripheral sequence. Notably, Gly277, Pro285, and Phe398 in human mutated to Asp, Leu, and Ile, respectively, in equine. The amino acid numbering refers to hBChE as reported in PDB. Therefore, different inhibition potencies at the two enzymes may be expected and this was indeed observed for compounds <b>24</b>, <b>39</b>, <b>21</b>, and <b>37</b> (46% and 14% at 10 μM and IC<sub>50</sub> = 0.89 and 9.3 μM versus IC<sub>50</sub> = 0.69, 0.63, 11, and 1.1 μM, respectively). In contrast, compounds <b>5</b> and <b>11</b> displayed submicromolar inhibition potencies on hBChE close to the ones observed on esBChE.</div><div class="NLM_p">Appealing inhibition profiles resulted for compounds <b>5</b>, <b>37</b>, and <b>39</b>. The first displayed submicromolar potencies at all the four tested human enzymes, along with a significant, but limited, selectivity for hMAO-B (SI = 13.5) and no selectivity for either one of the two ChEs. The latter two showed high hMAO-B inhibitory potencies and selectivities (IC<sub>50</sub> = 10 and 24 nM, and SI = 1580 and 542, respectively) and also a good hAChE inhibitory potency and selectivity (IC<sub>50</sub> = 0.12 and 0.33 μM, and SI = 77.5 and ≫30, respectively).</div><div class="NLM_p last">Taking into account inhibition potencies, selectivity data, and physicochemical parameters, inhibitor <b>37</b> was selected for a preliminary evaluation of its ability to cross blood–brain barrier (BBB) and its cytotoxicity and cytoprotective properties.</div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">BBB Permeability and Toxicity Profiling of Compound <b>37</b></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">MDCK-MDR1 cell lines are known to express P-glycoprotein (P-gp), which plays an important role in the efflux transport of drugs from brain to blood. Thus, we were particularly interested to see if compound <b>37</b> was able to permeate by passive diffusion the BBB and to interact with P-gp as well. To this purpose, transport studies were performed on MDCKII-MDR1 cells which are characterized by high P-gp expression and represent a well-established in vitro model mimicking the BBB.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76, 77)</a> Transport studies were conducted in both apical-to-basal (AP-BL) and basal-to-apical (BL-AP) directions, and the results were reported in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>. Fluorescein isothiocyanate-dextran (FD4) and diazepam were used as paracellular and transcellular markers, respectively, of cell monolayers’ integrity and as internal controls to verify tight junction integrity during the assay; the results for controls were within the expected values. Both apparent permeabilities (AP-BL, 1.91 × 10<sup>–5</sup> cm·s<sup>–1</sup>; BL-AP, 3.38 × 10<sup>–5</sup> cm·s<sup>–1</sup>) were comparable with those of diazepam, thus supporting a good BBB penetration. The efflux ratio (ER) equal to 1.77 detected for compound <b>37</b> disclosed no significant differences in <i>P</i><sub>app</sub> values between AP-to-BL and BL-to-AP direction. Because a value of ER greater than 2 indicates that a test compound is likely to be a substrate for P-gp transport, the measured value suggested that compound should be able to permeate the monolayer without significant interactions with such efflux system.</div><div class="NLM_p">The effects of compound <b>37</b> on the viability of human neuroblastoma cell line SH-SY5Y were studied, using donepezil as reference compound. As shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>, compound <b>37</b>, like donepezil, was not cytotoxic at the tested concentrations ranging from 0.1 to 50 μM after 24, 48, and 72 h of incubation. The neuroprotective capacity of <b>37</b> against oxidative stress was also evaluated using the same cell line and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) for the generation of exogenous free radicals. Cells were incubated with <b>37</b> at two nontoxic concentrations (1 and 10 μM) for 24 h, then, H<sub>2</sub>O<sub>2</sub> (60 μM) was added and the cells maintained for further 24 h. Cell death was determined using the MTT assay. As shown in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>, compound <b>37</b> at 10 μM concentration prevented the H<sub>2</sub>O<sub>2</sub>-induced cell death (ca. 25%) with a statistically significant effect (<i>P</i> < 0.01).</div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0010.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Viability of human neuroblastoma SH-SY5Y cells exposed to compound <b>37</b> at different concentrations and incubation times. SH-SY5Y cells were incubated with increasing concentrations (range 0.1–50 μM) of the test compounds for 24, 48, and 72 h. Untreated cells were used as control. Results are expressed as percentage of viable cells observed after treatment with compounds <b>37</b> and donepezil vs untreated control cells (100%) and shown as mean ± SD (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0011.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Percentage of cell survival in the human neuroblastoma cell line SH-SY5Y of compound <b>37</b> in the following conditions: untreated cells (gray column), in the presence of H<sub>2</sub>O<sub>2</sub> (60 μM) alone (black column), in the presence of both H<sub>2</sub>O<sub>2</sub> (60 μM), and compound <b>37</b> (1 and 10 μM, white columns). Data represent means ± SD (<i>n</i> = 3); statistical significance was estimated using one-way ANOVA and Bonferroni post hoc test (** <i>P</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67733" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67733" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The most salient features emerging from the SARs and SSRs of the two classes of compounds examined in this paper can be summarized as follows. Highly flexible inhibitors of the <i>N</i>-benzyl, <i>N</i>-alkyloxy coumarin series in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> showed good inhibitory activities at the target enzymes when bearing a penta- or hexamethylene linkers but low selectivity (see compounds <b>5</b>, <b>6</b>, <b>11</b>, and <b>12</b> in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The inhibitors bearing a more rigid xylyl linker (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) displayed good inhibitory potencies and high rMAO-B over rMAO-A selectivity ratios. Compound <b>21</b>, a more rigid analogue of <b>6</b>, exhibited good activities and selectivity toward rMAO-B and eeAChE. <i>Meta</i>-chlorobenzyl analogues (i.e., <b>27</b>, <b>29</b>, and <b>30</b>) showed an improved inhibition at eeAChE but a worse inhibition at rMAO-B, whereas in contrast the <i>para</i>-cyanobenzyl analogues <b>31</b>, <b>33</b>, and <b>36</b> showed better potencies toward rMAO-B and decreased potencies toward eeAChE. The more polar and hydrophilic 4-hydroxymethyl derivatives <b>37</b>–<b>39</b> displayed the most interesting activity profiles with low submicromolar activity at the three target enzymes rMAO-B, eeAChE, and esBChE and low or no activity at rMAO-A.</div><div class="NLM_p">More interesting results came from the assays of selected inhibitors on human MAOs and AChE. In comparison with nonhuman enzymes, a significant increase of inhibitory activities was observed for hMAOs, more pronounced on hMAO-B, with a consequent increase of the selectivity index. More limited variations, generally a decrease of inhibitory potency, were instead observed with hAChE and hBChE. The most interesting inhibitors, e.g., <b>21</b>, <b>24</b>, <b>37</b>, and <b>39</b>, showed excellent activity profiles with low nanomolar inhibitory potency on hMAO-B, high MAO-B over MAO-A selectivity, and submicromolar potency on hAChE. Kinetic inhibition data and docking studies on selected compounds suggested a mixed-type mechanism of inhibition and binding interactions at both the CAS and PAS of AChE. Therefore, our compounds do behave as dual binding site inhibitors and have the potential to block another pathological mechanism of AD, that is, the AChE-promoted Aβ aggregation taking place at the PAS.<a onclick="showRef(event, 'ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref78 ref79">(78, 79)</a></div><div class="NLM_p">Ultimately, our hybridization strategy proved successful in designing and optimizing novel coumarin-containing compounds targeting MAO-B and ChEs, two key enzymes involved in AD, PD, and other neurodegenerative diseases, with well-balanced inhibition potencies. Activity, selectivity, and physicochemical properties were improved compared to other ligands targeting the same enzymes described so far.<a onclick="showRef(event, 'ref53 ref54 ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref53 ref54 ref55 ref56 ref57">(53-57)</a> Moreover, toxicity, neuroprotection, and transport data, as preliminarily assessed using cell-based models, suggested that the 4-hydroxymethyl coumarin derivative <b>37</b>, which resulted the most promising inhibitor, is devoid of significant neurotoxicity, shows moderate neuroprotective effects against H<sub>2</sub>O<sub>2</sub>-induced cell death, as well as a good BBB permeability profile with limited P-gp affinity.</div><div class="NLM_p last">In conclusion, some of the multipotent inhibitors reported herein, and compound <b>37</b> in particular, may be considered promising leads for further preclinical studies in cognitive and neurodegenerative disease models.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemistry</h3><div class="NLM_p">Starting materials, reagents, and analytical grade solvents were purchased from Sigma-Aldrich Europe. All reactions were routinely checked by TLC using Merck Kieselgel 60 F254 aluminum plates and visualized by UV light. Microwave reactions were performed in a Milestone MicroSynth apparatus, setting temperature and hold times, fixing maximum irradiation power to 500 W and heating ramp times to 2 min. The purity of all the intermediates was checked by <sup>1</sup>H NMR and ESI-MS. ESI-MS analyses were performed on an Agilent 1100 LC–MSD trap system VL. Flash chromatographic separations were performed on a Biotage SP1 purification system using flash cartridges prepacked with KP-Sil 32–63 μm, 60 Å silica. Elemental analyses were performed on a EuroEA 3000 analyzer only on the final compounds. The measured values for C, H, and N agreed to within ±0.40% of the theoretical values. Melting points (MP) were taken on a Gallenkamp MFB 595010 M apparatus (open capillary method) and are uncorrected. Nuclear magnetic resonance (NMR) spectra were recorded at 300 MHz on a Varian Mercury 300 instrument at ambient temperature in the specified deuterated solvent. Chemical shifts (δ) are quoted in parts per million (ppm) and are referenced to the residual solvent peak. The coupling constants <i>J</i> are given in hertz (Hz). The following abbreviations were used: s (singlet), d (doublet), t (triplet), dd (doublet of doublet), m (multiplet), brs (broad signal). Signals due to NH/OH protons were located by deuterium exchange with D<sub>2</sub>O. Noncommercial 7-hydroxy-3-methylcoumarin,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> 7-hydroxy-3,4-dimethylcoumarin,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> 7-hydroxy-3-cyanocoumarin,<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> and 7-hydroxy-4-(hydroxymethyl)coumarin,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> were prepared as referenced.</div><div class="NLM_p last">Analytical data of final compounds <b>2</b>–<b>40</b>, <b>42</b>, <b>43</b>, and <b>45</b> are reported in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>. Analytical details and spectroscopic data of all the intermediates <b>1a</b>–<b>k</b> and final compounds are available as <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure for the Synthesis of 7-(ω-Bromoalkyloxy)-3,4-dimethylcoumarins <b>1a</b>–<b>d</b>, 7-(3-(bromomethyl)benzyloxy)coumarin <b>1e</b>, and 7-(4-(Bromomethyl)benzyloxy)-3,4-substituted Coumarins <b>1f</b>–<b>k</b></h3><div class="NLM_p">A Pyrex vessel was charged with a magnetic stirring bar, and then the appropriate 7-hydroxycoumarin derivative (5.0 mmol) and potassium carbonate (0.70 g, 5.0 mmol) were suspended in dry acetonitrile (20 mL). The suitable commercially available dibromo-derivative (1,ω-dibromoalkane or α,α′-dibromo-<i>m</i>-xylene or α,α′-dibromo-<i>p</i>-xylene, 25 mmol) was added. The reactor was placed in a microwave apparatus and irradiated at 130 °C for 30 min. After cooling to room temperature, the solid residue was filtered and washed with dichloromethane. The solution was concentrated to dryness, and the resulting crude was purified through flash chromatography (gradient eluent, different mixtures of ethyl acetate in <i>n</i>-hexane).</div><div id="sec8_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-(4-(Bromomethyl)phenyl)ethanol (<b>41a</b>)</h4><div class="NLM_p last">(4-Bromomethyl)phenylacetic acid (0.60 g, 2.6 mmol) was dissolved under magnetic stirring with 8 mL of anhydrous THF in a flame-dried round-bottomed flask kept to 0 °C. Borane·dimethyl sulfide (0.40 mL, 3.9 mmol) was then added dropwise and the mixture carefully cooled to room temperature and then left for additional 2 h. Water was cautiously added, and the organic solvent was evaporated. Aqueous layer was extracted with ethyl acetate; the organic layers were collected, dried over sodium sulfate, and evaporated to dryness to give the title product. Yield: 87%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 2.69 (t, <i>J</i> = 7.1 Hz, 2H), 3.57 (t, <i>J</i> = 7.1 Hz, 1H, exch D<sub>2</sub>O), 3.79–3.87 (m, 2H), 4.66 (s, 2H), 7.18 (d, <i>J</i> = 7.7 Hz, 2H), 7.33 (d, <i>J</i> = 7.7 Hz, 2H).</div></div><div id="sec8_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 7-{[4-(2-Hydroxyethyl)benzyl]oxy}-2<i>H</i>-chromen-2-one (<b>41b</b>)</h4><div class="NLM_p last">A Pyrex vessel was charged with a magnetic stirring bar, and then 7-hydroxycoumarin (0.32 g, 2.0 mmol) and potassium carbonate (0.28 g, 2.0 mmol) were suspended in dry acetone (12 mL). Bromide <b>41a</b> (0.43 g, 2.0 mmol) was added, and the reactor was placed in a microwave apparatus and irradiated at 130 °C for 30 min. After cooling to room temperature, the solid residue was filtered and washed with dichloromethane. The solution was concentrated to dryness, and the resulting oil was purified through flash chromatography (gradient eluent, methanol in dichloromethane 0% → 10%). Yield: 77%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 2.70 (t, <i>J</i> = 7.1 Hz, 2H), 3.56–3.61 (m, 2H), 4.59–4.63 (m, 1H, exch. D<sub>2</sub>O), 5.15 (s, 2H), 6.27 (d, <i>J</i> = 9.6 Hz, 1H), 6.98–7.06 (m, 2H), 7.35 (d, <i>J</i> = 8.0 Hz, 2H), 7.22 (d, <i>J</i> = 8.0 Hz, 2H), 7.62 (d, <i>J</i> = 8.5 Hz, 1H), 7.97 (d, <i>J</i> = 9.6 Hz, 1H).</div></div><div id="sec8_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 7-(4-(2-Bromoethyl)benzyloxy)-2<i>H</i>-chromen-2-one (<b>41c</b>)</h4><div class="NLM_p last">Intermediate <b>41b</b> (0.40 g, 1.4 mmol) was dissolved in 5.0 mL of anhydrous dichloromethane under stirring with carbon tetrabromide (0.49 g, 1.5 mmol). To this mixture, a solution of triphenylphosphine (0.43 g, 1.6 mmol) in 5.0 mL of anhydrous dichloromethane was dropped at 0 °C and the resulting solution was kept at room temperature for 4 h. Evaporation of the solvent and purification by flash chromatography (gradient eluent, ethyl acetate in <i>n</i>-hexane 0% → 60%) afforded bromide <b>41c</b>. Yield: 77% yield. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.12 (t, <i>J</i> = 7.1 Hz, 2H), 3.72 (t, <i>J</i> = 7.1 Hz, 2H), 5.17 (s, 2H), 6.28 (d, <i>J</i> = 9.6 Hz, 1H), 7.00 (dd, <i>J</i><sub>1</sub> = 8.5 Hz, <i>J</i><sub>2</sub> = 2.5 Hz, 1H), 7.06 (d, <i>J</i> = 2.5 Hz, 1H), 7.29 (d, <i>J</i> = 8.0 Hz, 2H), 7.40 (d, <i>J</i> = 8.0 Hz, 2H), 7.62 (d, <i>J</i> = 8.5 Hz, 1H), 7.97 (d, <i>J</i> = 9.6 Hz, 1H).</div></div><div id="sec8_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (2<i>E</i>)-<i>N</i>-(3-Methoxyphenyl)-3-phenylacrylamide (<b>44a</b>)</h4><div class="NLM_p last">To a suspension of <i>trans</i>-cinnamic acid (0.89 g, 6.0 mmol) in dry dichloromethane (5.0 mL), thionyl chloride (5.0 mL) was added. The resulting reaction mixture was refluxed for 6 h and then concentrated to dryness. The oily residue was dissolved in dry dichloromethane (20 mL), and <i>m</i>-anisidine (0.67 mL, 6.0 mmol) was slowly added. After refluxing for 4 h, the solvent was evaporated under vacuum and the resulting crude was crystallized from hot ethanol. Yield: 70%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 3.73 (s, 3H), 6.61–6.66 (m, 1H), 6.81 (d, <i>J</i> = 15.7 Hz, 1H), 7.18–7.25 (m, 2H), 7.36–7.46 (m, 4H), 7.53–7.62 (m, 3H), 10.17 (s, 1H, exch, D<sub>2</sub>O).</div></div><div id="sec8_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 7-Hydroxy-2-quinolinone (<b>44b</b>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></h4><div class="NLM_p last">Phenylacrylamide <b>44a</b> (0.63 g, 2.5 mmol) was dissolved in chlorobenzene (12 mL) in a flame-dried round-bottomed flask. AlCl<sub>3</sub> (1.3 g, 10 mmol) was added portionwise while cooling to 0 °C. The reaction mixture was refluxed for 8 h, then cooled and poured into crushed ice. The resulting precipitate was washed with chloroform followed by diethyl ether, thus yielding the desired intermediate. Yield: 67%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 6.19 (d, <i>J</i> = 9.3 Hz, 1H), 6.59–6.71 (m, 2H), 7.42 (d, <i>J</i> = 8.3 Hz, 1H), 7.72 (d, <i>J</i> = 9.3 Hz, 1H), 10.08 (s, 1H, exch. D<sub>2</sub>O), 11.48 (s, 1H, exch. D<sub>2</sub>O).</div></div><div id="sec8_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 7-(4-(Bromomethyl)benzyloxy)-2<i>H</i>-quinolin-2-one (<b>44c</b>)</h4><div class="NLM_p last">In a Pyrex vessel charged with a magnetic and a Weflon stirring bar, phenol <b>44b</b> (0.24 g, 1.5 mmol) and potassium carbonate (0.21 g, 1.5 mmol) were suspended in dry acetone (10 mL). α,α′-Dibromo-<i>p</i>-xylene (1.2 g, 4.5 mmol) was added, and the reactor was placed in a microwave apparatus and irradiated at 130 °C for 30 min. After cooling to room temperature, the solid residue was filtered off and washed with dichloromethane. The solution was concentrated to dryness, and the resulting crude solid was purified through flash chromatography (gradient eluent, methanol in dichloromethane 0% → 10%). Yield: 49%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ: 4.71 (s, 2H), 5.13 (s, 2H), 6.28 (d, <i>J</i> = 9.3 Hz, 1H), 6.84–6.85 (m, 2H), 7.40–7.57 (m, 5H), 7.78 (d, <i>J</i> = 9.3 Hz, 1H), 11.60 (brs, 1H, exch. D<sub>2</sub>O).</div></div></div><div id="sec8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure for the Synthesis of Final Compounds <b>2</b>–<b>40</b>, <b>42</b>, <b>43</b>, and <b>45</b></h3><div class="NLM_p last">Appropriate bromide <b>1a</b>–<b>k</b>, <b>41c</b>, or <b>44c</b> (0.50 mmol) were suspended under magnetic stirring in 4.0 mL of anhydrous acetonitrile in a Pyrex microwave reactor in the presence of potassium carbonate (0.64 g, 0.50 mmol) and a catalytic amount of potassium iodide (for compounds <b>2</b>–<b>12</b> and <b>42</b>–<b>43</b>). Benzylamine (2.5 mmol), suitable substituted <i>N-</i>methylbenzylamine<a onclick="showRef(event, 'ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref81 ref82">(81, 82)</a> (0.75 mmol), or <i>N</i>-ethylbenzylamine (0.75 mmol) was added. The vessel was placed in a microwave apparatus and heated at 130 °C for 30 min. After cooling to room temperature, the reaction mixture was poured into ice-cold water (50 g) and extracted with dichloromethane (3 × 20 mL). The organic fractions were collected, dried over anhydrous sodium sulfate, and evaporated to dryness to give a residue that was crystallized from an appropriate solvent (as indicated in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) or purified by flash chromatography (gradient eluent: different mixtures of methanol in dichloromethane or ethyl acetate in <i>n</i>-hexane). Compounds <b>2</b>, <b>3</b>, <b>7</b>–<b>10</b>, and <b>12</b> were crystallized as hydrochlorides by treatment with HCl 1.25 N in ethanol. Compounds <b>5</b>, <b>14</b>, <b>16</b>–<b>18</b>, <b>22</b>–<b>37</b>, <b>39</b>–<b>40</b>, <b>42</b>, <b>43</b>, and <b>45</b> were transformed into the corresponding hydrochloride salts by treating the crude oil with HCl 4.0 N in 1,4-dioxane (commercially available) or by dissolving the solid crude in the minimum volume of 1,4-dioxane before adding HCl 4.0 N in 1,4-dioxane.</div></div><div id="sec8_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Rat and Human Monoamine Oxidase Inhibition Assays</h3><div class="NLM_p">rMAO inhibitory activity of compounds in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1–3">Tables 1–3</a> was assessed using a continuous spectrophotometric assay,<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> monitoring the rate of oxidation of the nonselective nonfluorescent MAO substrate kynuramine to 4-hydroxyquinoline. MAO-A and MAO-B activities in rat mitochondrial preparations were assayed using as the controls the selective and irreversible inhibitors clorgyline (250 nM) and (−)-<span class="smallcaps smallerCapital">l</span>-deprenyl (250 nM), respectively. IC<sub>50</sub> values were determined by nonlinear regression of MAO inhibition vs −log of the concentration plots, using the program Origin, version 6.0 (Microcal Software Inc., Northampton, MA).</div><div class="NLM_p">Human monoamine oxidase inhibition assays were carried out with a fluorescence based method,<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> also using kynuramine as nonselective substrate of MAO-A and MAO-B. Briefly, reactions were performed in triplicate in black, flat-bottomed polystyrene 96-well microtiter plates (FluoroNunc/LumiNund, MaxiSorpTM surface, NUNC, Roskild, Denmark) containing potassium phosphate buffer (158 μL), an aqueous stock solution of kynuramine 0.5 mM (final kynuramine concentration corresponding to 50 μM), and DMSO solution of inhibitor in final concentrations ranging from 10<sup>–4</sup> to 10<sup>–11</sup> M. Samples were incubated at 37 °C, and then diluted human recombinant MAO-A and MAO-B (Supersomes; BD Gentest, Woburn, MA) were delivered to obtain final protein concentrations of 0.009 and 0.015 mg/mL, respectively. Incubation was carried out at 37 °C for 30 min, and then the reactions were stopped by addition of 75 μL of 2N NaOH.</div><div class="NLM_p last">Formation of 4-hydroxyquinoline was quantified with a 96-well microplate fluorescence reader (FLx 800, BioTek Instruments, Inc. Winoosli, USA) at excitation/emission wavelengths of 310/400 nm (20 nm slit width for excitation, 30 nm slit width for emission). Inhibitory activities (IC<sub>50</sub>s) were determined by means of nonlinear regressions performed with GraphPad Prism 5.0 software. Results are the mean of at least two independent experiments.</div></div><div id="sec8_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Electric Eel, Equine Serum, and Human Cholinesterases Inhibition Assays</h3><div class="NLM_p last">The spectrophotometric Ellman’s test<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> for in vitro inhibition assay of AChE from electric eel (463 U/mg; Sigma) and BChE from equine serum (13 U/mg; Sigma) was followed as previously described.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The concentration of compound which determined 50% inhibition of the cholinesterase activity (IC<sub>50</sub>) was calculated by nonlinear regression of the response/log(concentration) curve, using GraphPad Prism version 5. Kinetic studies were performed with the same test conditions, using six concentrations of substrate (from 0.033 to 0.2 mM) and four concentrations of inhibitor (0–1 μM). Apparent inhibition constants and kinetic parameters were calculated within the “Enzyme kinetics” module of Prism. Inhibition tests on human recombinant AChE (2770 U/mg; Sigma) and BChE from human serum (50 U/mg; Sigma) were run under the same experimental conditions used for eeAChE.</div></div><div id="sec8_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Bidirectional Transport Studies on MDCKII-MDR1 Monolayers</h3><div class="NLM_p">MDCKII-MDR1 cells were cultured in DMEM medium and seeded at a density of 100000 cell/cm<sup>2</sup> onto polyester 12-well Transwell inserts (pore size 0.4 μm, 12 mm diameter, apical volume 0.5 mL, basolateral volume 1.5 mL). MDCKII-MDR1 cell barrier function was verified prior to the described transport experiments by means of trans-epithelial electrical resistance (TEER) using an EVOM apparatus, and the measurement of the flux of fluorescein isothiocyanate–dextran (FD4, Sigma-Aldrich, Italy) (200 μg/mL) and diazepam (75 μM). The TEER was measured in growth media (DMEM) at room temperature and calculated as the measured resistance minus the resistance of an empty Transwell (blank without cells). Cell monolayers with TEER values 800 Ohm/cm<sup>2</sup> were used. Following the TEER measurements, the cells were equilibrated in transport medium in both the apical and basolateral chambers for 30 min at 37 °C. The composition of transport medium was as follows: 0.4 mM K<sub>2</sub>HPO<sub>4</sub>, 25 mM NaHCO<sub>3</sub>, 3 mM KCl, 122 mM NaCl, and 10 mM glucose, pH = 7.4, and osmolarity 300 mOsm as determined by a freeze point based osmometer. At time 0, culture medium was aspirated from both the AP and BL chambers of each insert, and cell monolayers were washed three times (10 min per wash) with Dulbecco’s Phosphate Buffered Saline (DPBS) pH = 7.4. Finally, a solution of compound diluted in transport medium was added to the apical or basolateral chamber. For AP-to-BL or BL-to-AP flux studies, the drug solution was added in the AP chamber or in the BL chamber, respectively. Except for FD4, which was solubilized directly in the assay medium at a concentration of 200 μg/mL, the other compounds were first dissolved in DMSO and then diluted with the assay medium to a final concentration of 75 μM. Next, the tested solutions were added to the donor side (0.5 mL for the AP chamber and 1.5 mL for the BL chamber), and fresh assay medium was placed in the receiver compartment. The percentage of DMSO never exceeded 1% (v/v) in the samples. The transport experiments were carried out under cell culture conditions (37 °C, 5% CO<sub>2</sub>, 95% humidity). After incubation time of 120 min, samples were removed from the apical and basolateral side of the monolayer and then stored until further analysis.</div><div class="NLM_p">Quantitative analysis of compounds <b>37</b> and diazepam were performed through UV–visible (Vis) spectroscopy using a PerkinElmer double-beam UV–visible spectrophotometer Lambda Bio 20 (Milan, Italy), equipped with 10 mm path-length-matched quartz cells. Standard calibration curves were prepared at maximum absorption wavelength of each compound using PBS as solvent and were linear (<i>r</i><sup>2</sup> = 0.999) over the range of tested concentration (from 5 to 100 μM). The FD4 samples were analyzed with a Victor3 fluorimeter (Wallac Victor3, 1420 multilabel counter, PerkinElmer) at excitation and emission wavelengths of 485 and 535 nm, respectively. Each compound was tested in triplicate, and the experiments were repeated three times.</div><div class="NLM_p last">The apparent permeability, in units of cm/s, was calculated using the following equation:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/jm-2015-00599b_m001.gif" alt="" /></img></span>where “<i>V</i><sub>A</sub>” is the volume in the acceptor well, “area” is the surface area of the membrane, “time” is the total transport time, “[drug]<sub>acceptor</sub>” is the concentration of the drug measured by UV-spectroscopy, and “[drug]<sub>initial</sub>” is the initial drug concentration in the AP or BL chamber. Efflux ratio (ER) was calculated using the following equation: ER = <i>P</i><sub>app</sub>, BL-AP/<i>P</i><sub>app</sub>, AP-BL, where <i>P</i><sub>app</sub>, BL-AP is the apparent permeability of basal-to-apical transport, and <i>P</i><sub>app</sub>, AP-BL is the apparent permeability of apical-to-basal transport. An efflux ratio greater than 2 indicates that a test compound is likely to be a substrate for P-gp transport.</div></div><div id="sec8_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Cytotoxicity Assays</h3><div class="NLM_p last">Human neuroblastoma cells SH-SY5Y were maintained at 37 °C in a humidified incubator containing 5% CO<sub>2</sub> in DMEM nutrient (Lonza) supplemented with 10% heat inactivated FBS, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin. Cells were dispensed into 96-well microtiter plates at a density of 10000 cells/well. Following overnight incubation, cells were treated with a range of compound concentrations (0.1–50 μM). Then the plates were incubated at 37 °C for 24, 48, and 72 h. An amount of 10 μL of 0.5% w/v MTT was further added to each wel,l and the plates were incubated for an additional 3 h at 37 °C. Finally the cells were lysed by addition of 100 μL of DMSO/EtOH 1:1 (v/v) solution. The absorbance at 570 nm was determined using a PerkinElmer 2030 multilabel reader Victor TM X3.</div></div><div id="sec8_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Neuroprotection against Oxidative Stress</h3><div class="NLM_p last">Human neuroblastoma SH-SY5Y cells were dispensed into 96-well microtiter plates at a density of 10000 cells/well. Following overnight incubation, cells were treated with a range of compound concentrations (1 and 10 μM) at time zero and maintained for 24 h. Then, the media were replaced by fresh media still containing the drug plus the cytotoxic stimulus represented by 60 μM H<sub>2</sub>O<sub>2</sub> that was left for an additional 24 h period. Thereafter, cell survival was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay. The putative cytotoxic effects of <b>37</b> and of H<sub>2</sub>O<sub>2</sub> were studied by exposing the cells to the compound at the highest concentration used in the neuroprotection studies for 24 h. Each compound was tested in triplicate, and the experiments were repeated three times. Statistical significance was assigned to <i>p</i> < 0.01 and calculated using a one-way analysis of variance (ANOVA) followed by the Bonferroni post hoc tests (GraphPad Prism vers. 5). Where indicated, standard error of the mean (SD) for data points has been calculated and the number of experiments is given (<i>n</i>).</div></div><div id="sec8_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Molecular Docking</h3><div class="NLM_p last">GOLD (version 5.2), a genetic algorithm-based software, was used for the docking study. ChemPLP was selected as a fitness function. Automatic genetic algorithm parameter settings were used. All the crystal structures used in docking simulations were retrieved from the Protein Data Bank. In particular, the entry codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EVE">1EVE</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7">4EY7</a> were downloaded for modeling hAChE and TcAChE, respectively; the entry code<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V60"> 2V60</a> was downloaded for hMAO-B, whereas a previously built homology modeling was used for rMAO-B.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The Protein Preparation Wizard available from Schroedinger<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> was used for the protein pretreatment in order to add missing hydrogen atoms, define the protonation states at pH equal to 7.4. and tautomers for histidine residues and to soft-minimize the whole structure. For each simulation, 10 conformations were generated for each inhibitor in a sphere of a 17 Å, using as references the centroids of ligand cocrystallized in <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EVE">1EVE</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V60">2V60</a>. In MAO docking runs, the X-ray coordinates of 7-(3-chlorobenzyloxy)-4-carboxaldehyde-coumarin taken from <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V60">2V60</a> were used asa scaffold to constrain bias binding mode toward MAO-B. In addition, the side chains of Glu206, Tyr112, Asn116, and His115 (mutated to Tyr115 in the case of rMAO-B) were set be flexible. Finally, eight ordered water molecules were explicitly taken into account in docking runs, as elsewhere reported.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00599">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Analytical and spectroscopic (<sup>1</sup>H NMR) data for intermediates <b>1a</b>–<b>k</b> and final compounds <b>2</b>–<b>40</b>, <b>42</b>, <b>43</b>, and <b>45</b> (PDF); SMILES data (CSV). The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b00599" class="ext-link">10.1021/acs.jmedchem.5b00599</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00599/suppl_file/jm5b00599_si_001.pdf">jm5b00599_si_001.pdf (196.71 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00599/suppl_file/jm5b00599_si_002.csv">jm5b00599_si_002.csv (2.43 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00599" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25074" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25074" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Catto</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, Via E. Orabona 4, I-70125 Bari, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5e333f2c3d31703d3f2a2a311e2b30373c3f70372a"><span class="__cf_email__" data-cfemail="f4999586979bda979580809bb4819a9d9695da9d80">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angelo Carotti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, Via E. Orabona 4, I-70125 Bari, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#14757a7371787b3a7775667b60607d54617a7d76753a7d60"><span class="__cf_email__" data-cfemail="e1808f86848d8ecf8280938e959588a1948f888380cf8895">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberta Farina</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, Via E. Orabona 4, I-70125 Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leonardo Pisani</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, Via E. Orabona 4, I-70125 Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Orazio Nicolotti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, Via E. Orabona 4, I-70125 Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Domenico Gadaleta</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, Via E. Orabona 4, I-70125 Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nunzio Denora</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, Via E. Orabona 4, I-70125 Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramon Soto-Otero</span> - <span class="hlFld-Affiliation affiliation">Grupo
de Neuroquimica, Departamento de Bioquimica y Biologia Molecular,
Facultad de Medicina, Universidad de Santiago
de Compostela, San Francisco
I, E-15782, Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Estefania Mendez-Alvarez</span> - <span class="hlFld-Affiliation affiliation">Grupo
de Neuroquimica, Departamento de Bioquimica y Biologia Molecular,
Facultad de Medicina, Universidad de Santiago
de Compostela, San Francisco
I, E-15782, Santiago
de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carolina S. Passos</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, University of
Geneva, University of Lausanne, Quai Ernest Ansermet 30, CH-1211, Geneva 4, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanni Muncipinto</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, Via E. Orabona 4, I-70125 Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cosimo D. Altomare</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari “Aldo Moro”, Via E. Orabona 4, I-70125 Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandra Nurisso</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, University of
Geneva, University of Lausanne, Quai Ernest Ansermet 30, CH-1211, Geneva 4, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pierre-Alain Carrupt</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, University of
Geneva, University of Lausanne, Quai Ernest Ansermet 30, CH-1211, Geneva 4, Switzerland</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors contributed to the writing of the manuscript, gave approval to the final version of the manuscript and declared no conflict of interest.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d3205e5199-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46118" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46118" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">WE thank MIUR (Rome, Italy) for partial financial support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i41" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i41"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> Abbreviations Used</h2><tr><td class="NLM_term">3D-QSAR</td><td class="NLM_def"><p class="first last">three-dimensional quantitative structure–activity relationships</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">beta amyloid protein</p></td></tr><tr><td class="NLM_term">ACh</td><td class="NLM_def"><p class="first last">acetylcholine</p></td></tr><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">AChEI</td><td class="NLM_def"><p class="first last">AChE inhibitors</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">BChE</td><td class="NLM_def"><p class="first last">butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">CAS</td><td class="NLM_def"><p class="first last">catalytic anionic binding site</p></td></tr><tr><td class="NLM_term">DBS</td><td class="NLM_def"><p class="first last">dual binding site</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s Modified Eagle Medium</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">ESI-MS</td><td class="NLM_def"><p class="first last">electrospray ionization mass spectrometry</p></td></tr><tr><td class="NLM_term">FAD</td><td class="NLM_def"><p class="first last">flavin adenine dinucleotide</p></td></tr><tr><td class="NLM_term">FD4</td><td class="NLM_def"><p class="first last">fluorescein isothiocyanate-dextran</p></td></tr><tr><td class="NLM_term">MAO-A</td><td class="NLM_def"><p class="first last">monoamine oxidase A</p></td></tr><tr><td class="NLM_term">MAO-B</td><td class="NLM_def"><p class="first last">monoamine oxidase B</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">ND</td><td class="NLM_def"><p class="first last">neurodegenerative disease</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub> AP-BL</td><td class="NLM_def"><p class="first last">apparent permeability apical-to-basal</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub> BL-AP</td><td class="NLM_def"><p class="first last">apparent permeability basal-to-apical</p></td></tr><tr><td class="NLM_term">PAS</td><td class="NLM_def"><p class="first last">peripheral anionic binding site</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">SSR</td><td class="NLM_def"><p class="first last">structure–selectivity relationships</p></td></tr><tr><td class="NLM_term">TEER</td><td class="NLM_def"><p class="first last">trans-epithelial electrical resistance</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21671" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21671" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 84 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Banerjee, S.</span><span> </span><span class="NLM_article-title">The Macroeconomics of Dementia—Will the World Economy get Alzheimer’s Disease?</span> <span class="citation_source-journal">Arch. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">709</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2Fj.arcmed.2012.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23085453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FmvVKgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2012&pages=705-709&author=S.+Banerjee&title=The+Macroeconomics+of+Dementia%E2%80%94Will+the+World+Economy+get+Alzheimer%E2%80%99s+Disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The macroeconomics of dementia--will the world economy get Alzheimer's disease?</span></div><div class="casAuthors">Banerjee Sube</div><div class="citationInfo"><span class="NLM_cas:title">Archives of medical research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">705-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Health is firmly on the economic radar.  It is big business.  In 2009, the proportion of the Gross Domestic Product spent on health care varied between 6.4% in Mexico and 17.4% in the U.S., with the UK at 9.8% and Germany, Switzerland and Canada ∼11%.  These are considerable amounts of money and they are growing.  With all projections pointing to a growth in the numbers of older people, the pressure on budgets will only increase.  In this paper we will consider the role of dementia in this.  METHODS:  Demographic and economic data were combined and policy implications developed.  RESULTS:  The costs of dementia dwarf those of the illnesses that are currently prioritized at a national and international level such as HIV, cancer, heart disease, stroke and diabetes.  Based on simple demographics, the costs of dementia are set to increase by 85% by 2030, with developing countries bearing an increasing share of the economic burden.  CONCLUSIONS:  The data suggest that dementia is a clear and present economic challenge for the world from the macro level down to the individual.  Before the crisis, governmental structural primary deficits were generally improving and this would have given time and resource to meet the challenges of ageing in general and dementia in particular.  However, increasing government debt over the past 3 years has had the effect of our needing to implement reforms to contain the risks to sovereign budgets sooner rather than later.  This is not an issue that can be ignored.  Inaction will only lead to further debt accumulation in the medium term and the death of systems of care in the long term.  Across the developed world, the main long-term fiscal challenges come from health care costs, and dementia is a major driver of those costs.  There is a need for budgetary consolidation and pension reform more generally.  But, given that dementia is the highest ticket health and social care item that we have, making up 60% of long term care spending according to some estimates, then targeted investment in early intervention and in research (into causes, cure and care) are likely to be of major value in personal, societal, political, and economic terms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSR6ETBO6bFkf69nzq6467DfW6udTcc2ebZ2Sbh3KQ2Ubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FmvVKgtg%253D%253D&md5=0c003dabd300569448962f65a056cf3c</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2Fj.arcmed.2012.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arcmed.2012.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26atitle%3DThe%2520Macroeconomics%2520of%2520Dementia%25E2%2580%2594Will%2520the%2520World%2520Economy%2520get%2520Alzheimer%25E2%2580%2599s%2520Disease%253F%26jtitle%3DArch.%2520Med.%2520Res.%26date%3D2012%26volume%3D43%26spage%3D705%26epage%3D709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Narayan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehsani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S.</span><span> </span><span class="NLM_article-title">Combating Neurodegenerative Disease with Chemical Probes and Model Systems</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">911</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1038%2Fnchembio.1663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=25325702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOisrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=911-920&author=P.+Narayanauthor=S.+Ehsaniauthor=S.+Lindquist&title=Combating+Neurodegenerative+Disease+with+Chemical+Probes+and+Model+Systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Combating neurodegenerative disease with chemical probes and model systems</span></div><div class="casAuthors">Narayan, Priyanka; Ehsani, Sepehr; Lindquist, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">911-920</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The disheartening results of recent clin. trials for neurodegenerative disease (ND) therapeutics underscore the need for a more comprehensive understanding of the underlying disease biol. before effective therapies can be devised.  One hallmark of many NDs is a disruption in protein homeostasis.  Therefore, investigating the role of protein homeostasis in these diseases is central to delineating their underlying pathobiol.  Here, we review the seminal role that chem. biol. has played in furthering the research on and treatment of dysfunctional protein homeostasis in NDs.  We also discuss the vital and predictive role of model systems in identifying conserved homeostasis pathways and genes therein that are altered in neurodegeneration.  Integrating approaches from chem. biol. with the use of model systems yields a powerful toolkit with which to unravel the complexities of ND biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXPyatlzrBVLVg90H21EOLACvtfcHk0lgqX3uuSNs_HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOisrzE&md5=440b79365af1fb637ad7db8e51b1149f</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1663%26sid%3Dliteratum%253Aachs%26aulast%3DNarayan%26aufirst%3DP.%26aulast%3DEhsani%26aufirst%3DS.%26aulast%3DLindquist%26aufirst%3DS.%26atitle%3DCombating%2520Neurodegenerative%2520Disease%2520with%2520Chemical%2520Probes%2520and%2520Model%2520Systems%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D911%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Trippier, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labby, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawker, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mataka, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3121</span><span class="NLM_x">–</span> <span class="NLM_lpage">3147</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3015926" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFeju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3121-3147&author=P.+C.+Trippierauthor=K.+J.+Labbyauthor=D.+D.+Hawkerauthor=J.+J.+Matakaauthor=R.+B.+Silverman&title=Target-+and+Mechanism-Based+Therapeutics+for+Neurodegenerative+Diseases%3A+Strength+in+Numbers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers</span></div><div class="casAuthors">Trippier, Paul C.; Jansen Labby, Kristin; Hawker, Dustin D.; Mataka, Jan J.; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3121-3147</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of new therapeutics for the treatment of neurodegenerative pathophysiologies currently stands at a crossroads.  This presents an opportunity to transition future drug discovery efforts to target disease modification, an area in which much still remains unknown.  In this Perspective we examine recent progress in the areas of neurodegenerative drug discovery, focusing on some of the most common targets and mechanisms: N-methyl-d-aspartic acid (NMDA) receptors, voltage gated calcium channels (VGCCs), neuronal nitric oxide synthase (nNOS), oxidative stress from reactive oxygen species, and protein aggregation.  These represent the key players identified in neurodegeneration and are part of a complex, intertwined signaling cascade.  The synergistic delivery of two or more compds. directed against these targets, along with the design of small mols. with multiple modes of action, should be explored in pursuit of more effective clin. treatments for neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjl83DGjxqKrVg90H21EOLACvtfcHk0lg-0uxNS-zadw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFeju78%253D&md5=a8ea6d8cf4f9d3bba76d40ceacc9c26d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm3015926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3015926%26sid%3Dliteratum%253Aachs%26aulast%3DTrippier%26aufirst%3DP.%2BC.%26aulast%3DLabby%26aufirst%3DK.%2BJ.%26aulast%3DHawker%26aufirst%3DD.%2BD.%26aulast%3DMataka%26aufirst%3DJ.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DTarget-%2520and%2520Mechanism-Based%2520Therapeutics%2520for%2520Neurodegenerative%2520Diseases%253A%2520Strength%2520in%2520Numbers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3121%26epage%3D3147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Alzheimer’s Association</span><span> </span><span class="NLM_article-title">2015 Alzheimer’s disease facts and figures</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2Fj.jalz.2015.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=25984581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=332-384&author=Alzheimer%E2%80%99s+Association&title=2015+Alzheimer%E2%80%99s+disease+facts+and+figures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2015.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2015.02.003%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3D2015%2520Alzheimer%25E2%2580%2599s%2520disease%2520facts%2520and%2520figures%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2015%26volume%3D11%26spage%3D332%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Misra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhi, B.</span><span> </span><span class="NLM_article-title">Drug Development Status for Alzheimer’s Disease: Present Scenario</span> <span class="citation_source-journal">Neurol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1007%2Fs10072-013-1316-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23392897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A280%3ADC%252BC3szms1Kitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=831-839&author=S.+Misraauthor=B.+Medhi&title=Drug+Development+Status+for+Alzheimer%E2%80%99s+Disease%3A+Present+Scenario"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Drug development status for Alzheimer's disease: present scenario</span></div><div class="casAuthors">Misra Shubham; Medhi Bikash</div><div class="citationInfo"><span class="NLM_cas:title">Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">831-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recent advances in the understanding of Alzheimer's disease pathogenesis have led to the development of numerous compounds that might ameliorate the disease process.  Research in the field of Alzheimer's disease therapy has been partly successful in terms of developing symptomatic treatments, but also had several failures in terms of developing disease-modifying therapies.  These successes and failures have led to a debate about the potential deficiencies in our understanding of the pathogenesis of Alzheimer's disease and potential pitfalls in diagnosis, choice of therapeutic targets, development of drug candidates, and design of clinical trials.  Many clinical and experimental studies are ongoing, but we need to acknowledge that a single cure for Alzheimer's disease is unlikely to be found and that the approach to drug development for this disorder needs to be reconsidered.  Preclinical research is constantly providing us with new information on pieces of the complex Alzheimer's disease puzzle, and an analysis of this information might reveal patterns of pharmacological interactions instead of single potential drug targets.  Several promising randomized controlled trials are ongoing, and the increased collaboration between pharmaceutical companies, basic researchers, and clinical researchers has the potential to bring us closer to developing an optimum pharmaceutical approach for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR91t6pN3J72a_dlEzl_fBafW6udTcc2eZySX_RdySMF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szms1Kitg%253D%253D&md5=fd14da8bea6c53dbc5c00bfd961421d9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs10072-013-1316-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10072-013-1316-x%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DS.%26aulast%3DMedhi%26aufirst%3DB.%26atitle%3DDrug%2520Development%2520Status%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Present%2520Scenario%26jtitle%3DNeurol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D831%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Berk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, M. N.</span><span> </span><span class="NLM_article-title">Successes and Failures for Drugs in Late-Stage Development for Alzheimer’s Disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">792</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1007%2Fs40266-013-0108-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=783-792&author=C.+Berkauthor=M.+N.+Sabbagh&title=Successes+and+Failures+for+Drugs+in+Late-Stage+Development+for+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs40266-013-0108-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-013-0108-6%26sid%3Dliteratum%253Aachs%26aulast%3DBerk%26aufirst%3DC.%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26atitle%3DSuccesses%2520and%2520Failures%2520for%2520Drugs%2520in%2520Late-Stage%2520Development%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DDrugs%2520Aging%26date%3D2013%26volume%3D10%26spage%3D783%26epage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Querfurth, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1056%2FNEJMra0909142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=20107219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=329-344&author=H.+W.+Querfurthauthor=F.+M.+LaFerla&title=Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Querfurth, Henry W.; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-344</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The role of β-amyloid peptide in spontaneous self-aggregation in brain in Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPeniV_Jn6orVg90H21EOLACvtfcHk0lg-0uxNS-zadw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D&md5=c116f6a6b8fed9af9f5282cc4b755c70</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0909142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0909142%26sid%3Dliteratum%253Aachs%26aulast%3DQuerfurth%26aufirst%3DH.%2BW.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D329%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chakrabarti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakurta, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, M.</span><span> </span><span class="NLM_article-title">Oxidative Stress and Amyloid Beta Toxicity in Alzheimer’s Disease: Intervention in a Complex Relationship by Antioxidants</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4648</span><span class="NLM_x">–</span> <span class="NLM_lpage">4664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.2174%2F09298673113209990152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23834172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWktLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=4648-4664&author=S.+Chakrabartiauthor=M.+Sinhaauthor=I.+G.+Thakurtaauthor=P.+Banerjeeauthor=M.+Chattopadhyay&title=Oxidative+Stress+and+Amyloid+Beta+Toxicity+in+Alzheimer%E2%80%99s+Disease%3A+Intervention+in+a+Complex+Relationship+by+Antioxidants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress and Amyloid Beta Toxicity in Alzheimerμs Disease: Intervention in a Complex Relationship by Antioxidants</span></div><div class="casAuthors">Chakrabarti, S.; Sinha, M.; Thakurta, I. G.; Banerjee, P.; Chattopadhyay, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">4648-4664</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The elucidation of the intriguing relationship between oxidative stress and Alzheimer's disease is crucial to understand the pathogenesis of the disease as also to design a suitable drug trial with antioxidants against this condition.  We begin by reviewing the basic facts about Alzheimer's disease and the chem. and biol. of oxygen free radicals with particular ref. to the cellular adaptive response through redox-signalling pathways.  The post-mortem evidence of oxidative damage in the brain of Alzheimer's disease patients is overwhelming which is also supported by the similar changes in transgenic mice models of this disease.  However, the causal relationship of oxidative stress with amyloid beta pathol. or the genesis of Alzheimer's disease is not clear.  Considering the available evidence the review suggests that the oxidative stress could be an early event in the disease process and may trigger various adaptive responses such as the alterations of amyloid beta metab. and the activation of stress responsive kinases which can subsequently lead to neuronal degeneration and AD pathol.  Further, we have presented a large body of evidence from various studies to highlight the beneficial effects of antioxidants against amyloid beta toxicity or AD pathol. in animal or cell based models of AD.  The failure of clin. trials with antioxidants against AD has been mentioned and the possible causes of such failures have been analyzed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbccFT304pFbVg90H21EOLACvtfcHk0lj1UD0xb-KCGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWktLbM&md5=4800a4d627796a80debab27e8b694dd6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F09298673113209990152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113209990152%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DS.%26aulast%3DSinha%26aufirst%3DM.%26aulast%3DThakurta%26aufirst%3DI.%2BG.%26aulast%3DBanerjee%26aufirst%3DP.%26aulast%3DChattopadhyay%26aufirst%3DM.%26atitle%3DOxidative%2520Stress%2520and%2520Amyloid%2520Beta%2520Toxicity%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Intervention%2520in%2520a%2520Complex%2520Relationship%2520by%2520Antioxidants%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D4648%26epage%3D4664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Terry, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span> </span><span class="NLM_article-title">The Cholinergic Hypothesis of Age and Alzheimer’s Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">827</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1124%2Fjpet.102.041616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=12805474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVehsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=821-827&author=A.+V.+Terryauthor=J.+J.+Buccafusco&title=The+Cholinergic+Hypothesis+of+Age+and+Alzheimer%E2%80%99s+Disease-Related+Cognitive+Deficits%3A+Recent+Challenges+and+Their+Implications+for+Novel+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development</span></div><div class="casAuthors">Terry, A. V., Jr.; Buccafusco, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">821-827</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The cholinergic hypothesis was initially presented over 20 yr ago and suggests that a dysfunction of acetylcholine contg. neurons in the brain contributes substantially to the cognitive decline obsd. in those with advanced age and Alzheimer's disease (AD).  This premise has since served as the basis for the majority of treatment strategies and drug development approaches for AD to date.  Recent studies of the brains of patients who had mild cognitive impairment or early stage AD in which choline acetyltransferase and/or acetylcholinesterase activity was unaffected (or even up-regulated) have, however, led some to challenge the validity of the hypothesis as well as the rationale for using cholinomimetics to treat the disorder, particularly in the earlier stages.  These challenges, primarily based on assays of post mortem enzyme activity, should be taken in perspective and evaluated within the wide range of cholinergic abnormalities known to exist in both aging and AD.  The results of both post mortem and antemortem studies in aged humans and AD patients, as well as animal expts. suggest that a host of cholinergic abnormalities including alterations in choline transport, acetylcholine release, nicotinic and muscarinic receptor expression, neurotrophin support, and perhaps axonal transport may all contribute to cognitive abnormalities in aging and AD.  Cholinergic abnormalities may also contribute to noncognitive behavioral abnormalities as well as the deposition of toxic neuritic plaques in AD.  Therefore, cholinergic-based strategies will likely remain valid as one approach to rational drug development for the treatment of AD other forms of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPatJs_N3wu7Vg90H21EOLACvtfcHk0lj1UD0xb-KCGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVehsb8%253D&md5=bd52a7d752cc5e51a3866c3ed2ace8f0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.041616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.041616%26sid%3Dliteratum%253Aachs%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Cholinergic%2520Hypothesis%2520of%2520Age%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease-Related%2520Cognitive%2520Deficits%253A%2520Recent%2520Challenges%2520and%2520Their%2520Implications%2520for%2520Novel%2520Drug%2520Development%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D821%26epage%3D827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Anand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, B.</span><span> </span><span class="NLM_article-title">A Review on Cholinesterase Inhibitors for Alzheimer’s Disease</span> <span class="citation_source-journal">Arch. Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1007%2Fs12272-013-0036-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23435942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=375-399&author=P.+Anandauthor=B.+Singh&title=A+Review+on+Cholinesterase+Inhibitors+for+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A review on cholinesterase inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Anand, Preet; Singh, Baldev</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-399</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), a progressive neurodegenerative disorder, is characterized by the deficits in the cholinergic system and deposition of beta amyloid (Aβ) in the form of neurofibrillary tangles and amyloid plaques.  Since the cholinergic system plays an important role in the regulation of learning and memory processes, it has been targetted for the design of anti-Alzheimer's drugs.  Cholinesterase inhibitors enhance cholinergic transmission directly by inhibiting the enzyme acetylcholinesterase (AChE) which hydrolyzes acetylcholine.  Furthermore, it has been also demonstrated that both acetylcholinesterase and butrylcholinesterase (BuChE) play an important role in Aβ-aggregation during the early stages of senile plaque formation.  Therefore, AChE and BuChE inhibition have been documented as crit. targets for the effective management of AD by an increase in the availability of acetylcholine in the brain regions and decrease in the Aβ deposition.  This review discusses the different classes of cholinesterase inhibitors including tacrine, donepezil, rivastigmine, galantamine, xanthostigmine, para-aminobenzoic acid, coumarin, flavonoid, and pyrrolo-isoxazole analogs developed for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe8p6U3r94ubVg90H21EOLACvtfcHk0lj1UD0xb-KCGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWju70%253D&md5=a8b48dbf6a7e7b988759182ad8cd9b6a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs12272-013-0036-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-013-0036-3%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DB.%26atitle%3DA%2520Review%2520on%2520Cholinesterase%2520Inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DArch.%2520Pharm.%2520Res.%26date%3D2013%26volume%3D36%26spage%3D375%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Cheewakriengkrai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span> </span><span class="NLM_article-title">A 10-Year Perspective on Donepezil</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1517%2F14656566.2013.760543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23316713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVeqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=331-338&author=L.+Cheewakriengkraiauthor=S.+Gauthier&title=A+10-Year+Perspective+on+Donepezil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A 10-year perspective on</span></div><div class="casAuthors">Cheewakriengkrai, Laksanun; Gauthier, Serge</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-338</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: is the first cholinesterase inhibitor widely used for the treatment of Alzheimer's disease (AD).  Its pharmacol. actions are straightforward, enhancing cholinergic activity both in the brain and systemically, with a long-enough half-life to allow for once a day dosing.  Its efficacy has been approved for use in mild-to-moderate AD stage for improvement of symptoms for 10 years, and now it is also approved for use in severe stage.Areas covered: This review article will offer a 10-yr perspective on the use of donepezil in clin. practice against AD and related disorders.  In addn. to discussing the information from randomized clin. trials and from the drug monograph, this article will seek to facilitate the clin. development and clin. use of the next generation of drugs for AD.Expert opinion: Adjustments about expectations and safe use of donepezil were made over time based on such clin. experiences.  Offering a cholinesterase inhibitor to patients with mild-to-moderate AD clearly showed advantages.  If well tolerated, donepezil should be continued in the severe stages of AD as long as the patient appears to benefit from a slower clin. decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqisQxuCbLA-bVg90H21EOLACvtfcHk0li8Kes8ErclRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVeqt7g%253D&md5=af78c5a7ba73b97ac2a1710c063f1fed</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F14656566.2013.760543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2013.760543%26sid%3Dliteratum%253Aachs%26aulast%3DCheewakriengkrai%26aufirst%3DL.%26aulast%3DGauthier%26aufirst%3DS.%26atitle%3DA%252010-Year%2520Perspective%2520on%2520Donepezil%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2013%26volume%3D14%26spage%3D331%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossberg, G. T.</span><span> </span><span class="NLM_article-title">Use of Memantine for the Treatment of Dementia</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1586%2Fern.11.132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=21955192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ClsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=1359-1370&author=D.+Loauthor=G.+T.+Grossberg&title=Use+of+Memantine+for+the+Treatment+of+Dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Use of memantine for the treatment of dementia</span></div><div class="casAuthors">Lo, Daphne; Grossberg, George T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1359-1370</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  The term dementia'' encompasses a no. of neurodegenerative diseases of which Alzheimer''s disease (AD) is the most common.  Prior to 2003, cholinesterase inhibitors, such as donezepil, were the only class of drugs approved to treat mild-to-moderate AD.  In 2003, memantine became the first drug approved by the US FDA to treat moderate-to-severe AD.  Currently, both memantine and donepezil are FDA approved for the treatment of moderate-to-severe AD.  This article examines the pharmacol. profile of memantine, evidence for memantine''s efficacy in moderate-to-severe AD and other dementias, its novel use in other neuropsychiatric disorders and future implications and research directions for memantine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGdBuGdnw3bVg90H21EOLACvtfcHk0li8Kes8ErclRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ClsbnM&md5=1108b2e6b6328bbafa7394f43205e450</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1586%2Fern.11.132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.11.132%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DD.%26aulast%3DGrossberg%26aufirst%3DG.%2BT.%26atitle%3DUse%2520of%2520Memantine%2520for%2520the%2520Treatment%2520of%2520Dementia%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2011%26volume%3D11%26spage%3D1359%26epage%3D1370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Darvesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geula, C.</span><span> </span><span class="NLM_article-title">Neurobiology of Butyrylcholinesterase</span> <span class="citation_source-journal">Nature Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1038%2Fnrn1035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=131-138&author=S.+Darveshauthor=D.+A.+Hopkinsauthor=C.+Geula&title=Neurobiology+of+Butyrylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrn1035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1035%26sid%3Dliteratum%253Aachs%26aulast%3DDarvesh%26aufirst%3DS.%26aulast%3DHopkins%26aufirst%3DD.%2BA.%26aulast%3DGeula%26aufirst%3DC.%26atitle%3DNeurobiology%2520of%2520Butyrylcholinesterase%26jtitle%3DNature%2520Rev.%2520Neurosci.%26date%3D2003%26volume%3D2%26spage%3D131%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalk, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehret-Sabatier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goeldner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelsen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Quaternary Ligand Binding to Aromatic Residues in the Active-Site Gorge of Acetylcholinesterase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">9031</span><span class="NLM_x">–</span> <span class="NLM_lpage">9035</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1073%2Fpnas.90.19.9031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=8415649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVCgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=9031-9035&author=M.+Harelauthor=I.+Schalkauthor=L.+Ehret-Sabatierauthor=F.+Bouetauthor=M.+Goeldnerauthor=C.+Hirthauthor=P.+H.+Axelsenauthor=I.+Silmanauthor=J.+L.+Sussman&title=Quaternary+Ligand+Binding+to+Aromatic+Residues+in+the+Active-Site+Gorge+of+Acetylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase</span></div><div class="casAuthors">Harel, M.; Schalk, I.; Ehret-Sabatier, L.; Bouet, F.; Goeldner, M.; Hirth, C.; Axelsen, P. H.; Silman, I.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9031-5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The binding sites of Torpedo acetylcholinesterase (AChE; EC 3.1.1.7) for quaternary ligands were investigated by x-ray crystallog. and photoaffinity labeling.  The crystal structures of complexes with ligands were detd. at 2.8-Å resoln.  In a complex with edrophonium, the quaternary N atom of the ligand interacted with the indole of Trp-84, and its m-OH group displayed bifurcated H-bonding to 2 members of the catalytic triad, Ser-200 and His-440.  In a complex with tacrine, the acridine was stacked against the indole of Trp-84.  The bisquaternary ligand, decamethonium, was oriented along the narrow gorge leading to the active site; one quaternary group was apposed to the indole of Trp-84 and the other to that of Trp-279, near the top of the gorge.  The only major conformational difference between the 3 complexes was in the orientation of the Ph ring of Phe-330.  In the decamethonium complex, it lay parallel to the surface of the gorge; in the other 2 complexes it was positioned to make contact with the bound ligand.  This close interaction was confirmed by photoaffinity labeling by the photosensitive probe, 3H-labeled p-(N,N-dimethylamino)benzenediazonium fluoroborate, which labeled, predominantly, Phe-330 within the active site.  The labeling of Trp-279 was also obsd.  One mole of label was incorporated per mol of AChE inactivated, indicating that the labeling of Trp-279 and that of Phe-330 were mutually exclusive.  The structural and chem. data, together, showed the important role of arom. groups as binding sites for quaternary ligands, and they provided complementary evidence assigning Trp-84 and Phe-330 to the anionic subsite of the active site and Trp-279 to the peripheral anionic site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVCccIwJSrW7Vg90H21EOLACvtfcHk0li8Kes8ErclRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVCgtrc%253D&md5=6ee8dbaf1919d254a1cb62895f1a4444</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.19.9031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.19.9031%26sid%3Dliteratum%253Aachs%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DSchalk%26aufirst%3DI.%26aulast%3DEhret-Sabatier%26aufirst%3DL.%26aulast%3DBouet%26aufirst%3DF.%26aulast%3DGoeldner%26aufirst%3DM.%26aulast%3DHirth%26aufirst%3DC.%26aulast%3DAxelsen%26aufirst%3DP.%2BH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DQuaternary%2520Ligand%2520Binding%2520to%2520Aromatic%2520Residues%2520in%2520the%2520Active-Site%2520Gorge%2520of%2520Acetylcholinesterase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1993%26volume%3D90%26spage%3D9031%26epage%3D9035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kryger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Structure of Acetylcholinesterase Complexed with E2020 (Aricept): Implications for the Design of New Anti-Alzheimer Drugs</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2FS0969-2126%2899%2980040-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10368299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADyaK1MXitFGitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=297-307&author=G.+Krygerauthor=I.+Silmanauthor=J.+L.+Sussman&title=Structure+of+Acetylcholinesterase+Complexed+with+E2020+%28Aricept%29%3A+Implications+for+the+Design+of+New+Anti-Alzheimer+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs</span></div><div class="casAuthors">Kryger, Gitay; Silman, Israel; Sussman, Joel L.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-307</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Background: Several cholinesterase inhibitors are either being utilized for symptomatic treatment of Alzheimer's disease or are in advanced clin. trials.  E2020, marketed as Aricept, is a member of a large family of N-benzylpiperidine-based acetylcholinesterase (AChE) inhibitors developed, synthesized, and evaluated by the Eisai Company in Japan.  These inhibitors were designed on the basis of QSAR studies, prior to elucidation of the 3-dimensional structure of Torpedo californica AChE (TcAChE).  E2020 significantly enhances performance in animal models of cholinergic hypofunction and has a high affinity for AChE, binding to both elec. eel and mouse AChE in the nanomolar range.  Results: The exptl. structure of the E2020-TcAChE complex pinpoints specific interactions responsible for the high affinity and selectivity demonstrated previously.  It shows that E2020 has an unique orientation along the active-site gorge, extending from the anionic subsite of the active site, at the bottom, to the peripheral anionic site, at the top, via arom. stacking interactions with conserved arom. amino acid residues.  E2020 does not, however, interact directly with either the catalytic triad or the oxyanion hole, but only indirectly via solvent mols.  Conclusions: The study shows, a posteriori, that the design of E2020 took advantage of several important features of the active-site gorge of AChE to produce a drug with both high affinity for AChE and a high degree of selectivity for AChE vs. butyrylcholinesterase (BChE).  It also delineates voids within the gorge that are not occupied by E2020 and could provide sites for potential modification of E2020 to produce drugs with improved pharmacol. profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgomkZ6v86u7Vg90H21EOLACvtfcHk0lj2rw77YM3YdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFGitbo%253D&md5=e91e20bdfea0a795ced76fac5aee1205</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2899%2980040-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252899%252980040-9%26sid%3Dliteratum%253Aachs%26aulast%3DKryger%26aufirst%3DG.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DStructure%2520of%2520Acetylcholinesterase%2520Complexed%2520with%2520E2020%2520%2528Aricept%2529%253A%2520Implications%2520for%2520the%2520Design%2520of%2520New%2520Anti-Alzheimer%2520Drugs%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D297%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valgimigli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amorati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolondi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djemil, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">From the Dual Function Lead AP2238 to AP2469, a Multi-Target-Directed Ligand for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Pharmacol. Res. Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">e00023</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=e00023&author=A.+Tarozziauthor=M.+Bartoliniauthor=L.+Piazziauthor=L.+Valgimigliauthor=R.+Amoratiauthor=C.+Bolondiauthor=A.+Djemilauthor=F.+Manciniauthor=V.+Andrisanoauthor=A.+Rampa&title=From+the+Dual+Function+Lead+AP2238+to+AP2469%2C+a+Multi-Target-Directed+Ligand+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DValgimigli%26aufirst%3DL.%26aulast%3DAmorati%26aufirst%3DR.%26aulast%3DBolondi%26aufirst%3DC.%26aulast%3DDjemil%26aufirst%3DA.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DFrom%2520the%2520Dual%2520Function%2520Lead%2520AP2238%2520to%2520AP2469%252C%2520a%2520Multi-Target-Directed%2520Ligand%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2014%26volume%3D2%26spage%3De00023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Dvira, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase: From 3D Structure to Function</span> <span class="citation_source-journal">Chem. Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2Fj.cbi.2010.01.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=20138030" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2010&pages=10-22&author=H.+Dviraauthor=I.+Silmanauthor=M.+Harelauthor=T.+L.+Rosenberryauthor=J.+L.+Sussman&title=Acetylcholinesterase%3A+From+3D+Structure+to+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2010.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2010.01.042%26sid%3Dliteratum%253Aachs%26aulast%3DDvira%26aufirst%3DH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DAcetylcholinesterase%253A%2520From%25203D%2520Structure%2520to%2520Function%26jtitle%3DChem.%2520Biol.%2520Interact.%26date%3D2010%26volume%3D187%26spage%3D10%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giangreco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Coumarin Derivatives Tethered to an Edrophonium-like Fragment as Highly Potent and Selective Dual Binding Site Acetylcholinesterase Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1616</span><span class="NLM_x">–</span> <span class="NLM_lpage">1630</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1616-1630&author=L.+Pisaniauthor=M.+Cattoauthor=I.+Giangrecoauthor=F.+Leonettiauthor=O.+Nicolottiauthor=A.+Stefanachiauthor=S.+Cellamareauthor=A.+Carotti&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Coumarin+Derivatives+Tethered+to+an+Edrophonium-like+Fragment+as+Highly+Potent+and+Selective+Dual+Binding+Site+Acetylcholinesterase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DGiangreco%26aufirst%3DI.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Coumarin%2520Derivatives%2520Tethered%2520to%2520an%2520Edrophonium-like%2520Fragment%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Dual%2520Binding%2520Site%2520Acetylcholinesterase%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1616%26epage%3D1630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesce, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Coumarin Alkylamines as Potent and Selective Dual Binding Site Inhibitors of Acetylcholinesterase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=146-152&author=M.+Cattoauthor=L.+Pisaniauthor=F.+Leonettiauthor=O.+Nicolottiauthor=P.+Pesceauthor=A.+Stefanachiauthor=S.+Cellamareauthor=A.+Carotti&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Coumarin+Alkylamines+as+Potent+and+Selective+Dual+Binding+Site+Inhibitors+of+Acetylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DPesce%26aufirst%3DP.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Coumarin%2520Alkylamines%2520as%2520Potent%2520and%2520Selective%2520Dual%2520Binding%2520Site%2520Inhibitors%2520of%2520Acetylcholinesterase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D146%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Homo- and Heterobivalent Edrophonium-like Ammonium Salts as Highly Potent, Dual Binding Site AChE Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">7450</span><span class="NLM_x">–</span> <span class="NLM_lpage">7456</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=7450-7456&author=F.+Leonettiauthor=M.+Cattoauthor=O.+Nicolottiauthor=L.+Pisaniauthor=A.+Cappaauthor=A.+Stefanachiauthor=A.+Carotti&title=Homo-+and+Heterobivalent+Edrophonium-like+Ammonium+Salts+as+Highly+Potent%2C+Dual+Binding+Site+AChE+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCappa%26aufirst%3DA.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DHomo-%2520and%2520Heterobivalent%2520Edrophonium-like%2520Ammonium%2520Salts%2520as%2520Highly%2520Potent%252C%2520Dual%2520Binding%2520Site%2520AChE%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D7450%26epage%3D7456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Conejo-Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Carmen Nunez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Homodimeric Bis-Quaternary Heterocyclic Ammonium Salts as Potent Acetyl- and Butyrylcholinesterase Inhibitors: A Systematic Investigation of the Influence of Linker and Cationic Heads over Affinity and Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2627</span><span class="NLM_x">–</span> <span class="NLM_lpage">2645</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101299d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2627-2645&author=A.+Conejo-Garciaauthor=L.+Pisaniauthor=M.+del+Carmen+Nunezauthor=M.+Cattoauthor=O.+Nicolottiauthor=F.+Leonettiauthor=J.+M.+Camposauthor=M.+A.+Galloauthor=A.+Espinosaauthor=A.+Carotti&title=Homodimeric+Bis-Quaternary+Heterocyclic+Ammonium+Salts+as+Potent+Acetyl-+and+Butyrylcholinesterase+Inhibitors%3A+A+Systematic+Investigation+of+the+Influence+of+Linker+and+Cationic+Heads+over+Affinity+and+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm101299d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101299d%26sid%3Dliteratum%253Aachs%26aulast%3DConejo-Garcia%26aufirst%3DA.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3Ddel%2BCarmen%2BNunez%26aufirst%3DM.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCampos%26aufirst%3DJ.%2BM.%26aulast%3DGallo%26aufirst%3DM.%2BA.%26aulast%3DEspinosa%26aufirst%3DA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DHomodimeric%2520Bis-Quaternary%2520Heterocyclic%2520Ammonium%2520Salts%2520as%2520Potent%2520Acetyl-%2520and%2520Butyrylcholinesterase%2520Inhibitors%253A%2520A%2520Systematic%2520Investigation%2520of%2520the%2520Influence%2520of%2520Linker%2520and%2520Cationic%2520Heads%2520over%2520Affinity%2520and%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2627%26epage%3D2645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giangreco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Discovery of a Potent and Selective Hetero-bivalent AChE Inhibitor via Bioisosteric Replacement</span> <span class="citation_source-journal">Mol. Inform.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1002%2Fminf.201000126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjs1Wrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=133-136&author=O.+Nicolottiauthor=L.+Pisaniauthor=M.+Cattoauthor=F.+Leonettiauthor=I.+Giangrecoauthor=A.+Stefanachiauthor=A.+Carotti&title=Discovery+of+a+Potent+and+Selective+Hetero-bivalent+AChE+Inhibitor+via+Bioisosteric+Replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective Hetero-Bivalent AChE Inhibitor via Bioisosteric Replacement</span></div><div class="casAuthors">Nicolotti, Orazio; Pisani, Leonardo; Catto, Marco; Leonetti, Francesco; Giangreco, Ilenia; Stefanachi, Angela; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">133-136</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The concept of the scaffold hopping was applied via the bioisosteric replacement from coumarin to quinolone to develop new and potent hetero-bivalent acetylcholinesterase inhibitors.  This study showed that the rational design inspired by fundamental principles of medicinal chem. represents still a valid strategy for mol. discovery.  In particular, the docking-assisted bioisosteric replacement from 4-methylcoumarin to 1,4-dimethylquinolin-2(1H)-one proved successful for the discovery of new bioactive mol. entities with improved affinity and selectivity towards AChE.  Indeed, the 1-methylquinolin-2(1H)-one ring is a privileged structure occurring in a large no. of compds. biasing many biol. targets but never so far AChE and BChE.  In this regards, addnl. studies are on the way to enhance the results herein described through the synthesis of a new series of having decorated and augmented analogs of inhibitors that might found potential therapeutic applications in AD, and glaucoma, neuromuscular blockade after surgical anesthesia and myasthenia gravis, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrd6N-NSSWCbVg90H21EOLACvtfcHk0lhs2x3e2WvExg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjs1Wrurs%253D&md5=c171b8ea96c5a67669f2df0867edbcc2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fminf.201000126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201000126%26sid%3Dliteratum%253Aachs%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DGiangreco%26aufirst%3DI.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520and%2520Selective%2520Hetero-bivalent%2520AChE%2520Inhibitor%2520via%2520Bioisosteric%2520Replacement%26jtitle%3DMol.%2520Inform.%26date%3D2011%26volume%3D30%26spage%3D133%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Candia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borisova, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varlamov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voskressensky, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span> </span><span class="NLM_article-title">Ester Derivatives of Annulated Tetrahydroazocines: A New Class of Selective Acetylcholinesterase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">7205</span><span class="NLM_x">–</span> <span class="NLM_lpage">7212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2Fj.bmc.2006.06.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=16843666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFGjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=7205-7212&author=A.+Carottiauthor=M.+De+Candiaauthor=M.+Cattoauthor=T.+N.+Borisovaauthor=A.+V.+Varlamovauthor=E.+Mendez-Alvarezauthor=R.+Soto-Oteroauthor=L.+G.+Voskressenskyauthor=C.+Altomare&title=Ester+Derivatives+of+Annulated+Tetrahydroazocines%3A+A+New+Class+of+Selective+Acetylcholinesterase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Ester derivatives of annulated tetrahydroazocines: A new class of selective acetylcholinesterase inhibitors</span></div><div class="casAuthors">Carotti, Andrea; de Candia, Modesto; Catto, Marco; Borisova, Tatiana N.; Varlamov, Alexey V.; Mendez-Alvarez, Estefania; Soto-Otero, Ramon; Voskressensky, Leonid G.; Altomare, Cosimo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7205-7212</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of ester derivs. of annulated tetrahydroazocines, namely 2,3,6,11-tetrahydro-1H-azocino[4,5-b]indoles (5-10), 2,3,6,7-tetrahydro-1H-azocino[5,4-b]indoles (11-14), and 4,7,8,9-tetrahydro-1H-pyrrolo[2,3-d]azocines (15-18), synthesized through an efficient 6 → 8 membered ring expansion procedure, were investigated for their acetylcholinesterase (AChE) inhibitory activities.  Most of the compds. acted as AChE inhibitors in vitro, with IC50 values ranging from 5 to 40 μM.  The most potent compds. 11 and 15, both as racemic mixts., proved selective toward AChE, exhibiting selectivity ratios vs. butyrylcholinesterase (BuChE) of ca. 15 and more than 20, resp.  Structure-activity studies highlighted, among other factors, lipophilicity as a property modulating the AChE inhibition potency, as shown by a reasonable parabolic correlation between pIC50 and exptl. 1-octanol/water partition coeff. (log P), which described the prevailing behavior of the examd. compds. (r2 = 0.665).  Mol. docking simulations using the X-ray crystal structure of AChE from Torpedo californica suggested possible binding modes of the tetrahydroazocine ester derivs. 11 and 15.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUaZF-2sZJcrVg90H21EOLACvtfcHk0lhs2x3e2WvExg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFGjt7c%253D&md5=97994e53d58b4d572f0ad72975c8596d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.06.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.06.055%26sid%3Dliteratum%253Aachs%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DDe%2BCandia%26aufirst%3DM.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DBorisova%26aufirst%3DT.%2BN.%26aulast%3DVarlamov%26aufirst%3DA.%2BV.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DVoskressensky%26aufirst%3DL.%2BG.%26aulast%3DAltomare%26aufirst%3DC.%26atitle%3DEster%2520Derivatives%2520of%2520Annulated%2520Tetrahydroazocines%253A%2520A%2520New%2520Class%2520of%2520Selective%2520Acetylcholinesterase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D7205%26epage%3D7212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Tasso, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giangreco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparatore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boido, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparatore, F.</span><span> </span><span class="NLM_article-title">Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Potent Inhibitors of Acetyl- and Butyrylcholinesterase with Potential in Alzheimer’s Disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2170</span><span class="NLM_x">–</span> <span class="NLM_lpage">2184</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2170-2184&author=B.+Tassoauthor=M.+Cattoauthor=O.+Nicolottiauthor=F.+Novelliauthor=M.+Tonelliauthor=I.+Giangrecoauthor=L.+Pisaniauthor=A.+Sparatoreauthor=V.+Boidoauthor=A.+Carottiauthor=F.+Sparatore&title=Quinolizidinyl+Derivatives+of+Bi-+and+Tricyclic+Systems+as+Potent+Inhibitors+of+Acetyl-+and+Butyrylcholinesterase+with+Potential+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTasso%26aufirst%3DB.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DNovelli%26aufirst%3DF.%26aulast%3DTonelli%26aufirst%3DM.%26aulast%3DGiangreco%26aufirst%3DI.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DSparatore%26aufirst%3DA.%26aulast%3DBoido%26aufirst%3DV.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSparatore%26aufirst%3DF.%26atitle%3DQuinolizidinyl%2520Derivatives%2520of%2520Bi-%2520and%2520Tricyclic%2520Systems%2520as%2520Potent%2520Inhibitors%2520of%2520Acetyl-%2520and%2520Butyrylcholinesterase%2520with%2520Potential%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2170%26epage%3D2184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berezin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Re, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loizou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetriades, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Stradis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campagna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koutentis, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Benzo[<i>e</i>][1,2,4]triazin-7(1<i>H</i>)-one and [1,2,4]-Triazino[5,6,1-<i>jk</i>]carbazol-6-one Derivatives as Dual Inhibitors of Beta-Amyloid Aggregation and Acetyl/Butyryl Cholinesterase</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2012&pages=84-97&author=M.+Cattoauthor=A.+A.+Berezinauthor=D.+Lo+Reauthor=G.+Loizouauthor=M.+Demetriadesauthor=A.+De+Stradisauthor=F.+Campagnaauthor=P.+A.+Koutentisauthor=A.+Carotti&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Benzo%5Be%5D%5B1%2C2%2C4%5Dtriazin-7%281H%29-one+and+%5B1%2C2%2C4%5D-Triazino%5B5%2C6%2C1-jk%5Dcarbazol-6-one+Derivatives+as+Dual+Inhibitors+of+Beta-Amyloid+Aggregation+and+Acetyl%2FButyryl+Cholinesterase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DBerezin%26aufirst%3DA.%2BA.%26aulast%3DLo%2BRe%26aufirst%3DD.%26aulast%3DLoizou%26aufirst%3DG.%26aulast%3DDemetriades%26aufirst%3DM.%26aulast%3DDe%2BStradis%26aufirst%3DA.%26aulast%3DCampagna%26aufirst%3DF.%26aulast%3DKoutentis%26aufirst%3DP.%2BA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Benzo%255Be%255D%255B1%252C2%252C4%255Dtriazin-7%25281H%2529-one%2520and%2520%255B1%252C2%252C4%255D-Triazino%255B5%252C6%252C1-jk%255Dcarbazol-6-one%2520Derivatives%2520as%2520Dual%2520Inhibitors%2520of%2520Beta-Amyloid%2520Aggregation%2520and%2520Acetyl%252FButyryl%2520Cholinesterase%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D58%26spage%3D84%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, K. F.</span><span> </span><span class="NLM_article-title">The Therapeutic Potential of Monoamine Oxidase Inhibitors</span> <span class="citation_source-journal">Nature Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1038%2Fnrn1883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=16552415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Gksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=295-309&author=M.+B.+Youdimauthor=D.+Edmondsonauthor=K.+F.+Tipton&title=The+Therapeutic+Potential+of+Monoamine+Oxidase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic potential of monoamine oxidase inhibitors</span></div><div class="casAuthors">Youdim, Moussa B. H.; Edmondson, Dale; Tipton, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-309</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidase inhibitors were among the first antidepressants to be discovered and have long been used as such.  It now seems that many of these agents might have therapeutic value in several common neurodegenerative conditions, independently of their inhibition of monoamine oxidase activity.  However, many claims and some counter-claims have been made about the physiol. importance of these enzymes and the potential of their inhibitors.  We evaluate these arguments in the light of what we know, and still have to learn, of the structure, function and genetics of the monoamine oxidases and the disparate actions of their inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3A0wRL6nnL7Vg90H21EOLACvtfcHk0lhPipIKyBWB2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Gksrs%253D&md5=b35546920d95fa031ff2f884949372a7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrn1883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1883%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DEdmondson%26aufirst%3DD.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DThe%2520Therapeutic%2520Potential%2520of%2520Monoamine%2520Oxidase%2520Inhibitors%26jtitle%3DNature%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D295%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubalek, F.</span><span> </span><span class="NLM_article-title">Structure and Mechanism of Monoamine Oxidases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1983</span><span class="NLM_x">–</span> <span class="NLM_lpage">1993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.2174%2F0929867043364784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=15279562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=1983-1993&author=D.+E.+Edmondsonauthor=A.+Matteviauthor=C.+Bindaauthor=M.+Liauthor=F.+Hubalek&title=Structure+and+Mechanism+of+Monoamine+Oxidases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and mechanism of monoamine oxidase</span></div><div class="casAuthors">Edmondson, D. E.; Mattevi, A.; Binda, C.; Li, M.; Hubalek, F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1983-1993</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidases A and B (MAO A and MAO B) are mitochondrial outer membrane-bound flavoproteins that catalyze the oxidative deamination of neurotransmitters and biogenic amines.  A no. of mechanism-based inhibitors have been developed for clin. use as antidepressants and as neuroprotective drugs.  To facilitate the development of more effective and specific inhibitors, a detailed understanding of the structures and catalytic mechanisms of these enzymes is required.  The recent development of high level expression systems for producing recombinant human liver MAO A and MAO B in Pichia pastoris has facilitated the detn. of the 3-dimensional crystal structures of MAO B (up to 1.7 Å resoln.) in complex with different reversible (isatin, 1,4-diphenyl-2-butene) and irreversible inhibitors (pargyline, N-(2-aminoethyl)-p-chlorobenzamide, and trans-2-phenylcyclopropylamine).  The binding of substrates or inhibitors to MAO B involves an initial negotiation of a protein loop occurring near the surface of the membrane and 2 hydrophobic cavities, an "entrance" cavity, and an "active site" cavity.  These 2 cavities can either be sep. or in a fused state depending on the conformation of the Ile-199 side-chain, which appears to function as a gate.  The amine function of the bound substrate approaches the re face of the bent and "puckered" covalent FAD through an "arom. cage" formed by 2 Tyr residues that are perpendicular to the plane of the flavin ring.  No amino acid residues that could function as acids or bases are found near the catalytic site.  The existing structural data on MAO B support previous QSAR results and are also supportive of a proposed polar nucleophilic mechanism for MAO A and B catalysis rather than the alternatively proposed single electron transfer mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaQv9eLs73u7Vg90H21EOLACvtfcHk0lhPipIKyBWB2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7s%253D&md5=270a408e70f5a136f49489ff7b5fd482</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F0929867043364784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364784%26sid%3Dliteratum%253Aachs%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHubalek%26aufirst%3DF.%26atitle%3DStructure%2520and%2520Mechanism%2520of%2520Monoamine%2520Oxidases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D1983%26epage%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Grimsby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J. C.</span><span> </span><span class="NLM_article-title">Tissue Distribution of Human Monoamine Oxidase-A and Oxidase-B Messenger-RNA</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1111%2Fj.1471-4159.1990.tb03121.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=2398352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADyaK3cXmtVyksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=1166-1169&author=J.+Grimsbyauthor=N.+C.+Lanauthor=R.+Neveauthor=K.+Chenauthor=J.+C.+Shih&title=Tissue+Distribution+of+Human+Monoamine+Oxidase-A+and+Oxidase-B+Messenger-RNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue distribution of human monoamine oxidase A and B mRNA</span></div><div class="casAuthors">Grimsby, Joseph; Lan, Nancy C.; Neve, Rachael; Chen, Kevin; Shih, Jean C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1166-9</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Northern anal. using 32P-labeled subfragments of human liver MAO A and B cDNA clone detected a 5- and 3-kb transcript, resp., in most human tissues examd.  However, fetal heart and thymus express minute amts. of MAO A transcript, whereas fetal brain, muscle, thymus, spleen, meninges, and placenta express minute amts. of MAO B transcript.  Small intestine and placenta express, in addn. to the MAO A 5-kb transcript, a 2-kb transcript, which may arise from an alternative polyadenylation site.  MAO A and B transcripts are expressed in similar regions of adult human being.  The highest concns. of these transcripts were located in frontal cortex and locus ceruleus.  This study demonstrates the tissue-specific distribution of the MAO genes and will provide insight into the physiol. functions of MAO A and B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNhXyOI-PQ87Vg90H21EOLACvtfcHk0lhPipIKyBWB2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtVyksrY%253D&md5=e3f1af76b4168d94b13811471cf46fc5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1990.tb03121.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1990.tb03121.x%26sid%3Dliteratum%253Aachs%26aulast%3DGrimsby%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DN.%2BC.%26aulast%3DNeve%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26atitle%3DTissue%2520Distribution%2520of%2520Human%2520Monoamine%2520Oxidase-A%2520and%2520Oxidase-B%2520Messenger-RNA%26jtitle%3DJ.%2520Neurochem.%26date%3D1990%26volume%3D55%26spage%3D1166%26epage%3D1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S. B.</span><span> </span><span class="NLM_article-title">Selective Inhibitors of Monoamine Oxidase A and B: Biochemical, Pharmacological, and Clinical Properties</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1002%2Fmed.2610040303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=6379342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADyaL2cXltVegu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1984&pages=323-358&author=C.+J.+Fowlerauthor=S.+B.+Ross&title=Selective+Inhibitors+of+Monoamine+Oxidase+A+and+B%3A+Biochemical%2C+Pharmacological%2C+and+Clinical+Properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibitors of monoamine oxidase A and B:  biochemical, pharmacological, and clinical properties</span></div><div class="casAuthors">Fowler, Christopher J.; Ross, Svante B.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-58</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    </div><div class="casAbstract">A review with 253 refs. on the pharmacol. of selective inhibitors of monoamine oxidase  [9001-66-5] A and B in humans and lab. animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMN7PoFJsHd7Vg90H21EOLACvtfcHk0lju-TRdKwsV-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXltVegu74%253D&md5=6a730e6651384a31adcdf31ffc278879</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610040303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610040303%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DRoss%26aufirst%3DS.%2BB.%26atitle%3DSelective%2520Inhibitors%2520of%2520Monoamine%2520Oxidase%2520A%2520and%2520B%253A%2520Biochemical%252C%2520Pharmacological%252C%2520and%2520Clinical%2520Properties%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1984%26volume%3D4%26spage%3D323%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campagna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Targeting Monoamine Oxidases with Multipotent Ligands: An Emerging Strategy in the Search of New Drugs Against Neurodegenerative Diseases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.2174%2F092986711797379302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=21864289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyitb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4568-4587&author=L.+Pisaniauthor=M.+Cattoauthor=F.+Leonettiauthor=O.+Nicolottiauthor=A.+Stefanachiauthor=F.+Campagnaauthor=A.+Carotti&title=Targeting+Monoamine+Oxidases+with+Multipotent+Ligands%3A+An+Emerging+Strategy+in+the+Search+of+New+Drugs+Against+Neurodegenerative+Diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases</span></div><div class="casAuthors">Pisani, L.; Catto, M.; Leonetti, F.; Nicolotti, O.; Stefanachi, A.; Campagna, F.; Carotti, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4568-4587</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The socioeconomic burden of multi-factorial pathologies, such as neurodegenerative diseases (NDs), is enormous worldwide.  Unfortunately, no proven disease-modifying therapy is available yet and in most cases (e.g., Alzheimer's and Parkinson's disease) the approved drugs exert only palliative and symptomatic effects.  Nowadays, an emerging strategy for the discovery of disease-modifying drugs is based on the multi-target directed ligand (MTDL) design, an innovative shift from the traditional approach one-drug-one-target to the more ambitious one-drug-more-targets goal.  Herein, we review the discovery strategy, the mechanism of action and the biopharmacol. evaluation of multipotent ligands exhibiting monoamine oxidase (MAO) inhibition as the core activity with a potential for the treatment of NDs.  In particular, MAO inhibitors exhibiting addnl. acetylcholinesterase (AChE) or nitric oxide synthase (NOS) inhibition, or ion chelation/antioxidant-radical scavenging/anti-inflammatory/A2A receptor antagonist/APP processing modulating activities have been thoroughly examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4N8fMdFNcwrVg90H21EOLACvtfcHk0lju-TRdKwsV-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyitb7O&md5=2463da84a1da0142e353ff9d3a354fe6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F092986711797379302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797379302%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCampagna%26aufirst%3DF.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DTargeting%2520Monoamine%2520Oxidases%2520with%2520Multipotent%2520Ligands%253A%2520An%2520Emerging%2520Strategy%2520in%2520the%2520Search%2520of%2520New%2520Drugs%2520Against%2520Neurodegenerative%2520Diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4568%26epage%3D4587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Salat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolosa, E.</span><span> </span><span class="NLM_article-title">Levodopa in the Treatment of Parkinson’s Disease: Current Status and New Developments</span> <span class="citation_source-journal">J. Parkinson’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23948989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A280%3ADC%252BC3sbgsVylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=255-269&author=D.+Salatauthor=E.+Tolosa&title=Levodopa+in+the+Treatment+of+Parkinson%E2%80%99s+Disease%3A+Current+Status+and+New+Developments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Levodopa in the treatment of Parkinson's disease: current status and new developments</span></div><div class="casAuthors">Salat David; Tolosa Eduardo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Parkinson's disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-69</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Levodopa, a dopamine precursor, is an effective and well-tolerated dopamine replacement agent used to treat Parkinson's disease (PD).  Oral levodopa has been widely used for over 40 years, often in combination with a dopa-decarboxylase inhibitor (DDCI), which reduces many treatment complications, extending its half-life and increasing levodopa availability to the brain.  Entacapone, a catechol-O-methyltransferase inhibitor, can also be used to improve the bioavailability of levodopa, especially when used in conjunction with a DDCI.  During early-stage PD, treatment will depend on the severity of symptoms; if greater symptomatic effect is required then levodopa or dopamine agonists are usually the drugs of choice.  The ability to remain employable or physically active is an important goal in younger patients, therefore, in some instances levodopa initiation should be considered early on, either as a monotherapy or in combination with other drugs.  The clinical use of levodopa may eventually be limited by the development of various treatment-related complications, including response fluctuations, dyskinesia and psychiatric problems.  Motor complications are related to the intermittent delivery of dopamine-replacing drugs to the brain.  Triple combination of levodopa/carbidopa/entacapone available in a single tablet in multiple levodopa dose strengths offers flexibility and helps control response fluctuations.  Recent developments in treatment with levodopa try to obtain continuous delivery with levodopa and include duodenal infusion of a levodopa/carbidopa, transdermal levodopa patch, and oral pro-levodopa.  Levodopa remains the most potent dopaminergic therapy for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvVIddGtbpMLFU0A1HOshhfW6udTcc2eabIifLHSz-zbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbgsVylsg%253D%253D&md5=22353c48466ace7aaf820c75aa3762be</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalat%26aufirst%3DD.%26aulast%3DTolosa%26aufirst%3DE.%26atitle%3DLevodopa%2520in%2520the%2520Treatment%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520Current%2520Status%2520and%2520New%2520Developments%26jtitle%3DJ.%2520Parkinson%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D3%26spage%3D255%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">De Colibus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lustig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Three-Dimensional Structure of Human Monoamine Oxidase A (MAO-A): Relation to the Structures of Rat MAO-A and Human MAO-B</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">12684</span><span class="NLM_x">–</span> <span class="NLM_lpage">12689</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=12684-12689&author=L.+De+Colibusauthor=M.+Liauthor=C.+Bindaauthor=A.+Lustigauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Three-Dimensional+Structure+of+Human+Monoamine+Oxidase+A+%28MAO-A%29%3A+Relation+to+the+Structures+of+Rat+MAO-A+and+Human+MAO-B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BColibus%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DLustig%26aufirst%3DA.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DThree-Dimensional%2520Structure%2520of%2520Human%2520Monoamine%2520Oxidase%2520A%2520%2528MAO-A%2529%253A%2520Relation%2520to%2520the%2520Structures%2520of%2520Rat%2520MAO-A%2520and%2520Human%2520MAO-B%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D12684%26epage%3D12689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Son, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukihara, T.</span><span> </span><span class="NLM_article-title">Structure of Human Monoamine Oxidase A at 2.2-Å Resolution: The Control of Opening the Entry for Substrates/inhibitors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">5739</span><span class="NLM_x">–</span> <span class="NLM_lpage">5744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=5739-5744&author=S.-Y.+Sonauthor=J.+Maauthor=Y.+Kondouauthor=M.+Yoshimuraauthor=E.+Yamashitaauthor=T.+Tsukihara&title=Structure+of+Human+Monoamine+Oxidase+A+at+2.2-%C3%85+Resolution%3A+The+Control+of+Opening+the+Entry+for+Substrates%2Finhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DS.-Y.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DKondou%26aufirst%3DY.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DE.%26aulast%3DTsukihara%26aufirst%3DT.%26atitle%3DStructure%2520of%2520Human%2520Monoamine%2520Oxidase%2520A%2520at%25202.2-%25C3%2585%2520Resolution%253A%2520The%2520Control%2520of%2520Opening%2520the%2520Entry%2520for%2520Substrates%252Finhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D5739%26epage%3D5744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton-Vinson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubalek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Structure of Human Monoamine Oxidase B, a Drug Target for the Treatment of Neurological Disorders</span> <span class="citation_source-journal">Nature Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1038%2Fnsb732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD38XitV2rsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=22-26&author=C.+Bindaauthor=P.+Newton-Vinsonauthor=F.+Hubalekauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structure+of+Human+Monoamine+Oxidase+B%2C+a+Drug+Target+for+the+Treatment+of+Neurological+Disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders</span></div><div class="casAuthors">Binda, Claudia; Newton-Vinson, Paige; Hubalek, Frantisek; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-26</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO B) is a mitochondrial outer membrane flavoenzyme that is a well-known target for antidepressant and neuroprotective drugs.  Here, the authors detd. the structure of the human liver enzyme to 3 Å resoln.  Human liver MAO B was found to bind to the membrane through a C-terminal transmembrane helix and apolar loops located at various positions in the sequence.  The electron d. showed that pargyline, an analog of the clin. used MAO B inhibitor, deprenyl, binds covalently to the flavin N5 atom.  The active site of MAO B consisted of a 420-Å3 hydrophobic substrate cavity interconnected to an entrance cavity of 290 Å3.  The recognition site for the substrate amino group was an arom. cage formed by Tyr-398 and Tyr-435.  The structure provides a framework for probing the catalytic mechanism, understanding the differences between the MAO A and B isoforms and designing specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8p43h-vsPi7Vg90H21EOLACvtfcHk0ligfCWzVle4_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitV2rsg%253D%253D&md5=261d3b1375d833bbfd0a23bdade49be6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnsb732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb732%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DNewton-Vinson%26aufirst%3DP.%26aulast%3DHubalek%26aufirst%3DF.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructure%2520of%2520Human%2520Monoamine%2520Oxidase%2520B%252C%2520a%2520Drug%2520Target%2520for%2520the%2520Treatment%2520of%2520Neurological%2520Disorders%26jtitle%3DNature%2520Struct.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D22%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubalek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of the <i>N</i>-Propargylaminoindan Class</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1767</span><span class="NLM_x">–</span> <span class="NLM_lpage">1774</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031087c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1767-1774&author=C.+Bindaauthor=F.+Hubalekauthor=M.+Liauthor=Y.+Herzigauthor=J.+Sterlingauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Crystal+Structures+of+Monoamine+Oxidase+B+in+Complex+with+Four+Inhibitors+of+the+N-Propargylaminoindan+Class"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of the N-Propargylaminoindan Class</span></div><div class="casAuthors">Binda, Claudia; Hubalek, Frantisek; Li, Min; Herzig, Yaacov; Sterling, Jeffrey; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1767-1774</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO B) is an outer mitochondrial membrane enzyme that catalyzes the oxidn. of arylalkylamine neurotransmitters.  The crystal structures of MAO B in complex with four of the N-propargylaminoindan class of MAO covalent inhibitors (rasagiline, N-propargyl-1(S)-aminoindan, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan) have been detd. at a resoln. of better than 2.1 Å.  Rasagiline, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan adopt essentially the same conformation with the extended propargyl chain covalently bound to the flavin and the indan ring located in the rear of the substrate cavity.  N-Propargyl-1(S)-aminoindan binds with the indan ring in a flipped conformation with respect to the other inhibitors, which causes a slight movement of the Tyr326 side chain.  Four ordered water mols. are an integral part of the active site and establish H-bond interactions to the inhibitor atoms.  These structural studies may guide future drug design to improve selectivity and efficacy by introducing appropriate substituents on the rasagiline mol. scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkiXn0OI5eubVg90H21EOLACvtfcHk0likm-czs4_UFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit70%253D&md5=7b3df3c611e3f0dd59342a59096402dd</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm031087c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031087c%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DHubalek%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DCrystal%2520Structures%2520of%2520Monoamine%2520Oxidase%2520B%2520in%2520Complex%2520with%2520Four%2520Inhibitors%2520of%2520the%2520N-Propargylaminoindan%2520Class%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1767%26epage%3D1774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5848</span><span class="NLM_x">–</span> <span class="NLM_lpage">5852</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070677y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5848-5852&author=C.+Bindaauthor=J.+Wangauthor=L.+Pisaniauthor=C.+Cacciaauthor=A.+Carottiauthor=P.+Salvatiauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structures+of+Human+Monoamine+Oxidase+B+Complexes+with+Selective+Noncovalent+Inhibitors%3A+Safinamide+and+Coumarin+Analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span></div><div class="casAuthors">Binda, Claudia; Wang, Jin; Pisani, Leonardo; Caccia, Carla; Carotti, Angelo; Salvati, Patricia; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5848-5852</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structures of human monoamine oxidase B (MAO B) in complex with safinamide and two coumarin derivs., all sharing a common benzyloxy substituent, were detd. by x-ray crystallog.  These compds. competitively inhibit MAO B with Ki values in the 0.1-0.5 μM range that are 30-700-fold lower than those obsd. with MAO A.  The inhibitors bind noncovalently to MAO B, occupying both the entrance and the substrate cavities and showing a similarly oriented benzyloxy substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPIubufo89bVg90H21EOLACvtfcHk0likm-czs4_UFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI&md5=448f65696f4870e2301f46a6f015e35c</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm070677y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070677y%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructures%2520of%2520Human%2520Monoamine%2520Oxidase%2520B%2520Complexes%2520with%2520Selective%2520Noncovalent%2520Inhibitors%253A%2520Safinamide%2520and%2520Coumarin%2520Analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5848%26epage%3D5852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielczyk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruenblatt, E.</span><span> </span><span class="NLM_article-title">Monoamine Oxidase-B Inhibition in Alzheimer’s Disease</span> <span class="citation_source-journal">Neurotoxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1–2</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1%E2%80%932&publication_year=2004&pages=271-277&author=P.+Riedererauthor=W.+Danielczykauthor=E.+Gruenblatt&title=Monoamine+Oxidase-B+Inhibition+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DDanielczyk%26aufirst%3DW.%26aulast%3DGruenblatt%26aufirst%3DE.%26atitle%3DMonoamine%2520Oxidase-B%2520Inhibition%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNeurotoxicology%26date%3D2004%26volume%3D1%25E2%2580%25932%26spage%3D271%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Qureshi, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehler, M. F.</span><span> </span><span class="NLM_article-title">Advances in Epigenetics and Epigenomics for Neurodegenerative Diseases</span> <span class="citation_source-journal">Curr. Neurol. Neurosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1007%2Fs11910-011-0210-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=21671162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFehsbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=464-473&author=I.+A.+Qureshiauthor=M.+F.+Mehler&title=Advances+in+Epigenetics+and+Epigenomics+for+Neurodegenerative+Diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Epigenetics and Epigenomics for Neurodegenerative Diseases</span></div><div class="casAuthors">Qureshi, Irfan A.; Mehler, Mark F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neurology and Neuroscience Reports</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">464-473</span>CODEN:
                <span class="NLM_cas:coden">CNNRBS</span>;
        ISSN:<span class="NLM_cas:issn">1534-6293</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  In the post-genomic era, epigenetic factors-literally those that are "over" or "above" genetic ones and responsible for controlling the expression and function of genes-have emerged as important mediators of development and aging; gene-gene and gene-environmental interactions; and the pathophysiol. of complex disease states.  Here, we provide a brief overview of the major epigenetic mechanisms (ie, DNA methylation, histone modifications and chromatin remodeling, and non-coding RNA regulation).  We highlight the nearly ubiquitous profiles of epigenetic dysregulation that have been found in Alzheimer's and other neurodegenerative diseases.  We also review innovative methods and technologies that enable the characterization of individual epigenetic modifications and more widespread epigenomic states at high resoln.  We conclude that, together with complementary genetic, genomic, and related approaches, interrogating epigenetic and epigenomic profiles in neurodegenerative diseases represent important and increasingly practical strategies for advancing our understanding of and the diagnosis and treatment of these disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZkkQqmghzS7Vg90H21EOLACvtfcHk0lg_EeKnbXhLDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFehsbzL&md5=831926d139658506313f6fa5df6a09a6</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs11910-011-0210-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11910-011-0210-2%26sid%3Dliteratum%253Aachs%26aulast%3DQureshi%26aufirst%3DI.%2BA.%26aulast%3DMehler%26aufirst%3DM.%2BF.%26atitle%3DAdvances%2520in%2520Epigenetics%2520and%2520Epigenomics%2520for%2520Neurodegenerative%2520Diseases%26jtitle%3DCurr.%2520Neurol.%2520Neurosci.%2520Rep.%26date%3D2011%26volume%3D11%26spage%3D464%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Recent Advances in the Multitarget-Directed Ligands Approach for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Leonauthor=A.+G.+Garciaauthor=J.+Marco-Contelles&title=Recent+Advances+in+the+Multitarget-Directed+Ligands+Approach+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeon%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Multitarget-Directed%2520Ligands%2520Approach%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Morphy, J. R.; Harris, C. J.</span> <span class="citation_source-book">Designing Multi-Target Drugs</span>; <span class="NLM_publisher-name">RSC Publishing</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1039%2F9781849734912" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+R.+Morphy&author=C.+J.+Harris&title=Designing+Multi-Target+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1039%2F9781849734912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849734912%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DJ.%2BR.%26btitle%3DDesigning%2520Multi-Target%2520Drugs%26pub%3DRSC%2520Publishing%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span> </span><span class="NLM_article-title">CNS Targets for Multifunctional Drugs in the Treatment of Alzheimer’s and Parkinson’s Diseases</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2005&pages=519-537&author=M.+B.+Youdimauthor=J.+J.+Buccafusco&title=CNS+Targets+for+Multifunctional+Drugs+in+the+Treatment+of+Alzheimer%E2%80%99s+and+Parkinson%E2%80%99s+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26atitle%3DCNS%2520Targets%2520for%2520Multifunctional%2520Drugs%2520in%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520and%2520Parkinson%25E2%2580%2599s%2520Diseases%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2005%26volume%3D112%26spage%3D519%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, A. V.,  Jr.</span><span> </span><span class="NLM_article-title">Multiple Central Nervous System Targets for Eliciting Beneficial Effects on Memory and Cognition</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">438</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=11046074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsl2ksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=438-446&author=J.+J.+Buccafuscoauthor=A.+V.+Terry&title=Multiple+Central+Nervous+System+Targets+for+Eliciting+Beneficial+Effects+on+Memory+and+Cognition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple central nervous system targets for eliciting beneficial effects on memory and cognition</span></div><div class="casAuthors">Buccafusco, Jerry J.; Terry, Alvin V., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">438-446</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review with 62 refs.  The development of drugs for the treatment of disorders of cognition has benefited from a more precise knowledge of the loss of specific neural pathways assocd. with certain neurodegenerative diseases such as Alzheimer's disease (AD).  The loss of basal forebrain cholinergic neurons in AD has engendered the development of new compds. that target various aspects of the cholinergic system.  However, limitations in the effectiveness of the most common of these, the anticholinesterases, have fueled the race to provide more efficacious compds.  In an attempt to avoid side effects and improve efficacy, other neuronal targets have been considered, including receptors for norepinephrine, dopamine, serotonin, excitatory amino acids, neural peptides, and others.  Our lab. has had the opportunity to study the memory-enhancing potential of many of the compds. developed expressly for these neuronal targets in macaques.  Upon reviewing 21 such studies it was evident that: (1) To varying degrees, pharmacol. manipulation of each target yielded improved task performance.  (2) Combining pharmacol. targets could lead to additive or synergistic effects on task performance.  (3) Mature adult and aged monkeys provided equiv. ests. of drug effectiveness.  (4) There appeared to be no limiting level of task improvement for compds. tested in aged and younger monkeys.  (5) Certain of these agents also exhibited potential disease-modifying actions.  Thus, certain memory-enhancing agents may prove more useful when implemented early in the course of a disease such as AD, and they also may enjoy a wide application for the treatment of the memory decline assocd. with normal aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO8d1OPKK1X7Vg90H21EOLACvtfcHk0lgBtgx5gPhpHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsl2ksL4%253D&md5=36177fdad665ece8159c0a094ab6ca9d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26aulast%3DTerry%26aufirst%3DA.%2BV.%26atitle%3DMultiple%2520Central%2520Nervous%2520System%2520Targets%2520for%2520Eliciting%2520Beneficial%2520Effects%2520on%2520Memory%2520and%2520Cognition%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D295%26spage%3D438%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giangreco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Introcaso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Strategies of Multi-Objective Optimization in Drug Discovery and Development</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1517%2F17460441.2011.588696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=22646211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOjs73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=871-884&author=O.+Nicolottiauthor=I.+Giangrecoauthor=A.+Introcasoauthor=F.+Leonettiauthor=A.+Stefanachiauthor=A.+Carotti&title=Strategies+of+Multi-Objective+Optimization+in+Drug+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies of multi-objective optimization in drug discovery and development</span></div><div class="casAuthors">Nicolotti, Orazio; Giangreco, Ilenia; Introcaso, Antonellina; Leonetti, Francesco; Stefanachi, Angela; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">871-884</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Drug discovery and development is a typical multi-objective problem and its successes or failures depend on the simultaneous control of numerous, often conflicting, mol. and pharmacol. properties.  Multi-objective optimization strategies represent a new approach to capture the occurrence of varying optimal solns. based on trade-offs among the objectives taken into account.  In view of this, multi-objective optimization aims to discover a set of satisfactory compromises that may in turn be used to find the global optimal soln. by optimizing numerous dependent properties simultaneously.Areas covered: The authors review the potential of multi-objective strategies in a no. of fields including: drug library design; substructure mining; the derivation of quant. structure-activity relationship models; ranking of docking poses.  The authors also discuss the potential of multi-objective strategies in controlling competing properties for absorption, distribution, metab. and elimination/toxicity optimization.Expert opinion: It is very clear to those who work in drug discovery and development that the success of rational drug design is largely dependent on the control of a no. of, often conflicting, objectives.  Therefore, multi-objective optimization methods, which have recently been introduced to the field of mol. discovery, represent the ultimate frontier in chemoinformatics.  The widespread use of these multi-objective techniques has provided new opportunities in medicinal chem. as seen through its use in a no. of applications for chemoinformatics both within academia and the pharmaceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8M1aDWIxb5LVg90H21EOLACvtfcHk0ljmXXwMk47qOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOjs73K&md5=851d5f57b3e33704ca82b64cc38a85d7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1517%2F17460441.2011.588696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2011.588696%26sid%3Dliteratum%253Aachs%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DGiangreco%26aufirst%3DI.%26aulast%3DIntrocaso%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DStrategies%2520of%2520Multi-Objective%2520Optimization%2520in%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D871%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Kneubuehler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thull, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Inhibition of Monoamine Oxidase-B by 5<i>H</i>-Indeno[1,2-<i>c</i>]pyridazines: Biological Activities, Quantitative Structure–Activity Relationships (QSARs) and 3DQSARs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3874</span><span class="NLM_x">–</span> <span class="NLM_lpage">3883</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00019a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3874-3883&author=S.+Kneubuehlerauthor=U.+Thullauthor=C.+Altomareauthor=V.+Cartaauthor=P.+Gaillardauthor=P.+A.+Carruptauthor=A.+Carottiauthor=B.+Testa&title=Inhibition+of+Monoamine+Oxidase-B+by+5H-Indeno%5B1%2C2-c%5Dpyridazines%3A+Biological+Activities%2C+Quantitative+Structure%E2%80%93Activity+Relationships+%28QSARs%29+and+3DQSARs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm00019a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00019a018%26sid%3Dliteratum%253Aachs%26aulast%3DKneubuehler%26aufirst%3DS.%26aulast%3DThull%26aufirst%3DU.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarta%26aufirst%3DV.%26aulast%3DGaillard%26aufirst%3DP.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520Monoamine%2520Oxidase-B%2520by%25205H-Indeno%255B1%252C2-c%255Dpyridazines%253A%2520Biological%2520Activities%252C%2520Quantitative%2520Structure%25E2%2580%2593Activity%2520Relationships%2520%2528QSARs%2529%2520and%25203DQSARs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3874%26epage%3D3883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Gnerre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Inhibition of Monoamine Oxidases by Functionalized Coumarin Derivatives: Biological Activities, QSARs, and 3D-QSARs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4747</span><span class="NLM_x">–</span> <span class="NLM_lpage">4758</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm001028o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4747-4758&author=C.+Gnerreauthor=M.+Cattoauthor=F.+Leonettiauthor=P.+Weberauthor=P.-A.+Carruptauthor=C.+Altomareauthor=A.+Carottiauthor=B.+Testa&title=Inhibition+of+Monoamine+Oxidases+by+Functionalized+Coumarin+Derivatives%3A+Biological+Activities%2C+QSARs%2C+and+3D-QSARs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm001028o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001028o%26sid%3Dliteratum%253Aachs%26aulast%3DGnerre%26aufirst%3DC.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DWeber%26aufirst%3DP.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520Monoamine%2520Oxidases%2520by%2520Functionalized%2520Coumarin%2520Derivatives%253A%2520Biological%2520Activities%252C%2520QSARs%252C%2520and%25203D-QSARs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4747%26epage%3D4758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Structural Insights into Monoamine Oxidase Inhibitory Potency and Selectivity of 7-Substituted Coumarins from Ligand- and Target-Based Approaches</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4912</span><span class="NLM_x">–</span> <span class="NLM_lpage">4925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060183l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4912-4925&author=M.+Cattoauthor=O.+Nicolottiauthor=F.+Leonettiauthor=A.+Carottiauthor=A.+D.+Faviaauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=A.+Carotti&title=Structural+Insights+into+Monoamine+Oxidase+Inhibitory+Potency+and+Selectivity+of+7-Substituted+Coumarins+from+Ligand-+and+Target-Based+Approaches"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm060183l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060183l%26sid%3Dliteratum%253Aachs%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DStructural%2520Insights%2520into%2520Monoamine%2520Oxidase%2520Inhibitory%2520Potency%2520and%2520Selectivity%2520of%25207-Substituted%2520Coumarins%2520from%2520Ligand-%2520and%2520Target-Based%2520Approaches%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4912%26epage%3D4925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Carotti, A.; Melloni, P.; Thaler, F.; Caccia, C.; Maestroni, S.; Salvati, P.</span><span> </span><span class="NLM_article-title">Substituted Aminoalkyl and Amidoalkyl Benzopyran Derivatives</span>. WO 2006/102958 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=A.+Carotti&author=P.+Melloni&author=F.+Thaler&author=C.+Caccia&author=S.+Maestroni&author=P.+Salvati&title=Substituted+Aminoalkyl+and+Amidoalkyl+Benzopyran+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DSubstituted%2520Aminoalkyl%2520and%2520Amidoalkyl%2520Benzopyran%2520Derivatives%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campagna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thull, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span> </span><span class="NLM_article-title">Synthesis and Monoamine Oxidase Inhibitory Activity of New Pyridazine-,Pyrimidine-, and 1,2,4-Triazine-Containing Tricyclic Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5364</span><span class="NLM_x">–</span> <span class="NLM_lpage">5371</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070728r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5364-5371&author=A.+Carottiauthor=M.+Cattoauthor=F.+Leonettiauthor=F.+Campagnaauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=U.+Thullauthor=B.+Testaauthor=C.+Altomare&title=Synthesis+and+Monoamine+Oxidase+Inhibitory+Activity+of+New+Pyridazine-%2CPyrimidine-%2C+and+1%2C2%2C4-Triazine-Containing+Tricyclic+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm070728r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070728r%26sid%3Dliteratum%253Aachs%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCampagna%26aufirst%3DF.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DThull%26aufirst%3DU.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DAltomare%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520Monoamine%2520Oxidase%2520Inhibitory%2520Activity%2520of%2520New%2520Pyridazine-%252CPyrimidine-%252C%2520and%25201%252C2%252C4-Triazine-Containing%2520Tricyclic%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5364%26epage%3D5371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capaldi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muncipinto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Solid-Phase Synthesis and Insights into Structure–Activity Relationships of Safinamide Analogues as Potent and Selective Inhibitors of Type B Monoamine Oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4909</span><span class="NLM_x">–</span> <span class="NLM_lpage">4916</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070725e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4909-4916&author=F.+Leonettiauthor=C.+Capaldiauthor=L.+Pisaniauthor=O.+Nicolottiauthor=G.+Muncipintoauthor=A.+Stefanachiauthor=S.+Cellamareauthor=C.+Cacciaauthor=A.+Carotti&title=Solid-Phase+Synthesis+and+Insights+into+Structure%E2%80%93Activity+Relationships+of+Safinamide+Analogues+as+Potent+and+Selective+Inhibitors+of+Type+B+Monoamine+Oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm070725e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070725e%26sid%3Dliteratum%253Aachs%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCapaldi%26aufirst%3DC.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DSolid-Phase%2520Synthesis%2520and%2520Insights%2520into%2520Structure%25E2%2580%2593Activity%2520Relationships%2520of%2520Safinamide%2520Analogues%2520as%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Type%2520B%2520Monoamine%2520Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4909%26epage%3D4916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muncipinto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miscioscia, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passeleu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2<i>H</i>-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6685</span><span class="NLM_x">–</span> <span class="NLM_lpage">6706</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9010127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6685-6706&author=L.+Pisaniauthor=G.+Muncipintoauthor=T.+F.+Misciosciaauthor=O.+Nicolottiauthor=F.+Leonettiauthor=M.+Cattoauthor=C.+Cacciaauthor=P.+Salvatiauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=C.+Passeleuauthor=A.+Carotti&title=Discovery+of+a+Novel+Class+of+Potent+Coumarin+Monoamine+Oxidase+B+Inhibitors%3A+Development+and+Biopharmacological+Profiling+of+7-%5B%283-Chlorobenzyl%29oxy%5D-4-%5B%28methylamino%29methyl%5D-2H-chromen-2-one+Methanesulfonate+%28NW-1772%29+as+a+Highly+Potent%2C+Selective%2C+Reversible%2C+and+Orally+Active+Monoamine+Oxidase+B+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm9010127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9010127%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DMiscioscia%26aufirst%3DT.%2BF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DPasseleu%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Potent%2520Coumarin%2520Monoamine%2520Oxidase%2520B%2520Inhibitors%253A%2520Development%2520and%2520Biopharmacological%2520Profiling%2520of%25207-%255B%25283-Chlorobenzyl%2529oxy%255D-4-%255B%2528methylamino%2529methyl%255D-2H-chromen-2-one%2520Methanesulfonate%2520%2528NW-1772%2529%2520as%2520a%2520Highly%2520Potent%252C%2520Selective%252C%2520Reversible%252C%2520and%2520Orally%2520Active%2520Monoamine%2520Oxidase%2520B%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6685%26epage%3D6706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barletta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Introcaso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Discovery, Biological Evaluation, and Structure–Activity and −Selectivity Relationships of 6′-Substituted (<i>E</i>)-2-(Benzofuran-3(2<i>H</i>)-ylidene)-<i>N</i>-methylacetamides, a Novel Class of Potent and Selective Monoamine Oxidase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2651</span><span class="NLM_x">–</span> <span class="NLM_lpage">2664</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4000769" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2651-2664&author=L.+Pisaniauthor=M.+Barlettaauthor=R.+Soto-Oteroauthor=O.+Nicolottiauthor=E.+Mendez-Alvarezauthor=M.+Cattoauthor=A.+Introcasoauthor=A.+Stefanachiauthor=S.+Cellamareauthor=C.+Altomareauthor=A.+Carotti&title=Discovery%2C+Biological+Evaluation%2C+and+Structure%E2%80%93Activity+and+%E2%88%92Selectivity+Relationships+of+6%E2%80%B2-Substituted+%28E%29-2-%28Benzofuran-3%282H%29-ylidene%29-N-methylacetamides%2C+a+Novel+Class+of+Potent+and+Selective+Monoamine+Oxidase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm4000769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000769%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DBarletta%26aufirst%3DM.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DIntrocaso%26aufirst%3DA.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDiscovery%252C%2520Biological%2520Evaluation%252C%2520and%2520Structure%25E2%2580%2593Activity%2520and%2520%25E2%2588%2592Selectivity%2520Relationships%2520of%25206%25E2%2580%25B2-Substituted%2520%2528E%2529-2-%2528Benzofuran-3%25282H%2529-ylidene%2529-N-methylacetamides%252C%2520a%2520Novel%2520Class%2520of%2520Potent%2520and%2520Selective%2520Monoamine%2520Oxidase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2651%26epage%3D2664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Bruehlmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ooms, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Coumarin Derivatives as Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3195</span><span class="NLM_x">–</span> <span class="NLM_lpage">3198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3195-3198&author=C.+Bruehlmannauthor=F.+Oomsauthor=P.+A.+Carruptauthor=B.+Testaauthor=M.+Cattoauthor=F.+Leonettiauthor=C.+Altomareauthor=A.+Carotti&title=Coumarin+Derivatives+as+Dual+Inhibitors+of+Acetylcholinesterase+and+Monoamine+Oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBruehlmann%26aufirst%3DC.%26aulast%3DOoms%26aufirst%3DF.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DCoumarin%2520Derivatives%2520as%2520Dual%2520Inhibitors%2520of%2520Acetylcholinesterase%2520and%2520Monoamine%2520Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3195%26epage%3D3198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Carotti, A.</span>MAOs Long March: From Toxic First-Generation Drugs to Isoform-Selective, Reversible and Multi-Target Inhibitors. <span class="NLM_conf-name">Frontiers in CNS and Oncology Medicinal Chemistry, ACS-EFMC</span>, <span class="NLM_conf-loc">Siena, Italy</span>, <span class="NLM_conf-date">October 7–9, 2007</span>,  <span class="NLM_fpage">COMC-059</span>; <span class="NLM_publisher-name">American Chemical Society, Division of Medicinal Chemistry</span>, <span class="NLM_publisher-loc">Washington DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">, </span>CODEN: 69KAR2.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=COMC-059&conference=Frontiers+in+CNS+and+Oncology+Medicinal+Chemistry%2C+ACS-EFMC&author=A.+Carotti&title=MAOs+Long+March%3A+From+Toxic+First-Generation+Drugs+to+Isoform-Selective%2C+Reversible+and+Multi-Target+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DCarotti%26aufirst%3DA.%26jtitle%3DMAOs%2520Long%2520March%253A%2520From%2520Toxic%2520First-Generation%2520Drugs%2520to%2520Isoform-Selective%252C%2520Reversible%2520and%2520Multi-Target%2520Inhibitors%26spage%3DCOMC-059%26pub%3DAmerican%2520Chemical%2520Society%252C%2520Division%2520of%2520Medicinal%2520Chemistry%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskolczi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rantal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagyva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zekany, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krais, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Novel Dual Inhibitors of AChE and MAO Derived from Hydroxy Aminoindan and Phenethylamine as Potential Treatment for Alzheimer’s Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020120c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5260-5279&author=J.+Sterlingauthor=Y.+Herzigauthor=T.+Gorenauthor=N.+Finkelsteinauthor=D.+Lernerauthor=W.+Goldenbergauthor=I.+Miskolcziauthor=S.+Molnarauthor=F.+Rantalauthor=T.+Tamasauthor=G.+Tothauthor=A.+Zagyvaauthor=A.+Zekanyauthor=G.+Lavianauthor=A.+Grossauthor=R.+Friedmanauthor=M.+Razinauthor=W.+Huangauthor=B.+Kraisauthor=M.+Chorevauthor=M.+B.+H.+Youdimauthor=M.+Weinstock&title=Novel+Dual+Inhibitors+of+AChE+and+MAO+Derived+from+Hydroxy+Aminoindan+and+Phenethylamine+as+Potential+Treatment+for+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm020120c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020120c%26sid%3Dliteratum%253Aachs%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DGoren%26aufirst%3DT.%26aulast%3DFinkelstein%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DD.%26aulast%3DGoldenberg%26aufirst%3DW.%26aulast%3DMiskolczi%26aufirst%3DI.%26aulast%3DMolnar%26aufirst%3DS.%26aulast%3DRantal%26aufirst%3DF.%26aulast%3DTamas%26aufirst%3DT.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DZagyva%26aufirst%3DA.%26aulast%3DZekany%26aufirst%3DA.%26aulast%3DLavian%26aufirst%3DG.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DRazin%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DKrais%26aufirst%3DB.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DNovel%2520Dual%2520Inhibitors%2520of%2520AChE%2520and%2520MAO%2520Derived%2520from%2520Hydroxy%2520Aminoindan%2520and%2520Phenethylamine%2520as%2520Potential%2520Treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5260%26epage%3D5279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Ríos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chioua, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriepa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraleda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gálvez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valderas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Multipotent MAO and Cholinesterase Inhibitors for the Treatment of Alzheimer’s Disease: Synthesis, Pharmacological Analysis and Molecular Modeling of Heterocyclic Substituted Alkyl and Cycloalkyl Propargyl Amine</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=251-262&author=A.+Samadiauthor=C.+de+los+R%C3%ADosauthor=I.+Boleaauthor=M.+Chiouaauthor=I.+Iriepaauthor=I.+Moraledaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=E.+G%C3%A1lvezauthor=C.+Valderasauthor=M.+Unzetaauthor=J.+Marco-Contelles&title=Multipotent+MAO+and+Cholinesterase+Inhibitors+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease%3A+Synthesis%2C+Pharmacological+Analysis+and+Molecular+Modeling+of+Heterocyclic+Substituted+Alkyl+and+Cycloalkyl+Propargyl+Amine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3Dde%2Blos%2BR%25C3%25ADos%26aufirst%3DC.%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DG%25C3%25A1lvez%26aufirst%3DE.%26aulast%3DValderas%26aufirst%3DC.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DMultipotent%2520MAO%2520and%2520Cholinesterase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Synthesis%252C%2520Pharmacological%2520Analysis%2520and%2520Molecular%2520Modeling%2520of%2520Heterocyclic%2520Substituted%2520Alkyl%2520and%2520Cycloalkyl%2520Propargyl%2520Amine%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D52%26spage%3D251%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Yanez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vina, D.</span><span> </span><span class="NLM_article-title">Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1692</span><span class="NLM_x">–</span> <span class="NLM_lpage">1706</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.2174%2F15680266113139990120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23889051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFeks7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1692-1706&author=M.+Yanezauthor=D.+Vina&title=Dual+Inhibitors+of+Monoamine+Oxidase+and+Cholinesterase+for+the+Treatment+of+Alzheimer+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease</span></div><div class="casAuthors">Yanez, Matilde; Vina, Dolores</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1692-1706</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common neurodegenerative disorder and the most prevalent cause of dementia with ageing.  The etiol. of this illness is rather complex and not completely known but deposits of aberrant β- amyloid protein, as well as τ-protein hyperphosphorylation, oxidative stress, dyshomeostasis of biometals and low levels of acetylcholine (ACh) seem to play a significant role.  Such complex etiol. of AD has encouraged active research in the development of multi-target drugs with two or more complementary biol. activities, since they may represent an important advance in the treatment of this disease.  Dual inhibitors combining anti-acetyl cholinesterase (AChE) and antimonoamine oxidase (MAO) activities in one mol. entity have been recently reported.  Inhibition of AChE increases neurotransmission at cholinergic synapses and reduce temporally the cognitive deficit.  AChE also participates in other functions related to neuronal development, differentiation, adhesion and β-amyloid protein processing.  In addn. MAOB inhibition retards further deterioration of cognitive functions.  In this review relevant aspects about structure, mechanism and pharmacol. effects of these dual inhibitors are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobskqipuIoBrVg90H21EOLACvtfcHk0liPMaL4jLdEKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFeks7nI&md5=e467fb980e69c634ff966204188a2f62</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990120%26sid%3Dliteratum%253Aachs%26aulast%3DYanez%26aufirst%3DM.%26aulast%3DVina%26aufirst%3DD.%26atitle%3DDual%2520Inhibitors%2520of%2520Monoamine%2520Oxidase%2520and%2520Cholinesterase%2520for%2520the%2520Treatment%2520of%2520Alzheimer%2520Disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1692%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Passos, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simões-Pires, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurisso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soldi, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Oliveira, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Faria, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcourt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottfried, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriques, A. T.</span><span> </span><span class="NLM_article-title">Indole Alkaloids of Psychotria as Multifunctional Cholinesterases and Monoamine Oxidases Inhibitors</span> <span class="citation_source-journal">Phytochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2013&pages=8-20&author=C.+S.+Passosauthor=C.+A.+Sim%C3%B5es-Piresauthor=A.+Nurissoauthor=T.+C.+Soldiauthor=L.+Katoauthor=C.+M.+de+Oliveiraauthor=E.+O.+de+Fariaauthor=L.+Marcourtauthor=C.+Gottfriedauthor=P.-A.+Carruptauthor=A.+T.+Henriques&title=Indole+Alkaloids+of+Psychotria+as+Multifunctional+Cholinesterases+and+Monoamine+Oxidases+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPassos%26aufirst%3DC.%2BS.%26aulast%3DSim%25C3%25B5es-Pires%26aufirst%3DC.%2BA.%26aulast%3DNurisso%26aufirst%3DA.%26aulast%3DSoldi%26aufirst%3DT.%2BC.%26aulast%3DKato%26aufirst%3DL.%26aulast%3Dde%2BOliveira%26aufirst%3DC.%2BM.%26aulast%3Dde%2BFaria%26aufirst%3DE.%2BO.%26aulast%3DMarcourt%26aufirst%3DL.%26aulast%3DGottfried%26aufirst%3DC.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DHenriques%26aufirst%3DA.%2BT.%26atitle%3DIndole%2520Alkaloids%2520of%2520Psychotria%2520as%2520Multifunctional%2520Cholinesterases%2520and%2520Monoamine%2520Oxidases%2520Inhibitors%26jtitle%3DPhytochemistry%26date%3D2013%26volume%3D86%26spage%3D8%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandel, S. A.</span><span> </span><span class="NLM_article-title">From Anti-Parkinson’s Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer’s Disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1155%2F2012%2F204623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=22387411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsF2mt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=1-16&author=H.+Zhengauthor=T.+Amitauthor=O.+Bar-Amauthor=M.+Fridkinauthor=M.+B.+H.+Youdimauthor=S.+A.+Mandel&title=From+Anti-Parkinson%E2%80%99s+Drug+Rasagiline+to+Novel+Multitarget+Iron+Chelators+with+Acetylcholinesterase+and+Monoamine+Oxidase+Inhibitory+and+Neuroprotective+Properties+for+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">From Anti-Parkinson's Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer's Disease</span></div><div class="casAuthors">Zheng, Hailin; Amit, Tamar; Bar-Am, Orit; Fridkin, Mati; Youdim, Moussa B. H.; Mandel, Silvia A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a multifactorial syndrome involving a complex array of different, while related, factors in its progression.  Accordingly, novel approaches that can simultaneously modulate several disease-related targets hold great promise for the effective treatment of AD.  This review describes the development of novel hybrid mols. with multimodal activity, including: i) M30, the brain permeable selective monoamine oxidase (MAO)-A and -B inhibitor with chelating and neuroprotective activity; ii) HLA20, a brain permeable metal chelator with neuroprotective activity; iii) HLA20A, an acetylcholinesterase (AChE) inhibitor with site-activated chelating and neuroprotective activity; iv) M30D, an AChE and MAO-A and -B inhibitor with site-activated chelating and neuroprotective activity; and v) analogs of the neuroprotective aminoacid peptide, NAPVSIPQ.  HLA20A and M30D act as pro-chelators and can be activated to liberate their resp. active chelators HLA20 and M30 through pseudo inhibition of AChE.  We first discuss the knowledge and structure-based strategy for the rational design of these novel compds.  Then, we review our recent studies on these drug candidates, regarding their wide range in vitro and in vivo activities, with emphasis on antioxidant-chelating potency and AchE and MAO-A and -B inhibitory activity, as well as neuroprotective/neurorescue effects.  Finally, we discuss the diverse mol. mechanisms of action of these compds. with relevance to AD, including modulation of amyloid-β and amyloid-β protein precursor expression/processing; induction of cell cycle arrest; inhibition of neuronal death markers; and upregulation of neurotrophic factors, as well as activation of protein kinase signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKWwqpwgN677Vg90H21EOLACvtfcHk0liTR15XpxwI1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsF2mt7w%253D&md5=e9635ab8952fef29f96f01fe97b77de8</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1155%2F2012%2F204623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F204623%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DFridkin%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DMandel%26aufirst%3DS.%2BA.%26atitle%3DFrom%2520Anti-Parkinson%25E2%2580%2599s%2520Drug%2520Rasagiline%2520to%2520Novel%2520Multitarget%2520Iron%2520Chelators%2520with%2520Acetylcholinesterase%2520and%2520Monoamine%2520Oxidase%2520Inhibitory%2520and%2520Neuroprotective%2520Properties%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D30%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monjas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">Multipotent, Permeable Drug ASS234 Inhibits Aβ Aggregation, Possesses Antioxidant Properties and Protects from Aβ-induced Apoptosis In Vitro</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.2174%2F15672050113109990151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23919774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKkurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=797-808&author=I.+Boleaauthor=A.+Gellaauthor=L.+Monjasauthor=C.+Perezauthor=M.+I.+Rodriguez-Francoauthor=J.+Marco-Contellesauthor=A.+Samadiauthor=M.+Unzeta&title=Multipotent%2C+Permeable+Drug+ASS234+Inhibits+A%CE%B2+Aggregation%2C+Possesses+Antioxidant+Properties+and+Protects+from+A%CE%B2-induced+Apoptosis+In+Vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Multipotent, Permeable Drug ASS234 Inhibits Aβ Aggregation, Possesses Antioxidant Properties and Protects from Aβ-induced Apoptosis In Vitro</span></div><div class="casAuthors">Bolea, Irene; Gella, Alejandro; Monjas, Leticia; Perez, Concepcion; Isabel Rodriguez-Franco, Maria; Marco-Contelles, Jose; Samadi, Abdelouahid; Unzeta, Mercedes</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">797-808</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Amyloid beta (Aβ ) aggregation and deposition is a key pathol. hallmark of AD.  Growing evidence suggests that neurotoxicity of this peptide is related to the formation of toxic oligomeric aggregates.  Therefore, a deeply investigated therapeutic strategy comes at present from blocking the formation of these species to non-toxic aggregates.  Among other considered strategies, the multi-target approach has been proposed as a more suitable potential therapy, precisely due to the multifactorial nature of AD.  In this context, we recently identified ASS234, a novel compd. that possesses a significant multipotent profile since it is able to inhibit cholinesterase and monoamine oxidase enzymes as well as to interfere in Aβ aggregation process.  In this work, we investigated more in detail the effects of ASS234 on Aβ aggregation and toxicity in vitro as well as we explored its ability to penetrate to the CNS.  We report that ASS234 inhibited Aβ 1-42 self-aggregation more efficiently than that of Aβ 1-40, limiting the formation of fibrillar and oligomeric species.  Addnl., ASS234 completely blocked the aggregation mediated by AChE of both Aβ 1-42 and Aβ 1-40, showing a dual binding site to AChE.  Interestingly, ASS234 significantly reduced A β 1-42-mediated toxicity in SH-SY5Y human neuroblastoma cells through the prevention of the mitochondrial apoptosis pathway activation.  Also importantly, we obsd. a significant ability of ASS234 to capture free-radical species in vitro as well as a potent effect in preventing the Aβ 1-42-induced depletion of antioxidant enzymes (catalase and SOD-1).  Finally, we report the capability of ASS234 to cross the bloodbrain barrier.  Overall, our in vitro results show that ASS234 may have an impact on different processes involved in AD pathogenesis and provide evidences that it has encouraging attributes as a therapeutic lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-iJK3Tv_vLbVg90H21EOLACvtfcHk0liTR15XpxwI1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKkurjI&md5=cde2691678d766d1890a903ecc131394</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.2174%2F15672050113109990151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15672050113109990151%26sid%3Dliteratum%253Aachs%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DGella%26aufirst%3DA.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DMultipotent%252C%2520Permeable%2520Drug%2520ASS234%2520Inhibits%2520A%25CE%25B2%2520Aggregation%252C%2520Possesses%2520Antioxidant%2520Properties%2520and%2520Protects%2520from%2520A%25CE%25B2-induced%2520Apoptosis%2520In%2520Vitro%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2013%26volume%3D10%26spage%3D797%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Bautista-Aguilera, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chioua, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolic, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agbaba, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraleda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriepa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Multipotent Cholinesterase/Monoamine Oxidase Inhibitors for the Treatment of Alzheimer’s Disease: Design, Synthesis, Biochemical Evaluation, ADMET, Molecular Modeling, and QSAR Analysis of Novel Donepezil–Pyridyl Hybrids</span> <span class="citation_source-journal">Drug Des. Devel. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1910</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=25378907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A280%3ADC%252BC2M3ms1alug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=1893-1910&author=O.+M.+Bautista-Aguileraauthor=G.+Estebanauthor=M.+Chiouaauthor=K.+Nikolicauthor=D.+Agbabaauthor=I.+Moraledaauthor=I.+Iriepaauthor=E.+Sorianoauthor=A.+Samadiauthor=M.+Unzetaauthor=J.+Marco-Contelles&title=Multipotent+Cholinesterase%2FMonoamine+Oxidase+Inhibitors+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease%3A+Design%2C+Synthesis%2C+Biochemical+Evaluation%2C+ADMET%2C+Molecular+Modeling%2C+and+QSAR+Analysis+of+Novel+Donepezil%E2%80%93Pyridyl+Hybrids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids</span></div><div class="casAuthors">Bautista-Aguilera Oscar M; Chioua Mourad; Samadi Abdelouahid; Marco-Contelles Jose; Esteban Gerard; Unzeta Mercedes; Nikolic Katarina; Agbaba Danica; Moraleda Ignacio; Iriepa Isabel; Soriano Elena</div><div class="citationInfo"><span class="NLM_cas:title">Drug design, development and therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1893-910</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The design, synthesis, and biochemical evaluation of donepezil-pyridyl hybrids (DPHs) as multipotent cholinesterase (ChE) and monoamine oxidase (MAO) inhibitors for the potential treatment of Alzheimer's disease (AD) is reported.  The 3D-quantitative structure-activity relationship study was used to define 3D-pharmacophores for inhibition of MAO A/B, acetylcholinesterase (AChE), and butyrylcholinesterase (BuChE) enzymes and to design DPHs as novel multi-target drug candidates with potential impact in the therapy of AD.  DPH14 (Electrophorus electricus AChE [EeAChE]: half maximal inhibitory concentration [IC50] =1.1±0.3 nM; equine butyrylcholinesterase [eqBuChE]: IC50 =600±80 nM) was 318-fold more potent for the inhibition of AChE, and 1.3-fold less potent for the inhibition of BuChE than the reference compound ASS234.  DPH14 is a potent human recombinant BuChE (hBuChE) inhibitor, in the same range as DPH12 or DPH16, but 13.1-fold less potent than DPH15 for the inhibition of human recombinant AChE (hAChE).  Compared with donepezil, DPH14 is almost equipotent for the inhibition of hAChE, and 8.8-fold more potent for hBuChE.  Concerning human monoamine oxidase (hMAO) A inhibition, only DPH9 and 5 proved active, compound DPH9 being the most potent (IC50 [MAO A] =5,700±2,100 nM).  For hMAO B, only DPHs 13 and 14 were moderate inhibitors, and compound DPH14 was the most potent (IC50 [MAO B] =3,950±940 nM).  Molecular modeling of inhibitor DPH14 within EeAChE showed a binding mode with an extended conformation, interacting simultaneously with both catalytic and peripheral sites of EeAChE thanks to a linker of appropriate length.  Absortion, distribution, metabolism, excretion and toxicity analysis showed that structures lacking phenyl-substituent show better druglikeness profiles; in particular, DPHs13-15 showed the most suitable absortion, distribution, metabolism, excretion and toxicity properties.  Novel donepezil-pyridyl hybrid DPH14 is a potent, moderately selective hAChE and selective irreversible hMAO B inhibitor which might be considered as a promising compound for further development for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpLMbTfemCUrFU0A1HOshhfW6udTcc2ebY5afKrNen_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3ms1alug%253D%253D&md5=3b3ba418a994f9a5aa796dc3710260a0</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3DO.%2BM.%26aulast%3DEsteban%26aufirst%3DG.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DNikolic%26aufirst%3DK.%26aulast%3DAgbaba%26aufirst%3DD.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DMultipotent%2520Cholinesterase%252FMonoamine%2520Oxidase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Design%252C%2520Synthesis%252C%2520Biochemical%2520Evaluation%252C%2520ADMET%252C%2520Molecular%2520Modeling%252C%2520and%2520QSAR%2520Analysis%2520of%2520Novel%2520Donepezil%25E2%2580%2593Pyridyl%2520Hybrids%26jtitle%3DDrug%2520Des.%2520Devel.%2520Ther.%26date%3D2014%26volume%3D8%26spage%3D1893%26epage%3D1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Avramovich-Tirosh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">Therapeutic Targets and Potential of the Novel Brain Permeable Multifunctional Iron Chelator–Monoamine Oxidase Inhibitor Drug, M-30, for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1111%2Fj.1471-4159.2006.04258.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=17144902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFaksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=490-502&author=Y.+Avramovich-Tiroshauthor=T.+Amitauthor=O.+Bar-Amauthor=H.+Zhengauthor=M.+Fridkinauthor=M.+B.+H.+Youdim&title=Therapeutic+Targets+and+Potential+of+the+Novel+Brain+Permeable+Multifunctional+Iron+Chelator%E2%80%93Monoamine+Oxidase+Inhibitor+Drug%2C+M-30%2C+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Avramovich-Tirosh, Yael; Amit, Tamar; Bar-Am, Orit; Zheng, Hailin; Fridkin, Mati; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">490-502</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Novel therapeutic approaches for the treatment of neurodegenerative disorders comprise drug candidates designed specifically to act on multiple CNS targets.  We have synthesized a multifunctional non-toxic, brain permeable iron chelator drug, M-30, possessing propargyl monoamine oxidase (MAO) inhibitory neuroprotective and iron-chelating moieties, from our prototype iron chelator VK-28.  In the present study M-30 was shown to possess a wide range of pharmacol. activities, including pro-survival neurorescue effects, induction of neuronal differentiation and regulation of amyloid precursor protein (APP) and β-amyloid (Aβ) levels.  M-30 was found to decrease apoptosis of SH-SY5Y neuroblastoma cells in a neurorescue, serum deprivation model, via redn. of the pro-apoptotic proteins Bad and Bax, and inhibition of the apoptosis-assocd. phosphorylated H2A.X protein (Ser 139) and caspase 3 activation.  In addn., M-30 induced the out-growth of neurites, triggered cell cycle arrest in G0/G1 phase and enhanced the expression of growth assocd. protein-43.  Furthermore, M-30 markedly reduced the levels of cellular APP and β-C-terminal fragment (β-CTF) and the levels of the amyloidogenic Aβ peptide in the medium of SH-SY5Y cells and Chinese hamster ovary cells stably transfected with the APP 'Swedish' mutation.  Levels of the non-amyloidogenic sol. APPα and α-CTF in the medium and cell lysate resp. were coordinately increased.  These properties, together with its brain selective MAO inhibitory and propargylamine-dependent neuroprotective effects, suggest that M-30 might serve as an ideal drug for neurodegenerative disorders, such as Parkinson's and Alzheimer's diseases, in which oxidative stress and iron dysregulation have been implicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoounFPdTCar7Vg90H21EOLACvtfcHk0ljM04B-otX-2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFaksLo%253D&md5=cb26a3c8b8654118fbe10e7d92080413</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04258.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04258.x%26sid%3Dliteratum%253Aachs%26aulast%3DAvramovich-Tirosh%26aufirst%3DY.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DFridkin%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DTherapeutic%2520Targets%2520and%2520Potential%2520of%2520the%2520Novel%2520Brain%2520Permeable%2520Multifunctional%2520Iron%2520Chelator%25E2%2580%2593Monoamine%2520Oxidase%2520Inhibitor%2520Drug%252C%2520M-30%252C%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D100%26spage%3D490%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Matos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Cruz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez-Rodriguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santana, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olea-Azar, C.</span><span> </span><span class="NLM_article-title">Remarkable Antioxidant Properties of a Series of Hydroxy-3-arylcoumarins</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3900</span><span class="NLM_x">–</span> <span class="NLM_lpage">3906</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3900-3906&author=M.+J.+Matosauthor=F.+P%C3%A9rez-Cruzauthor=S.+Vazquez-Rodriguezauthor=E.+Uriarteauthor=L.+Santanaauthor=F.+Borgesauthor=C.+Olea-Azar&title=Remarkable+Antioxidant+Properties+of+a+Series+of+Hydroxy-3-arylcoumarins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DP%25C3%25A9rez-Cruz%26aufirst%3DF.%26aulast%3DVazquez-Rodriguez%26aufirst%3DS.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DOlea-Azar%26aufirst%3DC.%26atitle%3DRemarkable%2520Antioxidant%2520Properties%2520of%2520a%2520Series%2520of%2520Hydroxy-3-arylcoumarins%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3900%26epage%3D3906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Li, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, L. Y.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of Flavonoid Derivatives as Potential Multifunctional Acetylcholinesterase Inhibitors Against Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2636</span><span class="NLM_x">–</span> <span class="NLM_lpage">2641</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2636-2641&author=R.+S.+Liauthor=X.+B.+Wangauthor=X.+J.+Huauthor=L.+Y.+Kong&title=Design%2C+Synthesis+and+Evaluation+of+Flavonoid+Derivatives+as+Potential+Multifunctional+Acetylcholinesterase+Inhibitors+Against+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%2BS.%26aulast%3DWang%26aufirst%3DX.%2BB.%26aulast%3DHu%26aufirst%3DX.%2BJ.%26aulast%3DKong%26aufirst%3DL.%2BY.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%2520Flavonoid%2520Derivatives%2520as%2520Potential%2520Multifunctional%2520Acetylcholinesterase%2520Inhibitors%2520Against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2636%26epage%3D2641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span> </span><span class="NLM_article-title">Multitarget-Directed Benzylideneindanone Derivatives: Anti-β-Amyloid (Aβ) Aggregation, Antioxidant, Metal Chelation, and Monoamine Oxidase B (MAO-B) Inhibition Properties against Alzheimer’s Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8483</span><span class="NLM_x">–</span> <span class="NLM_lpage">8492</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300978h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8483-8492&author=L.+Huangauthor=C.+Luauthor=Y.+Sunauthor=F.+Maoauthor=Z.+Luoauthor=T.+Suauthor=H.+Jiangauthor=W.+Shanauthor=X.+Li&title=Multitarget-Directed+Benzylideneindanone+Derivatives%3A+Anti-%CE%B2-Amyloid+%28A%CE%B2%29+Aggregation%2C+Antioxidant%2C+Metal+Chelation%2C+and+Monoamine+Oxidase+B+%28MAO-B%29+Inhibition+Properties+against+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm300978h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300978h%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DSu%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DShan%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DMultitarget-Directed%2520Benzylideneindanone%2520Derivatives%253A%2520Anti-%25CE%25B2-Amyloid%2520%2528A%25CE%25B2%2529%2520Aggregation%252C%2520Antioxidant%252C%2520Metal%2520Chelation%252C%2520and%2520Monoamine%2520Oxidase%2520B%2520%2528MAO-B%2529%2520Inhibition%2520Properties%2520against%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8483%26epage%3D8492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Molecular Basis of Neuroprotective Activities of Rasagiline and the anti Alzheimer Drug, TV3326, [(<i>N</i>-Propargyl-(3<b>R</b>)-aminoindan-5-yl)-ethyl Methyl Carbamate]</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1023%2FA%3A1015131516649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslSkt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=555-573&author=M.+B.+H.+Youdimauthor=M.+Weinstock&title=Molecular+Basis+of+Neuroprotective+Activities+of+Rasagiline+and+the+anti+Alzheimer+Drug%2C+TV3326%2C+%5B%28N-Propargyl-%283R%29-aminoindan-5-yl%29-ethyl+Methyl+Carbamate%5D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate]</span></div><div class="casAuthors">Youdim, Moussa B. H.; Weinstock, Marta</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">555-573</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">A review.  Rasagiline (N-propargyl-1-(R)-aminoindan) is a selective, irreversible monoamine oxidase B (MAO B) inhibitor which has been developed as an anti-Parkinson drug.  In controlled monotherapy and as adjunct to L-dopa it has shown anti-Parkinson activity.  In cell culture (PC-12 and neuroblastoma SH-SY5Y cells) it exhibits neuroprotective and antiapoptotic activity against several neurotoxins (SIN-1, MPTP, 6-hydroxydopamine and N-methyl-(R)-salsolinol) and ischemia.  In vivo, it reduces the sequelae of traumatic brain injury in mice and speeds their recovery.  The neuroprotective activity of rasagaline does not result from MAO B inhibition, since its S-enantiomer, TVP1022, which has 1000-fold weaker MAO inhibitory activity, exhibits similar neuroprotective properties.  Introduction of a carbamate moiety into the rasagiline mol. to confer cholinesterase inhibitory activity for the treatment of Alzheimer's disease, resulted in compds. TV3326 [(N-Propargyl-(3R)Aminoindan-5-YL)-Et Me Carbamate] and its S-enantiomer TV3279 [(N-Propargyl-(3S)Aminoindan-5-YL)-Et Me Carbamate], which retain the neuroprotective activities of rasagiline and TVP1.022.  They also antagonize scopolamine-induced impairments in spatial memory.  In addn., TV3326 exhibits brain-selective MAO A and B inhibitory activity after chronic administration and has antidepressant-like activity in the forced swim test.  This is assocd. with an increase in brain levels of serotonin.  The antiapoptotic activity of these propargylamine-contg. derivs. may be related to their ability to delay the opening of voltage-dependent anion channels (VDAC), which are part of the mitochondrial permeability transition pore.  The propargylarnine moiety is responsible for the increase in the mitochondrial family of Bcl-2 proteins, prevention in the fall in mitochondrial membrane potential, prevention of the activation of caspase 3, and of translocation of glycerlatdehyde-3-phosphate dehydrogenase from the cytoplasm to the nucleus.  The latter processes are closely assocd. with neurotoxin-induced apoptosis.  Rasagiline interacts with and prevents the binding of PK11195 to the pro-apoptotic peripheral benzodiazepine receptor, which together with Bcl-2, hexokinase, porin, and adenine nucleotide translocator constitutes part of the VDAC.  Furthermore, rasagiline, TV3326 and TV3279 are able to influence the processing of amyloid precursor protein by activation of alpha-secretase and increasing the release of sol. alpha APP in rat PC-12 and human neuroblastoma SH-SY5Y cells and in rat and mice cortex and hippocampus.  This process has been shown to involve the upregulation of PKC and MAP kinase.  It is quite likely that the induction of Bcl-2 and activation of PKC by rasagiline and TV3326 is closely linked to the anti-apoptotic action of these drugs and their ability to process APP by activation of alpha-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooLWVipqroE7Vg90H21EOLACvtfcHk0liJYv57ITq15Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslSkt7g%253D&md5=6069320591cce7df19a0f29f91cf6911</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015131516649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015131516649%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DMolecular%2520Basis%2520of%2520Neuroprotective%2520Activities%2520of%2520Rasagiline%2520and%2520the%2520anti%2520Alzheimer%2520Drug%252C%2520TV3326%252C%2520%255B%2528N-Propargyl-%25283R%2529-aminoindan-5-yl%2529-ethyl%2520Methyl%2520Carbamate%255D%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2002%26volume%3D21%26spage%3D555%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Anderson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCrodden, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, K. F.</span><span> </span><span class="NLM_article-title">Monoamine Oxidase Inhibitors and the Cheese Effect</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1145</span><span class="NLM_x">–</span> <span class="NLM_lpage">1149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1007%2FBF00978365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=8255365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADyaK2cXitlWjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1993&pages=1145-1149&author=M.+C.+Andersonauthor=F.+Hasanauthor=J.+M.+McCroddenauthor=K.+F.+Tipton&title=Monoamine+Oxidase+Inhibitors+and+the+Cheese+Effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase inhibitors and the cheese effect</span></div><div class="casAuthors">Anderson, Mary C.; Hasan, Farris; McCrodden, John M.; Tipton, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1145-9</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    </div><div class="casAbstract">The behavior of inhibitors of monoamine oxidase-A (MAO-A) is considered in terms of the possibility of having an effective antidepressant that does not give rise to hypertensive interactions with dietary tyramine.  Studies with punch-biopsy samples of human intestine and rat intestinal samples show MAO-A to be the predominant form of the enzyme in both species.  Transport studies with everted rat intestinal prepns. indicate that tyramine is extensively metabolized during transport through the intestine.  Selective inhibition of MAO-A by clorgyline results in a large increase in the amt. of unchanged tyramine transported, whereas selective inhibition of MAO-B with L-deprenyl (selegiline) has no significant effect.  The behavior of reversible MAO-A inhibitors can significantly reduce, but not entirely eliminate, these effects on the intestinal metab. of tyramine, but only if the inhibition is competitive in nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDISgk8VH-8LVg90H21EOLACvtfcHk0liJYv57ITq15Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlWjsQ%253D%253D&md5=e9d85b743f7fdde68276428940940cac</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1007%2FBF00978365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00978365%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DM.%2BC.%26aulast%3DHasan%26aufirst%3DF.%26aulast%3DMcCrodden%26aufirst%3DJ.%2BM.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DMonoamine%2520Oxidase%2520Inhibitors%2520and%2520the%2520Cheese%2520Effect%26jtitle%3DNeurochem.%2520Res.%26date%3D1993%26volume%3D18%26spage%3D1145%26epage%3D1149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Macdonald, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darvesh, S.</span><span> </span><span class="NLM_article-title">Cholinesterase Inhibition in Alzheimer’s Disease: Is Specificity the Answer?</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=24898642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKns77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=379-384&author=I.+R.+Macdonaldauthor=K.+Rockwoodauthor=E.+Martinauthor=S.+Darvesh&title=Cholinesterase+Inhibition+in+Alzheimer%E2%80%99s+Disease%3A+Is+Specificity+the+Answer%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Cholinesterase Inhibition in Alzheimer's Disease: Is Specificity the Answer?</span></div><div class="casAuthors">Macdonald, Ian R.; Rockwood, Kenneth; Martin, Earl; Darvesh, Sultan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">379-384</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Cholinesterase inhibitors are the std. of care for Alzheimer's disease (AD).  Acetylcholinesterase (AChE) catalyzes the hydrolysis of the cholinergic neurotransmitter acetylcholine.  However, the related enzyme butyrylcholinesterase (BuChE) also breaks down acetylcholine and is likewise targeted by the same clin. cholinesterase inhibitors.  The lack of clin. efficacy for the highly specific and potent AChE inhibitor, (-) huperzine A, is intriguing, given the known cholinergic deficit in AD.  Based on the proven efficacy of inhibitors affecting both cholinesterases and the apparent failure of specific AChE inhibition, focused BuChE inhibition seems important for more effective treatment of AD.  Therefore, BuChE-selective inhibitors provide promise for improved benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY0L1sVpCa_7Vg90H21EOLACvtfcHk0liJYv57ITq15Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKns77M&md5=010bac9c291fd9c4d44e97fb5fa065f0</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacdonald%26aufirst%3DI.%2BR.%26aulast%3DRockwood%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DDarvesh%26aufirst%3DS.%26atitle%3DCholinesterase%2520Inhibition%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Is%2520Specificity%2520the%2520Answer%253F%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D42%26spage%3D379%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Greig, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utsuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahiri, D. K.</span><span> </span><span class="NLM_article-title">A New Therapeutic Target in AD Treatment: Attention to Butyrylcholinesterase</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1185%2F03007990152673800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=11900310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslSnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2001&pages=159-165&author=N.+H.+Greigauthor=T.+Utsukiauthor=Q.-S.+Yuauthor=X.+Zhuauthor=H.+W.+Hollowayauthor=T.+A.+Perryauthor=B.+Leeauthor=D.+H.+Ingramauthor=D.+K.+Lahiri&title=A+New+Therapeutic+Target+in+AD+Treatment%3A+Attention+to+Butyrylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A new therapeutic target in Alzheimer's disease treatment: Attention to butyrylcholinesterase</span></div><div class="casAuthors">Greig, Nigel H.; Utsuki, Tada; Yu, Qian-sheng; Zhu, Xiaoxiang; Holloway, Harold W.; Perry, TracyAnn; Lee, Bong; Ingram, Donald K.; Lahiri, Debomoy K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-165</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">LibraPharm Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the elderly, characterized by widespread loss of central cholinergic function.  The only symptomatic treatment proven effective to date is the use of cholinesterase (ChE) inhibitors to augment surviving cholinergic activity.  ChE inhibitors act on the enzymes that hydrolyze acetylcholine (ACh) following synaptic release.  In the healthy brain, acetylcholinesterase (AChE) predominates (80%) and butyrylcholinesterase (BuChE) is considered to play a minor role in regulating brain ACh levels.  In the AD brain, BuChE activity rises while AChE activity remains unchanged or declines.  Therefore both enzymes are likely to have involvement in regulating ACh levels and represent legitimate therapeutic targets to ameliorate the cholinergic deficit.  The two enzymes differ in location, substrate specificity and kinetics.  Recent evidence suggests that BuChE may also have a role in the etiol. and progression of AD beyond regulation of synaptic ACh levels.  Exptl. evidence from the use of agents with enhanced selectivity for BuChE (cymserine, MF-8622) and ChE inhibitors such as rivastigmine, which have a dual inhibitory action on both AChE and BuChE, indicate potential therapeutic benefits of inhibiting both AChE and BuChE in AD and related dementias.  The development of specific BuChE inhibitors and the continued use of ChE inhibitors with the ability to inhibit BuChE in addn. to AChE should lead to improved clin. outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq4MokwgwULbVg90H21EOLACvtfcHk0liJYv57ITq15Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslSnug%253D%253D&md5=bf6513e8d8d7edd39f6b95342a238128</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1185%2F03007990152673800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F03007990152673800%26sid%3Dliteratum%253Aachs%26aulast%3DGreig%26aufirst%3DN.%2BH.%26aulast%3DUtsuki%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DQ.-S.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DHolloway%26aufirst%3DH.%2BW.%26aulast%3DPerry%26aufirst%3DT.%2BA.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DIngram%26aufirst%3DD.%2BH.%26aulast%3DLahiri%26aufirst%3DD.%2BK.%26atitle%3DA%2520New%2520Therapeutic%2520Target%2520in%2520AD%2520Treatment%253A%2520Attention%2520to%2520Butyrylcholinesterase%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2001%26volume%3D17%26spage%3D159%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Braccio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadaleta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Fine Molecular Tuning at Position 4 of 2<i>H</i>-Chromen-2-one Derivatives in the Search of Potent and Selective Monoamine Oxidase B Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=723-739&author=L.+Pisaniauthor=M.+Cattoauthor=O.+Nicolottiauthor=G.+Grossiauthor=M.+Di+Braccioauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=A.+Stefanachiauthor=D.+Gadaletaauthor=A.+Carotti&title=Fine+Molecular+Tuning+at+Position+4+of+2H-Chromen-2-one+Derivatives+in+the+Search+of+Potent+and+Selective+Monoamine+Oxidase+B+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DGrossi%26aufirst%3DG.%26aulast%3DDi%2BBraccio%26aufirst%3DM.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DGadaleta%26aufirst%3DD.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DFine%2520Molecular%2520Tuning%2520at%2520Position%25204%2520of%25202H-Chromen-2-one%2520Derivatives%2520in%2520the%2520Search%2520of%2520Potent%2520and%2520Selective%2520Monoamine%2520Oxidase%2520B%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D70%26spage%3D723%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadaleta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Braccio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">In Silico Design of Novel 2<i>H</i>-Chromen-2-one Derivatives as Potent and Selective MAO-B Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=98-105&author=L.+Pisaniauthor=R.+Farinaauthor=O.+Nicolottiauthor=D.+Gadaletaauthor=R.+Soto-Oteroauthor=M.+Cattoauthor=M.+Di+Braccioauthor=E.+Mendez-Alvarezauthor=A.+Carotti&title=In+Silico+Design+of+Novel+2H-Chromen-2-one+Derivatives+as+Potent+and+Selective+MAO-B+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DFarina%26aufirst%3DR.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DGadaleta%26aufirst%3DD.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DDi%2BBraccio%26aufirst%3DM.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DIn%2520Silico%2520Design%2520of%2520Novel%25202H-Chromen-2-one%2520Derivatives%2520as%2520Potent%2520and%2520Selective%2520MAO-B%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D89%26spage%3D98%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Wang, T.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzeng, C.-C.</span><span> </span><span class="NLM_article-title">Lewis Acid Catalyzed Reaction of Cinnamanilides: Competition of Intramolecular and Intermolecular Friedel–Crafts Reaction</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1055%2Fs-1997-1505" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1997&pages=87-90&author=T.-C.+Wangauthor=Y.-L.+Chenauthor=K.-H.+Leeauthor=C.-C.+Tzeng&title=Lewis+Acid+Catalyzed+Reaction+of+Cinnamanilides%3A+Competition+of+Intramolecular+and+Intermolecular+Friedel%E2%80%93Crafts+Reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1055%2Fs-1997-1505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1997-1505%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.-C.%26aulast%3DChen%26aufirst%3DY.-L.%26aulast%3DLee%26aufirst%3DK.-H.%26aulast%3DTzeng%26aufirst%3DC.-C.%26atitle%3DLewis%2520Acid%2520Catalyzed%2520Reaction%2520of%2520Cinnamanilides%253A%2520Competition%2520of%2520Intramolecular%2520and%2520Intermolecular%2520Friedel%25E2%2580%2593Crafts%2520Reaction%26jtitle%3DSynthesis%26date%3D1997%26volume%3D9%26spage%3D87%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feartherstone, R. M.</span><span> </span><span class="NLM_article-title">A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Feartherstone&title=A+New+and+Rapid+Colorimetric+Determination+of+Acetylcholinesterase+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0liFaH1yTH7VYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeartherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520New%2520and%2520Rapid%2520Colorimetric%2520Determination%2520of%2520Acetylcholinesterase%2520Activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Novaroli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reist, M.</span><span> </span><span class="NLM_article-title">Impact of Species-Dependent Differences on Screening, Design, and Development of MAO-B Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6264</span><span class="NLM_x">–</span> <span class="NLM_lpage">6272</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060441e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6264-6272&author=L.+Novaroliauthor=A.+Dainaauthor=E.+Favreauthor=J.+Bravoauthor=A.+Carottiauthor=F.+Leonettiauthor=M.+Cattoauthor=P.-A.+Carruptauthor=M.+Reist&title=Impact+of+Species-Dependent+Differences+on+Screening%2C+Design%2C+and+Development+of+MAO-B+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm060441e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060441e%26sid%3Dliteratum%253Aachs%26aulast%3DNovaroli%26aufirst%3DL.%26aulast%3DDaina%26aufirst%3DA.%26aulast%3DFavre%26aufirst%3DE.%26aulast%3DBravo%26aufirst%3DJ.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DReist%26aufirst%3DM.%26atitle%3DImpact%2520of%2520Species-Dependent%2520Differences%2520on%2520Screening%252C%2520Design%252C%2520and%2520Development%2520of%2520MAO-B%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6264%26epage%3D6272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Denizot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, R.</span><span> </span><span class="NLM_article-title">Rapid Colorimetric Assay for Cell Growth and Survival. Modifications to the Tetrazolium Dye Procedure Giving Improved Sensitivity and Reliability</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2F0022-1759%2886%2990368-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=3486233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1986&pages=271-277&author=F.+Denizotauthor=R.+Lang&title=Rapid+Colorimetric+Assay+for+Cell+Growth+and+Survival.+Modifications+to+the+Tetrazolium+Dye+Procedure+Giving+Improved+Sensitivity+and+Reliability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability</span></div><div class="casAuthors">Denizot F; Lang R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-7</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A convenient way to estimate the number of viable cells growing in microtitre tray wells is to use a colorimetric assay and an automatic microplate scanning spectrophotometer.  One such assay, developed by Mosmann, depends on the reduction by living cells of tetrazolium salt, MTT, to form a blue formazan product.  However the original technique has several technical limitations, namely a less than optimal sensitivity, a variable background due to protein precipitation on adding an organic solvent to dissolve the blue formazan product, and a low solubility of the product.  These problems have been overcome by the following modifications: avoidance of serum in the incubation medium, thus overcoming precipitation problems in the organic solvent; avoidance of phenol red in the incubation medium, thus avoiding the use of acid in the final solvent which altered the spectral properties of the formazan; elimination of the medium containing MTT after the reaction and subsequent use of pure propanol or ethanol to rapidly solubilize the formazan; use of a higher concentration of MTT; use of half-area microtitre trays to increase the spectrophotometer readings from a given amount of formazan; use of a more judicious reference wavelength in a dual wavelength spectrophotometer.  With these modifications the reliability and sensitivity of the test have been increased to the point where it can in many cases replace the [3H]thymidine uptake assay to measure cell proliferation or survival in growth factor or cytotoxicity assays.  Examples of its use in IL-2 assays are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpURYu5ihmxO98rul4nhSdfW6udTcc2eYy1VNOmFwkqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D&md5=9e5506f28a0b29b20046b7e21bb5527e</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2886%2990368-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252886%252990368-6%26sid%3Dliteratum%253Aachs%26aulast%3DDenizot%26aufirst%3DF.%26aulast%3DLang%26aufirst%3DR.%26atitle%3DRapid%2520Colorimetric%2520Assay%2520for%2520Cell%2520Growth%2520and%2520Survival.%2520Modifications%2520to%2520the%2520Tetrazolium%2520Dye%2520Procedure%2520Giving%2520Improved%2520Sensitivity%2520and%2520Reliability%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1986%26volume%3D89%26spage%3D271%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. D.</span><span> </span><span class="NLM_article-title">Improved Protein–Ligand Docking Using GOLD</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=609-623&author=M.+L.+Verdonkauthor=J.+C.+Coleauthor=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=R.+D.+Taylor&title=Improved+Protein%E2%80%93Ligand+Docking+Using+GOLD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DTaylor%26aufirst%3DR.%2BD.%26atitle%3DImproved%2520Protein%25E2%2580%2593Ligand%2520Docking%2520Using%2520GOLD%26jtitle%3DProteins%26date%3D2003%26volume%3D52%26spage%3D609%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Liao, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, R.-B.</span><span> </span><span class="NLM_article-title">The Multiple Roles of Histidine in Protein Interactions</span> <span class="citation_source-journal">Chem. Cent. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1186%2F1752-153X-7-44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23452343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVKkt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=44&author=S.-M.+Liaoauthor=Q.-S.+Duauthor=J.-Z.+Mengauthor=Z.-W.+Pangauthor=R.-B.+Huang&title=The+Multiple+Roles+of+Histidine+in+Protein+Interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The multiple roles of histidine in protein interactions</span></div><div class="casAuthors">Liao, Si-Ming; Du, Qi-Shi; Meng, Jian-Zong; Pang, Zong-Wen; Huang, Ri-Bo</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry Central Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">CCJHA2</span>;
        ISSN:<span class="NLM_cas:issn">1752-153X</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background: Among the 20 natural amino acids histidine is the most active and versatile member that plays the multiple roles in protein interactions, often the key residue in enzyme catalytic reactions.  A theor. and comprehensive study on the structural features and interaction properties of histidine is certainly helpful.  Results: Four interaction types of histidine are quant. calcd., including: (1) Cation-π interactions, in which the histidine acts as the arom. π-motif in neutral form (His), or plays the cation role in protonated form (His+); (2) π-π stacking interactions between histidine and other arom. amino acids; (3) Hydrogen-π interactions between histidine and other arom. amino acids; (4) Coordinate interactions between histidine and metallic cations.  The energies of π-π stacking interactions and hydrogen-π interactions are calcd. using CCSD/6-31+G(d,p).  The energies of cation-π interactions and coordinate interactions are calcd. using B3LYP/6-31+G(d,p) method and adjusted by empirical method for dispersion energy.  Conclusions: The coordinate interactions between histidine and metallic cations are the strongest one acting in broad range, followed by the cation-π, hydrogen-π, and π-π stacking interactions.  When the histidine is in neutral form, the cation-π interactions are attractive; when it is protonated (His+), the interactions turn to repulsive.  The two protonation forms (and pKa values) of histidine are reversibly switched by the attractive and repulsive cation-π interactions.  In proteins the π-π stacking interaction between neutral histidine and arom. amino acids (Phe, Tyr, Trp) are in the range from -3.0 to -4.0 kcal/mol, significantly larger than the van der Waals energies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkXNwq2c1K9LVg90H21EOLACvtfcHk0lgbwOi7oJXi3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVKkt70%253D&md5=7e59a381a12431be19c6f251ee1ecf5a</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1186%2F1752-153X-7-44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1752-153X-7-44%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DS.-M.%26aulast%3DDu%26aufirst%3DQ.-S.%26aulast%3DMeng%26aufirst%3DJ.-Z.%26aulast%3DPang%26aufirst%3DZ.-W.%26aulast%3DHuang%26aufirst%3DR.-B.%26atitle%3DThe%2520Multiple%2520Roles%2520of%2520Histidine%2520in%2520Protein%2520Interactions%26jtitle%3DChem.%2520Cent.%2520J.%26date%3D2013%26volume%3D7%26spage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquintana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopedota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latrofa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, G.</span><span> </span><span class="NLM_article-title">Translocator Protein (TSPO) Ligand–Ara-C (Cytarabine) Conjugates as a Strategy to Deliver Antineoplastic Drugs and to Enhance Drug Clinical Potential</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2255</span><span class="NLM_x">–</span> <span class="NLM_lpage">2269</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp100235w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyks7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=2255-2269&author=N.+Denoraauthor=V.+Laquintanaauthor=A.+Trapaniauthor=A.+Lopedotaauthor=A.+Latrofaauthor=J.+M.+Galloauthor=G.+Trapani&title=Translocator+Protein+%28TSPO%29+Ligand%E2%80%93Ara-C+%28Cytarabine%29+Conjugates+as+a+Strategy+to+Deliver+Antineoplastic+Drugs+and+to+Enhance+Drug+Clinical+Potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Translocator Protein (TSPO) Ligand-Ara-C (Cytarabine) Conjugates as a Strategy To Deliver Antineoplastic Drugs and To Enhance Drug Clinical Potential</span></div><div class="casAuthors">Denora, Nunzio; Laquintana, Valentino; Trapani, Adriana; Lopedota, Angela; Latrofa, Andrea; Gallo, James M.; Trapani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2255-2269</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The aim of this work was to evaluate TSPO ligand-Ara-C conjugation as an approach for the selective delivery of the antineoplastic agent to brain tumors as well as for overcome P-gp resistance induction obsd. for the majority of cytotoxic agents, enhancing the drug clin. potential.  To this end, novel N-imidazopyridinacetyl-Ara-C conjugates have been prepd. and evaluated for their cytotoxicity against glioma cell lines.  Conjugate (I) resulted stable in both phosphate buffer and physiol. medium.  In all cases, the release of free Ara-C from hydrolyzed conjugates was checked by HPLC and ESI-MS anal.  Conjugates (II) and I displayed very high in vitro TSPO affinity and selectivity, and, hence, they may possess potential for targeted brain delivery.  Due to the favorable features displayed by the conjugate I, it was further evaluated on glioma cell lines, expressing high levels of TSPO, in the presence and in the absence of specific nucleoside transport (NT) inhibitors.  In contrast to that obsd. for the free Ara-C, the presence of NT inhibitors did not reduce the cytotoxic activity of I.  Moreover, conjugate I, as N4-acyl deriv. of Ara-C, should be resistant to inactivation by cytidine deaminase, and it may possess enhanced propensity to target brain tumor cells characterized by a reduced expression of NTs.  In addn., this conjugate behaves as a clear P-gp modulator and thereby may be useful to reverse MDR.  Transport studies across the MDCKII-MDR1 monolayer indicated that conjugate I should overcome the BBB by transcellular pathway.  All these features may be useful for enhancing the clin. potential of the nucleoside drug Ara-C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlPSCWV14q97Vg90H21EOLACvtfcHk0lgbwOi7oJXi3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyks7nJ&md5=97dfb1bb26e96783537794143c661363</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fmp100235w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp100235w%26sid%3Dliteratum%253Aachs%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DLaquintana%26aufirst%3DV.%26aulast%3DTrapani%26aufirst%3DA.%26aulast%3DLopedota%26aufirst%3DA.%26aulast%3DLatrofa%26aufirst%3DA.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26aulast%3DTrapani%26aufirst%3DG.%26atitle%3DTranslocator%2520Protein%2520%2528TSPO%2529%2520Ligand%25E2%2580%2593Ara-C%2520%2528Cytarabine%2529%2520Conjugates%2520as%2520a%2520Strategy%2520to%2520Deliver%2520Antineoplastic%2520Drugs%2520and%2520to%2520Enhance%2520Drug%2520Clinical%2520Potential%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2010%26volume%3D7%26spage%3D2255%26epage%3D2269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casanueva, O. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, J.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase Accelerates Assembly of Amyloid-Beta-Peptides into Alzheimer’s Fibrils: Possible Role of the Peripheral Site of the Enzyme</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=881-891&author=N.+C.+Inestrosaauthor=A.+Alvarezauthor=C.+A.+P%C3%A9rezauthor=R.+D.+Morenoauthor=M.+Vicenteauthor=C.+Linkerauthor=O.+I.+Casanuevaauthor=C.+Sotoauthor=J.+Garrido&title=Acetylcholinesterase+Accelerates+Assembly+of+Amyloid-Beta-Peptides+into+Alzheimer%E2%80%99s+Fibrils%3A+Possible+Role+of+the+Peripheral+Site+of+the+Enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%2BA.%26aulast%3DMoreno%26aufirst%3DR.%2BD.%26aulast%3DVicente%26aufirst%3DM.%26aulast%3DLinker%26aufirst%3DC.%26aulast%3DCasanueva%26aufirst%3DO.%2BI.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DJ.%26atitle%3DAcetylcholinesterase%2520Accelerates%2520Assembly%2520of%2520Amyloid-Beta-Peptides%2520into%2520Alzheimer%25E2%2580%2599s%2520Fibrils%253A%2520Possible%2520Role%2520of%2520the%2520Peripheral%2520Site%2520of%2520the%2520Enzyme%26jtitle%3DNeuron%26date%3D1996%26volume%3D16%26spage%3D881%26epage%3D891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arroyo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blas, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Structural Determinants of the Multifunctional Profile of Dual Binding Site Acetylcholinesterase Inhibitors as Anti-Alzheimer Agents</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2818</span><span class="NLM_x">–</span> <span class="NLM_lpage">2836</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.2174%2F138161210793176536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=20698824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Kit7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2818-2836&author=C.+Galdeanoauthor=E.+Viaynaauthor=P.+Arroyoauthor=A.+Bidon-Chanalauthor=J.+R.+Blasauthor=D.+Mu%C3%B1oz-Torreroauthor=F.+J.+Luque&title=Structural+Determinants+of+the+Multifunctional+Profile+of+Dual+Binding+Site+Acetylcholinesterase+Inhibitors+as+Anti-Alzheimer+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents</span></div><div class="casAuthors">Galdeano, Carles; Viayna, Elisabet; Arroyo, Pau; Bidon-Chanal, Axel; Blas, J. Ramon; Munoz-Torrero, Diego; Luque, F. Javier</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2818-2836</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Dual binding site acetylcholinesterase inhibitors have recently emerged as a new class of anti-Alzheimer agents with potential to pos. modify the course of the disease.  These compds. exhibit a multifunctional pharmacol. profile arising from interaction with several biol. targets involved upstream and downstream in the neurodegenerative cascade of Alzheimer's disease (AD).  The primary target of these compds. is the enzyme acetylcholinesterase (AChE).  Interaction of dual binding site AChE inhibitors with AChE results in a potent inhibitory activity of AChE and AChE-induced β-amyloid peptide (Aβ) aggregation.  Some dual binding site AChE inhibitors take on added value a significant ability to addnl. inhibit the enzymes butyrylcholinesterase and BACE-1, involved in the co-regulation of the hydrolysis of the neurotransmitter acetylcholine and in Aβ formation, resp.  The structural determinants which mediate the interaction of dual binding site AChE inhibitors with these three important enzymes for AD treatment are herein reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo457mAEj15dLVg90H21EOLACvtfcHk0lgbwOi7oJXi3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Kit7zN&md5=ab536e0a9ac6d65de266e014592ddeb0</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.2174%2F138161210793176536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210793176536%26sid%3Dliteratum%253Aachs%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DArroyo%26aufirst%3DP.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DBlas%26aufirst%3DJ.%2BR.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DStructural%2520Determinants%2520of%2520the%2520Multifunctional%2520Profile%2520of%2520Dual%2520Binding%2520Site%2520Acetylcholinesterase%2520Inhibitors%2520as%2520Anti-Alzheimer%2520Agents%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D2818%26epage%3D2836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquintana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopalco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimmino, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laconca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuffrida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, G.</span><span> </span><span class="NLM_article-title">Novel Codrugs with GABAergic Activity for Dopamine Delivery in the Brain</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2Fj.ijpharm.2012.08.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=22940209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlaiurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2012&pages=221-231&author=N.+Denoraauthor=T.+Cassanoauthor=V.+Laquintanaauthor=A.+Lopalcoauthor=A.+Trapaniauthor=C.+S.+Cimminoauthor=L.+Laconcaauthor=A.+Giuffridaauthor=G.+Trapani&title=Novel+Codrugs+with+GABAergic+Activity+for+Dopamine+Delivery+in+the+Brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Novel codrugs with GABAergic activity for dopamine delivery in the brain</span></div><div class="casAuthors">Denora, Nunzio; Cassano, Tommaso; Laquintana, Valentino; Lopalco, Antonio; Trapani, Adriana; Cimmino, Concetta Stefania; Laconca, Leonardo; Giuffrida, Andrea; Trapani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">437</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">221-231</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This study investigates the use of codrugs of the GABAergic agent 2-phenyl-imidazo[1,2-a]pyridinacetamide and dopamine (DA) or Et ester L-Dopa (LD) as a strategy to deliver DA and simultaneously activate GABA-receptors in the brain.  For this purpose, both DA and LD Et ester were linked by carbamate bond to imidazo[1,2-a]pyridine acetamide moieties to yield two DA- and two LD-imidazopyridine derivs.  These compds. were evaluated in vitro to assess their stability, binding affinities and cell membrane transport, and in vivo to assess their bio-availability via microdialysis studies.  The two DA derivs. were adequately stable in buffered soln., but underwent cleavage in dild. human serum.  By contrast, the LD derivs. were unstable in buffered soln.  Receptor binding studies showed that the DA-imidazopyridine carbamates had binding affinity for benzodiazepine receptors in the nanomolar range.  Brain microdialysis expts. indicated that i.p. administration of the DA derivs. sustained DA levels in rat striatum over a 4-h period.  These results suggest that DA-imidazopyridine carbamates are new DA codrugs with potential application for DA replacement therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2ZywfNEZEqbVg90H21EOLACvtfcHk0lgqCIx5jxL_eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlaiurnP&md5=fb9f8c41492bfccc09a24dd20b659b90</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2012.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2012.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DCassano%26aufirst%3DT.%26aulast%3DLaquintana%26aufirst%3DV.%26aulast%3DLopalco%26aufirst%3DA.%26aulast%3DTrapani%26aufirst%3DA.%26aulast%3DCimmino%26aufirst%3DC.%2BS.%26aulast%3DLaconca%26aufirst%3DL.%26aulast%3DGiuffrida%26aufirst%3DA.%26aulast%3DTrapani%26aufirst%3DG.%26atitle%3DNovel%2520Codrugs%2520with%2520GABAergic%2520Activity%2520for%2520Dopamine%2520Delivery%2520in%2520the%2520Brain%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2012%26volume%3D437%26spage%3D221%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Fringuelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piermatti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzo, F.</span><span> </span><span class="NLM_article-title">One-pot Synthesis of 3-Carboxycoumarins via Consecutive Knoevenagel–Pinner Reactions in Water</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2331</span><span class="NLM_x">–</span> <span class="NLM_lpage">2334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=2331-2334&author=F.+Fringuelliauthor=O.+Piermattiauthor=F.+Pizzo&title=One-pot+Synthesis+of+3-Carboxycoumarins+via+Consecutive+Knoevenagel%E2%80%93Pinner+Reactions+in+Water"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFringuelli%26aufirst%3DF.%26aulast%3DPiermatti%26aufirst%3DO.%26aulast%3DPizzo%26aufirst%3DF.%26atitle%3DOne-pot%2520Synthesis%2520of%25203-Carboxycoumarins%2520via%2520Consecutive%2520Knoevenagel%25E2%2580%2593Pinner%2520Reactions%2520in%2520Water%26jtitle%3DSynthesis%26date%3D2003%26volume%3D15%26spage%3D2331%26epage%3D2334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Cholinesterase inhibitors: SAR and Enzyme Inhibitory Activity of 3-[ω-(Benzylmethylamino)alkoxy]xanthen-9-ones</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=575-585&author=L.+Piazziauthor=F.+Bellutiauthor=A.+Bisiauthor=S.+Gobbiauthor=S.+Rizzoauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=M.+Recanatiniauthor=A.+Rampa&title=Cholinesterase+inhibitors%3A+SAR+and+Enzyme+Inhibitory+Activity+of+3-%5B%CF%89-%28Benzylmethylamino%29alkoxy%5Dxanthen-9-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DRizzo%26aufirst%3DS.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DCholinesterase%2520inhibitors%253A%2520SAR%2520and%2520Enzyme%2520Inhibitory%2520Activity%2520of%25203-%255B%25CF%2589-%2528Benzylmethylamino%2529alkoxy%255Dxanthen-9-ones%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D575%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Kumpaty, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharyya, S.</span><span> </span><span class="NLM_article-title">Synthesis of <i>N</i>-Methyl Secondary Amines</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1411</span><span class="NLM_x">–</span> <span class="NLM_lpage">1416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1081%2FSCC-120018703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslOntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=1411-1416&author=H.+J.+Kumpatyauthor=J.+S.+Williamsonauthor=S.+Bhattacharyya&title=Synthesis+of+N-Methyl+Secondary+Amines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of N-methyl secondary amines</span></div><div class="casAuthors">Kumpaty, Hephzibah J.; Williamson, John S.; Bhattacharyya, Sukanta</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1411-1416</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A diverse set of N-Me secondary amines are obtained in high yields by an expedient reductive alkylation of com. available methanolic methylamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_a3rEkjrXU7Vg90H21EOLACvtfcHk0lgqCIx5jxL_eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslOntLY%253D&md5=5faafb68f1fc784b62ace3a661a1e728</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1081%2FSCC-120018703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FSCC-120018703%26sid%3Dliteratum%253Aachs%26aulast%3DKumpaty%26aufirst%3DH.%2BJ.%26aulast%3DWilliamson%26aufirst%3DJ.%2BS.%26aulast%3DBhattacharyya%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520N-Methyl%2520Secondary%2520Amines%26jtitle%3DSynth.%2520Commun.%26date%3D2003%26volume%3D33%26spage%3D1411%26epage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Sellero, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Rivadulla, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamas, M.</span><span> </span><span class="NLM_article-title">Inhibition of Brain Monoamine Oxidase by Adducts of 1,2,3,4-Tetrahydroisoquinoline with Components of Cigarette Smoke</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">–</span> <span class="NLM_lpage">1727</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1997&pages=1719-1727&author=E.+Mendez-Alvarezauthor=R.+Soto-Oteroauthor=I.+Sanchez-Selleroauthor=L.+M.+Lopez-Rivadullaauthor=M.+Lamas&title=Inhibition+of+Brain+Monoamine+Oxidase+by+Adducts+of+1%2C2%2C3%2C4-Tetrahydroisoquinoline+with+Components+of+Cigarette+Smoke"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DSanchez-Sellero%26aufirst%3DI.%26aulast%3DLopez-Rivadulla%26aufirst%3DL.%2BM.%26aulast%3DLamas%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520Brain%2520Monoamine%2520Oxidase%2520by%2520Adducts%2520of%25201%252C2%252C3%252C4-Tetrahydroisoquinoline%2520with%2520Components%2520of%2520Cigarette%2520Smoke%26jtitle%3DLife%2520Sci.%26date%3D1997%26volume%3D60%26spage%3D1719%26epage%3D1727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Sastry, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adzhigirey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annabhimoju, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span> </span><span class="NLM_article-title">Protein and Ligand Preparation: Parameters, Protocols, and Influence on Virtual Screening Enrichments</span> <span class="citation_source-journal">J. Comput.- Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+M.+Sastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+Ligand+Preparation%3A+Parameters%2C+Protocols%2C+and+Influence+on+Virtual+Screening+Enrichments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Sastry G Madhavi; Adzhigirey Matvey; Day Tyler; Annabhimoju Ramakrishna; Sherman Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of computer-aided molecular design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepared prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove atomic clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addition, ligands must be prepared to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system preparation is generally accepted in the field, an extensive study of the preparation steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in preparing a system for virtual screening.  We first explore a large number of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper preparation and that neglecting certain steps of the preparation process produces a systematic degradation in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the preparation that impact database enrichment.  While the work presented here was performed with the Protein Preparation Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQd2Qiai-OqeXqj_yg7twvpfW6udTcc2ebgm_0HbiztXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D&md5=9eb1a820e121aca2742ed53f24481ace</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DG.%2BM.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520Ligand%2520Preparation%253A%2520Parameters%252C%2520Protocols%252C%2520and%2520Influence%2520on%2520Virtual%2520Screening%2520Enrichments%26jtitle%3DJ.%2520Comput.-%2520Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 67 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Alexander A. Titov, Maxim S. Kobzev, Marco Catto, Modesto de Candia, Nicola Gambacorta, Nunzio Denora, Leonardo Pisani, Orazio Nicolotti, Tatiana N. Borisova, Alexey V. Varlamov, Leonid G. Voskressensky, <span class="NLM_string-name hlFld-ContribAuthor">Cosimo D. Altomare</span>. </span><span class="cited-content_cbyCitation_article-title">Away from Flatness: Unprecedented Nitrogen-Bridged Cyclopenta[a]indene Derivatives as Novel Anti-Alzheimer Multitarget Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (2)
                                     , 340-353. <a href="https://doi.org/10.1021/acschemneuro.0c00706" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00706%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DAway%252Bfrom%252BFlatness%25253A%252BUnprecedented%252BNitrogen-Bridged%252BCyclopenta%25255Ba%25255Dindene%252BDerivatives%252Bas%252BNovel%252BAnti-Alzheimer%252BMultitarget%252BAgents%26aulast%3DTitov%26aufirst%3DAlexander%2BA.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D02112020%26date%3D21122020%26date%3D04012021%26volume%3D12%26issue%3D2%26spage%3D340%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Carina Lemke, Joscha Christmann, Jiafei Yin, José M. Alonso, Estefanía Serrano, Mourad Chioua, Lhassane Ismaili, María Angeles Martínez-Grau, Christopher D. Beadle, Tatiana Vetman, Florian M. Dato, Ulrike Bartz, Paul W. Elsinghorst, Markus Pietsch, Christa E. Müller, Isabel Iriepa, Timo Wille, José Marco-Contelles, <span class="NLM_string-name hlFld-ContribAuthor">Michael Gütschow</span>. </span><span class="cited-content_cbyCitation_article-title">Chromenones as Multineurotargeting Inhibitors of Human Enzymes. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (26)
                                     , 22161-22168. <a href="https://doi.org/10.1021/acsomega.9b03409" title="DOI URL">https://doi.org/10.1021/acsomega.9b03409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b03409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b03409%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DChromenones%252Bas%252BMultineurotargeting%252BInhibitors%252Bof%252BHuman%252BEnzymes%26aulast%3DLemke%26aufirst%3DCarina%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14102019%26date%3D21112019%26date%3D11122019%26volume%3D4%26issue%3D26%26spage%3D22161%26epage%3D22168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhiren Wang, Jinhui Hu, Xiaoping Yang, Xing Feng, Xingshu Li, Ling Huang, <span class="NLM_string-name hlFld-ContribAuthor">Albert S. C. Chan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of Orally Bioavailable Quinoline–Indole Derivatives as Innovative Multitarget-Directed Ligands: Promotion of Cell Proliferation in the Adult Murine Hippocampus for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 1871-1894. <a href="https://doi.org/10.1021/acs.jmedchem.7b01417" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01417%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BOrally%252BBioavailable%252BQuinoline%2525E2%252580%252593Indole%252BDerivatives%252Bas%252BInnovative%252BMultitarget-Directed%252BLigands%25253A%252BPromotion%252Bof%252BCell%252BProliferation%252Bin%252Bthe%252BAdult%252BMurine%252BHippocampus%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWang%26aufirst%3DZhiren%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D23092017%26date%3D15022018%26date%3D08022018%26volume%3D61%26issue%3D5%26spage%3D1871%26epage%3D1894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei  Cai</span>, <span class="hlFld-ContribAuthor ">Si-Qiang  Fang</span>, <span class="hlFld-ContribAuthor ">Xue-Lian  Yang</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Qiao-Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Hao  Hong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>, and <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>  . </span><span class="cited-content_cbyCitation_article-title">Rational Design and Multibiological Profiling of Novel Donepezil–Trolox Hybrids against Alzheimer’s Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (11)
                                     , 2496-2511. <a href="https://doi.org/10.1021/acschemneuro.7b00257" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00257%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DRational%252BDesign%252Band%252BMultibiological%252BProfiling%252Bof%252BNovel%252BDonepezil%2525E2%252580%252593Trolox%252BHybrids%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%25252C%252Bwith%252BCholinergic%25252C%252BAntioxidant%25252C%252BNeuroprotective%25252C%252Band%252BCognition%252BEnhancing%252BProperties%26aulast%3DCai%26aufirst%3DPei%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10072017%26date%3D14082017%26date%3D25082017%26date%3D15112017%26date%3D14082017%26volume%3D8%26issue%3D11%26spage%3D2496%26epage%3D2511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Roberta  Farina</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Rosa Maria  Iacobazzi</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Saverio  Cellamare</span>, <span class="hlFld-ContribAuthor ">Giuseppe Felice  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Nunzio  Denora</span>, <span class="hlFld-ContribAuthor ">Ramon  Soto-Otero</span>, <span class="hlFld-ContribAuthor ">Lydia  Siragusa</span>, <span class="hlFld-ContribAuthor ">Cosimo Damiano  Altomare</span>, and <span class="hlFld-ContribAuthor ">Angelo  Carotti</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (14)
                                     , 6791-6806. <a href="https://doi.org/10.1021/acs.jmedchem.6b00562" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00562</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00562%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploring%252BBasic%252BTail%252BModifications%252Bof%252BCoumarin-Based%252BDual%252BAcetylcholinesterase-Monoamine%252BOxidase%252BB%252BInhibitors%25253A%252BIdentification%252Bof%252BWater-Soluble%25252C%252BBrain-Permeant%252BNeuroprotective%252BMultitarget%252BAgents%26aulast%3DPisani%26aufirst%3DLeonardo%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D13042016%26date%3D07072016%26date%3D28072016%26date%3D27062016%26volume%3D59%26issue%3D14%26spage%3D6791%26epage%3D6806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yangjing  Lv</span>, <span class="hlFld-ContribAuthor ">Renren  Bai</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105070. <a href="https://doi.org/10.1016/j.bioorg.2021.105070" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DStructural%252Bexploration%252Bof%252Bmultifunctional%252Bmonoamine%252Boxidase%252BB%252Binhibitors%252Bas%252Bpotential%252Bdrug%252Bcandidates%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhang%26aufirst%3DChangjun%26date%3D2021%26volume%3D114%26spage%3D105070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abderrazzak  Bouhaoui</span>, <span class="hlFld-ContribAuthor ">Mohammed  Eddahmi</span>, <span class="hlFld-ContribAuthor ">Mustapha  Dib</span>, <span class="hlFld-ContribAuthor ">Mostafa  Khouili</span>, <span class="hlFld-ContribAuthor ">Alfredo  Aires</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Latifa  Bouissane</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Properties of Coumarin Derivatives. A Review. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (24)
                                     , 5848-5870. <a href="https://doi.org/10.1002/slct.202101346" title="DOI URL">https://doi.org/10.1002/slct.202101346</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202101346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202101346%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Band%252BBiological%252BProperties%252Bof%252BCoumarin%252BDerivatives.%252BA%252BReview%26aulast%3DBouhaoui%26aufirst%3DAbderrazzak%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D24%26spage%3D5848%26epage%3D5870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhikun  Liu</span>, <span class="hlFld-ContribAuthor ">Bin  Zhang</span>, <span class="hlFld-ContribAuthor ">Shengjin  Xia</span>, <span class="hlFld-ContribAuthor ">Lei  Fang</span>, <span class="hlFld-ContribAuthor ">Shaohua  Gou</span>. </span><span class="cited-content_cbyCitation_article-title">ROS-responsive and multifunctional anti-Alzheimer prodrugs: Tacrine-ibuprofen hybrids via a phenyl boronate linker. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 112997. <a href="https://doi.org/10.1016/j.ejmech.2020.112997" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112997</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112997%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DROS-responsive%252Band%252Bmultifunctional%252Banti-Alzheimer%252Bprodrugs%25253A%252BTacrine-ibuprofen%252Bhybrids%252Bvia%252Ba%252Bphenyl%252Bboronate%252Blinker%26aulast%3DLiu%26aufirst%3DZhikun%26date%3D2021%26volume%3D212%26spage%3D112997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheunopa C.  Mzezewa</span>, <span class="hlFld-ContribAuthor ">Sylvester I.  Omoruyi</span>, <span class="hlFld-ContribAuthor ">Luke S.  Zondagh</span>, <span class="hlFld-ContribAuthor ">Sarel F.  Malan</span>, <span class="hlFld-ContribAuthor ">Okobi E.  Ekpo</span>, <span class="hlFld-ContribAuthor ">Jacques  Joubert</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer’s disease agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 1607-1621. <a href="https://doi.org/10.1080/14756366.2021.1913137" title="DOI URL">https://doi.org/10.1080/14756366.2021.1913137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2021.1913137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2021.1913137%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252B3%25252C7-substituted%252Bcoumarin%252Bderivatives%252Bas%252Bmultifunctional%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bagents%26aulast%3DMzezewa%26aufirst%3DSheunopa%2BC.%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D1607%26epage%3D1621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vittorio  Canale</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Grychowska</span>, <span class="hlFld-ContribAuthor ">Rafał  Kurczab</span>, <span class="hlFld-ContribAuthor ">Mateusz  Ryng</span>, <span class="hlFld-ContribAuthor ">Abdul Raheem  Keeri</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Satała</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Olejarz-Maciej</span>, <span class="hlFld-ContribAuthor ">Paulina  Koczurkiewicz</span>, <span class="hlFld-ContribAuthor ">Marcin  Drop</span>, <span class="hlFld-ContribAuthor ">Klaudia  Blicharz</span>, <span class="hlFld-ContribAuthor ">Kamil  Piska</span>, <span class="hlFld-ContribAuthor ">Elżbieta  Pękala</span>, <span class="hlFld-ContribAuthor ">Paulina  Janiszewska</span>, <span class="hlFld-ContribAuthor ">Martyna  Krawczyk</span>, <span class="hlFld-ContribAuthor ">Maria  Walczak</span>, <span class="hlFld-ContribAuthor ">Severine  Chaumont-Dubel</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">Philippe  Marin</span>, <span class="hlFld-ContribAuthor ">Piotr  Popik</span>, <span class="hlFld-ContribAuthor ">Paweł  Zajdel</span>. </span><span class="cited-content_cbyCitation_article-title">A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>208 </em>, 112765. <a href="https://doi.org/10.1016/j.ejmech.2020.112765" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112765</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112765%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bdual-acting%252B5-HT6%252Breceptor%252Binverse%252Bagonist%25252FMAO-B%252Binhibitor%252Bdisplays%252Bglioprotective%252Band%252Bpro-cognitive%252Bproperties%26aulast%3DCanale%26aufirst%3DVittorio%26date%3D2020%26volume%3D208%26spage%3D112765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosa  Purgatorio</span>, <span class="hlFld-ContribAuthor ">Nicola  Gambacorta</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Modesto  de Candia</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Alba  Espargaró</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabaté</span>, <span class="hlFld-ContribAuthor ">Saverio  Cellamare</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Cosimo  Altomare</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore Modeling and 3D-QSAR Study of Indole and Isatin Derivatives as Antiamyloidogenic Agents Targeting Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (23)
                                     , 5773. <a href="https://doi.org/10.3390/molecules25235773" title="DOI URL">https://doi.org/10.3390/molecules25235773</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25235773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25235773%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPharmacophore%252BModeling%252Band%252B3D-QSAR%252BStudy%252Bof%252BIndole%252Band%252BIsatin%252BDerivatives%252Bas%252BAntiamyloidogenic%252BAgents%252BTargeting%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPurgatorio%26aufirst%3DRosa%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D23%26spage%3D5773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moustafa. A.  Gouda</span>, <span class="hlFld-ContribAuthor ">Ameen A.  Abu‐Hashem</span>, <span class="hlFld-ContribAuthor ">Mohammed A.  Salem</span>, <span class="hlFld-ContribAuthor ">Mohamed H.  Helal</span>, <span class="hlFld-ContribAuthor ">Mohammed  Al‐Ghorbani</span>, <span class="hlFld-ContribAuthor ">Wafaa S.  Hamama</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress on coumarin
              scaffold‐based
              anti‐microbial agents (Part
              III
              ). </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2020,</strong> <em>57 </em>
                                    (11)
                                     , 3784-3817. <a href="https://doi.org/10.1002/jhet.4100" title="DOI URL">https://doi.org/10.1002/jhet.4100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4100%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bon%252Bcoumarin%252Bscaffold%2525E2%252580%252590based%252Banti%2525E2%252580%252590microbial%252Bagents%252B%252528Part%252BIII%252B%252529%26aulast%3DGouda%26aufirst%3DMoustafa.%2BA.%26date%3D2020%26date%3D2020%26volume%3D57%26issue%3D11%26spage%3D3784%26epage%3D3817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ziwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Jingli  Min</span>, <span class="hlFld-ContribAuthor ">Mengdie  Chen</span>, <span class="hlFld-ContribAuthor ">Xia  Jiang</span>, <span class="hlFld-ContribAuthor ">Yingying  Xu</span>, <span class="hlFld-ContribAuthor ">Huali  Qin</span>, <span class="hlFld-ContribAuthor ">Wenjian  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">The structure-based optimization of δ-sultone-fused pyrazoles as selective BuChE inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>201 </em>, 112273. <a href="https://doi.org/10.1016/j.ejmech.2020.112273" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112273%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bstructure-based%252Boptimization%252Bof%252B%2525CE%2525B4-sultone-fused%252Bpyrazoles%252Bas%252Bselective%252BBuChE%252Binhibitors%26aulast%3DZhang%26aufirst%3DZiwen%26date%3D2020%26volume%3D201%26spage%3D112273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Chunli  Tang</span>, <span class="hlFld-ContribAuthor ">Chengyun  Pang</span>, <span class="hlFld-ContribAuthor ">Qing  Li</span>, <span class="hlFld-ContribAuthor ">Yuelian  Qin</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Nong</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Guo</span>, <span class="hlFld-ContribAuthor ">Maojun  Cheng</span>, <span class="hlFld-ContribAuthor ">Weizhong  Tang</span>, <span class="hlFld-ContribAuthor ">Ningsheng  Liang</span>, <span class="hlFld-ContribAuthor ">Neng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>202 </em>, 112475. <a href="https://doi.org/10.1016/j.ejmech.2020.112475" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112475%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Brasagiline-clorgyline%252Bhybrids%252Bas%252Bnovel%252Bdual%252Binhibitors%252Bof%252Bmonoamine%252Boxidase-B%252Band%252Bamyloid-%2525CE%2525B2%252Baggregation%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DXie%26aufirst%3DSai-Sai%26date%3D2020%26volume%3D202%26spage%3D112475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Rana</span>, <span class="hlFld-ContribAuthor ">Abhishek  Pareek</span>, <span class="hlFld-ContribAuthor ">Shivani  Bhardwaj</span>, <span class="hlFld-ContribAuthor ">Geeta  Arya</span>, <span class="hlFld-ContribAuthor ">Surendra  Nimesh</span>, <span class="hlFld-ContribAuthor ">Hemant  Arya</span>, <span class="hlFld-ContribAuthor ">Tarun K.  Bhatt</span>, <span class="hlFld-ContribAuthor ">Srinivasarao  Yaragorla</span>, <span class="hlFld-ContribAuthor ">Anuj K.  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Aryldiazoquinoline based multifunctional small molecules for modulating Aβ
              42
              aggregation and cholinesterase activity related to Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (48)
                                     , 28827-28837. <a href="https://doi.org/10.1039/D0RA05172A" title="DOI URL">https://doi.org/10.1039/D0RA05172A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA05172A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA05172A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAryldiazoquinoline%252Bbased%252Bmultifunctional%252Bsmall%252Bmolecules%252Bfor%252Bmodulating%252BA%2525CE%2525B2%252B42%252Baggregation%252Band%252Bcholinesterase%252Bactivity%252Brelated%252Bto%252BAlzheimer%252527s%252Bdisease%26aulast%3DRana%26aufirst%3DMonika%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D48%26spage%3D28827%26epage%3D28837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhixian  Shi</span>, <span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Yujin  Wang</span>, <span class="hlFld-ContribAuthor ">Zhichao  Lei</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>, <span class="hlFld-ContribAuthor ">Jianbo  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Novel NO-releasing scopoletin derivatives induce cell death via mitochondrial apoptosis pathway and cell cycle arrest. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112386. <a href="https://doi.org/10.1016/j.ejmech.2020.112386" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112386%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BNO-releasing%252Bscopoletin%252Bderivatives%252Binduce%252Bcell%252Bdeath%252Bvia%252Bmitochondrial%252Bapoptosis%252Bpathway%252Band%252Bcell%252Bcycle%252Barrest%26aulast%3DShi%26aufirst%3DZhixian%26date%3D2020%26volume%3D200%26spage%3D112386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fathima Sahla  Kavully</span>, <span class="hlFld-ContribAuthor ">Jong Min  Oh</span>, <span class="hlFld-ContribAuthor ">Sanal  Dev</span>, <span class="hlFld-ContribAuthor ">Swafvan  Kaipakasseri</span>, <span class="hlFld-ContribAuthor ">Ashique  Palakkathondi</span>, <span class="hlFld-ContribAuthor ">Ajeesh  Vengamthodi</span>, <span class="hlFld-ContribAuthor ">Rinshana Fathima  Abdul Azeez</span>, <span class="hlFld-ContribAuthor ">Anna Rita  Tondo</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>. </span><span class="cited-content_cbyCitation_article-title">Design of enamides as new selective monoamine oxidase-B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacy and Pharmacology</span><span> <strong>2020,</strong> <em>72 </em>
                                    (7)
                                     , 916-926. <a href="https://doi.org/10.1111/jphp.13264" title="DOI URL">https://doi.org/10.1111/jphp.13264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jphp.13264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjphp.13264%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacy%2520and%2520Pharmacology%26atitle%3DDesign%252Bof%252Benamides%252Bas%252Bnew%252Bselective%252Bmonoamine%252Boxidase-B%252Binhibitors%26aulast%3DKavully%26aufirst%3DFathima%2BSahla%26date%3D2020%26date%3D2020%26volume%3D72%26issue%3D7%26spage%3D916%26epage%3D926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Praveen P.N.  Rao</span>, <span class="hlFld-ContribAuthor ">Amy Trinh  Pham</span>, <span class="hlFld-ContribAuthor ">Arash  Shakeri</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of small molecules for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 289-322. <a href="https://doi.org/10.1016/B978-0-12-818349-6.00011-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-818349-6.00011-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818349-6.00011-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818349-6.00011-X%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252Bsmall%252Bmolecules%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DRao%26aufirst%3DPraveen%2BP.N.%26date%3D2020%26spage%3D289%26epage%3D322%26pub%3DElsevier%26atitle%3DSmall%252BMolecule%252BDrug%252BDiscovery%26date%3D2020%26volume%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Fu</span>, <span class="hlFld-ContribAuthor ">Fengqi  Bao</span>, <span class="hlFld-ContribAuthor ">Min  Gu</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiaoli  Ding</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Jinsong  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of quinolinone derivatives containing dithiocarbamate moiety as multifunctional AChE inhibitors for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 118-128. <a href="https://doi.org/10.1080/14756366.2019.1687460" title="DOI URL">https://doi.org/10.1080/14756366.2019.1687460</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1687460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1687460%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bquinolinone%252Bderivatives%252Bcontaining%252Bdithiocarbamate%252Bmoiety%252Bas%252Bmultifunctional%252BAChE%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DFu%26aufirst%3DJie%26date%3D2020%26date%3D2019%26volume%3D35%26issue%3D1%26spage%3D118%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aso Hameed  Hasan</span>, <span class="hlFld-ContribAuthor ">Syazwani Itri  Amran</span>, <span class="hlFld-ContribAuthor ">Faiq Hama  Saeed Hussain</span>, <span class="hlFld-ContribAuthor ">Baram Ahmed  Jaff</span>, <span class="hlFld-ContribAuthor ">Joazaizulfazli  Jamalis</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Docking and Recent Advances in the Design and Development of Cholinesterase Inhibitor Scaffolds: Coumarin Hybrids. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (48)
                                     , 14140-14156. <a href="https://doi.org/10.1002/slct.201903607" title="DOI URL">https://doi.org/10.1002/slct.201903607</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201903607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201903607%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DMolecular%252BDocking%252Band%252BRecent%252BAdvances%252Bin%252Bthe%252BDesign%252Band%252BDevelopment%252Bof%252BCholinesterase%252BInhibitor%252BScaffolds%25253A%252BCoumarin%252BHybrids%26aulast%3DHasan%26aufirst%3DAso%2BHameed%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D48%26spage%3D14140%26epage%3D14156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Reeta</span>, <span class="hlFld-ContribAuthor ">Seung Cheol  Baek</span>, <span class="hlFld-ContribAuthor ">Jae Pil  Lee</span>, <span class="hlFld-ContribAuthor ">T.M.  Rangarajan</span>, <span class="hlFld-ContribAuthor ">Ayushee</span>, <span class="hlFld-ContribAuthor ">Rishi Pal  Singh</span>, <span class="hlFld-ContribAuthor ">Manjula  Singh</span>, <span class="hlFld-ContribAuthor ">Giuseppe Felice  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>. </span><span class="cited-content_cbyCitation_article-title">Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">CNS & Neurological Disorders - Drug Targets</span><span> <strong>2019,</strong> <em>18 </em>
                                    (8)
                                     , 643-654. <a href="https://doi.org/10.2174/1871527318666190906101326" title="DOI URL">https://doi.org/10.2174/1871527318666190906101326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871527318666190906101326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871527318666190906101326%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520%2526%2520Neurological%2520Disorders%2520-%2520Drug%2520Targets%26atitle%3DEthyl%252BAcetohydroxamate%252BIncorporated%252BChalcones%25253A%252BUnveiling%252Ba%252BNovel%252BClass%252Bof%252BChalcones%252Bfor%252BMultitarget%252BMonoamine%252BOxidase-B%252BInhibitors%252BAgainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DReeta%26date%3D2019%26volume%3D18%26issue%3D8%26spage%3D643%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yaghoub  Pourshojaei</span>, <span class="hlFld-ContribAuthor ">Khalil  Eskandari</span>, <span class="hlFld-ContribAuthor ">Ali  Asadipour</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Significant Scaffolds to Design and Synthesis Cholinesterase Inhibitors as Anti-Alzheimer Agents. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (19)
                                     , 1577-1598. <a href="https://doi.org/10.2174/1389557519666190719143112" title="DOI URL">https://doi.org/10.2174/1389557519666190719143112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389557519666190719143112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389557519666190719143112%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BSignificant%252BScaffolds%252Bto%252BDesign%252Band%252BSynthesis%252BCholinesterase%252BInhibitors%252Bas%252BAnti-Alzheimer%252BAgents%26aulast%3DPourshojaei%26aufirst%3DYaghoub%26date%3D2019%26volume%3D19%26issue%3D19%26spage%3D1577%26epage%3D1598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Della Grace Thomas  Parambi</span>, <span class="hlFld-ContribAuthor ">Jong Min  Oh</span>, <span class="hlFld-ContribAuthor ">Seung Cheol  Baek</span>, <span class="hlFld-ContribAuthor ">Jae Pil  Lee</span>, <span class="hlFld-ContribAuthor ">Anna Rita  Tondo</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>93 </em>, 103335. <a href="https://doi.org/10.1016/j.bioorg.2019.103335" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103335</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103335%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Boxygenated%252Bchalcones%252Bas%252Bpotent%252Band%252Bselective%252BMAO-B%252Binhibitors%26aulast%3DParambi%26aufirst%3DDella%2BGrace%2BThomas%26date%3D2019%26volume%3D93%26spage%3D103335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria P.  Paramonova</span>, <span class="hlFld-ContribAuthor ">Alexander A.  Ozerov</span>, <span class="hlFld-ContribAuthor ">Alexander O.  Chizhov</span>, <span class="hlFld-ContribAuthor ">Robert  Snoeck</span>, <span class="hlFld-ContribAuthor ">Graciela  Andrei</span>, <span class="hlFld-ContribAuthor ">Anastasia L.  Khandazhinskaya</span>, <span class="hlFld-ContribAuthor ">Mikhail S.  Novikov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of uracil–coumarin conjugates as potential inhibitors of virus replication. </span><span class="cited-content_cbyCitation_journal-name">Mendeleev Communications</span><span> <strong>2019,</strong> <em>29 </em>
                                    (6)
                                     , 638-639. <a href="https://doi.org/10.1016/j.mencom.2019.11.010" title="DOI URL">https://doi.org/10.1016/j.mencom.2019.11.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mencom.2019.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mencom.2019.11.010%26sid%3Dliteratum%253Aachs%26jtitle%3DMendeleev%2520Communications%26atitle%3DSynthesis%252Bof%252Buracil%2525E2%252580%252593coumarin%252Bconjugates%252Bas%252Bpotential%252Binhibitors%252Bof%252Bvirus%252Breplication%26aulast%3DParamonova%26aufirst%3DMaria%2BP.%26date%3D2019%26volume%3D29%26issue%3D6%26spage%3D638%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bijo  Mathew</span>, <span class="hlFld-ContribAuthor ">Della G. T.  Parambi</span>, <span class="hlFld-ContribAuthor ">Githa E.  Mathew</span>, <span class="hlFld-ContribAuthor ">Md. Sahab  Uddin</span>, <span class="hlFld-ContribAuthor ">Sini T.  Inasu</span>, <span class="hlFld-ContribAuthor ">Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Akash  Marathakam</span>, <span class="hlFld-ContribAuthor ">Mazhuvancherry Kesavan  Unnikrishnan</span>, <span class="hlFld-ContribAuthor ">Simone  Carradori</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2019,</strong> <em>352 </em>
                                    (11)
                                     , 1900177. <a href="https://doi.org/10.1002/ardp.201900177" title="DOI URL">https://doi.org/10.1002/ardp.201900177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900177%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DEmerging%252Btherapeutic%252Bpotentials%252Bof%252Bdual%2525E2%252580%252590acting%252BMAO%252Band%252BAChE%252Binhibitors%252Bin%252BAlzheimer%252527s%252Band%252BParkinson%252527s%252Bdiseases%26aulast%3DMathew%26aufirst%3DBijo%26date%3D2019%26date%3D2019%26volume%3D352%26issue%3D11%26spage%3D1900177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paolo  Guglielmi</span>, <span class="hlFld-ContribAuthor ">Simone  Carradori</span>, <span class="hlFld-ContribAuthor ">Alessandra  Ammazzalorso</span>, <span class="hlFld-ContribAuthor ">Daniela  Secci</span>. </span><span class="cited-content_cbyCitation_article-title">Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (10)
                                     , 995-1035. <a href="https://doi.org/10.1080/17460441.2019.1637415" title="DOI URL">https://doi.org/10.1080/17460441.2019.1637415</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1637415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1637415%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DNovel%252Bapproaches%252Bto%252Bthe%252Bdiscovery%252Bof%252Bselective%252Bhuman%252Bmonoamine%252Boxidase-B%252Binhibitors%25253A%252Bis%252Bthere%252Broom%252Bfor%252Bimprovement%25253F%26aulast%3DGuglielmi%26aufirst%3DPaolo%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D10%26spage%3D995%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rati Kailash Prasad  Tripathi</span>, <span class="hlFld-ContribAuthor ">Senthil Raja  Ayyannan</span>. </span><span class="cited-content_cbyCitation_article-title">Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (5)
                                     , 1603-1706. <a href="https://doi.org/10.1002/med.21561" title="DOI URL">https://doi.org/10.1002/med.21561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21561%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMonoamine%252Boxidase-B%252Binhibitors%252Bas%252Bpotential%252Bneurotherapeutic%252Bagents%25253A%252BAn%252Boverview%252Band%252Bupdate%26aulast%3DTripathi%26aufirst%3DRati%2BKailash%2BPrasad%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D5%26spage%3D1603%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harbinder  Singh</span>, <span class="hlFld-ContribAuthor ">Jatinder Vir  Singh</span>, <span class="hlFld-ContribAuthor ">Kavita  Bhagat</span>, <span class="hlFld-ContribAuthor ">Harmandeep Kaur  Gulati</span>, <span class="hlFld-ContribAuthor ">Mohit  Sanduja</span>, <span class="hlFld-ContribAuthor ">Nitish  Kumar</span>, <span class="hlFld-ContribAuthor ">Nihar  Kinarivala</span>, <span class="hlFld-ContribAuthor ">Sahil  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (16)
                                     , 3477-3510. <a href="https://doi.org/10.1016/j.bmc.2019.06.033" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.06.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.06.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.06.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bapproaches%25252C%252Bdesign%252Bstrategies%25252C%252Bstructure%252Bactivity%252Brelationship%252Band%252Bmechanistic%252Binsights%252Bfor%252Btherapeutic%252Bcoumarin%252Bhybrids%26aulast%3DSingh%26aufirst%3DHarbinder%26date%3D2019%26volume%3D27%26issue%3D16%26spage%3D3477%26epage%3D3510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Balasubramanian  Lakshminarayanan</span>, <span class="hlFld-ContribAuthor ">Seung Cheol  Baek</span>, <span class="hlFld-ContribAuthor ">Jae Pil  Lee</span>, <span class="hlFld-ContribAuthor ">Nagappan  Kannappan</span>, <span class="hlFld-ContribAuthor ">Giuseppe Felice  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Thillainayagam  Subburaju</span>, <span class="hlFld-ContribAuthor ">Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>. </span><span class="cited-content_cbyCitation_article-title">Ethoxylated Head of Chalcones as a New Class of Multi‐Targeted MAO Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (21)
                                     , 6614-6619. <a href="https://doi.org/10.1002/slct.201901093" title="DOI URL">https://doi.org/10.1002/slct.201901093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201901093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201901093%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DEthoxylated%252BHead%252Bof%252BChalcones%252Bas%252Ba%252BNew%252BClass%252Bof%252BMulti%2525E2%252580%252590Targeted%252BMAO%252BInhibitors%26aulast%3DLakshminarayanan%26aufirst%3DBalasubramanian%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D21%26spage%3D6614%26epage%3D6619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peterson  de Andrade</span>, <span class="hlFld-ContribAuthor ">Susimaire P.  Mantoani</span>, <span class="hlFld-ContribAuthor ">Paulo Sérgio  Gonçalves Nunes</span>, <span class="hlFld-ContribAuthor ">Carlos Roca  Magadán</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Danilo Jordão  Xavier</span>, <span class="hlFld-ContribAuthor ">Elza Tiemi Sakamoto  Hojo</span>, <span class="hlFld-ContribAuthor ">Nuria E.  Campillo</span>, <span class="hlFld-ContribAuthor ">Ana  Martínez</span>, <span class="hlFld-ContribAuthor ">Ivone  Carvalho</span>. </span><span class="cited-content_cbyCitation_article-title">Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (6)
                                     , 931-943. <a href="https://doi.org/10.1016/j.bmc.2018.12.030" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.12.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.12.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DHighly%252Bpotent%252Band%252Bselective%252Baryl-1%25252C2%25252C3-triazolyl%252Bbenzylpiperidine%252Binhibitors%252Btoward%252Bbutyrylcholinesterase%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3Dde%2BAndrade%26aufirst%3DPeterson%26date%3D2019%26volume%3D27%26issue%3D6%26spage%3D931%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan-Wei  Tang</span>, <span class="hlFld-ContribAuthor ">Cun-Jian  Shi</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Yang</span>, <span class="hlFld-ContribAuthor ">Pei  Cai</span>, <span class="hlFld-ContribAuthor ">Qiao-Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Xue-Lian  Yang</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 307-319. <a href="https://doi.org/10.1016/j.ejmech.2018.11.040" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.11.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.11.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.11.040%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bisoprenylation-resveratrol%252Bdimer%252Bderivatives%252Bagainst%252BAlzheimer%252527s%252Bdisease%26aulast%3DTang%26aufirst%3DYan-Wei%26date%3D2019%26volume%3D163%26spage%3D307%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renyuan  Hong</span>, <span class="hlFld-ContribAuthor ">Xun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of monoamine oxidase inhibitors by medicinal chemistry approaches. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 10-25. <a href="https://doi.org/10.1039/C8MD00446C" title="DOI URL">https://doi.org/10.1039/C8MD00446C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00446C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00446C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252Bmonoamine%252Boxidase%252Binhibitors%252Bby%252Bmedicinal%252Bchemistry%252Bapproaches%26aulast%3DHong%26aufirst%3DRenyuan%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1%26spage%3D10%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Rosa Maria  Iacobazzi</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Mariagrazia  Rullo</span>, <span class="hlFld-ContribAuthor ">Roberta  Farina</span>, <span class="hlFld-ContribAuthor ">Nunzio  Denora</span>, <span class="hlFld-ContribAuthor ">Saverio  Cellamare</span>, <span class="hlFld-ContribAuthor ">Cosimo Damiano  Altomare</span>. </span><span class="cited-content_cbyCitation_article-title">Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>161 </em>, 292-309. <a href="https://doi.org/10.1016/j.ejmech.2018.10.016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInvestigating%252Balkyl%252Bnitrates%252Bas%252Bnitric%252Boxide%252Breleasing%252Bprecursors%252Bof%252Bmultitarget%252Bacetylcholinesterase-monoamine%252Boxidase%252BB%252Binhibitors%26aulast%3DPisani%26aufirst%3DLeonardo%26date%3D2019%26volume%3D161%26spage%3D292%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariagrazia  Rullo</span>, <span class="hlFld-ContribAuthor ">Mauro  Niso</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Antonio  Carrieri</span>, <span class="hlFld-ContribAuthor ">Nicola Antonio  Colabufo</span>, <span class="hlFld-ContribAuthor ">Saverio  Cellamare</span>, <span class="hlFld-ContribAuthor ">Cosimo Damiano  Altomare</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>161 </em>, 433-444. <a href="https://doi.org/10.1016/j.ejmech.2018.10.043" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.043%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1%25252C2%25252C3%25252C4-Tetrahydroisoquinoline%25252F2H-chromen-2-one%252Bconjugates%252Bas%252Bnanomolar%252BP-glycoprotein%252Binhibitors%25253A%252BMolecular%252Bdeterminants%252Bfor%252Baffinity%252Band%252Bselectivity%252Bover%252Bmultidrug%252Bresistance%252Bassociated%252Bprotein%252B1%26aulast%3DRullo%26aufirst%3DMariagrazia%26date%3D2019%26volume%3D161%26spage%3D433%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  He</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Jin-Shuai  Lan</span>, <span class="hlFld-ContribAuthor ">Jiaoli  Ding</span>, <span class="hlFld-ContribAuthor ">Yongbing  Sun</span>, <span class="hlFld-ContribAuthor ">Yuanying  Fang</span>, <span class="hlFld-ContribAuthor ">Neng  Jiang</span>, <span class="hlFld-ContribAuthor ">Zunhua  Yang</span>, <span class="hlFld-ContribAuthor ">Liyuan  Sun</span>, <span class="hlFld-ContribAuthor ">Yi  Jin</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer’s disease: Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>81 </em>, 512-528. <a href="https://doi.org/10.1016/j.bioorg.2018.09.010" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.09.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.09.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DCoumarin-dithiocarbamate%252Bhybrids%252Bas%252Bnovel%252Bmultitarget%252BAChE%252Band%252BMAO-B%252Binhibitors%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DHe%26aufirst%3DQi%26date%3D2018%26volume%3D81%26spage%3D512%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinhui  Hu</span>, <span class="hlFld-ContribAuthor ">Baijiao  An</span>, <span class="hlFld-ContribAuthor ">Tingting  Pan</span>, <span class="hlFld-ContribAuthor ">Zhengcunxiao  Li</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (21)
                                     , 5718-5729. <a href="https://doi.org/10.1016/j.bmc.2018.10.022" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.10.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.10.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bhistone%252Bdeacetylase%252Binhibitors%252Bpossessing%252Bglutathione%252Bperoxidase-like%252Band%252Bantioxidant%252Bactivities%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DHu%26aufirst%3DJinhui%26date%3D2018%26volume%3D26%26issue%3D21%26spage%3D5718%26epage%3D5729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei  Cai</span>, <span class="hlFld-ContribAuthor ">Si-Qiang  Fang</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Yang</span>, <span class="hlFld-ContribAuthor ">Xue-Lian  Yang</span>, <span class="hlFld-ContribAuthor ">Qiao-Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 161-176. <a href="https://doi.org/10.1016/j.ejmech.2018.08.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDonepezil-butylated%252Bhydroxytoluene%252B%252528BHT%252529%252Bhybrids%252Bas%252BAnti-Alzheimer%252527s%252Bdisease%252Bagents%252Bwith%252Bcholinergic%25252C%252Bantioxidant%25252C%252Band%252Bneuroprotective%252Bproperties%26aulast%3DCai%26aufirst%3DPei%26date%3D2018%26volume%3D157%26spage%3D161%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aliya  Ibrar</span>, <span class="hlFld-ContribAuthor ">Syeda Aaliya  Shehzadi</span>, <span class="hlFld-ContribAuthor ">Faiq  Saeed</span>, <span class="hlFld-ContribAuthor ">Imtiaz  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Developing hybrid molecule therapeutics for diverse enzyme inhibitory action: Active role of coumarin-based structural leads in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (13)
                                     , 3731-3762. <a href="https://doi.org/10.1016/j.bmc.2018.05.042" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.05.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.05.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDeveloping%252Bhybrid%252Bmolecule%252Btherapeutics%252Bfor%252Bdiverse%252Benzyme%252Binhibitory%252Baction%25253A%252BActive%252Brole%252Bof%252Bcoumarin-based%252Bstructural%252Bleads%252Bin%252Bdrug%252Bdiscovery%26aulast%3DIbrar%26aufirst%3DAliya%26date%3D2018%26volume%3D26%26issue%3D13%26spage%3D3731%26epage%3D3762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sirin  Uysal</span>, <span class="hlFld-ContribAuthor ">Sulunay  Parlar</span>, <span class="hlFld-ContribAuthor ">Ayse H.  Tarikogullari</span>, <span class="hlFld-ContribAuthor ">Fadime  Aydin Kose</span>, <span class="hlFld-ContribAuthor ">Vildan  Alptuzun</span>, <span class="hlFld-ContribAuthor ">Zeynep  Soyer</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation, and docking studies of some 5-chloro-2(3
              H
              )-benzoxazolone Mannich bases derivatives as cholinesterase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>351 </em>
                                    (3-4)
                                     , 1700273. <a href="https://doi.org/10.1002/ardp.201700273" title="DOI URL">https://doi.org/10.1002/ardp.201700273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201700273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201700273%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bdocking%252Bstudies%252Bof%252Bsome%252B5-chloro-2%2525283%252BH%252B%252529-benzoxazolone%252BMannich%252Bbases%252Bderivatives%252Bas%252Bcholinesterase%252Binhibitors%26aulast%3DUysal%26aufirst%3DSirin%26date%3D2018%26date%3D2018%26volume%3D351%26issue%3D3-4%26spage%3D1700273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Mariagrazia  Rullo</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Modesto  de Candia</span>, <span class="hlFld-ContribAuthor ">Antonio  Carrieri</span>, <span class="hlFld-ContribAuthor ">Saverio  Cellamare</span>, <span class="hlFld-ContribAuthor ">Cosimo Damiano  Altomare</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-property relationship study of the HPLC enantioselective retention of neuroprotective 7-[(1-alkylpiperidin-3-yl)methoxy]coumarin derivatives on an amylose-based chiral stationary phase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Separation Science</span><span> <strong>2018,</strong> <em>41 </em>
                                    (6)
                                     , 1376-1384. <a href="https://doi.org/10.1002/jssc.201701442" title="DOI URL">https://doi.org/10.1002/jssc.201701442</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jssc.201701442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjssc.201701442%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Separation%2520Science%26atitle%3DStructure-property%252Brelationship%252Bstudy%252Bof%252Bthe%252BHPLC%252Benantioselective%252Bretention%252Bof%252Bneuroprotective%252B7-%25255B%2525281-alkylpiperidin-3-yl%252529methoxy%25255Dcoumarin%252Bderivatives%252Bon%252Ban%252Bamylose-based%252Bchiral%252Bstationary%252Bphase%26aulast%3DPisani%26aufirst%3DLeonardo%26date%3D2018%26date%3D2018%26volume%3D41%26issue%3D6%26spage%3D1376%26epage%3D1384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi-Chao  Chen</span>, <span class="hlFld-ContribAuthor ">Guo-Liang  Qiu</span>, <span class="hlFld-ContribAuthor ">Bo  Li</span>, <span class="hlFld-ContribAuthor ">Jing-Bo  Shi</span>, <span class="hlFld-ContribAuthor ">Xin-Hua  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-Jian  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Tricyclic pyrazolo[1,5- d ][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>147 </em>, 194-204. <a href="https://doi.org/10.1016/j.ejmech.2018.02.002" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTricyclic%252Bpyrazolo%25255B1%25252C5-%252Bd%252B%25255D%25255B1%25252C4%25255Dbenzoxazepin-5%2525286H%252529-one%252Bscaffold%252Bderivatives%25253A%252BSynthesis%252Band%252Bbiological%252Bevaluation%252Bas%252Bselective%252BBuChE%252Binhibitors%26aulast%3DChen%26aufirst%3DShi-Chao%26date%3D2018%26volume%3D147%26spage%3D194%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela  Stefanachi</span>, <span class="hlFld-ContribAuthor ">Francesco  Leonetti</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Angelo  Carotti</span>. </span><span class="cited-content_cbyCitation_article-title">Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (2)
                                     , 250. <a href="https://doi.org/10.3390/molecules23020250" title="DOI URL">https://doi.org/10.3390/molecules23020250</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23020250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23020250%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DCoumarin%25253A%252BA%252BNatural%25252C%252BPrivileged%252Band%252BVersatile%252BScaffold%252Bfor%252BBioactive%252BCompounds%26aulast%3DStefanachi%26aufirst%3DAngela%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D2%26spage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Daniela  Trisciuzzi</span>, <span class="hlFld-ContribAuthor ">Domenico  Alberga</span>, <span class="hlFld-ContribAuthor ">Giuseppe Felice  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget Drug Design for Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 93-105. <a href="https://doi.org/10.1007/7653_2018_17" title="DOI URL">https://doi.org/10.1007/7653_2018_17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7653_2018_17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7653_2018_17%26sid%3Dliteratum%253Aachs%26atitle%3DMultitarget%252BDrug%252BDesign%252Bfor%252BNeurodegenerative%252BDiseases%26aulast%3DCatto%26aufirst%3DMarco%26date%3D2018%26date%3D2018%26spage%3D93%26epage%3D105%26pub%3DSpringer%2520New%2520York%26atitle%3DMulti-Target%252BDrug%252BDesign%252BUsing%252BChem-Bioinformatic%252BApproaches%26aulast%3DRoy%26aufirst%3DKunal%26date%3D2019%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cindy Juliet Cristancho  Ortiz</span>, <span class="hlFld-ContribAuthor ">Matheus  de Freitas Silva</span>, <span class="hlFld-ContribAuthor ">Vanessa Silva  Gontijo</span>, <span class="hlFld-ContribAuthor ">Flávia Pereira Dias  Viegas</span>, <span class="hlFld-ContribAuthor ">Kris Simone Tranches  Dias</span>, <span class="hlFld-ContribAuthor ">Claudio  Viegas</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Multi-target Directed Ligands as a Modern Approach for the Development of Innovative Drug Candidates for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 255-351. <a href="https://doi.org/10.1007/7653_2018_2" title="DOI URL">https://doi.org/10.1007/7653_2018_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7653_2018_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7653_2018_2%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Bof%252BMulti-target%252BDirected%252BLigands%252Bas%252Ba%252BModern%252BApproach%252Bfor%252Bthe%252BDevelopment%252Bof%252BInnovative%252BDrug%252BCandidates%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DOrtiz%26aufirst%3DCindy%2BJuliet%2BCristancho%26date%3D2018%26date%3D2018%26spage%3D255%26epage%3D351%26pub%3DSpringer%2520New%2520York%26atitle%3DMulti-Target%252BDrug%252BDesign%252BUsing%252BChem-Bioinformatic%252BApproaches%26aulast%3DRoy%26aufirst%3DKunal%26date%3D2019%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guo-Liang  Qiu</span>, <span class="hlFld-ContribAuthor ">Shao-Sheng  He</span>, <span class="hlFld-ContribAuthor ">Shi-Chao  Chen</span>, <span class="hlFld-ContribAuthor ">Bo  Li</span>, <span class="hlFld-ContribAuthor ">Hui-Hui  Wu</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Wen-Jian  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of tricyclic pyrazolo[1,5-
              c
              ][1,3]benzoxazin-5(5
              H
              )-one scaffolds as selective BuChE inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 1506-1515. <a href="https://doi.org/10.1080/14756366.2018.1488696" title="DOI URL">https://doi.org/10.1080/14756366.2018.1488696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1488696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1488696%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Btricyclic%252Bpyrazolo%25255B1%25252C5-%252Bc%252B%25255D%25255B1%25252C3%25255Dbenzoxazin-5%2525285%252BH%252B%252529-one%252Bscaffolds%252Bas%252Bselective%252BBuChE%252Binhibitors%26aulast%3DQiu%26aufirst%3DGuo-Liang%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D1506%26epage%3D1515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Lalut</span>, <span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>. </span><span class="cited-content_cbyCitation_article-title">Multiple Ligands in Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 477-508. <a href="https://doi.org/10.1002/9783527674381.ch16" title="DOI URL">https://doi.org/10.1002/9783527674381.ch16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch16%26sid%3Dliteratum%253Aachs%26atitle%3DMultiple%252BLigands%252Bin%252BNeurodegenerative%252BDiseases%26aulast%3DLalut%26aufirst%3DJulien%26date%3D2017%26date%3D2017%26spage%3D477%26epage%3D508%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Annalisa  De Palma</span>, <span class="hlFld-ContribAuthor ">Nicola  Giangregorio</span>, <span class="hlFld-ContribAuthor ">Daniela V.  Miniero</span>, <span class="hlFld-ContribAuthor ">Paolo  Pesce</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Francesco  Campagna</span>, <span class="hlFld-ContribAuthor ">Cosimo D.  Altomare</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>. </span><span class="cited-content_cbyCitation_article-title">Mannich base approach to 5-methoxyisatin 3-(4-isopropylphenyl)hydrazone: A water-soluble prodrug for a multitarget inhibition of cholinesterases, beta-amyloid fibrillization and oligomer-induced cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2017,</strong> <em>109 </em>, 381-388. <a href="https://doi.org/10.1016/j.ejps.2017.08.004" title="DOI URL">https://doi.org/10.1016/j.ejps.2017.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2017.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2017.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DMannich%252Bbase%252Bapproach%252Bto%252B5-methoxyisatin%252B3-%2525284-isopropylphenyl%252529hydrazone%25253A%252BA%252Bwater-soluble%252Bprodrug%252Bfor%252Ba%252Bmultitarget%252Binhibition%252Bof%252Bcholinesterases%25252C%252Bbeta-amyloid%252Bfibrillization%252Band%252Boligomer-induced%252Bcytotoxicity%26aulast%3DPisani%26aufirst%3DLeonardo%26date%3D2017%26volume%3D109%26spage%3D381%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Shuai  Lan</span>, <span class="hlFld-ContribAuthor ">Yue  Ding</span>, <span class="hlFld-ContribAuthor ">Yun  Liu</span>, <span class="hlFld-ContribAuthor ">Ping  Kang</span>, <span class="hlFld-ContribAuthor ">Jian-Wei  Hou</span>, <span class="hlFld-ContribAuthor ">Xin-Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Tong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel coumarin- N -benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 48-59. <a href="https://doi.org/10.1016/j.ejmech.2017.07.055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bcoumarin-%252BN%252B-benzyl%252Bpyridinium%252Bhybrids%252Bas%252Bmulti-target%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLan%26aufirst%3DJin-Shuai%26date%3D2017%26volume%3D139%26spage%3D48%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rona  Ramsay</span>, <span class="hlFld-ContribAuthor ">Keith  Tipton</span>. </span><span class="cited-content_cbyCitation_article-title">Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (7)
                                     , 1192. <a href="https://doi.org/10.3390/molecules22071192" title="DOI URL">https://doi.org/10.3390/molecules22071192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22071192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22071192%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAssessment%252Bof%252BEnzyme%252BInhibition%25253A%252BA%252BReview%252Bwith%252BExamples%252Bfrom%252Bthe%252BDevelopment%252Bof%252BMonoamine%252BOxidase%252Band%252BCholinesterase%252BInhibitory%252BDrugs%26aulast%3DRamsay%26aufirst%3DRona%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D7%26spage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva  Ramos</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>, <span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>. </span><span class="cited-content_cbyCitation_article-title">Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (8)
                                     <a href="https://doi.org/10.4155/fmc-2017-0014" title="DOI URL">https://doi.org/10.4155/fmc-2017-0014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0014%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DMelatonin%252Bas%252Ba%252Bversatile%252Bmolecule%252Bto%252Bdesign%252Bnovel%252Bmultitarget%252Bhybrids%252Bagainst%252Bneurodegeneration%26aulast%3DRamos%26aufirst%3DEva%26date%3D2017%26volume%3D9%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Matej  Sova</span>, <span class="hlFld-ContribAuthor ">Urban  Košak</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>. </span><span class="cited-content_cbyCitation_article-title">Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (8)
                                     , 811-832. <a href="https://doi.org/10.4155/fmc-2017-0036" title="DOI URL">https://doi.org/10.4155/fmc-2017-0036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0036%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDual%252Binhibitors%252Bof%252Bcholinesterases%252Band%252Bmonoamine%252Boxidases%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DKnez%26aufirst%3DDamijan%26date%3D2017%26volume%3D9%26issue%3D8%26spage%3D811%26epage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe Felice  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Domenico  Alberga</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Domenico  Gadaleta</span>, <span class="hlFld-ContribAuthor ">Daniela  Trisciuzzi</span>, <span class="hlFld-ContribAuthor ">Roberta  Farina</span>, <span class="hlFld-ContribAuthor ">Andrea  Carotti</span>, <span class="hlFld-ContribAuthor ">Gianluca  Lattanzi</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>. </span><span class="cited-content_cbyCitation_article-title">A rational approach to elucidate human monoamine oxidase molecular selectivity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2017,</strong> <em>101 </em>, 90-99. <a href="https://doi.org/10.1016/j.ejps.2017.02.008" title="DOI URL">https://doi.org/10.1016/j.ejps.2017.02.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2017.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2017.02.008%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DA%252Brational%252Bapproach%252Bto%252Belucidate%252Bhuman%252Bmonoamine%252Boxidase%252Bmolecular%252Bselectivity%26aulast%3DMangiatordi%26aufirst%3DGiuseppe%2BFelice%26date%3D2017%26volume%3D101%26spage%3D90%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bilqees  Sameem</span>, <span class="hlFld-ContribAuthor ">Mina  Saeedi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Mahdavi</span>, <span class="hlFld-ContribAuthor ">Abbas  Shafiee</span>. </span><span class="cited-content_cbyCitation_article-title">A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>128 </em>, 332-345. <a href="https://doi.org/10.1016/j.ejmech.2016.10.060" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.10.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.10.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.10.060%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Breview%252Bon%252Btacrine-based%252Bscaffolds%252Bas%252Bmulti-target%252Bdrugs%252B%252528MTDLs%252529%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DSameem%26aufirst%3DBilqees%26date%3D2017%26volume%3D128%26spage%3D332%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacques  Joubert</span>, <span class="hlFld-ContribAuthor ">Germaine B.  Foka</span>, <span class="hlFld-ContribAuthor ">Benjamin P.  Repsold</span>, <span class="hlFld-ContribAuthor ">Douglas W.  Oliver</span>, <span class="hlFld-ContribAuthor ">Erika  Kapp</span>, <span class="hlFld-ContribAuthor ">Sarel F.  Malan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>125 </em>, 853-864. <a href="https://doi.org/10.1016/j.ejmech.2016.09.041" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.09.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.09.041%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B7-substituted%252Bcoumarin%252Bderivatives%252Bas%252Bmultimodal%252Bmonoamine%252Boxidase-B%252Band%252Bcholinesterase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DJoubert%26aufirst%3DJacques%26date%3D2017%26volume%3D125%26spage%3D853%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zeynep  Soyer</span>, <span class="hlFld-ContribAuthor ">Sirin  Uysal</span>, <span class="hlFld-ContribAuthor ">Sulunay  Parlar</span>, <span class="hlFld-ContribAuthor ">Ayse Hande  Tarikogullari Dogan</span>, <span class="hlFld-ContribAuthor ">Vildan  Alptuzun</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2017,</strong> <em>32 </em>
                                    (1)
                                     , 13-19. <a href="https://doi.org/10.1080/14756366.2016.1226298" title="DOI URL">https://doi.org/10.1080/14756366.2016.1226298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2016.1226298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2016.1226298%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bof%252Bsome%252B4-phthalimidobenzenesulfonamide%252Bderivatives%252Bas%252Bacetylcholinesterase%252Band%252Bbutyrylcholinesterase%252Binhibitors%26aulast%3DSoyer%26aufirst%3DZeynep%26date%3D2017%26date%3D2016%26volume%3D32%26issue%3D1%26spage%3D13%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koichi  Takao</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Toda</span>, <span class="hlFld-ContribAuthor ">Takayuki  Saito</span>, <span class="hlFld-ContribAuthor ">Yoshiaki  Sugita</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Amide and Ester Derivatives of Cinnamic Acid and Its Analogs: Evaluation of Their Free Radical Scavenging and Monoamine Oxidase and Cholinesterase Inhibitory Activities. </span><span class="cited-content_cbyCitation_journal-name">CHEMICAL & PHARMACEUTICAL BULLETIN</span><span> <strong>2017,</strong> <em>65 </em>
                                    (11)
                                     , 1020-1027. <a href="https://doi.org/10.1248/cpb.c17-00416" title="DOI URL">https://doi.org/10.1248/cpb.c17-00416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c17-00416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c17-00416%26sid%3Dliteratum%253Aachs%26jtitle%3DCHEMICAL%2520%2526%2520PHARMACEUTICAL%2520BULLETIN%26atitle%3DSynthesis%252Bof%252BAmide%252Band%252BEster%252BDerivatives%252Bof%252BCinnamic%252BAcid%252Band%252BIts%252BAnalogs%25253A%252BEvaluation%252Bof%252BTheir%252BFree%252BRadical%252BScavenging%252Band%252BMonoamine%252BOxidase%252Band%252BCholinesterase%252BInhibitory%252BActivities%26aulast%3DTakao%26aufirst%3DKoichi%26date%3D2017%26volume%3D65%26issue%3D11%26spage%3D1020%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ornella  Di Pietro</span>, <span class="hlFld-ContribAuthor ">Nelson  Alencar</span>, <span class="hlFld-ContribAuthor ">Gerard  Esteban</span>, <span class="hlFld-ContribAuthor ">Elisabet  Viayna</span>, <span class="hlFld-ContribAuthor ">Natalia  Szałaj</span>, <span class="hlFld-ContribAuthor ">Javier  Vázquez</span>, <span class="hlFld-ContribAuthor ">Jordi  Juárez-Jiménez</span>, <span class="hlFld-ContribAuthor ">Irene  Sola</span>, <span class="hlFld-ContribAuthor ">Belén  Pérez</span>, <span class="hlFld-ContribAuthor ">Montse  Solé</span>, <span class="hlFld-ContribAuthor ">Mercedes  Unzeta</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>, <span class="hlFld-ContribAuthor ">F. Javier  Luque</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (20)
                                     , 4835-4854. <a href="https://doi.org/10.1016/j.bmc.2016.06.045" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.06.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.06.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.06.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BN-methyl-N-%25255B%2525281%25252C2%25252C3-triazol-4-yl%252529alkyl%25255Dpropargylamines%252Bas%252Bnovel%252Bmonoamine%252Boxidase%252BB%252Binhibitors%26aulast%3DDi%2BPietro%26aufirst%3DOrnella%26date%3D2016%26volume%3D24%26issue%3D20%26spage%3D4835%26epage%3D4854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>, <span class="hlFld-ContribAuthor ">Magdalena  Majekova</span>, <span class="hlFld-ContribAuthor ">Milagros  Medina</span>, <span class="hlFld-ContribAuthor ">Massimo  Valoti</span>. </span><span class="cited-content_cbyCitation_article-title">Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2016,</strong> <em>10 </em><a href="https://doi.org/10.3389/fnins.2016.00375" title="DOI URL">https://doi.org/10.3389/fnins.2016.00375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2016.00375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2016.00375%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DKey%252BTargets%252Bfor%252BMulti-Target%252BLigands%252BDesigned%252Bto%252BCombat%252BNeurodegeneration%26aulast%3DRamsay%26aufirst%3DRona%2BR.%26date%3D2016%26date%3D2016%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular aspects of monoamine oxidase B. </span><span class="cited-content_cbyCitation_journal-name">Progress in Neuro-Psychopharmacology and Biological Psychiatry</span><span> <strong>2016,</strong> <em>69 </em>, 81-89. <a href="https://doi.org/10.1016/j.pnpbp.2016.02.005" title="DOI URL">https://doi.org/10.1016/j.pnpbp.2016.02.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pnpbp.2016.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pnpbp.2016.02.005%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Neuro-Psychopharmacology%2520and%2520Biological%2520Psychiatry%26atitle%3DMolecular%252Baspects%252Bof%252Bmonoamine%252Boxidase%252BB%26aulast%3DRamsay%26aufirst%3DRona%2BR.%26date%3D2016%26volume%3D69%26spage%3D81%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José L.  Domínguez</span>, <span class="hlFld-ContribAuthor ">Fernando  Fernández-Nieto</span>, <span class="hlFld-ContribAuthor ">José M.  Brea</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">M. Rita  Paleo</span>, <span class="hlFld-ContribAuthor ">Silvia  Porto</span>, <span class="hlFld-ContribAuthor ">F. Javier  Sardina</span>, <span class="hlFld-ContribAuthor ">Marian  Castro</span>, <span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Angelo  Carotti</span>, <span class="hlFld-ContribAuthor ">Ramón  Soto-Otero</span>, <span class="hlFld-ContribAuthor ">Estefanía  Méndez-Alvarez</span>, <span class="hlFld-ContribAuthor ">M. Carmen  Villaverde</span>, <span class="hlFld-ContribAuthor ">Fredy  Sussman</span>. </span><span class="cited-content_cbyCitation_article-title">8-Aminomethyl-7-hydroxy-4-methylcoumarins as Multitarget Leads for Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2016,</strong> <em>1 </em>
                                    (11)
                                     , 2742-2749. <a href="https://doi.org/10.1002/slct.201600735" title="DOI URL">https://doi.org/10.1002/slct.201600735</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201600735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201600735%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3D8-Aminomethyl-7-hydroxy-4-methylcoumarins%252Bas%252BMultitarget%252BLeads%252Bfor%252BAlzheimer%252527s%252BDisease%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DJos%25C3%25A9%2BL.%26date%3D2016%26date%3D2016%26volume%3D1%26issue%3D11%26spage%3D2742%26epage%3D2749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi-Min  Wang</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Fan  Li</span>, <span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of donepezil–ferulic acid hybrids as multi-target-directed ligands against Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (5)
                                     , 990-998. <a href="https://doi.org/10.1039/C6MD00053C" title="DOI URL">https://doi.org/10.1039/C6MD00053C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00053C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00053C%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bdonepezil%2525E2%252580%252593ferulic%252Bacid%252Bhybrids%252Bas%252Bmulti-target-directed%252Bligands%252Bagainst%252BAlzheimer%252527s%252Bdisease%26aulast%3DXu%26aufirst%3DWei%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D5%26spage%3D990%26epage%3D998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sai-Sai  Xie</span>, <span class="hlFld-ContribAuthor ">Jin-Shuai  Lan</span>, <span class="hlFld-ContribAuthor ">Xiaobing  Wang</span>, <span class="hlFld-ContribAuthor ">Zhi-Min  Wang</span>, <span class="hlFld-ContribAuthor ">Neng  Jiang</span>, <span class="hlFld-ContribAuthor ">Fan  Li</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel donepezil–coumarin hybrids as multi-target agents for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (7)
                                     , 1528-1539. <a href="https://doi.org/10.1016/j.bmc.2016.02.023" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.02.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.02.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bdonepezil%2525E2%252580%252593coumarin%252Bhybrids%252Bas%252Bmulti-target%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DXie%26aufirst%3DSai-Sai%26date%3D2016%26volume%3D24%26issue%3D7%26spage%3D1528%26epage%3D1539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Chen</span>, <span class="hlFld-ContribAuthor ">Jie  Xiao</span>, <span class="hlFld-ContribAuthor ">Yong  Ni</span>, <span class="hlFld-ContribAuthor ">Han-Fei  Xu</span>, <span class="hlFld-ContribAuthor ">Min  Zheng</span>, <span class="hlFld-ContribAuthor ">Xu  Tong</span>, <span class="hlFld-ContribAuthor ">Tong-Tian  Zhang</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>, <span class="hlFld-ContribAuthor ">Wen-Jian  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one: Design, synthesis, model and use as hMAO-B inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (8)
                                     , 1741-1748. <a href="https://doi.org/10.1016/j.bmc.2016.02.045" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.02.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.02.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.02.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Btricyclic%252Bpyrazolo%25255B1%25252C5-d%25255D%25255B1%25252C4%25255Dbenzoxazepin-5%2525286H%252529-one%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Bmodel%252Band%252Buse%252Bas%252BhMAO-B%252Binhibitors%26aulast%3DChen%26aufirst%3DRui%26date%3D2016%26volume%3D24%26issue%3D8%26spage%3D1741%26epage%3D1748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michalina  Hebda</span>, <span class="hlFld-ContribAuthor ">Marek  Bajda</span>, <span class="hlFld-ContribAuthor ">Anna  Więckowska</span>, <span class="hlFld-ContribAuthor ">Natalia  Szałaj</span>, <span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, <span class="hlFld-ContribAuthor ">Dawid  Panek</span>, <span class="hlFld-ContribAuthor ">Justyna  Godyń</span>, <span class="hlFld-ContribAuthor ">Tomasz  Wichur</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (4)
                                     , 410. <a href="https://doi.org/10.3390/molecules21040410" title="DOI URL">https://doi.org/10.3390/molecules21040410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21040410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21040410%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252BMolecular%252BModelling%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BHeterodimeric%25252C%252BMultiple%252BLigands%252BTargeting%252BCholinesterases%252Band%252BAmyloid%252BBeta%26aulast%3DHebda%26aufirst%3DMichalina%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D4%26spage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo  Pisani</span>, <span class="hlFld-ContribAuthor ">Roberta  Farina</span>, <span class="hlFld-ContribAuthor ">Ramon  Soto-Otero</span>, <span class="hlFld-ContribAuthor ">Nunzio  Denora</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Mangiatordi</span>, <span class="hlFld-ContribAuthor ">Orazio  Nicolotti</span>, <span class="hlFld-ContribAuthor ">Estefania  Mendez-Alvarez</span>, <span class="hlFld-ContribAuthor ">Cosimo  Altomare</span>, <span class="hlFld-ContribAuthor ">Marco  Catto</span>, <span class="hlFld-ContribAuthor ">Angelo  Carotti</span>. </span><span class="cited-content_cbyCitation_article-title">Searching for Multi-Targeting Neurotherapeutics against Alzheimer’s: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (3)
                                     , 362. <a href="https://doi.org/10.3390/molecules21030362" title="DOI URL">https://doi.org/10.3390/molecules21030362</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21030362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21030362%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSearching%252Bfor%252BMulti-Targeting%252BNeurotherapeutics%252Bagainst%252BAlzheimer%2525E2%252580%252599s%25253A%252BDiscovery%252Bof%252BPotent%252BAChE-MAO%252BB%252BInhibitors%252Bthrough%252Bthe%252BDecoration%252Bof%252Bthe%252B2H-Chromen-2-one%252BStructural%252BMotif%26aulast%3DPisani%26aufirst%3DLeonardo%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D3%26spage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun  An</span>, <span class="hlFld-ContribAuthor ">Yali  Zhu</span>, <span class="hlFld-ContribAuthor ">Yuan  Yao</span>, <span class="hlFld-ContribAuthor ">Junjun  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Is it possible to reverse aged acetylcholinesterase inhibited by organophosphorus compounds? Insight from the theoretical study. </span><span class="cited-content_cbyCitation_journal-name">Physical Chemistry Chemical Physics</span><span> <strong>2016,</strong> <em>18 </em>
                                    (14)
                                     , 9838-9846. <a href="https://doi.org/10.1039/C5CP07991H" title="DOI URL">https://doi.org/10.1039/C5CP07991H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5CP07991H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5CP07991H%26sid%3Dliteratum%253Aachs%26jtitle%3DPhysical%2520Chemistry%2520Chemical%2520Physics%26atitle%3DIs%252Bit%252Bpossible%252Bto%252Breverse%252Baged%252Bacetylcholinesterase%252Binhibited%252Bby%252Borganophosphorus%252Bcompounds%25253F%252BInsight%252Bfrom%252Bthe%252Btheoretical%252Bstudy%26aulast%3DAn%26aufirst%3DYun%26date%3D2016%26date%3D2016%26volume%3D18%26issue%3D14%26spage%3D9838%26epage%3D9846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhupinder  Kumar</span>, <span class="hlFld-ContribAuthor ">Sheetal  Sheetal</span>, <span class="hlFld-ContribAuthor ">Anil K.  Mantha</span>, <span class="hlFld-ContribAuthor ">Vinod  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments on the structure–activity relationship studies of MAO inhibitors and their role in different neurological disorders. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (48)
                                     , 42660-42683. <a href="https://doi.org/10.1039/C6RA00302H" title="DOI URL">https://doi.org/10.1039/C6RA00302H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA00302H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA00302H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DRecent%252Bdevelopments%252Bon%252Bthe%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bstudies%252Bof%252BMAO%252Binhibitors%252Band%252Btheir%252Brole%252Bin%252Bdifferent%252Bneurological%252Bdisorders%26aulast%3DKumar%26aufirst%3DBhupinder%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D48%26spage%3D42660%26epage%3D42683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Chemical Structures of Reference AChE and MAO Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Hybridization strategy for flexible multitarget MAO-B/AChE inhibitors <b>2</b>–<b>12</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Hybridization strategy for rigid molecules as multitarget MAO-B/AChE inhibitors <b>13</b>–<b>40</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>2</b>–<b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) suitable dibromo-derivative (1,3-dibromopropane for <b>1a</b>, 1,4-dibromobutane for <b>1b</b>, 1,5-dibromopentane for <b>1c</b>, 1,6-dibromohexane for <b>1d</b>, α,α′-dibromo-<i>m</i>-xylene for <b>1e</b>, α,α′-dibromo-<i>p</i>-xylene for <b>1f</b>–<b>k</b>), K<sub>2</sub>CO<sub>3</sub>, dry acetonitrile, 30 min, 130 °C, MW; (b) substituted benzylamine, K<sub>2</sub>CO<sub>3</sub>, KI (cat.) (for compounds <b>2</b>–<b>12</b>), dry acetonitrile, 30 min, 130 °C, MW.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>42</b>–<b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BH<sub>3</sub>·SMe<sub>2</sub>, THF, 0 °C to room temperature, 4 h; (b) 7-hydroxycoumarin, K<sub>2</sub>CO<sub>3</sub>, dry acetonitrile, 130 °C, 30 min, MW; (c) CBr<sub>4</sub>, PPh<sub>3</sub>, dry dichloromethane, 0 °C to room temperature, 4 h; (d) benzylamine or <i>N</i>-benzylmethylamine, K<sub>2</sub>CO<sub>3</sub>, dry acetonitrile, KI (cat.), 130 °C, 30 min, MW.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0014.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of compound <b>45</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) cinnamoyl chloride, dry dichloromethane, 4 h, reflux, (ii) AlCl<sub>3</sub>, chlorobenzene, 8 h, reflux; (b) α,α′-dibromo-<i>p</i>-xylene, K<sub>2</sub>CO<sub>3</sub>, dry acetonitrile, 130 °C, 30 min, MW; (c) <i>N</i>-methylbenzylamine, K<sub>2</sub>CO<sub>3</sub>, dry acetonitrile, 130 °C, 30 min, MW.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Lineweaver–Burk plots of inhibition kinetics of compounds <b>11</b> (A), <b>24</b> (B), and <b>37</b> (C). Reciprocals of enzyme activity (eeAChE) vs reciprocals of substrate (<i>S</i>-acetylthiocholine) concentration in the presence of different concentrations (0−1 μM) of inhibitor. Concentrations used for inhibitors are reported in inserts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Docking poses of inhibitor <b>2</b> (A) and <b>11</b> (B) into human AChE binding site (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7">4EY7</a>). Inhibitors are represented in sticks, while relevant amino acid residues are in ball-and-sticks, colored according to the atom code (C atoms in cyan and green for inhibitors and amino acid residues, respectively). Docking scores are equal to −98.2 and −106.2 kJ/mol for inhibitor <b>2</b> and <b>11</b>, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking poses of inhibitor <b>32</b> into human (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V60">2V60</a>) (A) and rat MAO-B (homology model) (B) binding sites. Inhibitors and FAD cofactor are represented in sticks, while relevant amino acid residues are in ball-and-sticks, colored according to the atom code (C atoms in cyan, yellow, and green for inhibitors, cofactor, and amino acid residues, respectively). Docking scores are equal to −88.21 and −80.22 kJ/mol for inhibitor <b>32</b> into human and rat isoforms, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Docking poses of inhibitor <b>23</b> (A) and <b>33</b> (B) into rat MAO-B binding site (homology model). Inhibitors and FAD cofactor are represented in sticks, while relevant amino acid residues in ball-and-sticks, colored according to the atom code (C atoms in cyan, yellow, and green for inhibitors, cofactor, and amino acid residues, respectively).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Docking poses of inhibitor <b>37</b> into (A) hAChE (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7">4EY7</a>) and (B) hMAO-B (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V60">2V60</a>) binding sites. Inhibitors are represented in sticks, while relevant amino acid residues in ball-and-sticks, colored according to the atom code (C atoms in cyan and green for inhibitors and amino acid residues, respectively). Structural water molecules (that are HOH1159 and HOH1351 according to the numbering of <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V60">2V60</a>) are represented as red balls. Hydrogen bonds are represented as red dashed lines. Docking scores are equal to −109.38 and −95.95 kJ/mol for inhibitor <b>37</b> into hAChE and hMAO-B, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0010.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Viability of human neuroblastoma SH-SY5Y cells exposed to compound <b>37</b> at different concentrations and incubation times. SH-SY5Y cells were incubated with increasing concentrations (range 0.1–50 μM) of the test compounds for 24, 48, and 72 h. Untreated cells were used as control. Results are expressed as percentage of viable cells observed after treatment with compounds <b>37</b> and donepezil vs untreated control cells (100%) and shown as mean ± SD (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/medium/jm-2015-00599b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0011.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Percentage of cell survival in the human neuroblastoma cell line SH-SY5Y of compound <b>37</b> in the following conditions: untreated cells (gray column), in the presence of H<sub>2</sub>O<sub>2</sub> (60 μM) alone (black column), in the presence of both H<sub>2</sub>O<sub>2</sub> (60 μM), and compound <b>37</b> (1 and 10 μM, white columns). Data represent means ± SD (<i>n</i> = 3); statistical significance was estimated using one-way ANOVA and Bonferroni post hoc test (** <i>P</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-14/acs.jmedchem.5b00599/20150717/images/large/jm-2015-00599b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00599&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i43">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 84 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Banerjee, S.</span><span> </span><span class="NLM_article-title">The Macroeconomics of Dementia—Will the World Economy get Alzheimer’s Disease?</span> <span class="citation_source-journal">Arch. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">709</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2Fj.arcmed.2012.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23085453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FmvVKgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2012&pages=705-709&author=S.+Banerjee&title=The+Macroeconomics+of+Dementia%E2%80%94Will+the+World+Economy+get+Alzheimer%E2%80%99s+Disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">The macroeconomics of dementia--will the world economy get Alzheimer's disease?</span></div><div class="casAuthors">Banerjee Sube</div><div class="citationInfo"><span class="NLM_cas:title">Archives of medical research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">705-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Health is firmly on the economic radar.  It is big business.  In 2009, the proportion of the Gross Domestic Product spent on health care varied between 6.4% in Mexico and 17.4% in the U.S., with the UK at 9.8% and Germany, Switzerland and Canada ∼11%.  These are considerable amounts of money and they are growing.  With all projections pointing to a growth in the numbers of older people, the pressure on budgets will only increase.  In this paper we will consider the role of dementia in this.  METHODS:  Demographic and economic data were combined and policy implications developed.  RESULTS:  The costs of dementia dwarf those of the illnesses that are currently prioritized at a national and international level such as HIV, cancer, heart disease, stroke and diabetes.  Based on simple demographics, the costs of dementia are set to increase by 85% by 2030, with developing countries bearing an increasing share of the economic burden.  CONCLUSIONS:  The data suggest that dementia is a clear and present economic challenge for the world from the macro level down to the individual.  Before the crisis, governmental structural primary deficits were generally improving and this would have given time and resource to meet the challenges of ageing in general and dementia in particular.  However, increasing government debt over the past 3 years has had the effect of our needing to implement reforms to contain the risks to sovereign budgets sooner rather than later.  This is not an issue that can be ignored.  Inaction will only lead to further debt accumulation in the medium term and the death of systems of care in the long term.  Across the developed world, the main long-term fiscal challenges come from health care costs, and dementia is a major driver of those costs.  There is a need for budgetary consolidation and pension reform more generally.  But, given that dementia is the highest ticket health and social care item that we have, making up 60% of long term care spending according to some estimates, then targeted investment in early intervention and in research (into causes, cure and care) are likely to be of major value in personal, societal, political, and economic terms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSR6ETBO6bFkf69nzq6467DfW6udTcc2eYokyRRdSe5nrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FmvVKgtg%253D%253D&md5=0c003dabd300569448962f65a056cf3c</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2Fj.arcmed.2012.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arcmed.2012.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26atitle%3DThe%2520Macroeconomics%2520of%2520Dementia%25E2%2580%2594Will%2520the%2520World%2520Economy%2520get%2520Alzheimer%25E2%2580%2599s%2520Disease%253F%26jtitle%3DArch.%2520Med.%2520Res.%26date%3D2012%26volume%3D43%26spage%3D705%26epage%3D709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Narayan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehsani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindquist, S.</span><span> </span><span class="NLM_article-title">Combating Neurodegenerative Disease with Chemical Probes and Model Systems</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">911</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1038%2Fnchembio.1663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=25325702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOisrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=911-920&author=P.+Narayanauthor=S.+Ehsaniauthor=S.+Lindquist&title=Combating+Neurodegenerative+Disease+with+Chemical+Probes+and+Model+Systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Combating neurodegenerative disease with chemical probes and model systems</span></div><div class="casAuthors">Narayan, Priyanka; Ehsani, Sepehr; Lindquist, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">911-920</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The disheartening results of recent clin. trials for neurodegenerative disease (ND) therapeutics underscore the need for a more comprehensive understanding of the underlying disease biol. before effective therapies can be devised.  One hallmark of many NDs is a disruption in protein homeostasis.  Therefore, investigating the role of protein homeostasis in these diseases is central to delineating their underlying pathobiol.  Here, we review the seminal role that chem. biol. has played in furthering the research on and treatment of dysfunctional protein homeostasis in NDs.  We also discuss the vital and predictive role of model systems in identifying conserved homeostasis pathways and genes therein that are altered in neurodegeneration.  Integrating approaches from chem. biol. with the use of model systems yields a powerful toolkit with which to unravel the complexities of ND biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXPyatlzrBVLVg90H21EOLACvtfcHk0lhHYrkfKB-F2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOisrzE&md5=440b79365af1fb637ad7db8e51b1149f</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1663%26sid%3Dliteratum%253Aachs%26aulast%3DNarayan%26aufirst%3DP.%26aulast%3DEhsani%26aufirst%3DS.%26aulast%3DLindquist%26aufirst%3DS.%26atitle%3DCombating%2520Neurodegenerative%2520Disease%2520with%2520Chemical%2520Probes%2520and%2520Model%2520Systems%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D911%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Trippier, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labby, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawker, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mataka, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3121</span><span class="NLM_x">–</span> <span class="NLM_lpage">3147</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3015926" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFeju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3121-3147&author=P.+C.+Trippierauthor=K.+J.+Labbyauthor=D.+D.+Hawkerauthor=J.+J.+Matakaauthor=R.+B.+Silverman&title=Target-+and+Mechanism-Based+Therapeutics+for+Neurodegenerative+Diseases%3A+Strength+in+Numbers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers</span></div><div class="casAuthors">Trippier, Paul C.; Jansen Labby, Kristin; Hawker, Dustin D.; Mataka, Jan J.; Silverman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3121-3147</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The development of new therapeutics for the treatment of neurodegenerative pathophysiologies currently stands at a crossroads.  This presents an opportunity to transition future drug discovery efforts to target disease modification, an area in which much still remains unknown.  In this Perspective we examine recent progress in the areas of neurodegenerative drug discovery, focusing on some of the most common targets and mechanisms: N-methyl-d-aspartic acid (NMDA) receptors, voltage gated calcium channels (VGCCs), neuronal nitric oxide synthase (nNOS), oxidative stress from reactive oxygen species, and protein aggregation.  These represent the key players identified in neurodegeneration and are part of a complex, intertwined signaling cascade.  The synergistic delivery of two or more compds. directed against these targets, along with the design of small mols. with multiple modes of action, should be explored in pursuit of more effective clin. treatments for neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjl83DGjxqKrVg90H21EOLACvtfcHk0lh3tOPOaWtHuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFeju78%253D&md5=a8ea6d8cf4f9d3bba76d40ceacc9c26d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm3015926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3015926%26sid%3Dliteratum%253Aachs%26aulast%3DTrippier%26aufirst%3DP.%2BC.%26aulast%3DLabby%26aufirst%3DK.%2BJ.%26aulast%3DHawker%26aufirst%3DD.%2BD.%26aulast%3DMataka%26aufirst%3DJ.%2BJ.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DTarget-%2520and%2520Mechanism-Based%2520Therapeutics%2520for%2520Neurodegenerative%2520Diseases%253A%2520Strength%2520in%2520Numbers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3121%26epage%3D3147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Alzheimer’s Association</span><span> </span><span class="NLM_article-title">2015 Alzheimer’s disease facts and figures</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2Fj.jalz.2015.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=25984581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=332-384&author=Alzheimer%E2%80%99s+Association&title=2015+Alzheimer%E2%80%99s+disease+facts+and+figures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2015.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2015.02.003%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3D2015%2520Alzheimer%25E2%2580%2599s%2520disease%2520facts%2520and%2520figures%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2015%26volume%3D11%26spage%3D332%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Misra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhi, B.</span><span> </span><span class="NLM_article-title">Drug Development Status for Alzheimer’s Disease: Present Scenario</span> <span class="citation_source-journal">Neurol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1007%2Fs10072-013-1316-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23392897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A280%3ADC%252BC3szms1Kitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=831-839&author=S.+Misraauthor=B.+Medhi&title=Drug+Development+Status+for+Alzheimer%E2%80%99s+Disease%3A+Present+Scenario"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Drug development status for Alzheimer's disease: present scenario</span></div><div class="casAuthors">Misra Shubham; Medhi Bikash</div><div class="citationInfo"><span class="NLM_cas:title">Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">831-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recent advances in the understanding of Alzheimer's disease pathogenesis have led to the development of numerous compounds that might ameliorate the disease process.  Research in the field of Alzheimer's disease therapy has been partly successful in terms of developing symptomatic treatments, but also had several failures in terms of developing disease-modifying therapies.  These successes and failures have led to a debate about the potential deficiencies in our understanding of the pathogenesis of Alzheimer's disease and potential pitfalls in diagnosis, choice of therapeutic targets, development of drug candidates, and design of clinical trials.  Many clinical and experimental studies are ongoing, but we need to acknowledge that a single cure for Alzheimer's disease is unlikely to be found and that the approach to drug development for this disorder needs to be reconsidered.  Preclinical research is constantly providing us with new information on pieces of the complex Alzheimer's disease puzzle, and an analysis of this information might reveal patterns of pharmacological interactions instead of single potential drug targets.  Several promising randomized controlled trials are ongoing, and the increased collaboration between pharmaceutical companies, basic researchers, and clinical researchers has the potential to bring us closer to developing an optimum pharmaceutical approach for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR91t6pN3J72a_dlEzl_fBafW6udTcc2eaeBxdynzB5A7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szms1Kitg%253D%253D&md5=fd14da8bea6c53dbc5c00bfd961421d9</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs10072-013-1316-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10072-013-1316-x%26sid%3Dliteratum%253Aachs%26aulast%3DMisra%26aufirst%3DS.%26aulast%3DMedhi%26aufirst%3DB.%26atitle%3DDrug%2520Development%2520Status%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Present%2520Scenario%26jtitle%3DNeurol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D831%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Berk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, M. N.</span><span> </span><span class="NLM_article-title">Successes and Failures for Drugs in Late-Stage Development for Alzheimer’s Disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">792</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1007%2Fs40266-013-0108-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=783-792&author=C.+Berkauthor=M.+N.+Sabbagh&title=Successes+and+Failures+for+Drugs+in+Late-Stage+Development+for+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs40266-013-0108-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-013-0108-6%26sid%3Dliteratum%253Aachs%26aulast%3DBerk%26aufirst%3DC.%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26atitle%3DSuccesses%2520and%2520Failures%2520for%2520Drugs%2520in%2520Late-Stage%2520Development%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DDrugs%2520Aging%26date%3D2013%26volume%3D10%26spage%3D783%26epage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Querfurth, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1056%2FNEJMra0909142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=20107219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=329-344&author=H.+W.+Querfurthauthor=F.+M.+LaFerla&title=Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease</span></div><div class="casAuthors">Querfurth, Henry W.; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-344</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review.  The role of β-amyloid peptide in spontaneous self-aggregation in brain in Alzheimer's disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPeniV_Jn6orVg90H21EOLACvtfcHk0lh3tOPOaWtHuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqt7s%253D&md5=c116f6a6b8fed9af9f5282cc4b755c70</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMra0909142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra0909142%26sid%3Dliteratum%253Aachs%26aulast%3DQuerfurth%26aufirst%3DH.%2BW.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D329%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chakrabarti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakurta, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, M.</span><span> </span><span class="NLM_article-title">Oxidative Stress and Amyloid Beta Toxicity in Alzheimer’s Disease: Intervention in a Complex Relationship by Antioxidants</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4648</span><span class="NLM_x">–</span> <span class="NLM_lpage">4664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.2174%2F09298673113209990152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23834172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWktLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=4648-4664&author=S.+Chakrabartiauthor=M.+Sinhaauthor=I.+G.+Thakurtaauthor=P.+Banerjeeauthor=M.+Chattopadhyay&title=Oxidative+Stress+and+Amyloid+Beta+Toxicity+in+Alzheimer%E2%80%99s+Disease%3A+Intervention+in+a+Complex+Relationship+by+Antioxidants"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress and Amyloid Beta Toxicity in Alzheimerμs Disease: Intervention in a Complex Relationship by Antioxidants</span></div><div class="casAuthors">Chakrabarti, S.; Sinha, M.; Thakurta, I. G.; Banerjee, P.; Chattopadhyay, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">4648-4664</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The elucidation of the intriguing relationship between oxidative stress and Alzheimer's disease is crucial to understand the pathogenesis of the disease as also to design a suitable drug trial with antioxidants against this condition.  We begin by reviewing the basic facts about Alzheimer's disease and the chem. and biol. of oxygen free radicals with particular ref. to the cellular adaptive response through redox-signalling pathways.  The post-mortem evidence of oxidative damage in the brain of Alzheimer's disease patients is overwhelming which is also supported by the similar changes in transgenic mice models of this disease.  However, the causal relationship of oxidative stress with amyloid beta pathol. or the genesis of Alzheimer's disease is not clear.  Considering the available evidence the review suggests that the oxidative stress could be an early event in the disease process and may trigger various adaptive responses such as the alterations of amyloid beta metab. and the activation of stress responsive kinases which can subsequently lead to neuronal degeneration and AD pathol.  Further, we have presented a large body of evidence from various studies to highlight the beneficial effects of antioxidants against amyloid beta toxicity or AD pathol. in animal or cell based models of AD.  The failure of clin. trials with antioxidants against AD has been mentioned and the possible causes of such failures have been analyzed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbccFT304pFbVg90H21EOLACvtfcHk0lhXvh9dcC-GJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWktLbM&md5=4800a4d627796a80debab27e8b694dd6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F09298673113209990152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113209990152%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DS.%26aulast%3DSinha%26aufirst%3DM.%26aulast%3DThakurta%26aufirst%3DI.%2BG.%26aulast%3DBanerjee%26aufirst%3DP.%26aulast%3DChattopadhyay%26aufirst%3DM.%26atitle%3DOxidative%2520Stress%2520and%2520Amyloid%2520Beta%2520Toxicity%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Intervention%2520in%2520a%2520Complex%2520Relationship%2520by%2520Antioxidants%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D4648%26epage%3D4664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Terry, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span> </span><span class="NLM_article-title">The Cholinergic Hypothesis of Age and Alzheimer’s Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">827</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1124%2Fjpet.102.041616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=12805474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVehsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=821-827&author=A.+V.+Terryauthor=J.+J.+Buccafusco&title=The+Cholinergic+Hypothesis+of+Age+and+Alzheimer%E2%80%99s+Disease-Related+Cognitive+Deficits%3A+Recent+Challenges+and+Their+Implications+for+Novel+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development</span></div><div class="casAuthors">Terry, A. V., Jr.; Buccafusco, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">821-827</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The cholinergic hypothesis was initially presented over 20 yr ago and suggests that a dysfunction of acetylcholine contg. neurons in the brain contributes substantially to the cognitive decline obsd. in those with advanced age and Alzheimer's disease (AD).  This premise has since served as the basis for the majority of treatment strategies and drug development approaches for AD to date.  Recent studies of the brains of patients who had mild cognitive impairment or early stage AD in which choline acetyltransferase and/or acetylcholinesterase activity was unaffected (or even up-regulated) have, however, led some to challenge the validity of the hypothesis as well as the rationale for using cholinomimetics to treat the disorder, particularly in the earlier stages.  These challenges, primarily based on assays of post mortem enzyme activity, should be taken in perspective and evaluated within the wide range of cholinergic abnormalities known to exist in both aging and AD.  The results of both post mortem and antemortem studies in aged humans and AD patients, as well as animal expts. suggest that a host of cholinergic abnormalities including alterations in choline transport, acetylcholine release, nicotinic and muscarinic receptor expression, neurotrophin support, and perhaps axonal transport may all contribute to cognitive abnormalities in aging and AD.  Cholinergic abnormalities may also contribute to noncognitive behavioral abnormalities as well as the deposition of toxic neuritic plaques in AD.  Therefore, cholinergic-based strategies will likely remain valid as one approach to rational drug development for the treatment of AD other forms of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPatJs_N3wu7Vg90H21EOLACvtfcHk0lhXvh9dcC-GJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVehsb8%253D&md5=bd52a7d752cc5e51a3866c3ed2ace8f0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.041616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.041616%26sid%3Dliteratum%253Aachs%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Cholinergic%2520Hypothesis%2520of%2520Age%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease-Related%2520Cognitive%2520Deficits%253A%2520Recent%2520Challenges%2520and%2520Their%2520Implications%2520for%2520Novel%2520Drug%2520Development%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D821%26epage%3D827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Anand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, B.</span><span> </span><span class="NLM_article-title">A Review on Cholinesterase Inhibitors for Alzheimer’s Disease</span> <span class="citation_source-journal">Arch. Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1007%2Fs12272-013-0036-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23435942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFWju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=375-399&author=P.+Anandauthor=B.+Singh&title=A+Review+on+Cholinesterase+Inhibitors+for+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A review on cholinesterase inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Anand, Preet; Singh, Baldev</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">375-399</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), a progressive neurodegenerative disorder, is characterized by the deficits in the cholinergic system and deposition of beta amyloid (Aβ) in the form of neurofibrillary tangles and amyloid plaques.  Since the cholinergic system plays an important role in the regulation of learning and memory processes, it has been targetted for the design of anti-Alzheimer's drugs.  Cholinesterase inhibitors enhance cholinergic transmission directly by inhibiting the enzyme acetylcholinesterase (AChE) which hydrolyzes acetylcholine.  Furthermore, it has been also demonstrated that both acetylcholinesterase and butrylcholinesterase (BuChE) play an important role in Aβ-aggregation during the early stages of senile plaque formation.  Therefore, AChE and BuChE inhibition have been documented as crit. targets for the effective management of AD by an increase in the availability of acetylcholine in the brain regions and decrease in the Aβ deposition.  This review discusses the different classes of cholinesterase inhibitors including tacrine, donepezil, rivastigmine, galantamine, xanthostigmine, para-aminobenzoic acid, coumarin, flavonoid, and pyrrolo-isoxazole analogs developed for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe8p6U3r94ubVg90H21EOLACvtfcHk0lhXvh9dcC-GJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFWju70%253D&md5=a8b48dbf6a7e7b988759182ad8cd9b6a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs12272-013-0036-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-013-0036-3%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DB.%26atitle%3DA%2520Review%2520on%2520Cholinesterase%2520Inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DArch.%2520Pharm.%2520Res.%26date%3D2013%26volume%3D36%26spage%3D375%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Cheewakriengkrai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span> </span><span class="NLM_article-title">A 10-Year Perspective on Donepezil</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1517%2F14656566.2013.760543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23316713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVeqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=331-338&author=L.+Cheewakriengkraiauthor=S.+Gauthier&title=A+10-Year+Perspective+on+Donepezil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A 10-year perspective on</span></div><div class="casAuthors">Cheewakriengkrai, Laksanun; Gauthier, Serge</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-338</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: is the first cholinesterase inhibitor widely used for the treatment of Alzheimer's disease (AD).  Its pharmacol. actions are straightforward, enhancing cholinergic activity both in the brain and systemically, with a long-enough half-life to allow for once a day dosing.  Its efficacy has been approved for use in mild-to-moderate AD stage for improvement of symptoms for 10 years, and now it is also approved for use in severe stage.Areas covered: This review article will offer a 10-yr perspective on the use of donepezil in clin. practice against AD and related disorders.  In addn. to discussing the information from randomized clin. trials and from the drug monograph, this article will seek to facilitate the clin. development and clin. use of the next generation of drugs for AD.Expert opinion: Adjustments about expectations and safe use of donepezil were made over time based on such clin. experiences.  Offering a cholinesterase inhibitor to patients with mild-to-moderate AD clearly showed advantages.  If well tolerated, donepezil should be continued in the severe stages of AD as long as the patient appears to benefit from a slower clin. decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqisQxuCbLA-bVg90H21EOLACvtfcHk0lhXvh9dcC-GJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVeqt7g%253D&md5=af78c5a7ba73b97ac2a1710c063f1fed</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1517%2F14656566.2013.760543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2013.760543%26sid%3Dliteratum%253Aachs%26aulast%3DCheewakriengkrai%26aufirst%3DL.%26aulast%3DGauthier%26aufirst%3DS.%26atitle%3DA%252010-Year%2520Perspective%2520on%2520Donepezil%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2013%26volume%3D14%26spage%3D331%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossberg, G. T.</span><span> </span><span class="NLM_article-title">Use of Memantine for the Treatment of Dementia</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1586%2Fern.11.132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=21955192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ClsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=1359-1370&author=D.+Loauthor=G.+T.+Grossberg&title=Use+of+Memantine+for+the+Treatment+of+Dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Use of memantine for the treatment of dementia</span></div><div class="casAuthors">Lo, Daphne; Grossberg, George T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1359-1370</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  The term dementia'' encompasses a no. of neurodegenerative diseases of which Alzheimer''s disease (AD) is the most common.  Prior to 2003, cholinesterase inhibitors, such as donezepil, were the only class of drugs approved to treat mild-to-moderate AD.  In 2003, memantine became the first drug approved by the US FDA to treat moderate-to-severe AD.  Currently, both memantine and donepezil are FDA approved for the treatment of moderate-to-severe AD.  This article examines the pharmacol. profile of memantine, evidence for memantine''s efficacy in moderate-to-severe AD and other dementias, its novel use in other neuropsychiatric disorders and future implications and research directions for memantine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyGdBuGdnw3bVg90H21EOLACvtfcHk0lioqSINVGWRYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ClsbnM&md5=1108b2e6b6328bbafa7394f43205e450</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1586%2Fern.11.132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fern.11.132%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DD.%26aulast%3DGrossberg%26aufirst%3DG.%2BT.%26atitle%3DUse%2520of%2520Memantine%2520for%2520the%2520Treatment%2520of%2520Dementia%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2011%26volume%3D11%26spage%3D1359%26epage%3D1370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Darvesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geula, C.</span><span> </span><span class="NLM_article-title">Neurobiology of Butyrylcholinesterase</span> <span class="citation_source-journal">Nature Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1038%2Fnrn1035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=131-138&author=S.+Darveshauthor=D.+A.+Hopkinsauthor=C.+Geula&title=Neurobiology+of+Butyrylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrn1035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1035%26sid%3Dliteratum%253Aachs%26aulast%3DDarvesh%26aufirst%3DS.%26aulast%3DHopkins%26aufirst%3DD.%2BA.%26aulast%3DGeula%26aufirst%3DC.%26atitle%3DNeurobiology%2520of%2520Butyrylcholinesterase%26jtitle%3DNature%2520Rev.%2520Neurosci.%26date%3D2003%26volume%3D2%26spage%3D131%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalk, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehret-Sabatier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goeldner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelsen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Quaternary Ligand Binding to Aromatic Residues in the Active-Site Gorge of Acetylcholinesterase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">9031</span><span class="NLM_x">–</span> <span class="NLM_lpage">9035</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1073%2Fpnas.90.19.9031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=8415649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVCgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=9031-9035&author=M.+Harelauthor=I.+Schalkauthor=L.+Ehret-Sabatierauthor=F.+Bouetauthor=M.+Goeldnerauthor=C.+Hirthauthor=P.+H.+Axelsenauthor=I.+Silmanauthor=J.+L.+Sussman&title=Quaternary+Ligand+Binding+to+Aromatic+Residues+in+the+Active-Site+Gorge+of+Acetylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase</span></div><div class="casAuthors">Harel, M.; Schalk, I.; Ehret-Sabatier, L.; Bouet, F.; Goeldner, M.; Hirth, C.; Axelsen, P. H.; Silman, I.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9031-5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The binding sites of Torpedo acetylcholinesterase (AChE; EC 3.1.1.7) for quaternary ligands were investigated by x-ray crystallog. and photoaffinity labeling.  The crystal structures of complexes with ligands were detd. at 2.8-Å resoln.  In a complex with edrophonium, the quaternary N atom of the ligand interacted with the indole of Trp-84, and its m-OH group displayed bifurcated H-bonding to 2 members of the catalytic triad, Ser-200 and His-440.  In a complex with tacrine, the acridine was stacked against the indole of Trp-84.  The bisquaternary ligand, decamethonium, was oriented along the narrow gorge leading to the active site; one quaternary group was apposed to the indole of Trp-84 and the other to that of Trp-279, near the top of the gorge.  The only major conformational difference between the 3 complexes was in the orientation of the Ph ring of Phe-330.  In the decamethonium complex, it lay parallel to the surface of the gorge; in the other 2 complexes it was positioned to make contact with the bound ligand.  This close interaction was confirmed by photoaffinity labeling by the photosensitive probe, 3H-labeled p-(N,N-dimethylamino)benzenediazonium fluoroborate, which labeled, predominantly, Phe-330 within the active site.  The labeling of Trp-279 was also obsd.  One mole of label was incorporated per mol of AChE inactivated, indicating that the labeling of Trp-279 and that of Phe-330 were mutually exclusive.  The structural and chem. data, together, showed the important role of arom. groups as binding sites for quaternary ligands, and they provided complementary evidence assigning Trp-84 and Phe-330 to the anionic subsite of the active site and Trp-279 to the peripheral anionic site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVCccIwJSrW7Vg90H21EOLACvtfcHk0lioqSINVGWRYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVCgtrc%253D&md5=6ee8dbaf1919d254a1cb62895f1a4444</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.19.9031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.19.9031%26sid%3Dliteratum%253Aachs%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DSchalk%26aufirst%3DI.%26aulast%3DEhret-Sabatier%26aufirst%3DL.%26aulast%3DBouet%26aufirst%3DF.%26aulast%3DGoeldner%26aufirst%3DM.%26aulast%3DHirth%26aufirst%3DC.%26aulast%3DAxelsen%26aufirst%3DP.%2BH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DQuaternary%2520Ligand%2520Binding%2520to%2520Aromatic%2520Residues%2520in%2520the%2520Active-Site%2520Gorge%2520of%2520Acetylcholinesterase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1993%26volume%3D90%26spage%3D9031%26epage%3D9035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kryger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Structure of Acetylcholinesterase Complexed with E2020 (Aricept): Implications for the Design of New Anti-Alzheimer Drugs</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2FS0969-2126%2899%2980040-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10368299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADyaK1MXitFGitbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=297-307&author=G.+Krygerauthor=I.+Silmanauthor=J.+L.+Sussman&title=Structure+of+Acetylcholinesterase+Complexed+with+E2020+%28Aricept%29%3A+Implications+for+the+Design+of+New+Anti-Alzheimer+Drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs</span></div><div class="casAuthors">Kryger, Gitay; Silman, Israel; Sussman, Joel L.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-307</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Background: Several cholinesterase inhibitors are either being utilized for symptomatic treatment of Alzheimer's disease or are in advanced clin. trials.  E2020, marketed as Aricept, is a member of a large family of N-benzylpiperidine-based acetylcholinesterase (AChE) inhibitors developed, synthesized, and evaluated by the Eisai Company in Japan.  These inhibitors were designed on the basis of QSAR studies, prior to elucidation of the 3-dimensional structure of Torpedo californica AChE (TcAChE).  E2020 significantly enhances performance in animal models of cholinergic hypofunction and has a high affinity for AChE, binding to both elec. eel and mouse AChE in the nanomolar range.  Results: The exptl. structure of the E2020-TcAChE complex pinpoints specific interactions responsible for the high affinity and selectivity demonstrated previously.  It shows that E2020 has an unique orientation along the active-site gorge, extending from the anionic subsite of the active site, at the bottom, to the peripheral anionic site, at the top, via arom. stacking interactions with conserved arom. amino acid residues.  E2020 does not, however, interact directly with either the catalytic triad or the oxyanion hole, but only indirectly via solvent mols.  Conclusions: The study shows, a posteriori, that the design of E2020 took advantage of several important features of the active-site gorge of AChE to produce a drug with both high affinity for AChE and a high degree of selectivity for AChE vs. butyrylcholinesterase (BChE).  It also delineates voids within the gorge that are not occupied by E2020 and could provide sites for potential modification of E2020 to produce drugs with improved pharmacol. profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgomkZ6v86u7Vg90H21EOLACvtfcHk0lioqSINVGWRYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFGitbo%253D&md5=e91e20bdfea0a795ced76fac5aee1205</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2899%2980040-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252899%252980040-9%26sid%3Dliteratum%253Aachs%26aulast%3DKryger%26aufirst%3DG.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DStructure%2520of%2520Acetylcholinesterase%2520Complexed%2520with%2520E2020%2520%2528Aricept%2529%253A%2520Implications%2520for%2520the%2520Design%2520of%2520New%2520Anti-Alzheimer%2520Drugs%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D297%26epage%3D307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valgimigli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amorati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolondi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djemil, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">From the Dual Function Lead AP2238 to AP2469, a Multi-Target-Directed Ligand for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Pharmacol. Res. Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">e00023</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=e00023&author=A.+Tarozziauthor=M.+Bartoliniauthor=L.+Piazziauthor=L.+Valgimigliauthor=R.+Amoratiauthor=C.+Bolondiauthor=A.+Djemilauthor=F.+Manciniauthor=V.+Andrisanoauthor=A.+Rampa&title=From+the+Dual+Function+Lead+AP2238+to+AP2469%2C+a+Multi-Target-Directed+Ligand+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DValgimigli%26aufirst%3DL.%26aulast%3DAmorati%26aufirst%3DR.%26aulast%3DBolondi%26aufirst%3DC.%26aulast%3DDjemil%26aufirst%3DA.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DFrom%2520the%2520Dual%2520Function%2520Lead%2520AP2238%2520to%2520AP2469%252C%2520a%2520Multi-Target-Directed%2520Ligand%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2014%26volume%3D2%26spage%3De00023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Dvira, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberry, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase: From 3D Structure to Function</span> <span class="citation_source-journal">Chem. Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">187</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2Fj.cbi.2010.01.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=20138030" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2010&pages=10-22&author=H.+Dviraauthor=I.+Silmanauthor=M.+Harelauthor=T.+L.+Rosenberryauthor=J.+L.+Sussman&title=Acetylcholinesterase%3A+From+3D+Structure+to+Function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2010.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2010.01.042%26sid%3Dliteratum%253Aachs%26aulast%3DDvira%26aufirst%3DH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DAcetylcholinesterase%253A%2520From%25203D%2520Structure%2520to%2520Function%26jtitle%3DChem.%2520Biol.%2520Interact.%26date%3D2010%26volume%3D187%26spage%3D10%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giangreco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Coumarin Derivatives Tethered to an Edrophonium-like Fragment as Highly Potent and Selective Dual Binding Site Acetylcholinesterase Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1616</span><span class="NLM_x">–</span> <span class="NLM_lpage">1630</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1616-1630&author=L.+Pisaniauthor=M.+Cattoauthor=I.+Giangrecoauthor=F.+Leonettiauthor=O.+Nicolottiauthor=A.+Stefanachiauthor=S.+Cellamareauthor=A.+Carotti&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Coumarin+Derivatives+Tethered+to+an+Edrophonium-like+Fragment+as+Highly+Potent+and+Selective+Dual+Binding+Site+Acetylcholinesterase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DGiangreco%26aufirst%3DI.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Coumarin%2520Derivatives%2520Tethered%2520to%2520an%2520Edrophonium-like%2520Fragment%2520as%2520Highly%2520Potent%2520and%2520Selective%2520Dual%2520Binding%2520Site%2520Acetylcholinesterase%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1616%26epage%3D1630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesce, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Coumarin Alkylamines as Potent and Selective Dual Binding Site Inhibitors of Acetylcholinesterase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=146-152&author=M.+Cattoauthor=L.+Pisaniauthor=F.+Leonettiauthor=O.+Nicolottiauthor=P.+Pesceauthor=A.+Stefanachiauthor=S.+Cellamareauthor=A.+Carotti&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Coumarin+Alkylamines+as+Potent+and+Selective+Dual+Binding+Site+Inhibitors+of+Acetylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DPesce%26aufirst%3DP.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Coumarin%2520Alkylamines%2520as%2520Potent%2520and%2520Selective%2520Dual%2520Binding%2520Site%2520Inhibitors%2520of%2520Acetylcholinesterase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D146%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Homo- and Heterobivalent Edrophonium-like Ammonium Salts as Highly Potent, Dual Binding Site AChE Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">7450</span><span class="NLM_x">–</span> <span class="NLM_lpage">7456</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=7450-7456&author=F.+Leonettiauthor=M.+Cattoauthor=O.+Nicolottiauthor=L.+Pisaniauthor=A.+Cappaauthor=A.+Stefanachiauthor=A.+Carotti&title=Homo-+and+Heterobivalent+Edrophonium-like+Ammonium+Salts+as+Highly+Potent%2C+Dual+Binding+Site+AChE+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCappa%26aufirst%3DA.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DHomo-%2520and%2520Heterobivalent%2520Edrophonium-like%2520Ammonium%2520Salts%2520as%2520Highly%2520Potent%252C%2520Dual%2520Binding%2520Site%2520AChE%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D7450%26epage%3D7456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Conejo-Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Carmen Nunez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Homodimeric Bis-Quaternary Heterocyclic Ammonium Salts as Potent Acetyl- and Butyrylcholinesterase Inhibitors: A Systematic Investigation of the Influence of Linker and Cationic Heads over Affinity and Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2627</span><span class="NLM_x">–</span> <span class="NLM_lpage">2645</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101299d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2627-2645&author=A.+Conejo-Garciaauthor=L.+Pisaniauthor=M.+del+Carmen+Nunezauthor=M.+Cattoauthor=O.+Nicolottiauthor=F.+Leonettiauthor=J.+M.+Camposauthor=M.+A.+Galloauthor=A.+Espinosaauthor=A.+Carotti&title=Homodimeric+Bis-Quaternary+Heterocyclic+Ammonium+Salts+as+Potent+Acetyl-+and+Butyrylcholinesterase+Inhibitors%3A+A+Systematic+Investigation+of+the+Influence+of+Linker+and+Cationic+Heads+over+Affinity+and+Selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm101299d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101299d%26sid%3Dliteratum%253Aachs%26aulast%3DConejo-Garcia%26aufirst%3DA.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3Ddel%2BCarmen%2BNunez%26aufirst%3DM.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCampos%26aufirst%3DJ.%2BM.%26aulast%3DGallo%26aufirst%3DM.%2BA.%26aulast%3DEspinosa%26aufirst%3DA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DHomodimeric%2520Bis-Quaternary%2520Heterocyclic%2520Ammonium%2520Salts%2520as%2520Potent%2520Acetyl-%2520and%2520Butyrylcholinesterase%2520Inhibitors%253A%2520A%2520Systematic%2520Investigation%2520of%2520the%2520Influence%2520of%2520Linker%2520and%2520Cationic%2520Heads%2520over%2520Affinity%2520and%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2627%26epage%3D2645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giangreco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Discovery of a Potent and Selective Hetero-bivalent AChE Inhibitor via Bioisosteric Replacement</span> <span class="citation_source-journal">Mol. Inform.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1002%2Fminf.201000126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjs1Wrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=133-136&author=O.+Nicolottiauthor=L.+Pisaniauthor=M.+Cattoauthor=F.+Leonettiauthor=I.+Giangrecoauthor=A.+Stefanachiauthor=A.+Carotti&title=Discovery+of+a+Potent+and+Selective+Hetero-bivalent+AChE+Inhibitor+via+Bioisosteric+Replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent and Selective Hetero-Bivalent AChE Inhibitor via Bioisosteric Replacement</span></div><div class="casAuthors">Nicolotti, Orazio; Pisani, Leonardo; Catto, Marco; Leonetti, Francesco; Giangreco, Ilenia; Stefanachi, Angela; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">133-136</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The concept of the scaffold hopping was applied via the bioisosteric replacement from coumarin to quinolone to develop new and potent hetero-bivalent acetylcholinesterase inhibitors.  This study showed that the rational design inspired by fundamental principles of medicinal chem. represents still a valid strategy for mol. discovery.  In particular, the docking-assisted bioisosteric replacement from 4-methylcoumarin to 1,4-dimethylquinolin-2(1H)-one proved successful for the discovery of new bioactive mol. entities with improved affinity and selectivity towards AChE.  Indeed, the 1-methylquinolin-2(1H)-one ring is a privileged structure occurring in a large no. of compds. biasing many biol. targets but never so far AChE and BChE.  In this regards, addnl. studies are on the way to enhance the results herein described through the synthesis of a new series of having decorated and augmented analogs of inhibitors that might found potential therapeutic applications in AD, and glaucoma, neuromuscular blockade after surgical anesthesia and myasthenia gravis, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrd6N-NSSWCbVg90H21EOLACvtfcHk0lgJCidTt_y91w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjs1Wrurs%253D&md5=c171b8ea96c5a67669f2df0867edbcc2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fminf.201000126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201000126%26sid%3Dliteratum%253Aachs%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DGiangreco%26aufirst%3DI.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520and%2520Selective%2520Hetero-bivalent%2520AChE%2520Inhibitor%2520via%2520Bioisosteric%2520Replacement%26jtitle%3DMol.%2520Inform.%26date%3D2011%26volume%3D30%26spage%3D133%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Candia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borisova, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varlamov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voskressensky, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span> </span><span class="NLM_article-title">Ester Derivatives of Annulated Tetrahydroazocines: A New Class of Selective Acetylcholinesterase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">7205</span><span class="NLM_x">–</span> <span class="NLM_lpage">7212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2Fj.bmc.2006.06.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=16843666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFGjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=7205-7212&author=A.+Carottiauthor=M.+De+Candiaauthor=M.+Cattoauthor=T.+N.+Borisovaauthor=A.+V.+Varlamovauthor=E.+Mendez-Alvarezauthor=R.+Soto-Oteroauthor=L.+G.+Voskressenskyauthor=C.+Altomare&title=Ester+Derivatives+of+Annulated+Tetrahydroazocines%3A+A+New+Class+of+Selective+Acetylcholinesterase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Ester derivatives of annulated tetrahydroazocines: A new class of selective acetylcholinesterase inhibitors</span></div><div class="casAuthors">Carotti, Andrea; de Candia, Modesto; Catto, Marco; Borisova, Tatiana N.; Varlamov, Alexey V.; Mendez-Alvarez, Estefania; Soto-Otero, Ramon; Voskressensky, Leonid G.; Altomare, Cosimo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7205-7212</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of ester derivs. of annulated tetrahydroazocines, namely 2,3,6,11-tetrahydro-1H-azocino[4,5-b]indoles (5-10), 2,3,6,7-tetrahydro-1H-azocino[5,4-b]indoles (11-14), and 4,7,8,9-tetrahydro-1H-pyrrolo[2,3-d]azocines (15-18), synthesized through an efficient 6 → 8 membered ring expansion procedure, were investigated for their acetylcholinesterase (AChE) inhibitory activities.  Most of the compds. acted as AChE inhibitors in vitro, with IC50 values ranging from 5 to 40 μM.  The most potent compds. 11 and 15, both as racemic mixts., proved selective toward AChE, exhibiting selectivity ratios vs. butyrylcholinesterase (BuChE) of ca. 15 and more than 20, resp.  Structure-activity studies highlighted, among other factors, lipophilicity as a property modulating the AChE inhibition potency, as shown by a reasonable parabolic correlation between pIC50 and exptl. 1-octanol/water partition coeff. (log P), which described the prevailing behavior of the examd. compds. (r2 = 0.665).  Mol. docking simulations using the X-ray crystal structure of AChE from Torpedo californica suggested possible binding modes of the tetrahydroazocine ester derivs. 11 and 15.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUaZF-2sZJcrVg90H21EOLACvtfcHk0ljKd5vMU3Rhag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFGjt7c%253D&md5=97994e53d58b4d572f0ad72975c8596d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.06.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.06.055%26sid%3Dliteratum%253Aachs%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DDe%2BCandia%26aufirst%3DM.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DBorisova%26aufirst%3DT.%2BN.%26aulast%3DVarlamov%26aufirst%3DA.%2BV.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DVoskressensky%26aufirst%3DL.%2BG.%26aulast%3DAltomare%26aufirst%3DC.%26atitle%3DEster%2520Derivatives%2520of%2520Annulated%2520Tetrahydroazocines%253A%2520A%2520New%2520Class%2520of%2520Selective%2520Acetylcholinesterase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D7205%26epage%3D7212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Tasso, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giangreco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparatore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boido, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparatore, F.</span><span> </span><span class="NLM_article-title">Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Potent Inhibitors of Acetyl- and Butyrylcholinesterase with Potential in Alzheimer’s Disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2170</span><span class="NLM_x">–</span> <span class="NLM_lpage">2184</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2170-2184&author=B.+Tassoauthor=M.+Cattoauthor=O.+Nicolottiauthor=F.+Novelliauthor=M.+Tonelliauthor=I.+Giangrecoauthor=L.+Pisaniauthor=A.+Sparatoreauthor=V.+Boidoauthor=A.+Carottiauthor=F.+Sparatore&title=Quinolizidinyl+Derivatives+of+Bi-+and+Tricyclic+Systems+as+Potent+Inhibitors+of+Acetyl-+and+Butyrylcholinesterase+with+Potential+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTasso%26aufirst%3DB.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DNovelli%26aufirst%3DF.%26aulast%3DTonelli%26aufirst%3DM.%26aulast%3DGiangreco%26aufirst%3DI.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DSparatore%26aufirst%3DA.%26aulast%3DBoido%26aufirst%3DV.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSparatore%26aufirst%3DF.%26atitle%3DQuinolizidinyl%2520Derivatives%2520of%2520Bi-%2520and%2520Tricyclic%2520Systems%2520as%2520Potent%2520Inhibitors%2520of%2520Acetyl-%2520and%2520Butyrylcholinesterase%2520with%2520Potential%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2170%26epage%3D2184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berezin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Re, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loizou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetriades, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Stradis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campagna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koutentis, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation of Benzo[<i>e</i>][1,2,4]triazin-7(1<i>H</i>)-one and [1,2,4]-Triazino[5,6,1-<i>jk</i>]carbazol-6-one Derivatives as Dual Inhibitors of Beta-Amyloid Aggregation and Acetyl/Butyryl Cholinesterase</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2012&pages=84-97&author=M.+Cattoauthor=A.+A.+Berezinauthor=D.+Lo+Reauthor=G.+Loizouauthor=M.+Demetriadesauthor=A.+De+Stradisauthor=F.+Campagnaauthor=P.+A.+Koutentisauthor=A.+Carotti&title=Design%2C+Synthesis+and+Biological+Evaluation+of+Benzo%5Be%5D%5B1%2C2%2C4%5Dtriazin-7%281H%29-one+and+%5B1%2C2%2C4%5D-Triazino%5B5%2C6%2C1-jk%5Dcarbazol-6-one+Derivatives+as+Dual+Inhibitors+of+Beta-Amyloid+Aggregation+and+Acetyl%2FButyryl+Cholinesterase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DBerezin%26aufirst%3DA.%2BA.%26aulast%3DLo%2BRe%26aufirst%3DD.%26aulast%3DLoizou%26aufirst%3DG.%26aulast%3DDemetriades%26aufirst%3DM.%26aulast%3DDe%2BStradis%26aufirst%3DA.%26aulast%3DCampagna%26aufirst%3DF.%26aulast%3DKoutentis%26aufirst%3DP.%2BA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Benzo%255Be%255D%255B1%252C2%252C4%255Dtriazin-7%25281H%2529-one%2520and%2520%255B1%252C2%252C4%255D-Triazino%255B5%252C6%252C1-jk%255Dcarbazol-6-one%2520Derivatives%2520as%2520Dual%2520Inhibitors%2520of%2520Beta-Amyloid%2520Aggregation%2520and%2520Acetyl%252FButyryl%2520Cholinesterase%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D58%26spage%3D84%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, K. F.</span><span> </span><span class="NLM_article-title">The Therapeutic Potential of Monoamine Oxidase Inhibitors</span> <span class="citation_source-journal">Nature Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1038%2Fnrn1883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=16552415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Gksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=295-309&author=M.+B.+Youdimauthor=D.+Edmondsonauthor=K.+F.+Tipton&title=The+Therapeutic+Potential+of+Monoamine+Oxidase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic potential of monoamine oxidase inhibitors</span></div><div class="casAuthors">Youdim, Moussa B. H.; Edmondson, Dale; Tipton, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-309</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidase inhibitors were among the first antidepressants to be discovered and have long been used as such.  It now seems that many of these agents might have therapeutic value in several common neurodegenerative conditions, independently of their inhibition of monoamine oxidase activity.  However, many claims and some counter-claims have been made about the physiol. importance of these enzymes and the potential of their inhibitors.  We evaluate these arguments in the light of what we know, and still have to learn, of the structure, function and genetics of the monoamine oxidases and the disparate actions of their inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3A0wRL6nnL7Vg90H21EOLACvtfcHk0ljKd5vMU3Rhag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Gksrs%253D&md5=b35546920d95fa031ff2f884949372a7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrn1883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1883%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DEdmondson%26aufirst%3DD.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DThe%2520Therapeutic%2520Potential%2520of%2520Monoamine%2520Oxidase%2520Inhibitors%26jtitle%3DNature%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D295%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubalek, F.</span><span> </span><span class="NLM_article-title">Structure and Mechanism of Monoamine Oxidases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1983</span><span class="NLM_x">–</span> <span class="NLM_lpage">1993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.2174%2F0929867043364784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=15279562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=1983-1993&author=D.+E.+Edmondsonauthor=A.+Matteviauthor=C.+Bindaauthor=M.+Liauthor=F.+Hubalek&title=Structure+and+Mechanism+of+Monoamine+Oxidases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and mechanism of monoamine oxidase</span></div><div class="casAuthors">Edmondson, D. E.; Mattevi, A.; Binda, C.; Li, M.; Hubalek, F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1983-1993</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidases A and B (MAO A and MAO B) are mitochondrial outer membrane-bound flavoproteins that catalyze the oxidative deamination of neurotransmitters and biogenic amines.  A no. of mechanism-based inhibitors have been developed for clin. use as antidepressants and as neuroprotective drugs.  To facilitate the development of more effective and specific inhibitors, a detailed understanding of the structures and catalytic mechanisms of these enzymes is required.  The recent development of high level expression systems for producing recombinant human liver MAO A and MAO B in Pichia pastoris has facilitated the detn. of the 3-dimensional crystal structures of MAO B (up to 1.7 Å resoln.) in complex with different reversible (isatin, 1,4-diphenyl-2-butene) and irreversible inhibitors (pargyline, N-(2-aminoethyl)-p-chlorobenzamide, and trans-2-phenylcyclopropylamine).  The binding of substrates or inhibitors to MAO B involves an initial negotiation of a protein loop occurring near the surface of the membrane and 2 hydrophobic cavities, an "entrance" cavity, and an "active site" cavity.  These 2 cavities can either be sep. or in a fused state depending on the conformation of the Ile-199 side-chain, which appears to function as a gate.  The amine function of the bound substrate approaches the re face of the bent and "puckered" covalent FAD through an "arom. cage" formed by 2 Tyr residues that are perpendicular to the plane of the flavin ring.  No amino acid residues that could function as acids or bases are found near the catalytic site.  The existing structural data on MAO B support previous QSAR results and are also supportive of a proposed polar nucleophilic mechanism for MAO A and B catalysis rather than the alternatively proposed single electron transfer mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaQv9eLs73u7Vg90H21EOLACvtfcHk0lgRuLyqR6Oh2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslWmu7s%253D&md5=270a408e70f5a136f49489ff7b5fd482</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F0929867043364784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364784%26sid%3Dliteratum%253Aachs%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHubalek%26aufirst%3DF.%26atitle%3DStructure%2520and%2520Mechanism%2520of%2520Monoamine%2520Oxidases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D1983%26epage%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Grimsby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J. C.</span><span> </span><span class="NLM_article-title">Tissue Distribution of Human Monoamine Oxidase-A and Oxidase-B Messenger-RNA</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1111%2Fj.1471-4159.1990.tb03121.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=2398352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADyaK3cXmtVyksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=1166-1169&author=J.+Grimsbyauthor=N.+C.+Lanauthor=R.+Neveauthor=K.+Chenauthor=J.+C.+Shih&title=Tissue+Distribution+of+Human+Monoamine+Oxidase-A+and+Oxidase-B+Messenger-RNA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue distribution of human monoamine oxidase A and B mRNA</span></div><div class="casAuthors">Grimsby, Joseph; Lan, Nancy C.; Neve, Rachael; Chen, Kevin; Shih, Jean C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1166-9</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Northern anal. using 32P-labeled subfragments of human liver MAO A and B cDNA clone detected a 5- and 3-kb transcript, resp., in most human tissues examd.  However, fetal heart and thymus express minute amts. of MAO A transcript, whereas fetal brain, muscle, thymus, spleen, meninges, and placenta express minute amts. of MAO B transcript.  Small intestine and placenta express, in addn. to the MAO A 5-kb transcript, a 2-kb transcript, which may arise from an alternative polyadenylation site.  MAO A and B transcripts are expressed in similar regions of adult human being.  The highest concns. of these transcripts were located in frontal cortex and locus ceruleus.  This study demonstrates the tissue-specific distribution of the MAO genes and will provide insight into the physiol. functions of MAO A and B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNhXyOI-PQ87Vg90H21EOLACvtfcHk0lgRuLyqR6Oh2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtVyksrY%253D&md5=e3f1af76b4168d94b13811471cf46fc5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1990.tb03121.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1990.tb03121.x%26sid%3Dliteratum%253Aachs%26aulast%3DGrimsby%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DN.%2BC.%26aulast%3DNeve%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26atitle%3DTissue%2520Distribution%2520of%2520Human%2520Monoamine%2520Oxidase-A%2520and%2520Oxidase-B%2520Messenger-RNA%26jtitle%3DJ.%2520Neurochem.%26date%3D1990%26volume%3D55%26spage%3D1166%26epage%3D1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S. B.</span><span> </span><span class="NLM_article-title">Selective Inhibitors of Monoamine Oxidase A and B: Biochemical, Pharmacological, and Clinical Properties</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1002%2Fmed.2610040303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=6379342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADyaL2cXltVegu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1984&pages=323-358&author=C.+J.+Fowlerauthor=S.+B.+Ross&title=Selective+Inhibitors+of+Monoamine+Oxidase+A+and+B%3A+Biochemical%2C+Pharmacological%2C+and+Clinical+Properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibitors of monoamine oxidase A and B:  biochemical, pharmacological, and clinical properties</span></div><div class="casAuthors">Fowler, Christopher J.; Ross, Svante B.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">323-58</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    </div><div class="casAbstract">A review with 253 refs. on the pharmacol. of selective inhibitors of monoamine oxidase  [9001-66-5] A and B in humans and lab. animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMN7PoFJsHd7Vg90H21EOLACvtfcHk0lgRuLyqR6Oh2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXltVegu74%253D&md5=6a730e6651384a31adcdf31ffc278879</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610040303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610040303%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DRoss%26aufirst%3DS.%2BB.%26atitle%3DSelective%2520Inhibitors%2520of%2520Monoamine%2520Oxidase%2520A%2520and%2520B%253A%2520Biochemical%252C%2520Pharmacological%252C%2520and%2520Clinical%2520Properties%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1984%26volume%3D4%26spage%3D323%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campagna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Targeting Monoamine Oxidases with Multipotent Ligands: An Emerging Strategy in the Search of New Drugs Against Neurodegenerative Diseases</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.2174%2F092986711797379302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=21864289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyitb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4568-4587&author=L.+Pisaniauthor=M.+Cattoauthor=F.+Leonettiauthor=O.+Nicolottiauthor=A.+Stefanachiauthor=F.+Campagnaauthor=A.+Carotti&title=Targeting+Monoamine+Oxidases+with+Multipotent+Ligands%3A+An+Emerging+Strategy+in+the+Search+of+New+Drugs+Against+Neurodegenerative+Diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases</span></div><div class="casAuthors">Pisani, L.; Catto, M.; Leonetti, F.; Nicolotti, O.; Stefanachi, A.; Campagna, F.; Carotti, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">4568-4587</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The socioeconomic burden of multi-factorial pathologies, such as neurodegenerative diseases (NDs), is enormous worldwide.  Unfortunately, no proven disease-modifying therapy is available yet and in most cases (e.g., Alzheimer's and Parkinson's disease) the approved drugs exert only palliative and symptomatic effects.  Nowadays, an emerging strategy for the discovery of disease-modifying drugs is based on the multi-target directed ligand (MTDL) design, an innovative shift from the traditional approach one-drug-one-target to the more ambitious one-drug-more-targets goal.  Herein, we review the discovery strategy, the mechanism of action and the biopharmacol. evaluation of multipotent ligands exhibiting monoamine oxidase (MAO) inhibition as the core activity with a potential for the treatment of NDs.  In particular, MAO inhibitors exhibiting addnl. acetylcholinesterase (AChE) or nitric oxide synthase (NOS) inhibition, or ion chelation/antioxidant-radical scavenging/anti-inflammatory/A2A receptor antagonist/APP processing modulating activities have been thoroughly examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4N8fMdFNcwrVg90H21EOLACvtfcHk0lj-sZT-fpZKwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyitb7O&md5=2463da84a1da0142e353ff9d3a354fe6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F092986711797379302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797379302%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCampagna%26aufirst%3DF.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DTargeting%2520Monoamine%2520Oxidases%2520with%2520Multipotent%2520Ligands%253A%2520An%2520Emerging%2520Strategy%2520in%2520the%2520Search%2520of%2520New%2520Drugs%2520Against%2520Neurodegenerative%2520Diseases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4568%26epage%3D4587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Salat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolosa, E.</span><span> </span><span class="NLM_article-title">Levodopa in the Treatment of Parkinson’s Disease: Current Status and New Developments</span> <span class="citation_source-journal">J. Parkinson’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23948989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A280%3ADC%252BC3sbgsVylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=255-269&author=D.+Salatauthor=E.+Tolosa&title=Levodopa+in+the+Treatment+of+Parkinson%E2%80%99s+Disease%3A+Current+Status+and+New+Developments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Levodopa in the treatment of Parkinson's disease: current status and new developments</span></div><div class="casAuthors">Salat David; Tolosa Eduardo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Parkinson's disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-69</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Levodopa, a dopamine precursor, is an effective and well-tolerated dopamine replacement agent used to treat Parkinson's disease (PD).  Oral levodopa has been widely used for over 40 years, often in combination with a dopa-decarboxylase inhibitor (DDCI), which reduces many treatment complications, extending its half-life and increasing levodopa availability to the brain.  Entacapone, a catechol-O-methyltransferase inhibitor, can also be used to improve the bioavailability of levodopa, especially when used in conjunction with a DDCI.  During early-stage PD, treatment will depend on the severity of symptoms; if greater symptomatic effect is required then levodopa or dopamine agonists are usually the drugs of choice.  The ability to remain employable or physically active is an important goal in younger patients, therefore, in some instances levodopa initiation should be considered early on, either as a monotherapy or in combination with other drugs.  The clinical use of levodopa may eventually be limited by the development of various treatment-related complications, including response fluctuations, dyskinesia and psychiatric problems.  Motor complications are related to the intermittent delivery of dopamine-replacing drugs to the brain.  Triple combination of levodopa/carbidopa/entacapone available in a single tablet in multiple levodopa dose strengths offers flexibility and helps control response fluctuations.  Recent developments in treatment with levodopa try to obtain continuous delivery with levodopa and include duodenal infusion of a levodopa/carbidopa, transdermal levodopa patch, and oral pro-levodopa.  Levodopa remains the most potent dopaminergic therapy for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvVIddGtbpMLFU0A1HOshhfW6udTcc2ea70vMehJj5Irntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbgsVylsg%253D%253D&md5=22353c48466ace7aaf820c75aa3762be</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalat%26aufirst%3DD.%26aulast%3DTolosa%26aufirst%3DE.%26atitle%3DLevodopa%2520in%2520the%2520Treatment%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520Current%2520Status%2520and%2520New%2520Developments%26jtitle%3DJ.%2520Parkinson%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D3%26spage%3D255%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">De Colibus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lustig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Three-Dimensional Structure of Human Monoamine Oxidase A (MAO-A): Relation to the Structures of Rat MAO-A and Human MAO-B</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">12684</span><span class="NLM_x">–</span> <span class="NLM_lpage">12689</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=12684-12689&author=L.+De+Colibusauthor=M.+Liauthor=C.+Bindaauthor=A.+Lustigauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Three-Dimensional+Structure+of+Human+Monoamine+Oxidase+A+%28MAO-A%29%3A+Relation+to+the+Structures+of+Rat+MAO-A+and+Human+MAO-B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BColibus%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DLustig%26aufirst%3DA.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DThree-Dimensional%2520Structure%2520of%2520Human%2520Monoamine%2520Oxidase%2520A%2520%2528MAO-A%2529%253A%2520Relation%2520to%2520the%2520Structures%2520of%2520Rat%2520MAO-A%2520and%2520Human%2520MAO-B%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D12684%26epage%3D12689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Son, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukihara, T.</span><span> </span><span class="NLM_article-title">Structure of Human Monoamine Oxidase A at 2.2-Å Resolution: The Control of Opening the Entry for Substrates/inhibitors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">5739</span><span class="NLM_x">–</span> <span class="NLM_lpage">5744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=5739-5744&author=S.-Y.+Sonauthor=J.+Maauthor=Y.+Kondouauthor=M.+Yoshimuraauthor=E.+Yamashitaauthor=T.+Tsukihara&title=Structure+of+Human+Monoamine+Oxidase+A+at+2.2-%C3%85+Resolution%3A+The+Control+of+Opening+the+Entry+for+Substrates%2Finhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DS.-Y.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DKondou%26aufirst%3DY.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DE.%26aulast%3DTsukihara%26aufirst%3DT.%26atitle%3DStructure%2520of%2520Human%2520Monoamine%2520Oxidase%2520A%2520at%25202.2-%25C3%2585%2520Resolution%253A%2520The%2520Control%2520of%2520Opening%2520the%2520Entry%2520for%2520Substrates%252Finhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D5739%26epage%3D5744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton-Vinson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubalek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Structure of Human Monoamine Oxidase B, a Drug Target for the Treatment of Neurological Disorders</span> <span class="citation_source-journal">Nature Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1038%2Fnsb732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD38XitV2rsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=22-26&author=C.+Bindaauthor=P.+Newton-Vinsonauthor=F.+Hubalekauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structure+of+Human+Monoamine+Oxidase+B%2C+a+Drug+Target+for+the+Treatment+of+Neurological+Disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders</span></div><div class="casAuthors">Binda, Claudia; Newton-Vinson, Paige; Hubalek, Frantisek; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-26</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO B) is a mitochondrial outer membrane flavoenzyme that is a well-known target for antidepressant and neuroprotective drugs.  Here, the authors detd. the structure of the human liver enzyme to 3 Å resoln.  Human liver MAO B was found to bind to the membrane through a C-terminal transmembrane helix and apolar loops located at various positions in the sequence.  The electron d. showed that pargyline, an analog of the clin. used MAO B inhibitor, deprenyl, binds covalently to the flavin N5 atom.  The active site of MAO B consisted of a 420-Å3 hydrophobic substrate cavity interconnected to an entrance cavity of 290 Å3.  The recognition site for the substrate amino group was an arom. cage formed by Tyr-398 and Tyr-435.  The structure provides a framework for probing the catalytic mechanism, understanding the differences between the MAO A and B isoforms and designing specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8p43h-vsPi7Vg90H21EOLACvtfcHk0lj-sZT-fpZKwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitV2rsg%253D%253D&md5=261d3b1375d833bbfd0a23bdade49be6</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnsb732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb732%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DNewton-Vinson%26aufirst%3DP.%26aulast%3DHubalek%26aufirst%3DF.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructure%2520of%2520Human%2520Monoamine%2520Oxidase%2520B%252C%2520a%2520Drug%2520Target%2520for%2520the%2520Treatment%2520of%2520Neurological%2520Disorders%26jtitle%3DNature%2520Struct.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D22%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubalek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of the <i>N</i>-Propargylaminoindan Class</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1767</span><span class="NLM_x">–</span> <span class="NLM_lpage">1774</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031087c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1767-1774&author=C.+Bindaauthor=F.+Hubalekauthor=M.+Liauthor=Y.+Herzigauthor=J.+Sterlingauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Crystal+Structures+of+Monoamine+Oxidase+B+in+Complex+with+Four+Inhibitors+of+the+N-Propargylaminoindan+Class"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of the N-Propargylaminoindan Class</span></div><div class="casAuthors">Binda, Claudia; Hubalek, Frantisek; Li, Min; Herzig, Yaacov; Sterling, Jeffrey; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1767-1774</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO B) is an outer mitochondrial membrane enzyme that catalyzes the oxidn. of arylalkylamine neurotransmitters.  The crystal structures of MAO B in complex with four of the N-propargylaminoindan class of MAO covalent inhibitors (rasagiline, N-propargyl-1(S)-aminoindan, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan) have been detd. at a resoln. of better than 2.1 Å.  Rasagiline, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan adopt essentially the same conformation with the extended propargyl chain covalently bound to the flavin and the indan ring located in the rear of the substrate cavity.  N-Propargyl-1(S)-aminoindan binds with the indan ring in a flipped conformation with respect to the other inhibitors, which causes a slight movement of the Tyr326 side chain.  Four ordered water mols. are an integral part of the active site and establish H-bond interactions to the inhibitor atoms.  These structural studies may guide future drug design to improve selectivity and efficacy by introducing appropriate substituents on the rasagiline mol. scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkiXn0OI5eubVg90H21EOLACvtfcHk0ljgEuW3F9sAJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit70%253D&md5=7b3df3c611e3f0dd59342a59096402dd</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm031087c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031087c%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DHubalek%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DCrystal%2520Structures%2520of%2520Monoamine%2520Oxidase%2520B%2520in%2520Complex%2520with%2520Four%2520Inhibitors%2520of%2520the%2520N-Propargylaminoindan%2520Class%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1767%26epage%3D1774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Binda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmondson, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattevi, A.</span><span> </span><span class="NLM_article-title">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5848</span><span class="NLM_x">–</span> <span class="NLM_lpage">5852</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070677y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5848-5852&author=C.+Bindaauthor=J.+Wangauthor=L.+Pisaniauthor=C.+Cacciaauthor=A.+Carottiauthor=P.+Salvatiauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structures+of+Human+Monoamine+Oxidase+B+Complexes+with+Selective+Noncovalent+Inhibitors%3A+Safinamide+and+Coumarin+Analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span></div><div class="casAuthors">Binda, Claudia; Wang, Jin; Pisani, Leonardo; Caccia, Carla; Carotti, Angelo; Salvati, Patricia; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5848-5852</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structures of human monoamine oxidase B (MAO B) in complex with safinamide and two coumarin derivs., all sharing a common benzyloxy substituent, were detd. by x-ray crystallog.  These compds. competitively inhibit MAO B with Ki values in the 0.1-0.5 μM range that are 30-700-fold lower than those obsd. with MAO A.  The inhibitors bind noncovalently to MAO B, occupying both the entrance and the substrate cavities and showing a similarly oriented benzyloxy substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPIubufo89bVg90H21EOLACvtfcHk0ljgEuW3F9sAJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI&md5=448f65696f4870e2301f46a6f015e35c</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm070677y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070677y%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructures%2520of%2520Human%2520Monoamine%2520Oxidase%2520B%2520Complexes%2520with%2520Selective%2520Noncovalent%2520Inhibitors%253A%2520Safinamide%2520and%2520Coumarin%2520Analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5848%26epage%3D5852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielczyk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruenblatt, E.</span><span> </span><span class="NLM_article-title">Monoamine Oxidase-B Inhibition in Alzheimer’s Disease</span> <span class="citation_source-journal">Neurotoxicology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1–2</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1%E2%80%932&publication_year=2004&pages=271-277&author=P.+Riedererauthor=W.+Danielczykauthor=E.+Gruenblatt&title=Monoamine+Oxidase-B+Inhibition+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DDanielczyk%26aufirst%3DW.%26aulast%3DGruenblatt%26aufirst%3DE.%26atitle%3DMonoamine%2520Oxidase-B%2520Inhibition%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNeurotoxicology%26date%3D2004%26volume%3D1%25E2%2580%25932%26spage%3D271%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Qureshi, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehler, M. F.</span><span> </span><span class="NLM_article-title">Advances in Epigenetics and Epigenomics for Neurodegenerative Diseases</span> <span class="citation_source-journal">Curr. Neurol. Neurosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1007%2Fs11910-011-0210-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=21671162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFehsbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=464-473&author=I.+A.+Qureshiauthor=M.+F.+Mehler&title=Advances+in+Epigenetics+and+Epigenomics+for+Neurodegenerative+Diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Epigenetics and Epigenomics for Neurodegenerative Diseases</span></div><div class="casAuthors">Qureshi, Irfan A.; Mehler, Mark F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neurology and Neuroscience Reports</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">464-473</span>CODEN:
                <span class="NLM_cas:coden">CNNRBS</span>;
        ISSN:<span class="NLM_cas:issn">1534-6293</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  In the post-genomic era, epigenetic factors-literally those that are "over" or "above" genetic ones and responsible for controlling the expression and function of genes-have emerged as important mediators of development and aging; gene-gene and gene-environmental interactions; and the pathophysiol. of complex disease states.  Here, we provide a brief overview of the major epigenetic mechanisms (ie, DNA methylation, histone modifications and chromatin remodeling, and non-coding RNA regulation).  We highlight the nearly ubiquitous profiles of epigenetic dysregulation that have been found in Alzheimer's and other neurodegenerative diseases.  We also review innovative methods and technologies that enable the characterization of individual epigenetic modifications and more widespread epigenomic states at high resoln.  We conclude that, together with complementary genetic, genomic, and related approaches, interrogating epigenetic and epigenomic profiles in neurodegenerative diseases represent important and increasingly practical strategies for advancing our understanding of and the diagnosis and treatment of these disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZkkQqmghzS7Vg90H21EOLACvtfcHk0ljgEuW3F9sAJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFehsbzL&md5=831926d139658506313f6fa5df6a09a6</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs11910-011-0210-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11910-011-0210-2%26sid%3Dliteratum%253Aachs%26aulast%3DQureshi%26aufirst%3DI.%2BA.%26aulast%3DMehler%26aufirst%3DM.%2BF.%26atitle%3DAdvances%2520in%2520Epigenetics%2520and%2520Epigenomics%2520for%2520Neurodegenerative%2520Diseases%26jtitle%3DCurr.%2520Neurol.%2520Neurosci.%2520Rep.%26date%3D2011%26volume%3D11%26spage%3D464%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Recent Advances in the Multitarget-Directed Ligands Approach for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Leonauthor=A.+G.+Garciaauthor=J.+Marco-Contelles&title=Recent+Advances+in+the+Multitarget-Directed+Ligands+Approach+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeon%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Multitarget-Directed%2520Ligands%2520Approach%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Morphy, J. R.; Harris, C. J.</span> <span class="citation_source-book">Designing Multi-Target Drugs</span>; <span class="NLM_publisher-name">RSC Publishing</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1039%2F9781849734912" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+R.+Morphy&author=C.+J.+Harris&title=Designing+Multi-Target+Drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1039%2F9781849734912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1039%252F9781849734912%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DJ.%2BR.%26btitle%3DDesigning%2520Multi-Target%2520Drugs%26pub%3DRSC%2520Publishing%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span> </span><span class="NLM_article-title">CNS Targets for Multifunctional Drugs in the Treatment of Alzheimer’s and Parkinson’s Diseases</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2005&pages=519-537&author=M.+B.+Youdimauthor=J.+J.+Buccafusco&title=CNS+Targets+for+Multifunctional+Drugs+in+the+Treatment+of+Alzheimer%E2%80%99s+and+Parkinson%E2%80%99s+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26atitle%3DCNS%2520Targets%2520for%2520Multifunctional%2520Drugs%2520in%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520and%2520Parkinson%25E2%2580%2599s%2520Diseases%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2005%26volume%3D112%26spage%3D519%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, A. V.,  Jr.</span><span> </span><span class="NLM_article-title">Multiple Central Nervous System Targets for Eliciting Beneficial Effects on Memory and Cognition</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">295</span><span class="NLM_x">, </span> <span class="NLM_fpage">438</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=11046074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsl2ksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=438-446&author=J.+J.+Buccafuscoauthor=A.+V.+Terry&title=Multiple+Central+Nervous+System+Targets+for+Eliciting+Beneficial+Effects+on+Memory+and+Cognition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple central nervous system targets for eliciting beneficial effects on memory and cognition</span></div><div class="casAuthors">Buccafusco, Jerry J.; Terry, Alvin V., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">438-446</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review with 62 refs.  The development of drugs for the treatment of disorders of cognition has benefited from a more precise knowledge of the loss of specific neural pathways assocd. with certain neurodegenerative diseases such as Alzheimer's disease (AD).  The loss of basal forebrain cholinergic neurons in AD has engendered the development of new compds. that target various aspects of the cholinergic system.  However, limitations in the effectiveness of the most common of these, the anticholinesterases, have fueled the race to provide more efficacious compds.  In an attempt to avoid side effects and improve efficacy, other neuronal targets have been considered, including receptors for norepinephrine, dopamine, serotonin, excitatory amino acids, neural peptides, and others.  Our lab. has had the opportunity to study the memory-enhancing potential of many of the compds. developed expressly for these neuronal targets in macaques.  Upon reviewing 21 such studies it was evident that: (1) To varying degrees, pharmacol. manipulation of each target yielded improved task performance.  (2) Combining pharmacol. targets could lead to additive or synergistic effects on task performance.  (3) Mature adult and aged monkeys provided equiv. ests. of drug effectiveness.  (4) There appeared to be no limiting level of task improvement for compds. tested in aged and younger monkeys.  (5) Certain of these agents also exhibited potential disease-modifying actions.  Thus, certain memory-enhancing agents may prove more useful when implemented early in the course of a disease such as AD, and they also may enjoy a wide application for the treatment of the memory decline assocd. with normal aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO8d1OPKK1X7Vg90H21EOLACvtfcHk0liuNkEqqjitYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsl2ksL4%253D&md5=36177fdad665ece8159c0a094ab6ca9d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26aulast%3DTerry%26aufirst%3DA.%2BV.%26atitle%3DMultiple%2520Central%2520Nervous%2520System%2520Targets%2520for%2520Eliciting%2520Beneficial%2520Effects%2520on%2520Memory%2520and%2520Cognition%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D295%26spage%3D438%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giangreco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Introcaso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Strategies of Multi-Objective Optimization in Drug Discovery and Development</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1517%2F17460441.2011.588696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=22646211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOjs73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=871-884&author=O.+Nicolottiauthor=I.+Giangrecoauthor=A.+Introcasoauthor=F.+Leonettiauthor=A.+Stefanachiauthor=A.+Carotti&title=Strategies+of+Multi-Objective+Optimization+in+Drug+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies of multi-objective optimization in drug discovery and development</span></div><div class="casAuthors">Nicolotti, Orazio; Giangreco, Ilenia; Introcaso, Antonellina; Leonetti, Francesco; Stefanachi, Angela; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">871-884</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Drug discovery and development is a typical multi-objective problem and its successes or failures depend on the simultaneous control of numerous, often conflicting, mol. and pharmacol. properties.  Multi-objective optimization strategies represent a new approach to capture the occurrence of varying optimal solns. based on trade-offs among the objectives taken into account.  In view of this, multi-objective optimization aims to discover a set of satisfactory compromises that may in turn be used to find the global optimal soln. by optimizing numerous dependent properties simultaneously.Areas covered: The authors review the potential of multi-objective strategies in a no. of fields including: drug library design; substructure mining; the derivation of quant. structure-activity relationship models; ranking of docking poses.  The authors also discuss the potential of multi-objective strategies in controlling competing properties for absorption, distribution, metab. and elimination/toxicity optimization.Expert opinion: It is very clear to those who work in drug discovery and development that the success of rational drug design is largely dependent on the control of a no. of, often conflicting, objectives.  Therefore, multi-objective optimization methods, which have recently been introduced to the field of mol. discovery, represent the ultimate frontier in chemoinformatics.  The widespread use of these multi-objective techniques has provided new opportunities in medicinal chem. as seen through its use in a no. of applications for chemoinformatics both within academia and the pharmaceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8M1aDWIxb5LVg90H21EOLACvtfcHk0liuNkEqqjitYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOjs73K&md5=851d5f57b3e33704ca82b64cc38a85d7</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1517%2F17460441.2011.588696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2011.588696%26sid%3Dliteratum%253Aachs%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DGiangreco%26aufirst%3DI.%26aulast%3DIntrocaso%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DStrategies%2520of%2520Multi-Objective%2520Optimization%2520in%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D871%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Kneubuehler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thull, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaillard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Inhibition of Monoamine Oxidase-B by 5<i>H</i>-Indeno[1,2-<i>c</i>]pyridazines: Biological Activities, Quantitative Structure–Activity Relationships (QSARs) and 3DQSARs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3874</span><span class="NLM_x">–</span> <span class="NLM_lpage">3883</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00019a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3874-3883&author=S.+Kneubuehlerauthor=U.+Thullauthor=C.+Altomareauthor=V.+Cartaauthor=P.+Gaillardauthor=P.+A.+Carruptauthor=A.+Carottiauthor=B.+Testa&title=Inhibition+of+Monoamine+Oxidase-B+by+5H-Indeno%5B1%2C2-c%5Dpyridazines%3A+Biological+Activities%2C+Quantitative+Structure%E2%80%93Activity+Relationships+%28QSARs%29+and+3DQSARs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm00019a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00019a018%26sid%3Dliteratum%253Aachs%26aulast%3DKneubuehler%26aufirst%3DS.%26aulast%3DThull%26aufirst%3DU.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarta%26aufirst%3DV.%26aulast%3DGaillard%26aufirst%3DP.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520Monoamine%2520Oxidase-B%2520by%25205H-Indeno%255B1%252C2-c%255Dpyridazines%253A%2520Biological%2520Activities%252C%2520Quantitative%2520Structure%25E2%2580%2593Activity%2520Relationships%2520%2528QSARs%2529%2520and%25203DQSARs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3874%26epage%3D3883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Gnerre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Inhibition of Monoamine Oxidases by Functionalized Coumarin Derivatives: Biological Activities, QSARs, and 3D-QSARs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4747</span><span class="NLM_x">–</span> <span class="NLM_lpage">4758</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm001028o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4747-4758&author=C.+Gnerreauthor=M.+Cattoauthor=F.+Leonettiauthor=P.+Weberauthor=P.-A.+Carruptauthor=C.+Altomareauthor=A.+Carottiauthor=B.+Testa&title=Inhibition+of+Monoamine+Oxidases+by+Functionalized+Coumarin+Derivatives%3A+Biological+Activities%2C+QSARs%2C+and+3D-QSARs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm001028o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001028o%26sid%3Dliteratum%253Aachs%26aulast%3DGnerre%26aufirst%3DC.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DWeber%26aufirst%3DP.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520Monoamine%2520Oxidases%2520by%2520Functionalized%2520Coumarin%2520Derivatives%253A%2520Biological%2520Activities%252C%2520QSARs%252C%2520and%25203D-QSARs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4747%26epage%3D4758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Structural Insights into Monoamine Oxidase Inhibitory Potency and Selectivity of 7-Substituted Coumarins from Ligand- and Target-Based Approaches</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4912</span><span class="NLM_x">–</span> <span class="NLM_lpage">4925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060183l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4912-4925&author=M.+Cattoauthor=O.+Nicolottiauthor=F.+Leonettiauthor=A.+Carottiauthor=A.+D.+Faviaauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=A.+Carotti&title=Structural+Insights+into+Monoamine+Oxidase+Inhibitory+Potency+and+Selectivity+of+7-Substituted+Coumarins+from+Ligand-+and+Target-Based+Approaches"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm060183l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060183l%26sid%3Dliteratum%253Aachs%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DStructural%2520Insights%2520into%2520Monoamine%2520Oxidase%2520Inhibitory%2520Potency%2520and%2520Selectivity%2520of%25207-Substituted%2520Coumarins%2520from%2520Ligand-%2520and%2520Target-Based%2520Approaches%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4912%26epage%3D4925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Carotti, A.; Melloni, P.; Thaler, F.; Caccia, C.; Maestroni, S.; Salvati, P.</span><span> </span><span class="NLM_article-title">Substituted Aminoalkyl and Amidoalkyl Benzopyran Derivatives</span>. WO 2006/102958 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=A.+Carotti&author=P.+Melloni&author=F.+Thaler&author=C.+Caccia&author=S.+Maestroni&author=P.+Salvati&title=Substituted+Aminoalkyl+and+Amidoalkyl+Benzopyran+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DSubstituted%2520Aminoalkyl%2520and%2520Amidoalkyl%2520Benzopyran%2520Derivatives%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campagna, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thull, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span> </span><span class="NLM_article-title">Synthesis and Monoamine Oxidase Inhibitory Activity of New Pyridazine-,Pyrimidine-, and 1,2,4-Triazine-Containing Tricyclic Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5364</span><span class="NLM_x">–</span> <span class="NLM_lpage">5371</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070728r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5364-5371&author=A.+Carottiauthor=M.+Cattoauthor=F.+Leonettiauthor=F.+Campagnaauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=U.+Thullauthor=B.+Testaauthor=C.+Altomare&title=Synthesis+and+Monoamine+Oxidase+Inhibitory+Activity+of+New+Pyridazine-%2CPyrimidine-%2C+and+1%2C2%2C4-Triazine-Containing+Tricyclic+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm070728r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070728r%26sid%3Dliteratum%253Aachs%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCampagna%26aufirst%3DF.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DThull%26aufirst%3DU.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DAltomare%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520Monoamine%2520Oxidase%2520Inhibitory%2520Activity%2520of%2520New%2520Pyridazine-%252CPyrimidine-%252C%2520and%25201%252C2%252C4-Triazine-Containing%2520Tricyclic%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5364%26epage%3D5371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capaldi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muncipinto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Solid-Phase Synthesis and Insights into Structure–Activity Relationships of Safinamide Analogues as Potent and Selective Inhibitors of Type B Monoamine Oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4909</span><span class="NLM_x">–</span> <span class="NLM_lpage">4916</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070725e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4909-4916&author=F.+Leonettiauthor=C.+Capaldiauthor=L.+Pisaniauthor=O.+Nicolottiauthor=G.+Muncipintoauthor=A.+Stefanachiauthor=S.+Cellamareauthor=C.+Cacciaauthor=A.+Carotti&title=Solid-Phase+Synthesis+and+Insights+into+Structure%E2%80%93Activity+Relationships+of+Safinamide+Analogues+as+Potent+and+Selective+Inhibitors+of+Type+B+Monoamine+Oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm070725e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070725e%26sid%3Dliteratum%253Aachs%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCapaldi%26aufirst%3DC.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DSolid-Phase%2520Synthesis%2520and%2520Insights%2520into%2520Structure%25E2%2580%2593Activity%2520Relationships%2520of%2520Safinamide%2520Analogues%2520as%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Type%2520B%2520Monoamine%2520Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4909%26epage%3D4916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muncipinto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miscioscia, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passeleu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2<i>H</i>-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6685</span><span class="NLM_x">–</span> <span class="NLM_lpage">6706</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9010127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6685-6706&author=L.+Pisaniauthor=G.+Muncipintoauthor=T.+F.+Misciosciaauthor=O.+Nicolottiauthor=F.+Leonettiauthor=M.+Cattoauthor=C.+Cacciaauthor=P.+Salvatiauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=C.+Passeleuauthor=A.+Carotti&title=Discovery+of+a+Novel+Class+of+Potent+Coumarin+Monoamine+Oxidase+B+Inhibitors%3A+Development+and+Biopharmacological+Profiling+of+7-%5B%283-Chlorobenzyl%29oxy%5D-4-%5B%28methylamino%29methyl%5D-2H-chromen-2-one+Methanesulfonate+%28NW-1772%29+as+a+Highly+Potent%2C+Selective%2C+Reversible%2C+and+Orally+Active+Monoamine+Oxidase+B+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm9010127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9010127%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DMiscioscia%26aufirst%3DT.%2BF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DPasseleu%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Potent%2520Coumarin%2520Monoamine%2520Oxidase%2520B%2520Inhibitors%253A%2520Development%2520and%2520Biopharmacological%2520Profiling%2520of%25207-%255B%25283-Chlorobenzyl%2529oxy%255D-4-%255B%2528methylamino%2529methyl%255D-2H-chromen-2-one%2520Methanesulfonate%2520%2528NW-1772%2529%2520as%2520a%2520Highly%2520Potent%252C%2520Selective%252C%2520Reversible%252C%2520and%2520Orally%2520Active%2520Monoamine%2520Oxidase%2520B%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6685%26epage%3D6706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barletta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Introcaso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cellamare, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Discovery, Biological Evaluation, and Structure–Activity and −Selectivity Relationships of 6′-Substituted (<i>E</i>)-2-(Benzofuran-3(2<i>H</i>)-ylidene)-<i>N</i>-methylacetamides, a Novel Class of Potent and Selective Monoamine Oxidase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2651</span><span class="NLM_x">–</span> <span class="NLM_lpage">2664</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4000769" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2651-2664&author=L.+Pisaniauthor=M.+Barlettaauthor=R.+Soto-Oteroauthor=O.+Nicolottiauthor=E.+Mendez-Alvarezauthor=M.+Cattoauthor=A.+Introcasoauthor=A.+Stefanachiauthor=S.+Cellamareauthor=C.+Altomareauthor=A.+Carotti&title=Discovery%2C+Biological+Evaluation%2C+and+Structure%E2%80%93Activity+and+%E2%88%92Selectivity+Relationships+of+6%E2%80%B2-Substituted+%28E%29-2-%28Benzofuran-3%282H%29-ylidene%29-N-methylacetamides%2C+a+Novel+Class+of+Potent+and+Selective+Monoamine+Oxidase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm4000769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000769%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DBarletta%26aufirst%3DM.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DIntrocaso%26aufirst%3DA.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDiscovery%252C%2520Biological%2520Evaluation%252C%2520and%2520Structure%25E2%2580%2593Activity%2520and%2520%25E2%2588%2592Selectivity%2520Relationships%2520of%25206%25E2%2580%25B2-Substituted%2520%2528E%2529-2-%2528Benzofuran-3%25282H%2529-ylidene%2529-N-methylacetamides%252C%2520a%2520Novel%2520Class%2520of%2520Potent%2520and%2520Selective%2520Monoamine%2520Oxidase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2651%26epage%3D2664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Bruehlmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ooms, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Coumarin Derivatives as Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3195</span><span class="NLM_x">–</span> <span class="NLM_lpage">3198</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3195-3198&author=C.+Bruehlmannauthor=F.+Oomsauthor=P.+A.+Carruptauthor=B.+Testaauthor=M.+Cattoauthor=F.+Leonettiauthor=C.+Altomareauthor=A.+Carotti&title=Coumarin+Derivatives+as+Dual+Inhibitors+of+Acetylcholinesterase+and+Monoamine+Oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBruehlmann%26aufirst%3DC.%26aulast%3DOoms%26aufirst%3DF.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DCoumarin%2520Derivatives%2520as%2520Dual%2520Inhibitors%2520of%2520Acetylcholinesterase%2520and%2520Monoamine%2520Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3195%26epage%3D3198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Carotti, A.</span>MAOs Long March: From Toxic First-Generation Drugs to Isoform-Selective, Reversible and Multi-Target Inhibitors. <span class="NLM_conf-name">Frontiers in CNS and Oncology Medicinal Chemistry, ACS-EFMC</span>, <span class="NLM_conf-loc">Siena, Italy</span>, <span class="NLM_conf-date">October 7–9, 2007</span>,  <span class="NLM_fpage">COMC-059</span>; <span class="NLM_publisher-name">American Chemical Society, Division of Medicinal Chemistry</span>, <span class="NLM_publisher-loc">Washington DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">, </span>CODEN: 69KAR2.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=COMC-059&conference=Frontiers+in+CNS+and+Oncology+Medicinal+Chemistry%2C+ACS-EFMC&author=A.+Carotti&title=MAOs+Long+March%3A+From+Toxic+First-Generation+Drugs+to+Isoform-Selective%2C+Reversible+and+Multi-Target+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DCarotti%26aufirst%3DA.%26jtitle%3DMAOs%2520Long%2520March%253A%2520From%2520Toxic%2520First-Generation%2520Drugs%2520to%2520Isoform-Selective%252C%2520Reversible%2520and%2520Multi-Target%2520Inhibitors%26spage%3DCOMC-059%26pub%3DAmerican%2520Chemical%2520Society%252C%2520Division%2520of%2520Medicinal%2520Chemistry%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskolczi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rantal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagyva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zekany, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krais, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Novel Dual Inhibitors of AChE and MAO Derived from Hydroxy Aminoindan and Phenethylamine as Potential Treatment for Alzheimer’s Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020120c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5260-5279&author=J.+Sterlingauthor=Y.+Herzigauthor=T.+Gorenauthor=N.+Finkelsteinauthor=D.+Lernerauthor=W.+Goldenbergauthor=I.+Miskolcziauthor=S.+Molnarauthor=F.+Rantalauthor=T.+Tamasauthor=G.+Tothauthor=A.+Zagyvaauthor=A.+Zekanyauthor=G.+Lavianauthor=A.+Grossauthor=R.+Friedmanauthor=M.+Razinauthor=W.+Huangauthor=B.+Kraisauthor=M.+Chorevauthor=M.+B.+H.+Youdimauthor=M.+Weinstock&title=Novel+Dual+Inhibitors+of+AChE+and+MAO+Derived+from+Hydroxy+Aminoindan+and+Phenethylamine+as+Potential+Treatment+for+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm020120c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020120c%26sid%3Dliteratum%253Aachs%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DGoren%26aufirst%3DT.%26aulast%3DFinkelstein%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DD.%26aulast%3DGoldenberg%26aufirst%3DW.%26aulast%3DMiskolczi%26aufirst%3DI.%26aulast%3DMolnar%26aufirst%3DS.%26aulast%3DRantal%26aufirst%3DF.%26aulast%3DTamas%26aufirst%3DT.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DZagyva%26aufirst%3DA.%26aulast%3DZekany%26aufirst%3DA.%26aulast%3DLavian%26aufirst%3DG.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DRazin%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DKrais%26aufirst%3DB.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DNovel%2520Dual%2520Inhibitors%2520of%2520AChE%2520and%2520MAO%2520Derived%2520from%2520Hydroxy%2520Aminoindan%2520and%2520Phenethylamine%2520as%2520Potential%2520Treatment%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5260%26epage%3D5279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Ríos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chioua, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriepa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraleda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gálvez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valderas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Multipotent MAO and Cholinesterase Inhibitors for the Treatment of Alzheimer’s Disease: Synthesis, Pharmacological Analysis and Molecular Modeling of Heterocyclic Substituted Alkyl and Cycloalkyl Propargyl Amine</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=251-262&author=A.+Samadiauthor=C.+de+los+R%C3%ADosauthor=I.+Boleaauthor=M.+Chiouaauthor=I.+Iriepaauthor=I.+Moraledaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=E.+G%C3%A1lvezauthor=C.+Valderasauthor=M.+Unzetaauthor=J.+Marco-Contelles&title=Multipotent+MAO+and+Cholinesterase+Inhibitors+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease%3A+Synthesis%2C+Pharmacological+Analysis+and+Molecular+Modeling+of+Heterocyclic+Substituted+Alkyl+and+Cycloalkyl+Propargyl+Amine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3Dde%2Blos%2BR%25C3%25ADos%26aufirst%3DC.%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DG%25C3%25A1lvez%26aufirst%3DE.%26aulast%3DValderas%26aufirst%3DC.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DMultipotent%2520MAO%2520and%2520Cholinesterase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Synthesis%252C%2520Pharmacological%2520Analysis%2520and%2520Molecular%2520Modeling%2520of%2520Heterocyclic%2520Substituted%2520Alkyl%2520and%2520Cycloalkyl%2520Propargyl%2520Amine%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D52%26spage%3D251%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Yanez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vina, D.</span><span> </span><span class="NLM_article-title">Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1692</span><span class="NLM_x">–</span> <span class="NLM_lpage">1706</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.2174%2F15680266113139990120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23889051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFeks7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=1692-1706&author=M.+Yanezauthor=D.+Vina&title=Dual+Inhibitors+of+Monoamine+Oxidase+and+Cholinesterase+for+the+Treatment+of+Alzheimer+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease</span></div><div class="casAuthors">Yanez, Matilde; Vina, Dolores</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1692-1706</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common neurodegenerative disorder and the most prevalent cause of dementia with ageing.  The etiol. of this illness is rather complex and not completely known but deposits of aberrant β- amyloid protein, as well as τ-protein hyperphosphorylation, oxidative stress, dyshomeostasis of biometals and low levels of acetylcholine (ACh) seem to play a significant role.  Such complex etiol. of AD has encouraged active research in the development of multi-target drugs with two or more complementary biol. activities, since they may represent an important advance in the treatment of this disease.  Dual inhibitors combining anti-acetyl cholinesterase (AChE) and antimonoamine oxidase (MAO) activities in one mol. entity have been recently reported.  Inhibition of AChE increases neurotransmission at cholinergic synapses and reduce temporally the cognitive deficit.  AChE also participates in other functions related to neuronal development, differentiation, adhesion and β-amyloid protein processing.  In addn. MAOB inhibition retards further deterioration of cognitive functions.  In this review relevant aspects about structure, mechanism and pharmacol. effects of these dual inhibitors are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobskqipuIoBrVg90H21EOLACvtfcHk0liBRd1_I8Jdzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFeks7nI&md5=e467fb980e69c634ff966204188a2f62</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.2174%2F15680266113139990120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266113139990120%26sid%3Dliteratum%253Aachs%26aulast%3DYanez%26aufirst%3DM.%26aulast%3DVina%26aufirst%3DD.%26atitle%3DDual%2520Inhibitors%2520of%2520Monoamine%2520Oxidase%2520and%2520Cholinesterase%2520for%2520the%2520Treatment%2520of%2520Alzheimer%2520Disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2013%26volume%3D13%26spage%3D1692%26epage%3D1706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Passos, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simões-Pires, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurisso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soldi, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Oliveira, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Faria, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcourt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottfried, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriques, A. T.</span><span> </span><span class="NLM_article-title">Indole Alkaloids of Psychotria as Multifunctional Cholinesterases and Monoamine Oxidases Inhibitors</span> <span class="citation_source-journal">Phytochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2013&pages=8-20&author=C.+S.+Passosauthor=C.+A.+Sim%C3%B5es-Piresauthor=A.+Nurissoauthor=T.+C.+Soldiauthor=L.+Katoauthor=C.+M.+de+Oliveiraauthor=E.+O.+de+Fariaauthor=L.+Marcourtauthor=C.+Gottfriedauthor=P.-A.+Carruptauthor=A.+T.+Henriques&title=Indole+Alkaloids+of+Psychotria+as+Multifunctional+Cholinesterases+and+Monoamine+Oxidases+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPassos%26aufirst%3DC.%2BS.%26aulast%3DSim%25C3%25B5es-Pires%26aufirst%3DC.%2BA.%26aulast%3DNurisso%26aufirst%3DA.%26aulast%3DSoldi%26aufirst%3DT.%2BC.%26aulast%3DKato%26aufirst%3DL.%26aulast%3Dde%2BOliveira%26aufirst%3DC.%2BM.%26aulast%3Dde%2BFaria%26aufirst%3DE.%2BO.%26aulast%3DMarcourt%26aufirst%3DL.%26aulast%3DGottfried%26aufirst%3DC.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DHenriques%26aufirst%3DA.%2BT.%26atitle%3DIndole%2520Alkaloids%2520of%2520Psychotria%2520as%2520Multifunctional%2520Cholinesterases%2520and%2520Monoamine%2520Oxidases%2520Inhibitors%26jtitle%3DPhytochemistry%26date%3D2013%26volume%3D86%26spage%3D8%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandel, S. A.</span><span> </span><span class="NLM_article-title">From Anti-Parkinson’s Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer’s Disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1155%2F2012%2F204623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=22387411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsF2mt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=1-16&author=H.+Zhengauthor=T.+Amitauthor=O.+Bar-Amauthor=M.+Fridkinauthor=M.+B.+H.+Youdimauthor=S.+A.+Mandel&title=From+Anti-Parkinson%E2%80%99s+Drug+Rasagiline+to+Novel+Multitarget+Iron+Chelators+with+Acetylcholinesterase+and+Monoamine+Oxidase+Inhibitory+and+Neuroprotective+Properties+for+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">From Anti-Parkinson's Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer's Disease</span></div><div class="casAuthors">Zheng, Hailin; Amit, Tamar; Bar-Am, Orit; Fridkin, Mati; Youdim, Moussa B. H.; Mandel, Silvia A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a multifactorial syndrome involving a complex array of different, while related, factors in its progression.  Accordingly, novel approaches that can simultaneously modulate several disease-related targets hold great promise for the effective treatment of AD.  This review describes the development of novel hybrid mols. with multimodal activity, including: i) M30, the brain permeable selective monoamine oxidase (MAO)-A and -B inhibitor with chelating and neuroprotective activity; ii) HLA20, a brain permeable metal chelator with neuroprotective activity; iii) HLA20A, an acetylcholinesterase (AChE) inhibitor with site-activated chelating and neuroprotective activity; iv) M30D, an AChE and MAO-A and -B inhibitor with site-activated chelating and neuroprotective activity; and v) analogs of the neuroprotective aminoacid peptide, NAPVSIPQ.  HLA20A and M30D act as pro-chelators and can be activated to liberate their resp. active chelators HLA20 and M30 through pseudo inhibition of AChE.  We first discuss the knowledge and structure-based strategy for the rational design of these novel compds.  Then, we review our recent studies on these drug candidates, regarding their wide range in vitro and in vivo activities, with emphasis on antioxidant-chelating potency and AchE and MAO-A and -B inhibitory activity, as well as neuroprotective/neurorescue effects.  Finally, we discuss the diverse mol. mechanisms of action of these compds. with relevance to AD, including modulation of amyloid-β and amyloid-β protein precursor expression/processing; induction of cell cycle arrest; inhibition of neuronal death markers; and upregulation of neurotrophic factors, as well as activation of protein kinase signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKWwqpwgN677Vg90H21EOLACvtfcHk0liBRd1_I8Jdzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsF2mt7w%253D&md5=e9635ab8952fef29f96f01fe97b77de8</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1155%2F2012%2F204623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F204623%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DFridkin%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DMandel%26aufirst%3DS.%2BA.%26atitle%3DFrom%2520Anti-Parkinson%25E2%2580%2599s%2520Drug%2520Rasagiline%2520to%2520Novel%2520Multitarget%2520Iron%2520Chelators%2520with%2520Acetylcholinesterase%2520and%2520Monoamine%2520Oxidase%2520Inhibitory%2520and%2520Neuroprotective%2520Properties%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D30%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Bolea, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monjas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span> </span><span class="NLM_article-title">Multipotent, Permeable Drug ASS234 Inhibits Aβ Aggregation, Possesses Antioxidant Properties and Protects from Aβ-induced Apoptosis In Vitro</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">808</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.2174%2F15672050113109990151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23919774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKkurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=797-808&author=I.+Boleaauthor=A.+Gellaauthor=L.+Monjasauthor=C.+Perezauthor=M.+I.+Rodriguez-Francoauthor=J.+Marco-Contellesauthor=A.+Samadiauthor=M.+Unzeta&title=Multipotent%2C+Permeable+Drug+ASS234+Inhibits+A%CE%B2+Aggregation%2C+Possesses+Antioxidant+Properties+and+Protects+from+A%CE%B2-induced+Apoptosis+In+Vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Multipotent, Permeable Drug ASS234 Inhibits Aβ Aggregation, Possesses Antioxidant Properties and Protects from Aβ-induced Apoptosis In Vitro</span></div><div class="casAuthors">Bolea, Irene; Gella, Alejandro; Monjas, Leticia; Perez, Concepcion; Isabel Rodriguez-Franco, Maria; Marco-Contelles, Jose; Samadi, Abdelouahid; Unzeta, Mercedes</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">797-808</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Amyloid beta (Aβ ) aggregation and deposition is a key pathol. hallmark of AD.  Growing evidence suggests that neurotoxicity of this peptide is related to the formation of toxic oligomeric aggregates.  Therefore, a deeply investigated therapeutic strategy comes at present from blocking the formation of these species to non-toxic aggregates.  Among other considered strategies, the multi-target approach has been proposed as a more suitable potential therapy, precisely due to the multifactorial nature of AD.  In this context, we recently identified ASS234, a novel compd. that possesses a significant multipotent profile since it is able to inhibit cholinesterase and monoamine oxidase enzymes as well as to interfere in Aβ aggregation process.  In this work, we investigated more in detail the effects of ASS234 on Aβ aggregation and toxicity in vitro as well as we explored its ability to penetrate to the CNS.  We report that ASS234 inhibited Aβ 1-42 self-aggregation more efficiently than that of Aβ 1-40, limiting the formation of fibrillar and oligomeric species.  Addnl., ASS234 completely blocked the aggregation mediated by AChE of both Aβ 1-42 and Aβ 1-40, showing a dual binding site to AChE.  Interestingly, ASS234 significantly reduced A β 1-42-mediated toxicity in SH-SY5Y human neuroblastoma cells through the prevention of the mitochondrial apoptosis pathway activation.  Also importantly, we obsd. a significant ability of ASS234 to capture free-radical species in vitro as well as a potent effect in preventing the Aβ 1-42-induced depletion of antioxidant enzymes (catalase and SOD-1).  Finally, we report the capability of ASS234 to cross the bloodbrain barrier.  Overall, our in vitro results show that ASS234 may have an impact on different processes involved in AD pathogenesis and provide evidences that it has encouraging attributes as a therapeutic lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-iJK3Tv_vLbVg90H21EOLACvtfcHk0ljZWiheD7ylsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKkurjI&md5=cde2691678d766d1890a903ecc131394</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.2174%2F15672050113109990151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15672050113109990151%26sid%3Dliteratum%253Aachs%26aulast%3DBolea%26aufirst%3DI.%26aulast%3DGella%26aufirst%3DA.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DMultipotent%252C%2520Permeable%2520Drug%2520ASS234%2520Inhibits%2520A%25CE%25B2%2520Aggregation%252C%2520Possesses%2520Antioxidant%2520Properties%2520and%2520Protects%2520from%2520A%25CE%25B2-induced%2520Apoptosis%2520In%2520Vitro%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2013%26volume%3D10%26spage%3D797%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Bautista-Aguilera, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteban, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chioua, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolic, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agbaba, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraleda, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriepa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unzeta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span> </span><span class="NLM_article-title">Multipotent Cholinesterase/Monoamine Oxidase Inhibitors for the Treatment of Alzheimer’s Disease: Design, Synthesis, Biochemical Evaluation, ADMET, Molecular Modeling, and QSAR Analysis of Novel Donepezil–Pyridyl Hybrids</span> <span class="citation_source-journal">Drug Des. Devel. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1893</span><span class="NLM_x">–</span> <span class="NLM_lpage">1910</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=25378907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A280%3ADC%252BC2M3ms1alug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=1893-1910&author=O.+M.+Bautista-Aguileraauthor=G.+Estebanauthor=M.+Chiouaauthor=K.+Nikolicauthor=D.+Agbabaauthor=I.+Moraledaauthor=I.+Iriepaauthor=E.+Sorianoauthor=A.+Samadiauthor=M.+Unzetaauthor=J.+Marco-Contelles&title=Multipotent+Cholinesterase%2FMonoamine+Oxidase+Inhibitors+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease%3A+Design%2C+Synthesis%2C+Biochemical+Evaluation%2C+ADMET%2C+Molecular+Modeling%2C+and+QSAR+Analysis+of+Novel+Donepezil%E2%80%93Pyridyl+Hybrids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids</span></div><div class="casAuthors">Bautista-Aguilera Oscar M; Chioua Mourad; Samadi Abdelouahid; Marco-Contelles Jose; Esteban Gerard; Unzeta Mercedes; Nikolic Katarina; Agbaba Danica; Moraleda Ignacio; Iriepa Isabel; Soriano Elena</div><div class="citationInfo"><span class="NLM_cas:title">Drug design, development and therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1893-910</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The design, synthesis, and biochemical evaluation of donepezil-pyridyl hybrids (DPHs) as multipotent cholinesterase (ChE) and monoamine oxidase (MAO) inhibitors for the potential treatment of Alzheimer's disease (AD) is reported.  The 3D-quantitative structure-activity relationship study was used to define 3D-pharmacophores for inhibition of MAO A/B, acetylcholinesterase (AChE), and butyrylcholinesterase (BuChE) enzymes and to design DPHs as novel multi-target drug candidates with potential impact in the therapy of AD.  DPH14 (Electrophorus electricus AChE [EeAChE]: half maximal inhibitory concentration [IC50] =1.1±0.3 nM; equine butyrylcholinesterase [eqBuChE]: IC50 =600±80 nM) was 318-fold more potent for the inhibition of AChE, and 1.3-fold less potent for the inhibition of BuChE than the reference compound ASS234.  DPH14 is a potent human recombinant BuChE (hBuChE) inhibitor, in the same range as DPH12 or DPH16, but 13.1-fold less potent than DPH15 for the inhibition of human recombinant AChE (hAChE).  Compared with donepezil, DPH14 is almost equipotent for the inhibition of hAChE, and 8.8-fold more potent for hBuChE.  Concerning human monoamine oxidase (hMAO) A inhibition, only DPH9 and 5 proved active, compound DPH9 being the most potent (IC50 [MAO A] =5,700±2,100 nM).  For hMAO B, only DPHs 13 and 14 were moderate inhibitors, and compound DPH14 was the most potent (IC50 [MAO B] =3,950±940 nM).  Molecular modeling of inhibitor DPH14 within EeAChE showed a binding mode with an extended conformation, interacting simultaneously with both catalytic and peripheral sites of EeAChE thanks to a linker of appropriate length.  Absortion, distribution, metabolism, excretion and toxicity analysis showed that structures lacking phenyl-substituent show better druglikeness profiles; in particular, DPHs13-15 showed the most suitable absortion, distribution, metabolism, excretion and toxicity properties.  Novel donepezil-pyridyl hybrid DPH14 is a potent, moderately selective hAChE and selective irreversible hMAO B inhibitor which might be considered as a promising compound for further development for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpLMbTfemCUrFU0A1HOshhfW6udTcc2eZcMP1QprOTjLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3ms1alug%253D%253D&md5=3b3ba418a994f9a5aa796dc3710260a0</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBautista-Aguilera%26aufirst%3DO.%2BM.%26aulast%3DEsteban%26aufirst%3DG.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DNikolic%26aufirst%3DK.%26aulast%3DAgbaba%26aufirst%3DD.%26aulast%3DMoraleda%26aufirst%3DI.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DSoriano%26aufirst%3DE.%26aulast%3DSamadi%26aufirst%3DA.%26aulast%3DUnzeta%26aufirst%3DM.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DMultipotent%2520Cholinesterase%252FMonoamine%2520Oxidase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Design%252C%2520Synthesis%252C%2520Biochemical%2520Evaluation%252C%2520ADMET%252C%2520Molecular%2520Modeling%252C%2520and%2520QSAR%2520Analysis%2520of%2520Novel%2520Donepezil%25E2%2580%2593Pyridyl%2520Hybrids%26jtitle%3DDrug%2520Des.%2520Devel.%2520Ther.%26date%3D2014%26volume%3D8%26spage%3D1893%26epage%3D1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Avramovich-Tirosh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span> </span><span class="NLM_article-title">Therapeutic Targets and Potential of the Novel Brain Permeable Multifunctional Iron Chelator–Monoamine Oxidase Inhibitor Drug, M-30, for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1111%2Fj.1471-4159.2006.04258.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=17144902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFaksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=490-502&author=Y.+Avramovich-Tiroshauthor=T.+Amitauthor=O.+Bar-Amauthor=H.+Zhengauthor=M.+Fridkinauthor=M.+B.+H.+Youdim&title=Therapeutic+Targets+and+Potential+of+the+Novel+Brain+Permeable+Multifunctional+Iron+Chelator%E2%80%93Monoamine+Oxidase+Inhibitor+Drug%2C+M-30%2C+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Avramovich-Tirosh, Yael; Amit, Tamar; Bar-Am, Orit; Zheng, Hailin; Fridkin, Mati; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">490-502</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Novel therapeutic approaches for the treatment of neurodegenerative disorders comprise drug candidates designed specifically to act on multiple CNS targets.  We have synthesized a multifunctional non-toxic, brain permeable iron chelator drug, M-30, possessing propargyl monoamine oxidase (MAO) inhibitory neuroprotective and iron-chelating moieties, from our prototype iron chelator VK-28.  In the present study M-30 was shown to possess a wide range of pharmacol. activities, including pro-survival neurorescue effects, induction of neuronal differentiation and regulation of amyloid precursor protein (APP) and β-amyloid (Aβ) levels.  M-30 was found to decrease apoptosis of SH-SY5Y neuroblastoma cells in a neurorescue, serum deprivation model, via redn. of the pro-apoptotic proteins Bad and Bax, and inhibition of the apoptosis-assocd. phosphorylated H2A.X protein (Ser 139) and caspase 3 activation.  In addn., M-30 induced the out-growth of neurites, triggered cell cycle arrest in G0/G1 phase and enhanced the expression of growth assocd. protein-43.  Furthermore, M-30 markedly reduced the levels of cellular APP and β-C-terminal fragment (β-CTF) and the levels of the amyloidogenic Aβ peptide in the medium of SH-SY5Y cells and Chinese hamster ovary cells stably transfected with the APP 'Swedish' mutation.  Levels of the non-amyloidogenic sol. APPα and α-CTF in the medium and cell lysate resp. were coordinately increased.  These properties, together with its brain selective MAO inhibitory and propargylamine-dependent neuroprotective effects, suggest that M-30 might serve as an ideal drug for neurodegenerative disorders, such as Parkinson's and Alzheimer's diseases, in which oxidative stress and iron dysregulation have been implicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoounFPdTCar7Vg90H21EOLACvtfcHk0ljZWiheD7ylsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFaksLo%253D&md5=cb26a3c8b8654118fbe10e7d92080413</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04258.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04258.x%26sid%3Dliteratum%253Aachs%26aulast%3DAvramovich-Tirosh%26aufirst%3DY.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DFridkin%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26atitle%3DTherapeutic%2520Targets%2520and%2520Potential%2520of%2520the%2520Novel%2520Brain%2520Permeable%2520Multifunctional%2520Iron%2520Chelator%25E2%2580%2593Monoamine%2520Oxidase%2520Inhibitor%2520Drug%252C%2520M-30%252C%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D100%26spage%3D490%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Matos, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez-Cruz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez-Rodriguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uriarte, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santana, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olea-Azar, C.</span><span> </span><span class="NLM_article-title">Remarkable Antioxidant Properties of a Series of Hydroxy-3-arylcoumarins</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3900</span><span class="NLM_x">–</span> <span class="NLM_lpage">3906</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3900-3906&author=M.+J.+Matosauthor=F.+P%C3%A9rez-Cruzauthor=S.+Vazquez-Rodriguezauthor=E.+Uriarteauthor=L.+Santanaauthor=F.+Borgesauthor=C.+Olea-Azar&title=Remarkable+Antioxidant+Properties+of+a+Series+of+Hydroxy-3-arylcoumarins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DP%25C3%25A9rez-Cruz%26aufirst%3DF.%26aulast%3DVazquez-Rodriguez%26aufirst%3DS.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DOlea-Azar%26aufirst%3DC.%26atitle%3DRemarkable%2520Antioxidant%2520Properties%2520of%2520a%2520Series%2520of%2520Hydroxy-3-arylcoumarins%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3900%26epage%3D3906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Li, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, L. Y.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of Flavonoid Derivatives as Potential Multifunctional Acetylcholinesterase Inhibitors Against Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2636</span><span class="NLM_x">–</span> <span class="NLM_lpage">2641</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=2636-2641&author=R.+S.+Liauthor=X.+B.+Wangauthor=X.+J.+Huauthor=L.+Y.+Kong&title=Design%2C+Synthesis+and+Evaluation+of+Flavonoid+Derivatives+as+Potential+Multifunctional+Acetylcholinesterase+Inhibitors+Against+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%2BS.%26aulast%3DWang%26aufirst%3DX.%2BB.%26aulast%3DHu%26aufirst%3DX.%2BJ.%26aulast%3DKong%26aufirst%3DL.%2BY.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%2520Flavonoid%2520Derivatives%2520as%2520Potential%2520Multifunctional%2520Acetylcholinesterase%2520Inhibitors%2520Against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D2636%26epage%3D2641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Huang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span> </span><span class="NLM_article-title">Multitarget-Directed Benzylideneindanone Derivatives: Anti-β-Amyloid (Aβ) Aggregation, Antioxidant, Metal Chelation, and Monoamine Oxidase B (MAO-B) Inhibition Properties against Alzheimer’s Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8483</span><span class="NLM_x">–</span> <span class="NLM_lpage">8492</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300978h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8483-8492&author=L.+Huangauthor=C.+Luauthor=Y.+Sunauthor=F.+Maoauthor=Z.+Luoauthor=T.+Suauthor=H.+Jiangauthor=W.+Shanauthor=X.+Li&title=Multitarget-Directed+Benzylideneindanone+Derivatives%3A+Anti-%CE%B2-Amyloid+%28A%CE%B2%29+Aggregation%2C+Antioxidant%2C+Metal+Chelation%2C+and+Monoamine+Oxidase+B+%28MAO-B%29+Inhibition+Properties+against+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm300978h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300978h%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DSu%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DShan%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DMultitarget-Directed%2520Benzylideneindanone%2520Derivatives%253A%2520Anti-%25CE%25B2-Amyloid%2520%2528A%25CE%25B2%2529%2520Aggregation%252C%2520Antioxidant%252C%2520Metal%2520Chelation%252C%2520and%2520Monoamine%2520Oxidase%2520B%2520%2528MAO-B%2529%2520Inhibition%2520Properties%2520against%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8483%26epage%3D8492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Youdim, M. B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Molecular Basis of Neuroprotective Activities of Rasagiline and the anti Alzheimer Drug, TV3326, [(<i>N</i>-Propargyl-(3<b>R</b>)-aminoindan-5-yl)-ethyl Methyl Carbamate]</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1023%2FA%3A1015131516649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslSkt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=555-573&author=M.+B.+H.+Youdimauthor=M.+Weinstock&title=Molecular+Basis+of+Neuroprotective+Activities+of+Rasagiline+and+the+anti+Alzheimer+Drug%2C+TV3326%2C+%5B%28N-Propargyl-%283R%29-aminoindan-5-yl%29-ethyl+Methyl+Carbamate%5D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate]</span></div><div class="casAuthors">Youdim, Moussa B. H.; Weinstock, Marta</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">555-573</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">A review.  Rasagiline (N-propargyl-1-(R)-aminoindan) is a selective, irreversible monoamine oxidase B (MAO B) inhibitor which has been developed as an anti-Parkinson drug.  In controlled monotherapy and as adjunct to L-dopa it has shown anti-Parkinson activity.  In cell culture (PC-12 and neuroblastoma SH-SY5Y cells) it exhibits neuroprotective and antiapoptotic activity against several neurotoxins (SIN-1, MPTP, 6-hydroxydopamine and N-methyl-(R)-salsolinol) and ischemia.  In vivo, it reduces the sequelae of traumatic brain injury in mice and speeds their recovery.  The neuroprotective activity of rasagaline does not result from MAO B inhibition, since its S-enantiomer, TVP1022, which has 1000-fold weaker MAO inhibitory activity, exhibits similar neuroprotective properties.  Introduction of a carbamate moiety into the rasagiline mol. to confer cholinesterase inhibitory activity for the treatment of Alzheimer's disease, resulted in compds. TV3326 [(N-Propargyl-(3R)Aminoindan-5-YL)-Et Me Carbamate] and its S-enantiomer TV3279 [(N-Propargyl-(3S)Aminoindan-5-YL)-Et Me Carbamate], which retain the neuroprotective activities of rasagiline and TVP1.022.  They also antagonize scopolamine-induced impairments in spatial memory.  In addn., TV3326 exhibits brain-selective MAO A and B inhibitory activity after chronic administration and has antidepressant-like activity in the forced swim test.  This is assocd. with an increase in brain levels of serotonin.  The antiapoptotic activity of these propargylamine-contg. derivs. may be related to their ability to delay the opening of voltage-dependent anion channels (VDAC), which are part of the mitochondrial permeability transition pore.  The propargylarnine moiety is responsible for the increase in the mitochondrial family of Bcl-2 proteins, prevention in the fall in mitochondrial membrane potential, prevention of the activation of caspase 3, and of translocation of glycerlatdehyde-3-phosphate dehydrogenase from the cytoplasm to the nucleus.  The latter processes are closely assocd. with neurotoxin-induced apoptosis.  Rasagiline interacts with and prevents the binding of PK11195 to the pro-apoptotic peripheral benzodiazepine receptor, which together with Bcl-2, hexokinase, porin, and adenine nucleotide translocator constitutes part of the VDAC.  Furthermore, rasagiline, TV3326 and TV3279 are able to influence the processing of amyloid precursor protein by activation of alpha-secretase and increasing the release of sol. alpha APP in rat PC-12 and human neuroblastoma SH-SY5Y cells and in rat and mice cortex and hippocampus.  This process has been shown to involve the upregulation of PKC and MAP kinase.  It is quite likely that the induction of Bcl-2 and activation of PKC by rasagiline and TV3326 is closely linked to the anti-apoptotic action of these drugs and their ability to process APP by activation of alpha-secretase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooLWVipqroE7Vg90H21EOLACvtfcHk0lgUOJFFWCSzNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslSkt7g%253D&md5=6069320591cce7df19a0f29f91cf6911</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015131516649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015131516649%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DMolecular%2520Basis%2520of%2520Neuroprotective%2520Activities%2520of%2520Rasagiline%2520and%2520the%2520anti%2520Alzheimer%2520Drug%252C%2520TV3326%252C%2520%255B%2528N-Propargyl-%25283R%2529-aminoindan-5-yl%2529-ethyl%2520Methyl%2520Carbamate%255D%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2002%26volume%3D21%26spage%3D555%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Anderson, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCrodden, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, K. F.</span><span> </span><span class="NLM_article-title">Monoamine Oxidase Inhibitors and the Cheese Effect</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1145</span><span class="NLM_x">–</span> <span class="NLM_lpage">1149</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1007%2FBF00978365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=8255365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADyaK2cXitlWjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1993&pages=1145-1149&author=M.+C.+Andersonauthor=F.+Hasanauthor=J.+M.+McCroddenauthor=K.+F.+Tipton&title=Monoamine+Oxidase+Inhibitors+and+the+Cheese+Effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase inhibitors and the cheese effect</span></div><div class="casAuthors">Anderson, Mary C.; Hasan, Farris; McCrodden, John M.; Tipton, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1145-9</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    </div><div class="casAbstract">The behavior of inhibitors of monoamine oxidase-A (MAO-A) is considered in terms of the possibility of having an effective antidepressant that does not give rise to hypertensive interactions with dietary tyramine.  Studies with punch-biopsy samples of human intestine and rat intestinal samples show MAO-A to be the predominant form of the enzyme in both species.  Transport studies with everted rat intestinal prepns. indicate that tyramine is extensively metabolized during transport through the intestine.  Selective inhibition of MAO-A by clorgyline results in a large increase in the amt. of unchanged tyramine transported, whereas selective inhibition of MAO-B with L-deprenyl (selegiline) has no significant effect.  The behavior of reversible MAO-A inhibitors can significantly reduce, but not entirely eliminate, these effects on the intestinal metab. of tyramine, but only if the inhibition is competitive in nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDISgk8VH-8LVg90H21EOLACvtfcHk0lgUOJFFWCSzNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlWjsQ%253D%253D&md5=e9d85b743f7fdde68276428940940cac</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1007%2FBF00978365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00978365%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DM.%2BC.%26aulast%3DHasan%26aufirst%3DF.%26aulast%3DMcCrodden%26aufirst%3DJ.%2BM.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DMonoamine%2520Oxidase%2520Inhibitors%2520and%2520the%2520Cheese%2520Effect%26jtitle%3DNeurochem.%2520Res.%26date%3D1993%26volume%3D18%26spage%3D1145%26epage%3D1149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Macdonald, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darvesh, S.</span><span> </span><span class="NLM_article-title">Cholinesterase Inhibition in Alzheimer’s Disease: Is Specificity the Answer?</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=24898642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVKns77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=379-384&author=I.+R.+Macdonaldauthor=K.+Rockwoodauthor=E.+Martinauthor=S.+Darvesh&title=Cholinesterase+Inhibition+in+Alzheimer%E2%80%99s+Disease%3A+Is+Specificity+the+Answer%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Cholinesterase Inhibition in Alzheimer's Disease: Is Specificity the Answer?</span></div><div class="casAuthors">Macdonald, Ian R.; Rockwood, Kenneth; Martin, Earl; Darvesh, Sultan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">379-384</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Cholinesterase inhibitors are the std. of care for Alzheimer's disease (AD).  Acetylcholinesterase (AChE) catalyzes the hydrolysis of the cholinergic neurotransmitter acetylcholine.  However, the related enzyme butyrylcholinesterase (BuChE) also breaks down acetylcholine and is likewise targeted by the same clin. cholinesterase inhibitors.  The lack of clin. efficacy for the highly specific and potent AChE inhibitor, (-) huperzine A, is intriguing, given the known cholinergic deficit in AD.  Based on the proven efficacy of inhibitors affecting both cholinesterases and the apparent failure of specific AChE inhibition, focused BuChE inhibition seems important for more effective treatment of AD.  Therefore, BuChE-selective inhibitors provide promise for improved benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY0L1sVpCa_7Vg90H21EOLACvtfcHk0liBy4HrXjK-VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVKns77M&md5=010bac9c291fd9c4d44e97fb5fa065f0</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacdonald%26aufirst%3DI.%2BR.%26aulast%3DRockwood%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DDarvesh%26aufirst%3DS.%26atitle%3DCholinesterase%2520Inhibition%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Is%2520Specificity%2520the%2520Answer%253F%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D42%26spage%3D379%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Greig, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Utsuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahiri, D. K.</span><span> </span><span class="NLM_article-title">A New Therapeutic Target in AD Treatment: Attention to Butyrylcholinesterase</span> <span class="citation_source-journal">Curr. Med. Res. Opin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1185%2F03007990152673800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=11900310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD38XkslSnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2001&pages=159-165&author=N.+H.+Greigauthor=T.+Utsukiauthor=Q.-S.+Yuauthor=X.+Zhuauthor=H.+W.+Hollowayauthor=T.+A.+Perryauthor=B.+Leeauthor=D.+H.+Ingramauthor=D.+K.+Lahiri&title=A+New+Therapeutic+Target+in+AD+Treatment%3A+Attention+to+Butyrylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A new therapeutic target in Alzheimer's disease treatment: Attention to butyrylcholinesterase</span></div><div class="casAuthors">Greig, Nigel H.; Utsuki, Tada; Yu, Qian-sheng; Zhu, Xiaoxiang; Holloway, Harold W.; Perry, TracyAnn; Lee, Bong; Ingram, Donald K.; Lahiri, Debomoy K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medical Research and Opinion</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-165</span>CODEN:
                <span class="NLM_cas:coden">CMROCX</span>;
        ISSN:<span class="NLM_cas:issn">0300-7995</span>.
    
            (<span class="NLM_cas:orgname">LibraPharm Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the elderly, characterized by widespread loss of central cholinergic function.  The only symptomatic treatment proven effective to date is the use of cholinesterase (ChE) inhibitors to augment surviving cholinergic activity.  ChE inhibitors act on the enzymes that hydrolyze acetylcholine (ACh) following synaptic release.  In the healthy brain, acetylcholinesterase (AChE) predominates (80%) and butyrylcholinesterase (BuChE) is considered to play a minor role in regulating brain ACh levels.  In the AD brain, BuChE activity rises while AChE activity remains unchanged or declines.  Therefore both enzymes are likely to have involvement in regulating ACh levels and represent legitimate therapeutic targets to ameliorate the cholinergic deficit.  The two enzymes differ in location, substrate specificity and kinetics.  Recent evidence suggests that BuChE may also have a role in the etiol. and progression of AD beyond regulation of synaptic ACh levels.  Exptl. evidence from the use of agents with enhanced selectivity for BuChE (cymserine, MF-8622) and ChE inhibitors such as rivastigmine, which have a dual inhibitory action on both AChE and BuChE, indicate potential therapeutic benefits of inhibiting both AChE and BuChE in AD and related dementias.  The development of specific BuChE inhibitors and the continued use of ChE inhibitors with the ability to inhibit BuChE in addn. to AChE should lead to improved clin. outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq4MokwgwULbVg90H21EOLACvtfcHk0liBy4HrXjK-VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkslSnug%253D%253D&md5=bf6513e8d8d7edd39f6b95342a238128</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1185%2F03007990152673800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1185%252F03007990152673800%26sid%3Dliteratum%253Aachs%26aulast%3DGreig%26aufirst%3DN.%2BH.%26aulast%3DUtsuki%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DQ.-S.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DHolloway%26aufirst%3DH.%2BW.%26aulast%3DPerry%26aufirst%3DT.%2BA.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DIngram%26aufirst%3DD.%2BH.%26aulast%3DLahiri%26aufirst%3DD.%2BK.%26atitle%3DA%2520New%2520Therapeutic%2520Target%2520in%2520AD%2520Treatment%253A%2520Attention%2520to%2520Butyrylcholinesterase%26jtitle%3DCurr.%2520Med.%2520Res.%2520Opin.%26date%3D2001%26volume%3D17%26spage%3D159%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Braccio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanachi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadaleta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Fine Molecular Tuning at Position 4 of 2<i>H</i>-Chromen-2-one Derivatives in the Search of Potent and Selective Monoamine Oxidase B Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=723-739&author=L.+Pisaniauthor=M.+Cattoauthor=O.+Nicolottiauthor=G.+Grossiauthor=M.+Di+Braccioauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=A.+Stefanachiauthor=D.+Gadaletaauthor=A.+Carotti&title=Fine+Molecular+Tuning+at+Position+4+of+2H-Chromen-2-one+Derivatives+in+the+Search+of+Potent+and+Selective+Monoamine+Oxidase+B+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DGrossi%26aufirst%3DG.%26aulast%3DDi%2BBraccio%26aufirst%3DM.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DGadaleta%26aufirst%3DD.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DFine%2520Molecular%2520Tuning%2520at%2520Position%25204%2520of%25202H-Chromen-2-one%2520Derivatives%2520in%2520the%2520Search%2520of%2520Potent%2520and%2520Selective%2520Monoamine%2520Oxidase%2520B%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D70%26spage%3D723%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Pisani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolotti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadaleta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Braccio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">In Silico Design of Novel 2<i>H</i>-Chromen-2-one Derivatives as Potent and Selective MAO-B Inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=98-105&author=L.+Pisaniauthor=R.+Farinaauthor=O.+Nicolottiauthor=D.+Gadaletaauthor=R.+Soto-Oteroauthor=M.+Cattoauthor=M.+Di+Braccioauthor=E.+Mendez-Alvarezauthor=A.+Carotti&title=In+Silico+Design+of+Novel+2H-Chromen-2-one+Derivatives+as+Potent+and+Selective+MAO-B+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DFarina%26aufirst%3DR.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DGadaleta%26aufirst%3DD.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DDi%2BBraccio%26aufirst%3DM.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DIn%2520Silico%2520Design%2520of%2520Novel%25202H-Chromen-2-one%2520Derivatives%2520as%2520Potent%2520and%2520Selective%2520MAO-B%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D89%26spage%3D98%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Wang, T.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzeng, C.-C.</span><span> </span><span class="NLM_article-title">Lewis Acid Catalyzed Reaction of Cinnamanilides: Competition of Intramolecular and Intermolecular Friedel–Crafts Reaction</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1055%2Fs-1997-1505" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1997&pages=87-90&author=T.-C.+Wangauthor=Y.-L.+Chenauthor=K.-H.+Leeauthor=C.-C.+Tzeng&title=Lewis+Acid+Catalyzed+Reaction+of+Cinnamanilides%3A+Competition+of+Intramolecular+and+Intermolecular+Friedel%E2%80%93Crafts+Reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1055%2Fs-1997-1505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1997-1505%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.-C.%26aulast%3DChen%26aufirst%3DY.-L.%26aulast%3DLee%26aufirst%3DK.-H.%26aulast%3DTzeng%26aufirst%3DC.-C.%26atitle%3DLewis%2520Acid%2520Catalyzed%2520Reaction%2520of%2520Cinnamanilides%253A%2520Competition%2520of%2520Intramolecular%2520and%2520Intermolecular%2520Friedel%25E2%2580%2593Crafts%2520Reaction%26jtitle%3DSynthesis%26date%3D1997%26volume%3D9%26spage%3D87%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Ellman, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, V.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feartherstone, R. M.</span><span> </span><span class="NLM_article-title">A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Feartherstone&title=A+New+and+Rapid+Colorimetric+Determination+of+Acetylcholinesterase+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0liaAx77lpQ-3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeartherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520New%2520and%2520Rapid%2520Colorimetric%2520Determination%2520of%2520Acetylcholinesterase%2520Activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Novaroli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reist, M.</span><span> </span><span class="NLM_article-title">Impact of Species-Dependent Differences on Screening, Design, and Development of MAO-B Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6264</span><span class="NLM_x">–</span> <span class="NLM_lpage">6272</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060441e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6264-6272&author=L.+Novaroliauthor=A.+Dainaauthor=E.+Favreauthor=J.+Bravoauthor=A.+Carottiauthor=F.+Leonettiauthor=M.+Cattoauthor=P.-A.+Carruptauthor=M.+Reist&title=Impact+of+Species-Dependent+Differences+on+Screening%2C+Design%2C+and+Development+of+MAO-B+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm060441e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060441e%26sid%3Dliteratum%253Aachs%26aulast%3DNovaroli%26aufirst%3DL.%26aulast%3DDaina%26aufirst%3DA.%26aulast%3DFavre%26aufirst%3DE.%26aulast%3DBravo%26aufirst%3DJ.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DReist%26aufirst%3DM.%26atitle%3DImpact%2520of%2520Species-Dependent%2520Differences%2520on%2520Screening%252C%2520Design%252C%2520and%2520Development%2520of%2520MAO-B%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6264%26epage%3D6272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Denizot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, R.</span><span> </span><span class="NLM_article-title">Rapid Colorimetric Assay for Cell Growth and Survival. Modifications to the Tetrazolium Dye Procedure Giving Improved Sensitivity and Reliability</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2F0022-1759%2886%2990368-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=3486233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1986&pages=271-277&author=F.+Denizotauthor=R.+Lang&title=Rapid+Colorimetric+Assay+for+Cell+Growth+and+Survival.+Modifications+to+the+Tetrazolium+Dye+Procedure+Giving+Improved+Sensitivity+and+Reliability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability</span></div><div class="casAuthors">Denizot F; Lang R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunological methods</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">271-7</span>
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A convenient way to estimate the number of viable cells growing in microtitre tray wells is to use a colorimetric assay and an automatic microplate scanning spectrophotometer.  One such assay, developed by Mosmann, depends on the reduction by living cells of tetrazolium salt, MTT, to form a blue formazan product.  However the original technique has several technical limitations, namely a less than optimal sensitivity, a variable background due to protein precipitation on adding an organic solvent to dissolve the blue formazan product, and a low solubility of the product.  These problems have been overcome by the following modifications: avoidance of serum in the incubation medium, thus overcoming precipitation problems in the organic solvent; avoidance of phenol red in the incubation medium, thus avoiding the use of acid in the final solvent which altered the spectral properties of the formazan; elimination of the medium containing MTT after the reaction and subsequent use of pure propanol or ethanol to rapidly solubilize the formazan; use of a higher concentration of MTT; use of half-area microtitre trays to increase the spectrophotometer readings from a given amount of formazan; use of a more judicious reference wavelength in a dual wavelength spectrophotometer.  With these modifications the reliability and sensitivity of the test have been increased to the point where it can in many cases replace the [3H]thymidine uptake assay to measure cell proliferation or survival in growth factor or cytotoxicity assays.  Examples of its use in IL-2 assays are given.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRpURYu5ihmxO98rul4nhSdfW6udTcc2ebO3OxmviEC_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL287psl2jsA%253D%253D&md5=9e5506f28a0b29b20046b7e21bb5527e</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2886%2990368-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252886%252990368-6%26sid%3Dliteratum%253Aachs%26aulast%3DDenizot%26aufirst%3DF.%26aulast%3DLang%26aufirst%3DR.%26atitle%3DRapid%2520Colorimetric%2520Assay%2520for%2520Cell%2520Growth%2520and%2520Survival.%2520Modifications%2520to%2520the%2520Tetrazolium%2520Dye%2520Procedure%2520Giving%2520Improved%2520Sensitivity%2520and%2520Reliability%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1986%26volume%3D89%26spage%3D271%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Verdonk, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. D.</span><span> </span><span class="NLM_article-title">Improved Protein–Ligand Docking Using GOLD</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">623</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=609-623&author=M.+L.+Verdonkauthor=J.+C.+Coleauthor=M.+J.+Hartshornauthor=C.+W.+Murrayauthor=R.+D.+Taylor&title=Improved+Protein%E2%80%93Ligand+Docking+Using+GOLD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerdonk%26aufirst%3DM.%2BL.%26aulast%3DCole%26aufirst%3DJ.%2BC.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DTaylor%26aufirst%3DR.%2BD.%26atitle%3DImproved%2520Protein%25E2%2580%2593Ligand%2520Docking%2520Using%2520GOLD%26jtitle%3DProteins%26date%3D2003%26volume%3D52%26spage%3D609%26epage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Liao, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, J.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, R.-B.</span><span> </span><span class="NLM_article-title">The Multiple Roles of Histidine in Protein Interactions</span> <span class="citation_source-journal">Chem. Cent. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1186%2F1752-153X-7-44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23452343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVKkt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=44&author=S.-M.+Liaoauthor=Q.-S.+Duauthor=J.-Z.+Mengauthor=Z.-W.+Pangauthor=R.-B.+Huang&title=The+Multiple+Roles+of+Histidine+in+Protein+Interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The multiple roles of histidine in protein interactions</span></div><div class="casAuthors">Liao, Si-Ming; Du, Qi-Shi; Meng, Jian-Zong; Pang, Zong-Wen; Huang, Ri-Bo</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry Central Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">CCJHA2</span>;
        ISSN:<span class="NLM_cas:issn">1752-153X</span>.
    
            (<span class="NLM_cas:orgname">Chemistry Central Ltd.</span>)
        </div><div class="casAbstract">Background: Among the 20 natural amino acids histidine is the most active and versatile member that plays the multiple roles in protein interactions, often the key residue in enzyme catalytic reactions.  A theor. and comprehensive study on the structural features and interaction properties of histidine is certainly helpful.  Results: Four interaction types of histidine are quant. calcd., including: (1) Cation-π interactions, in which the histidine acts as the arom. π-motif in neutral form (His), or plays the cation role in protonated form (His+); (2) π-π stacking interactions between histidine and other arom. amino acids; (3) Hydrogen-π interactions between histidine and other arom. amino acids; (4) Coordinate interactions between histidine and metallic cations.  The energies of π-π stacking interactions and hydrogen-π interactions are calcd. using CCSD/6-31+G(d,p).  The energies of cation-π interactions and coordinate interactions are calcd. using B3LYP/6-31+G(d,p) method and adjusted by empirical method for dispersion energy.  Conclusions: The coordinate interactions between histidine and metallic cations are the strongest one acting in broad range, followed by the cation-π, hydrogen-π, and π-π stacking interactions.  When the histidine is in neutral form, the cation-π interactions are attractive; when it is protonated (His+), the interactions turn to repulsive.  The two protonation forms (and pKa values) of histidine are reversibly switched by the attractive and repulsive cation-π interactions.  In proteins the π-π stacking interaction between neutral histidine and arom. amino acids (Phe, Tyr, Trp) are in the range from -3.0 to -4.0 kcal/mol, significantly larger than the van der Waals energies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkXNwq2c1K9LVg90H21EOLACvtfcHk0liaAx77lpQ-3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVKkt70%253D&md5=7e59a381a12431be19c6f251ee1ecf5a</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1186%2F1752-153X-7-44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1752-153X-7-44%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DS.-M.%26aulast%3DDu%26aufirst%3DQ.-S.%26aulast%3DMeng%26aufirst%3DJ.-Z.%26aulast%3DPang%26aufirst%3DZ.-W.%26aulast%3DHuang%26aufirst%3DR.-B.%26atitle%3DThe%2520Multiple%2520Roles%2520of%2520Histidine%2520in%2520Protein%2520Interactions%26jtitle%3DChem.%2520Cent.%2520J.%26date%3D2013%26volume%3D7%26spage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquintana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopedota, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latrofa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, G.</span><span> </span><span class="NLM_article-title">Translocator Protein (TSPO) Ligand–Ara-C (Cytarabine) Conjugates as a Strategy to Deliver Antineoplastic Drugs and to Enhance Drug Clinical Potential</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2255</span><span class="NLM_x">–</span> <span class="NLM_lpage">2269</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp100235w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyks7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=2255-2269&author=N.+Denoraauthor=V.+Laquintanaauthor=A.+Trapaniauthor=A.+Lopedotaauthor=A.+Latrofaauthor=J.+M.+Galloauthor=G.+Trapani&title=Translocator+Protein+%28TSPO%29+Ligand%E2%80%93Ara-C+%28Cytarabine%29+Conjugates+as+a+Strategy+to+Deliver+Antineoplastic+Drugs+and+to+Enhance+Drug+Clinical+Potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Translocator Protein (TSPO) Ligand-Ara-C (Cytarabine) Conjugates as a Strategy To Deliver Antineoplastic Drugs and To Enhance Drug Clinical Potential</span></div><div class="casAuthors">Denora, Nunzio; Laquintana, Valentino; Trapani, Adriana; Lopedota, Angela; Latrofa, Andrea; Gallo, James M.; Trapani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2255-2269</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The aim of this work was to evaluate TSPO ligand-Ara-C conjugation as an approach for the selective delivery of the antineoplastic agent to brain tumors as well as for overcome P-gp resistance induction obsd. for the majority of cytotoxic agents, enhancing the drug clin. potential.  To this end, novel N-imidazopyridinacetyl-Ara-C conjugates have been prepd. and evaluated for their cytotoxicity against glioma cell lines.  Conjugate (I) resulted stable in both phosphate buffer and physiol. medium.  In all cases, the release of free Ara-C from hydrolyzed conjugates was checked by HPLC and ESI-MS anal.  Conjugates (II) and I displayed very high in vitro TSPO affinity and selectivity, and, hence, they may possess potential for targeted brain delivery.  Due to the favorable features displayed by the conjugate I, it was further evaluated on glioma cell lines, expressing high levels of TSPO, in the presence and in the absence of specific nucleoside transport (NT) inhibitors.  In contrast to that obsd. for the free Ara-C, the presence of NT inhibitors did not reduce the cytotoxic activity of I.  Moreover, conjugate I, as N4-acyl deriv. of Ara-C, should be resistant to inactivation by cytidine deaminase, and it may possess enhanced propensity to target brain tumor cells characterized by a reduced expression of NTs.  In addn., this conjugate behaves as a clear P-gp modulator and thereby may be useful to reverse MDR.  Transport studies across the MDCKII-MDR1 monolayer indicated that conjugate I should overcome the BBB by transcellular pathway.  All these features may be useful for enhancing the clin. potential of the nucleoside drug Ara-C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlPSCWV14q97Vg90H21EOLACvtfcHk0lhTQ41lDZ4asA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyks7nJ&md5=97dfb1bb26e96783537794143c661363</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fmp100235w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp100235w%26sid%3Dliteratum%253Aachs%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DLaquintana%26aufirst%3DV.%26aulast%3DTrapani%26aufirst%3DA.%26aulast%3DLopedota%26aufirst%3DA.%26aulast%3DLatrofa%26aufirst%3DA.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26aulast%3DTrapani%26aufirst%3DG.%26atitle%3DTranslocator%2520Protein%2520%2528TSPO%2529%2520Ligand%25E2%2580%2593Ara-C%2520%2528Cytarabine%2529%2520Conjugates%2520as%2520a%2520Strategy%2520to%2520Deliver%2520Antineoplastic%2520Drugs%2520and%2520to%2520Enhance%2520Drug%2520Clinical%2520Potential%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2010%26volume%3D7%26spage%3D2255%26epage%3D2269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pérez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casanueva, O. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, J.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase Accelerates Assembly of Amyloid-Beta-Peptides into Alzheimer’s Fibrils: Possible Role of the Peripheral Site of the Enzyme</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=881-891&author=N.+C.+Inestrosaauthor=A.+Alvarezauthor=C.+A.+P%C3%A9rezauthor=R.+D.+Morenoauthor=M.+Vicenteauthor=C.+Linkerauthor=O.+I.+Casanuevaauthor=C.+Sotoauthor=J.+Garrido&title=Acetylcholinesterase+Accelerates+Assembly+of+Amyloid-Beta-Peptides+into+Alzheimer%E2%80%99s+Fibrils%3A+Possible+Role+of+the+Peripheral+Site+of+the+Enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%2BA.%26aulast%3DMoreno%26aufirst%3DR.%2BD.%26aulast%3DVicente%26aufirst%3DM.%26aulast%3DLinker%26aufirst%3DC.%26aulast%3DCasanueva%26aufirst%3DO.%2BI.%26aulast%3DSoto%26aufirst%3DC.%26aulast%3DGarrido%26aufirst%3DJ.%26atitle%3DAcetylcholinesterase%2520Accelerates%2520Assembly%2520of%2520Amyloid-Beta-Peptides%2520into%2520Alzheimer%25E2%2580%2599s%2520Fibrils%253A%2520Possible%2520Role%2520of%2520the%2520Peripheral%2520Site%2520of%2520the%2520Enzyme%26jtitle%3DNeuron%26date%3D1996%26volume%3D16%26spage%3D881%26epage%3D891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Galdeano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arroyo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blas, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muñoz-Torrero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Structural Determinants of the Multifunctional Profile of Dual Binding Site Acetylcholinesterase Inhibitors as Anti-Alzheimer Agents</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2818</span><span class="NLM_x">–</span> <span class="NLM_lpage">2836</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.2174%2F138161210793176536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=20698824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Kit7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2818-2836&author=C.+Galdeanoauthor=E.+Viaynaauthor=P.+Arroyoauthor=A.+Bidon-Chanalauthor=J.+R.+Blasauthor=D.+Mu%C3%B1oz-Torreroauthor=F.+J.+Luque&title=Structural+Determinants+of+the+Multifunctional+Profile+of+Dual+Binding+Site+Acetylcholinesterase+Inhibitors+as+Anti-Alzheimer+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents</span></div><div class="casAuthors">Galdeano, Carles; Viayna, Elisabet; Arroyo, Pau; Bidon-Chanal, Axel; Blas, J. Ramon; Munoz-Torrero, Diego; Luque, F. Javier</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2818-2836</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Dual binding site acetylcholinesterase inhibitors have recently emerged as a new class of anti-Alzheimer agents with potential to pos. modify the course of the disease.  These compds. exhibit a multifunctional pharmacol. profile arising from interaction with several biol. targets involved upstream and downstream in the neurodegenerative cascade of Alzheimer's disease (AD).  The primary target of these compds. is the enzyme acetylcholinesterase (AChE).  Interaction of dual binding site AChE inhibitors with AChE results in a potent inhibitory activity of AChE and AChE-induced β-amyloid peptide (Aβ) aggregation.  Some dual binding site AChE inhibitors take on added value a significant ability to addnl. inhibit the enzymes butyrylcholinesterase and BACE-1, involved in the co-regulation of the hydrolysis of the neurotransmitter acetylcholine and in Aβ formation, resp.  The structural determinants which mediate the interaction of dual binding site AChE inhibitors with these three important enzymes for AD treatment are herein reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo457mAEj15dLVg90H21EOLACvtfcHk0lhTQ41lDZ4asA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Kit7zN&md5=ab536e0a9ac6d65de266e014592ddeb0</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.2174%2F138161210793176536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210793176536%26sid%3Dliteratum%253Aachs%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DArroyo%26aufirst%3DP.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DBlas%26aufirst%3DJ.%2BR.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DStructural%2520Determinants%2520of%2520the%2520Multifunctional%2520Profile%2520of%2520Dual%2520Binding%2520Site%2520Acetylcholinesterase%2520Inhibitors%2520as%2520Anti-Alzheimer%2520Agents%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D2818%26epage%3D2836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Denora, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquintana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopalco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimmino, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laconca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuffrida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapani, G.</span><span> </span><span class="NLM_article-title">Novel Codrugs with GABAergic Activity for Dopamine Delivery in the Brain</span> <span class="citation_source-journal">Int. J. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">437</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1016%2Fj.ijpharm.2012.08.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=22940209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlaiurnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=437&publication_year=2012&pages=221-231&author=N.+Denoraauthor=T.+Cassanoauthor=V.+Laquintanaauthor=A.+Lopalcoauthor=A.+Trapaniauthor=C.+S.+Cimminoauthor=L.+Laconcaauthor=A.+Giuffridaauthor=G.+Trapani&title=Novel+Codrugs+with+GABAergic+Activity+for+Dopamine+Delivery+in+the+Brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Novel codrugs with GABAergic activity for dopamine delivery in the brain</span></div><div class="casAuthors">Denora, Nunzio; Cassano, Tommaso; Laquintana, Valentino; Lopalco, Antonio; Trapani, Adriana; Cimmino, Concetta Stefania; Laconca, Leonardo; Giuffrida, Andrea; Trapani, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">437</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">221-231</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This study investigates the use of codrugs of the GABAergic agent 2-phenyl-imidazo[1,2-a]pyridinacetamide and dopamine (DA) or Et ester L-Dopa (LD) as a strategy to deliver DA and simultaneously activate GABA-receptors in the brain.  For this purpose, both DA and LD Et ester were linked by carbamate bond to imidazo[1,2-a]pyridine acetamide moieties to yield two DA- and two LD-imidazopyridine derivs.  These compds. were evaluated in vitro to assess their stability, binding affinities and cell membrane transport, and in vivo to assess their bio-availability via microdialysis studies.  The two DA derivs. were adequately stable in buffered soln., but underwent cleavage in dild. human serum.  By contrast, the LD derivs. were unstable in buffered soln.  Receptor binding studies showed that the DA-imidazopyridine carbamates had binding affinity for benzodiazepine receptors in the nanomolar range.  Brain microdialysis expts. indicated that i.p. administration of the DA derivs. sustained DA levels in rat striatum over a 4-h period.  These results suggest that DA-imidazopyridine carbamates are new DA codrugs with potential application for DA replacement therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2ZywfNEZEqbVg90H21EOLACvtfcHk0lhTQ41lDZ4asA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlaiurnP&md5=fb9f8c41492bfccc09a24dd20b659b90</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2012.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2012.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DCassano%26aufirst%3DT.%26aulast%3DLaquintana%26aufirst%3DV.%26aulast%3DLopalco%26aufirst%3DA.%26aulast%3DTrapani%26aufirst%3DA.%26aulast%3DCimmino%26aufirst%3DC.%2BS.%26aulast%3DLaconca%26aufirst%3DL.%26aulast%3DGiuffrida%26aufirst%3DA.%26aulast%3DTrapani%26aufirst%3DG.%26atitle%3DNovel%2520Codrugs%2520with%2520GABAergic%2520Activity%2520for%2520Dopamine%2520Delivery%2520in%2520the%2520Brain%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2012%26volume%3D437%26spage%3D221%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Fringuelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piermatti, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzo, F.</span><span> </span><span class="NLM_article-title">One-pot Synthesis of 3-Carboxycoumarins via Consecutive Knoevenagel–Pinner Reactions in Water</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2331</span><span class="NLM_x">–</span> <span class="NLM_lpage">2334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=2331-2334&author=F.+Fringuelliauthor=O.+Piermattiauthor=F.+Pizzo&title=One-pot+Synthesis+of+3-Carboxycoumarins+via+Consecutive+Knoevenagel%E2%80%93Pinner+Reactions+in+Water"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFringuelli%26aufirst%3DF.%26aulast%3DPiermatti%26aufirst%3DO.%26aulast%3DPizzo%26aufirst%3DF.%26atitle%3DOne-pot%2520Synthesis%2520of%25203-Carboxycoumarins%2520via%2520Consecutive%2520Knoevenagel%25E2%2580%2593Pinner%2520Reactions%2520in%2520Water%26jtitle%3DSynthesis%26date%3D2003%26volume%3D15%26spage%3D2331%26epage%3D2334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span> </span><span class="NLM_article-title">Cholinesterase inhibitors: SAR and Enzyme Inhibitory Activity of 3-[ω-(Benzylmethylamino)alkoxy]xanthen-9-ones</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=575-585&author=L.+Piazziauthor=F.+Bellutiauthor=A.+Bisiauthor=S.+Gobbiauthor=S.+Rizzoauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=M.+Recanatiniauthor=A.+Rampa&title=Cholinesterase+inhibitors%3A+SAR+and+Enzyme+Inhibitory+Activity+of+3-%5B%CF%89-%28Benzylmethylamino%29alkoxy%5Dxanthen-9-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DRizzo%26aufirst%3DS.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DCholinesterase%2520inhibitors%253A%2520SAR%2520and%2520Enzyme%2520Inhibitory%2520Activity%2520of%25203-%255B%25CF%2589-%2528Benzylmethylamino%2529alkoxy%255Dxanthen-9-ones%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D575%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Kumpaty, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharyya, S.</span><span> </span><span class="NLM_article-title">Synthesis of <i>N</i>-Methyl Secondary Amines</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1411</span><span class="NLM_x">–</span> <span class="NLM_lpage">1416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1081%2FSCC-120018703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjslOntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=1411-1416&author=H.+J.+Kumpatyauthor=J.+S.+Williamsonauthor=S.+Bhattacharyya&title=Synthesis+of+N-Methyl+Secondary+Amines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of N-methyl secondary amines</span></div><div class="casAuthors">Kumpaty, Hephzibah J.; Williamson, John S.; Bhattacharyya, Sukanta</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1411-1416</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A diverse set of N-Me secondary amines are obtained in high yields by an expedient reductive alkylation of com. available methanolic methylamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_a3rEkjrXU7Vg90H21EOLACvtfcHk0liNmaFYnphkDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjslOntLY%253D&md5=5faafb68f1fc784b62ace3a661a1e728</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1081%2FSCC-120018703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FSCC-120018703%26sid%3Dliteratum%253Aachs%26aulast%3DKumpaty%26aufirst%3DH.%2BJ.%26aulast%3DWilliamson%26aufirst%3DJ.%2BS.%26aulast%3DBhattacharyya%26aufirst%3DS.%26atitle%3DSynthesis%2520of%2520N-Methyl%2520Secondary%2520Amines%26jtitle%3DSynth.%2520Commun.%26date%3D2003%26volume%3D33%26spage%3D1411%26epage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Mendez-Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soto-Otero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Sellero, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Rivadulla, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamas, M.</span><span> </span><span class="NLM_article-title">Inhibition of Brain Monoamine Oxidase by Adducts of 1,2,3,4-Tetrahydroisoquinoline with Components of Cigarette Smoke</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">–</span> <span class="NLM_lpage">1727</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1997&pages=1719-1727&author=E.+Mendez-Alvarezauthor=R.+Soto-Oteroauthor=I.+Sanchez-Selleroauthor=L.+M.+Lopez-Rivadullaauthor=M.+Lamas&title=Inhibition+of+Brain+Monoamine+Oxidase+by+Adducts+of+1%2C2%2C3%2C4-Tetrahydroisoquinoline+with+Components+of+Cigarette+Smoke"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DSanchez-Sellero%26aufirst%3DI.%26aulast%3DLopez-Rivadulla%26aufirst%3DL.%2BM.%26aulast%3DLamas%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520Brain%2520Monoamine%2520Oxidase%2520by%2520Adducts%2520of%25201%252C2%252C3%252C4-Tetrahydroisoquinoline%2520with%2520Components%2520of%2520Cigarette%2520Smoke%26jtitle%3DLife%2520Sci.%26date%3D1997%26volume%3D60%26spage%3D1719%26epage%3D1727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Sastry, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adzhigirey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annabhimoju, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span> </span><span class="NLM_article-title">Protein and Ligand Preparation: Parameters, Protocols, and Influence on Virtual Screening Enrichments</span> <span class="citation_source-journal">J. Comput.- Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;key=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+M.+Sastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+Ligand+Preparation%3A+Parameters%2C+Protocols%2C+and+Influence+on+Virtual+Screening+Enrichments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Sastry G Madhavi; Adzhigirey Matvey; Day Tyler; Annabhimoju Ramakrishna; Sherman Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of computer-aided molecular design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepared prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove atomic clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addition, ligands must be prepared to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system preparation is generally accepted in the field, an extensive study of the preparation steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in preparing a system for virtual screening.  We first explore a large number of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper preparation and that neglecting certain steps of the preparation process produces a systematic degradation in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the preparation that impact database enrichment.  While the work presented here was performed with the Protein Preparation Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQd2Qiai-OqeXqj_yg7twvpfW6udTcc2eZYJDlovZ3mJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D&md5=9eb1a820e121aca2742ed53f24481ace</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DG.%2BM.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520Ligand%2520Preparation%253A%2520Parameters%252C%2520Protocols%252C%2520and%2520Influence%2520on%2520Virtual%2520Screening%2520Enrichments%26jtitle%3DJ.%2520Comput.-%2520Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EVE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1EVE','PDB','1EVE'); return false;">PDB: 1EVE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EY7','PDB','4EY7'); return false;">PDB: 4EY7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V60" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2V60','PDB','2V60'); return false;">PDB: 2V60</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i37"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00599">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_07235"></div></div></div></div></div><hr /></hr><p class="last">Analytical and spectroscopic (<sup>1</sup>H NMR) data for intermediates <b>1a</b>–<b>k</b> and final compounds <b>2</b>–<b>40</b>, <b>42</b>, <b>43</b>, and <b>45</b> (PDF); SMILES data (CSV). The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b00599">10.1021/acs.jmedchem.5b00599</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00599/suppl_file/jm5b00599_si_001.pdf">jm5b00599_si_001.pdf (196.71 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00599/suppl_file/jm5b00599_si_002.csv">jm5b00599_si_002.csv (2.43 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00599&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-14%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00599" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00599" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991f170e1e24bb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
